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Abstract 
 
“When gaining is loosing: insights into the function of ataxin-3 in neurons and its 
perturbation in the context of Machado-Joseph Disease” 
 
Ataxin-3 (ATXN3) is the protein involved in Machado-Joseph Disease (MJD), one of the nine 
neurodegenerative disorders known to be caused by a polyglutamine (polyQ) expansion. This polyQ 
tract causes the appearance of misfolded protein species, protein aggregates, neuronal dysfunction 
and cell death. ATXN3 is known to interact with polyubiquitin chains and to have deubiquitylating 
(DUB) activity in vitro, but its substrates and its cellular and physiological role(s) remain unknown, 
specially in neurons. Since the leading hypothesis concerning the pathogenesis of MJD is that the 
expanded polyQ tract confers a toxic gain of function of ATXN3, not much attention has been 
dedicated to its normal function. However, it is believed that a partial loss of the normal function of 
ATXN3 may also contribute to and modulate disease progression. 
This study was based on the idea that understanding the normal physiological role of ATXN3 
will be of relevance for our understanding of the pathogenesis of MJD.  
In this work, we explored the function of ATXN3 in neuronal cells and its perturbation in the 
context of MJD. We found that ATXN3 is required for neuronal differentiation and for normal cellular 
morphology, cytoskeleton organization, proliferation and survival. This phenotype is associated with 
increased proteasomal degradation of alpha5-integrin subunit (ITGA5) and reduced activation of 
integrin signaling. Interestingly, we show that silencing of ATXN3, overexpression of a catalytically 
inert version of the protein or a mutant protein bearing an expanded polyQ tract led to partially 
overlapping phenotypes, suggesting that a loss of the neuronal function of ATXN3 may be 
contributing to neurodegeneration.  
Consistent with a wider role of ATXN3 in the regulation of the cytoskeleton network, we 
found that loss of function of ATXN3 also leads to a deregulation of tau expression, namely a 
deregulation of tau exon 10 splicing. This event has a negative impact in neuronal morphology and 
differentiation. Additionally, we found that ATXN3 interacts with SFRS7, a regulator of tau splicing, 
and regulates its ubiquitylation levels. As similar alterations were found in the brain of a mouse 
model of MJD, it is likely that this mechanism is contributing to pathogenesis of this disorder. 
Hence, this work establishes for the first time a functional link between two key proteins involved in 
different neurodegenerative diseases. 
  xiv 
Lastly, we characterized the ubiquitome of neuronal cells lacking ATXN3 in an attempt to 
identify potential substrates of its DUB activity. We found that a large proportion of these proteins 
were involved in RNA post-transcriptional modification. Considering this, we analyzed by 
transcriptomic analysis and using reporter minigenes the global splicing pattern in neuronal cells 
upon silencing of ATXN3 and found that splicing was globally altered in these cells. These findings 
lead us to propose for the first time that ATXN3 plays a role in splicing regulation in neurons, a novel 
function for this protein. 
In summary, this work adds new knowledge about the relevance for neurons of one specific 
DUB, ataxin-3, and provides new clues about its biological functions and the pathways in which it is 
involved. It reinforces ATXN3’s involvement with the UPP and it also raises new hypotheses for its 
role in cytoskeleton organization and in splicing regulation. Additionally, it provides evidence for 
perturbation of the normal function of ATXN3 in the context of disease, through a dominant negative 
effect, which may have relevance for the development of future therapeutical strategies.  
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Resumo 
 
“Quando ganhar é perder: estudo da função da ataxina-3 e a sua perturbação no 
contexto da Doença de Machado-Joseph” 
 
A Ataxina-3 (ATXN3) é a proteína envolvida na Doença de Machado-Joseph (DMJ), uma das 
nove doenças neurodegenerativas que se sabe serem causadas por uma expansão de 
poliglutaminas (poliQ). Este trato de poliQ causa o aparecimento de espécies proteicas com uma 
conformação anormal, agregados proteicos, disfunção neuronal e morte celular. A ATXN3 interage 
com cadeias de poliubiquitina e tem atividade de ubiquitina hidrolase (DUB) in vitro, mas os seus 
substratos e a(s) sua(s) função(ões) fisiológica(s) permanecem desconhecidos, especialmente em 
neurónios. Dado que a hipótese actualmente mais aceite relativa ao mecanismo patogénico da DMJ 
considera que o trato de poliQ expandido confere um ganho tóxico de função à ATXN3, não tem sido 
dedicada muita atenção à sua função normal. Contudo, acredita-se que a perda parcial da função 
normal da ATXN3 também pode contribuir e modular a progressão da doença. 
 Este estudo baseou-se na ideia de que conhecer a função fisiológica normal da ATXN3 será 
relevante para conseguirmos compreender a patogénese da doença. 
 Neste estudo, explorámos a função da ATXN3 em neurónios e a sua perturbação pela 
expansão poliQ em DMJ. Descobrimos que a ATXN3 é necessária para a diferenciação neuronal e 
para a normal morfologia celular, organização do citosqueleto, proliferação e sobrevivência. Este 
fenótipo está associado a um aumento da degradação da subunidade 5-alpha da integrina (ITGA5) 
pelo proteossoma e uma ativação diminuída da sinalização pela via das integrinas. Curiosamente, 
demonstrámos que o silenciamento da ATXN3, a sobre-expressão de uma versão cataliticamente 
inerte da proteína ou de uma proteína mutante contendo um trato de poliQ expandido conduzem a 
fenótipos parcialmente sobreponíveis, sugerindo que a perda da função neuronal da ATXN3 pode 
contribuir para a neurodegeneração. 
 De forma consistente com um papel mais abrangente da ATXN3 na regulação da 
organização do citosqueleto, descobrimos que a perda de função da ATXN3 também origina uma 
desregulação da expressão da tau, nomeadamente uma desregulação do splicing do exão 10 da tau 
em células neuronais. Este evento tem um impacto negativo na sua morfologia e diferenciação. 
Além disso, descobrimos que a ATXN3 interage com o SFRS7, um factor regulador do splicing da 
tau, e regula os seus níveis de ubiquitilação. Considerando que alterações semelhantes foram 
  xvi 
encontradas no cérebro do modelo de DMJ em ratinho, este mecanismo parece contribuir para a 
patogénese. Este trabalho estabelece assim, pela primeira vez, uma ligação funcional entre duas 
proteínas chave envolvidas em diferentes doenças neurodegenerativas. 
 Por fim, caracterizámos o ubiquitoma de células neuronais silenciadas para a ATXN3, com 
o objectivo de identificar potenciais candidatos para a sua atividade DUB. Concluímos que uma 
grande proporção destas proteínas estão envolvidas na modificação pós-transcripcional do RNA. 
Tendo este dado em consideração, analisámos o padrão global do splicing por análises de 
transcriptómica e usando minigenes repórteres, e descobrimos que o splicing estava globalmente 
afetado nestas células. Estes achados levaram-nos a propor pela primeira vez que a ATXN3 
desempenha um papel na regulação do splicing em neurónios, uma nova função para esta proteína. 
 Em sumário, este trabalho amplia o conhecimento acerca da relevância para os neurónios 
de uma DUB específica, a ataxina-3, e fornece indicativos sobre as suas funções biológicas e as vias 
celulares onde está envolvida. Além disso, reforça o envolvimento da ATXN3 com a UPP, levantando 
também novas hipóteses para o seu papel na regulação do citosqueleto e na regulação do splicing. 
Adicionalmente, são apresentadas evidências para a perturbação da função normal da ATXN3 no 
contexto da doença através de um efeito dominante negativo, facto que poderá ser relevante para o 
desenvolvimento de futuras estratégias terapêuticas.  
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Thesis planning 
 
The present dissertation is organized in five different chapters. Chapter 1 is the General 
Introduction, the experimental work is presented in Chapter 2 to 4 in the shape of research articles 
(published and in preparation) and Chapter 5 is the General Discussion of the work. 
 
In chapter 1, a general introduction to the theme of this dissertation is provided. An 
overview of the Ubiquitin proteasome system (UPS) and its components is given, concerning its role 
in the neuronal function. Some considerations about the involvement of the UPS in 
neurodegenerative disorders are also made. Then, an extensive presentation is provided about 
Machado-Joseph disease (MJD) and ataxin-3 (ATXN3), the protein involved in this disorder. At the 
end, there is a compilation of the available evidence concerning the function of ATXN3 in cells, 
ranging from in vitro studies to known protein interactors. A brief description of pathways in which 
ATXN3 is thought to be involved is also provided. 
 
In chapter 2, the work “Dominant negative effect of polyglutamine expansion perturbs 
normal function of ataxin-3 in neuronal cells” shows that loss of function of ATXN3 has a negative 
impact on neuronal differentiation and deregulates proteasome degradation of alpha-5 integrin 
subunit, leading to decreased cell adhesion and disorganization of neuronal cytoskeleton. In this 
study we also present evidence suggesting a partial loss of this function of ataxin-3 in the context of 
MJD. 
 
Chapter 3, “Perturbation of ATXN3 function leads to Tau splicing deregulation and 
contributes to Machado-Joseph disease” focuses on the role of ATXN3 in the regulation of the 
neuronal cytoskeleton network, extending our knowledge of ATXN3 function. We show that depletion 
of ATXN3 in SH-SY5Y cells leads to a deregulation of tau exon 10 splicing, perturbing the 3R/4R tau 
ratio, a mechanism that seems to contribute for MJD pathogenesis. 
 
Chapter 4, “Loss of function of ATXN3 alters the ubiquitome of neuronal cells, negatively 
impacting on the splicing process” presents an exploratory work regarding the identification of 
candidate targets of ATXN3’s DUB activity. These potential substrates were searched using the  
  xxiv 
Tandem ubiquitin binding entities (TUBEs) system combined with mass spectrometry. We present 
data indicating that ATXN3 might be regulating RNA transport and processing in neurons, a 
hypothesis that we validated using reporter minigenes and transcriptomic analysis. 
 
The General Discussion of the dissertation, as well as the Future Perspectives, are presented in 
Chapter 5. 
 
Two appendices are included in this thesis; appendix 1 corresponds to the list of primers used in 
this work. Appendix 2 shows a list of the splicing factors with altered expression in ATXN3 knockdwn 
cells and the predicted upstream regulators of these factors. 
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1.1 The Ubiquitin-proteasome system 
The UPS is a highly conserved intracellular pathway for degradation of proteins [1]. The 26S 
proteasomes, localized both in the cytoplasm and in the nucleus [1, 2], are essential for cell quality 
control by eliminating defective proteins, and for regulation of fundamental cellular processes by 
rapid destruction of key proteins (Reviewed in [3]). More recently, the UPS has also emerged as a 
crucial mechanism in the regulation of many physiological functions of the nervous system 
(Reviewed in [4, 5]).  
Proteolysis by the UPS is highly regulated and precise: only selectively polyubiquitylated proteins are 
degraded by the proteasome, at the expense of ATP [6]. However, ubiquitylation of a substrate fated 
to be degraded can be reversed by deubiquitylating enzymes (DUBs). 
 
1.1.1 Roles of the ubiquitin signaling 
In all tissues, the UPS and the ubiquitin signaling play crucial roles in regulating the levels 
and/or the fate or localization of proteins acting in several basal processes: i) rapid degradation of 
proteins – termination of cellular processes and adaptation to new physiological conditions [7], ii) 
transcriptional regulation – degradation of transcriptional factors or alteration of their localization [8], 
iii) quality control mechanism – elimination of misfolded or damaged proteins that have arisen by 
biosynthesis errors, by mutations or damage by oxygen radicals and/or denaturation (protein aging) 
[9, 10], iv) source of amino acids – maintenance of cellular homeostasis at low energy costs by 
recycling of amino acids, v) non-proteolytic functions – monoubiquitylation tagging triggers 
internalization of cell surface proteins into the endocytic pathway [11]. 
More recently, an increasing amount of data has suggested that several UPS-related genes are 
causally linked to neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD), Amyotrophic lateral sclerosis (ALS), Frontotemporal dementias (FTD), Huntington’s 
disease (HD), and other polyglutamine (polyQ) diseases (Reviewed in [12]). Although not clearly 
sustained yet by experimental data, some authors additionally suggest that dysfunction of the UPS 
may also be a consequence of the neurodegeneration observed in these disorders [12]. Moreover, a 
better understanding and identification of the components involved in the UPS-mediated proteolysis 
have also implicated this mechanism in other disease conditions, as for example cardiac 
dysfunction, cancer, viral infections, inflammation, and autoimmune diseases [13]. Additionally, 
multiple lines of evidence support the concept that UPS components are promising drug target 
candidates for therapeutic intervention in many of these disorders (Reviewed in [14-18]).  
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1.1.2 (Poly)Ubiquitylation 
Ubiquitin (Ub) is a small 76 amino acid regulatory protein, highly conserved among 
eukaryotes. Ub first captured the interest of neuroscientists due to its presence in protein aggregates 
that were observed in various neurodegenerative diseases (Reviewed in [19-22]). Conjugation of Ub 
to a substrate through a series of enzymatic reactions is called ubiquitylation. Ub molecules can also 
be attached to other Ubs via an isopeptide linkage between the lysine residue of the previous Ub and 
the C-terminal glycine residue of the subsequent Ub [23] (Figure 1). Therefore, a target protein can 
be modified by a single Ub molecule (monoubiquitylation) or by a poly-Ub chain (polyubiquitylation). 
There are seven different lysine (K) residues in Ub that can potentially be used in vivo for Ub-chain 
synthesis – K6, K11, K27, K29, K33, K48 and K63. Depending on the type of ubiquitylation, the 
length of the Ub chain and the nature of Ub-Ub linkage, the modified protein is subjected to different 
fates (Reviewed in [24-27]). For example, proteins conjugated with K48-linked poly-Ub chains are 
usually targeted for proteasomal degradation. Monoubiquitylation and polyubiquitylation using other 
lysines, such as K63, have been implicated in non-degradative pathways, including regulation of 
subcellular localization, vesicular trafficking, protein sorting and activation of DNA repair [23, 27]. 
 
Figure 1. Diversity and specificity of ubiquitin signaling. Protein substrates can be 
monoubiquitylated (A) or multiubiquitylated (B), or even polyubiquitylated (C, D and E). Ubiquitin 
chains can form extended or closed conformations for one or more linkage type (B and C) or even 
forked chains with multiple ubiquitin attached to a common moiety (D). Adapted from [28]. 
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1.1.3 Ubiquitin-conjugating enzymes: E1, E2, E3 and E4 
 Ubiquitylation is a cascade of sequential reactions regulated by the action of three enzymes: 
E1 (Ub-activating enzyme), E2 (Ub-conjugating enzyme) and E3 (Ub-protein ligase) (Figure 2). The 
first reaction is the activation of Ub by the E1 enzyme in an ATP-dependent manner. The activated 
Ub is then transferred from the E1 to the active cysteine site of the E2 enzyme. Finally, the E3 
enzyme catalyzes the transfer of the Ub moiety to a lysine residue in the substrate protein. There are 
two major classes of E3s: the HECT domain and the RING finger E3s. Typically, DUBs oppose the 
activity of the E3s by mediating the removal of Ub from target proteins. Additionally, the E3s can 
regulate their own stability by ubiquitylating themselves, and DUBs may also regulate their 
proteasomal degradation, either by preventing or promoting it [29-31]. Among the three classes of 
ubiquitin-conjugating enzymes, the E2s are the more selective and are thought to interact with 
specific E3s, which largely determine the substrate specificity (Reviewed in [32]). The number of E2s 
in humans is estimated to be around 39 while the diversity of E3s is even greater (estimated to be 
about 475) [33]. Although the substrate specificity of ubiquitylation is essentially determined by the 
E3s, the diversity of E2s and E3 adaptor proteins, and the combination of E2s and E3s also 
contribute to a high degree of specificity [34].  
An additional component of the UPS is the E4 enzymes. E4s were initially shown to be 
involved in the elongation of short Ub chains [35], but, more recently, these enzymes were shown to 
edit polyubiquitin chains and it was suggested that they might be involved in the regulation of the 
activation of specific proteins, by acting on the switch between the mono and polyubiquitylated 
states of these target proteins (Reviewed in [36]). The number of E4 ligases encoded in eukaryotic 
genomes is still not knwon [33]. 
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Figure 2. The ubiquitylation cycle. Ubiquitylation requires the involvement of a E1 ubiquitin-
activating enzyme that transfers ubiquitin to the ubiquitin-conjugating enzyme (E2). Then, the E2 
transfers the ubiquitin molecule to an ubiquitin-protein ligase (E3) which subsequently ubiquitylates 
the substrate. In the case of K48 ubiquitylation, the substrate is sent for proteasomal degradation 
and ubiquitin is recycled. Adapted from www.tebu-bio.com. 
 
1.1.4 Deubiquitylating enzymes (DUBs) 
The DUBs are key regulators in the two major degradation pathways, the proteasomal and 
lysosomal (autophagy) routes, where they play different catalytic roles: i) processing of the Ub 
percursors, ii) editing and/or rescue of Ub conjugates, iii) recycling of Ub from Ub targeted 
conjugates, and iv) disassembly of anchored ubiquitin oligomers. Autophagy is an alternative 
pathway to the UPS, that can degrade long-lived proteins and protein aggregates which cannot be 
degraded by the proteasome [37, 38]. The fact that DUBs (and probably other UPS components) act 
on these two pathways is consistent with the observations that severe impairment of the proteasome 
also impairs autophagy and vice-versa [39]. The human genome encodes 80-90 DUBs, categorized 
into five classes based on the architecture of their catalytic domains: the USP family (ubiquitin 
specific proteases), the UCH family (ubiquitin C-terminal hydrolases), the OUT family (otubain 
protease), the Josephin/MJD family (genes containing the Josephin domain and ataxin-3), and the 
JAMM family (JAB1/MPN/MOV34 metaloenzyme).   
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USP family 
The USPs are the largest family of DUBs and are thought to specifically recognize the free 
carboxy-terminus Gly-Gly motif of Ub [40-43]. Several USPs have been associated with DNA repair 
pathways [44-47], control of differentiation and maintenance of stem cell characteristics in 
osteosarcoma cells [48], and regulation of tumor suppression proteins [49].  
 
UCH family 
The UCH family comprises DUBs that preferentially cleave Ub from small substrates [50] 
and other enzymes that can accommodate larger substrates in their catalytic site [51]. One of the 
most studied UCHs is the ubiquitin carboxyl-terminal hydrolase L1 (UCHL1). UCHL1 is a highly 
abundant neuronal enzyme involved in the stabilization and recycling of mono-Ub, and is known to 
be genetically linked to PD (Reviewed in [52, 53]) and a major target of oxidative damage in AD [54]. 
Additionally, aberrant expression of UCHL1 is observed in a variety of cancer types and has been 
associated with the determination of cellular invasiveness [55].  
 
OTU family 
Despite the structural conservation within the catalytic domain, OUT proteins show diverse 
specificity for Ub chain linkages. These enzymes have been linked to regulation of the pro-
inflamatory NFkB pathway (OUT protein A20) (Reviewed in [56-58]), to suppression of K63-linked 
polyubiquitylation of histones (that likely include H2A and H2AX) at DNA double-strand breaks 
(OTUB1) [59], and to the inhibition of the activity of associated E2 enzymes [59-61].  
 
JAMM family 
JAMMs are generally part of large multimeric complexes such as the proteasome lid 
complex and the endocytic ESCRT machinery (Reviewed in [62, 63]). While several members of this 
family show a strong preference for K63 polyUb chains, others preferably cleave Ub proximal to a 
substrate protein [64-66]. 
 
Josephin/MJD family 
Josephin/MJD DUBs seem to represent a relatively late addition to the Ub system, since no 
homologues were found in yeast [67]. So far, the substrates for these DUBs remain mostly 
unknown. The most well studied protein from this family is ataxin-3 (ATXN3). Although it has been 
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shown that ATXN3 is involved in Machado-Joseph disease (MJD) [68], its biological function remains 
poorly characterized. It was recently demonstrated that ATXN3 directly ubiquitylates Parkin [69] and 
most likely regulates the degradation of α5-integrin [70]. This will be further discussed in the next 
chapters. 
 
1.1.1.4 Non-catalytic activity of DUBs 
Not all DUB functions require catalytic activity. Many DUBs contain additional non-catalytic 
functions that mediate their function in membrane trafficking, cellular signaling, transcriptional 
regulation and DNA repair (Reviewe in [71]). Several DUBs, referred as housekeeping enzymes, 
such as Ubiquitin-specific protease 14 (USP14), the Ubiquitin-carboxy-terminal hydrolases 
UCH37/UCH-L5 and RPN11/POH1, protect Ub from degradation thus maintaining sufficient levels 
of free Ub that can be used for chain assembly [63]. Other DUBs regulate proteasome activity 
noncatalytically. For example, it was reported that Ubp6, the yeast homologue of human USP14, 
uses catalytic and noncatalytic mechanisms to modulate proteasome function; besides cleaving the 
Ub chains regulating proteasomal degradation of a specific substrate, Ubp6 appears to inhibit the 
proteasome directly, reducing the flux of some specific substrates through the proteasome [72]. 
Also, USP14 was shown to regulate synaptic function through a DUB-independent mechanism [73]. 
 
1.1.5 Adaptor proteins and Ub-like proteins 
As mentioned above, ubiquitylation generates a broad repertoire of signals that are not 
strictly related to the proteasomal degradation. Several adaptor proteins associated with the 
ubiquitin signalling have been recognized to contain protein domains that bind Ub. Such domains 
include the Ub-binding domains (UBLs), the Ub-associated domains (UBAs) and the Ub-interacting 
motifs (UIMs) (Reviewed in [74]).  
In addition, several other proteins with structural and biochemical similarity with Ub have 
been identified as modulating protein degradation. These proteins can be divided into two classes: 
proteins containing an Ub-domain (UDPs) and Ub-like proteins (UBLs). The UDPs are highly 
homologous to Ub but instead of conjugating with substrates, they function as adaptors, binding to 
Ub or Ubl proteins, and are able to bind to proteasome subunits [75]. UDP proteins include Rad23, 
Parkin and PLIC (protein linking IAP to the cytoskeleton) (Reviewed in [76, 77]). The UBLs can either 
freely or covalently form conjugates with proteins. Two examples of UBL proteins are NEDD8 
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(neuronal-precursor cell expressed developmentally downregulated 8) and SUMO (small ubiquitin-
like modifier) (Reviewed in [78]).  
The functions of these adaptor and Ub-like proteins are still poorly characterized, but it is 
thought that they can be identified by downstream receptors/interactors and can be used to regulate 
a large variety of cellular processes including cytoskeleton regulation, cell cycle control, mRNA 
processing, signal transduction, homeostasis, stress response, and metabolism (Reviewed in [76]). 
 
1.2 Role of Ubiquitin signalling in neuronal function 
The function of the nervous system relies on the precise formation of highly dynamic 
networks of synaptic connections. The UPS has emerged as a critical mechanism used by neurons 
to control the free pool of Ub and the renewal of internal components, both necessary for the normal 
nervous system development and function (Reviewed in [4]). During neuronal development, synapse 
formation and pruning [79, 80], axon pathfinding [81, 82] and neuronal migration [83, 84] are 
regulated by the UPS, as are inhibitory [85] and excitatory neurotransmission [85, 86] in the mature 
brain (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Roles for ubiquitin and protein degradation in neuronal function. The UPS regulates 
several aspects of synaptic biology, playing a role on neuronal function. Adapted from [87]. 
Chapter 1. General Introduction 
 10 
1.2.1 Transport of Ubiquitin in neurons 
Two classes of genes encode for Ub in mammalian genome: the genes encoding ribosomal 
fusion proteins Rsp27a and Uba52, and the polyubiquitin genes Ubb and Ubc. The levels of free Ub 
in a cell are determined by Ub synthesis and degradation, and by polyubiquitin chain assembly and 
disassembly. Nevertheless, both Ubb and Ubc genes are transcribed at increased rates in response 
to cell stress, as Ub is a component of the cellular response to heat shock and other stressors [88]. 
Following the de novo synthesis of Ub in the soma of the neuron, Ub is transported via axonal 
transport to axons and dendrites [89], a process that may take days or even months in certain 
neurons [90]. For this reason, although the levels of free Ub are maintained high in neurons, as a 
reservoir to allow for rapid responses to cell stimulation or stress, distal axons and dendrites are 
particularly vulnerable to stress and may be particularly sensitive to local fluctuations in Ub levels 
[91]. 
 
1.2.2 Neuronal migration 
Nervous system development requires proper migration of neuronal cells. Neuronal 
migration is regulated by a wide range of extracellular cues and intracellular signaling cascades, and 
dependent on cell adhesion proteins and various cell surface receptors, which, in turn, are regulated 
by the UPS and related components (Reviewed in [4]).  Many studies have shown that the neuronal 
migration is dependent, directly or indirectly, on the activity of E3 ligases, making ubiquitylation one 
of the intracellular signaling pathways regulating neuronal migration [92-94]. For example, it was 
recently described that the FBXO31-SCF centrosomal E3 ligase is required for an efficient migration 
of neurons in the developing cerebellum [94]. 
 
1.2.3 Axonal growth, guidance and morphogenesis 
Growth and guidance of axons are vital steps in the establishment of neuronal circuits. The 
UPS has been shown to regulate these processes through ubiquitylation and/or proteasomal 
degradation of proteins involved in the axonal cytoskeleton, transcription factors and small GTPases 
(Reviewed in [95]). The most well studied UPS-dependent regulators of axon growth and guidance 
are the PHR proteins, Nedd4, cdc20 and cdh1 E3 ligases. Cdh1, for example, was shown to bind to 
the anaphase-promoting complex (APC) [96], regulating the degradation/stability of specific 
transcription factors (such as Id2 and SnoN), impacting on axon growth [97-99]. Other E3 ligases, 
such as smurf-1, also have identified roles: smurf-1 was shown to directly target RhoA, a small 
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GTPase associated with the actin filaments network, for ubiquitylation and proteasomal degradation 
[100], thus enhancing axonal outgrowth [101].  
Notably, many E3 ligases that are important for axonal growth and guidance also regulate axonal 
morphogenesis. For example, PAM (an E3 ligase, member of the PHR family) primarily regulates 
axon growth and guidance, but it also plays a role in axon morphology [79, 102, 103]. 
 
1.2.4 Pre-synaptic function 
Growing evidence supports a contribution of the UPS to the regulation of synaptic physiology 
and transmission, by regulating the proteolysis of key presynaptic elements at the synaptic terminals 
(Reviewed in [74, 104-106]). Several regulatory molecules controlling long-term synaptic plasticity as 
well as synaptic transmission and short-term synaptic plasticity have been shown to be substrates 
for UPS-mediated degradation. For example, the protein Duc-13, which is critical in priming synaptic 
vesicles, accumulates in presynaptic terminals upon proteasome inhibition [107]. Also, specific Ub 
ligases interacting with syntaxin 1 – a presynaptic protein involved in synaptic vesicle exocytosis – 
and RIM1α (Rab3-interactig molecule 1α) – which acts as a presynaptic scaffold – have been 
identified [108, 109]. Additionally, it appears that the UPS also functions in recycling of synaptic 
vesicles and maintaining vesicle homeostasis [110]. Recently, Waith and colleagues described that 
presynaptic CaV2 channels are targets of the UPS, adding further to the relevance of UPS function in 
neurons [111]. 
 
1.2.5 Postsynaptic plasticity 
The discovery of UPS components and target proteins at synapses gave indirect evidence for 
a postsynaptic role of this system (Reviewed in [74, 112-114]). Subsequent studies indicated that 
the UPS modulates regulatory molecules, structural proteins and neurotransmitter receptors in the 
postsynaptic compartment [106]. Studies in Caenorhabditis elegans and mammalian neurons 
showed a role for ubiquitin in trafficking and endocytosis of neurotransmitter receptors such as 
AMPA [85], GABA [115], NMDA [116] and glycine receptors [117].  Also, Colledge and collaborators 
showed that the postsynaptic density protein PSD-95 is regulated by UPS-mediated degradation, 
which in turn modulates AMPA receptors [85]. In addition to PSD-95, the UPS seems to regulate 
several other proteins, namely structural proteins such as Shank, GKAP and AKAP97/150 [118]. 
Finally, there is also evidence that the UPS contributes for the regulation of spine shape by 
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modulating the degradation of SPAR, a protein that acts on the reorganization of the actin 
cytoskeleton at the spine [119]. 
 
1.2.6 Nonproteolytic functions of Ubiquitin signaling 
In recent years, mounting evidence suggests that Ub has also nonproteolytic functions; Ub 
or polyUb chains serve as a signal to recruit proteins harboring UBD, bringing together ubiquitylated 
substrates and Ub receptors to perform specific biological functions. These functions include 
membrane trafficking, protein kinase activation, transcriptional regulation and DNA repair (Reviewed 
in [120]). 
 
Membrane trafficking 
Monoubiquitylation and the attachment of K63-linked Ub dimers have been shown to 
maintain the balance between degradation, recycling and trafficking of cargo molecules and cell 
surface receptors [11, 62]. For example, depletion of the DUB AMSH accelerates epidermal growth 
factor receptor (EGFR) trafficking to lysosomes [121, 122]. 
 
Protein kinase activation 
K63 polyubiquitylation is an important post-transcriptional modification of signaling 
cascades, such as NF-kB and the Wnt pathway, playing a key role in the activation of protein kinases 
[123, 124]. For example, the DUB USP4 was shown to be required for the regulation of the Wnt 
signaling activation [125]. 
 
Transcriptional regulation and DNA repair 
DUBs can directly influence the structure of chromatin and coordinate DNA repair 
mechanisms or contribute to gene transcriptional regulation through reversible ubiquitylation of 
specific transcription factors and histones (Reviewed in [126]). It has been shown that certain DUBs 
can reverse monoubiquitylation of both H2A and H2B [127-130], impacting on multiple nuclear 
processes including mitosis, transcriptional initiation and elongation, mRNA export [127, 131-133] 
and gene silencing [46, 134].  
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1.3 The UPS and Ub in neurodegenerative disorders  
Components of the UPS have been linked to several diseases of the nervous system, 
including neurodevelopmental and neurodegenerative diseases (Reviewed in [5, 32, 135]). In some 
cases, mutations in specific UPS genes have been linked to the etiology of the disease while in other 
events, impairment of the UPS seems to be a late event in the pathogenesis (Reviewed in [136]). It 
is believed that one of the first effects of perturbations in UPS-mediated proteolysis is synaptic 
malfunction that is followed later in disease progression by cell death and/or degeneration 
(Reviewed in [137]). Nevertheless, it is still poorly understood whether UPS impairment is a cause or 
a consequence of the disease - or both. 
 
1.3.1 Ub deposition in protein aggregates 
Misfolded or aberrant proteins are targeted for degradation through the UPS [138]. Failure 
to remove misfolded proteins may lead to their sequestration in aggregates, a shared hallmark of 
many neurodegenerative disorders, including PD, AD, HD and other polyQ disorders (Reviewed in 
[139-144]). These aggregates are immunoreactive for Ub and UPS-associated components [21, 
136, 145]. However, the significance of these aggregates in the etiology of neurodegenerative 
disorders remains highly controversial. Several findings suggest that the visible aggregates do not 
fully correlate with neuronal death [146-149]. In contrast, several studies indicate that these Ub-rich 
aggregates contain the pathogenic protein (and in some cases the normal protein as well), UPS 
components, chaperones and transcription factors [150-155], which has been interpreted as 
evidence that sequestration of these key cellular proteins may lead to neuronal dysfunction and 
death. Additionally, a recent study showed a polyQ-induced global UPS impairment in vivo in an HD 
mouse model [156], while others exclude such an effect [157, 158]. Despite this discrepancy, the 
fact that mutations in UPS genes are linked to inherited neurological diseases supports the concept 
that UPS dysfunction might contribute to a wide range of nervous system diseases (Reviewed in [12, 
159]). 
 
1.3.2 The UPS in Parkinson’s disease (PD) 
PD is an age-related progressive neurodegenerative disorder affecting, among others, 
dopaminergic neurons of the substantia nigra (SN).  
The first evidence implicating a role for the UPS in PD came from the finding of disease-
causing mutations in the E3 ligase parkin, which is now known to be involved in proteasomal 
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degradation of several important neuronal substrates, including α-synuclein and synaptotagmin XI 
[160-164]. Ubiquitylated α-synuclein was shown to accumulate contributing to the formation of 
Lewy-like inclusions, providing more evidence for a role of the UPS in PD [165]. 
A link between proteasome dysfunction and PD has also been demonstrated in a mouse 
model using conditional depletion of the 26S proteasome through inactivation of a 19S proteasome 
subunit, Psmc1. Upon 26S proteasome depletion, these mice displayed neurodegeneration and 
Lewy-like inclusions containing Ub and α-synuclein in neurons of nigrostriatal pathway and forebrain, 
similar to the ones found in the brains of human PD patients [165, 166]. 
Consistent with a role for the UPS in PD, other components of this pathway also seem to 
play a role in PD pathology. For example, a missense mutation (I93M) in the UCHL1 was found in a 
pair of German siblings with inherited PD. Notably, this mutation markedly reduces UCHL1 DUB 
activity in vitro [52]. Mutations in the 26S ATPase of the regulatory subunit of the proteasome 
(PSMD4/RPN10) have also been described as increasing the risk for PD [166]. Furthermore, in vitro 
analyses of SN extracts from PD brains revealed a marked decrease in the activity of the 20S 
proteasome and in the levels of proteasomal core subunits [167, 168]. 
 
1.3.3 The UPS in Alzheimer’s disease (AD) 
AD is the most common neurodegenerative disorder, clinically characterized by progressive 
loss of memory and other cognitive skills, resulting in severe dementia. In the brain, the pathological 
signs include the presence of both intracellular neurofibrillary tangles containing 
hyperphosphorylated microtubule associated protein (MAPT) and extracellular amyloid-β plaques 
(Reviewed in [169]). The fact that these protein aggregates are ubiquitylated, strongly suggest that a 
malfunctioning or overloaded UPS may contribute for AD pathology [170-172]. In addition, several 
studies have implicated the UPS and proteolytic defects in AD. An ubiquitin mutant (UBB+1) was 
identified as a potent inhibitor of the proteasome in AD brains, and shown to accumulate and co-
localize with the amyloid plaques and neurofibrillary tangles [171]. Interestingly, ubiquitylation of 
UBB+1 was shown to be mediated by the ubiquitin-conjugating enzyme, E2-25K/HIP-2, found to be 
critical for Aβ toxicity in AD animal models [173]. Additionally, in vitro experiments showed that Aβ 
could bind and inhibit the proteasome, thus blocking degradation of ubiquitylated substrates [174, 
175]. The neuronally expressed DUB enzyme UCHL1 (linked to PD, as described above) was shown 
to have a highly reduced activity in AD brains due to its increased oxidation [176]. Also, both 
expression of the 26S protease regulatory subunit 6B (PSMC4, RTP3) [177] as well as the 
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proteasome function were shown to be reduced in several brain regions of AD patients (reviewed in 
[178]). 
 
1.3.4 The UPS in Huntington’s disease (HD) 
HD is one of the nine polyQ disorders known to date, which is caused by an expansion in 
the CAG repeat in the huntingtin (Htt) gene. The polyQ tract renders a mutant protein prone to 
aggregate, causing cellular toxicity [179-181]. The neuropathological changes in HD lead to a 
progressive cognitive decline ending in severe dementia, motor dysfunction and psychiatric 
disturbances, namely depression and psychosis [182]. Various studies suggested that the UPS is 
involved in the processing of mutant Htt, since intranuclear aggregates containing the mutant 
protein are positively stained for Ub and proteasome subunits in cell cultures, HD transgenic mouse 
models and human HD brains [152, 183, 184]. When present in the nucleus, Htt is degraded by the 
UPS [185]. However, experiments with purified 26S proteasomes showed that proteasomes may be 
unable to degrade the protein bearing a polyQ expansion. Thus, long polyQ sequences have been 
proposed to cause the clogging of the proteasome impairing UPS function [186].  
Indeed, several studies in cell models and in patient’s material have reported an impairment 
of the UPS and its components in HD. For example, a change in the activity of the 20S proteasome 
was shown in HD patient’s brains, causing an increase in the half-life of a polyubiquitylated reporter 
[187]. Furthermore, co-expression of mutant Htt with proteasomal subunits in cells revealed 
irreversible recruitment of proteasomes into HD aggregates [188]. Also, global proteasome 
impairment was reported when mutant aggregates were present both in the nucleus and in the 
cytoplasm of HEK293 cells [189]. 
Interestingly, experiments using a model for polyQ disorders showed that the E2-25K/HIP-2 
enzyme increases aggregation of polyQ proteins, in addition to its role in mediating the toxicity of Aβ 
and UBB1+ [190]. This suggests that the impairment of the UPS may be a common mechanism 
among several neurodegenerative disorders, irrespective of the toxic protein species. 
However, there are also contradictory reports regarding the relevance of the proteasome 
impairment for HD pathogenesis. For example, a recent study suggested that toxic forms of Htt do 
not impair proteasome function [191]. Also, no global impairment of UPS activities was found in an 
HD mouse model characterized by Mangiarini et al [184, 192]. These apparently opposing results 
may be in part explained by the discrepancy between results obtained from cell and mouse models 
[193, 194]. However, more recently, Ortega and collaborators proposed a possible explanation that 
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reconciles the data from cell models supporting the polyQ-induced UPS impairment with the 
contradictory findings of no impairment in mouse models – their results demonstrate that mutant 
Htt can indeed impair UPS function in vivo but that this is only a transient event due to the protective 
effect on mutant Htt aggregation [157]. 
 
1.3.5 The UPS in Ataxias 
Ataxia is a neurological symptom present in a group of disorders, generally caused by 
degeneration of neurons in the cerebellum, brain stem and spinocerebellar tracts, which is related 
with the patients’ loss of control of body movements. Several inherited ataxias are caused by an 
abnormal polyQ expansion within a variety of mutant proteins (Reviewed in [195]). As in HD, 
expanded polyQ bearing proteins tend to aggregate and form intranuclear inclusions. These 
inclusions contain several cellular components, including Ub and subunits of the proteasome, 
therefore suggesting a relationship between spinopontocerebellar neurodegeneration and the UPS 
[153-155]. In addition, some disease-causing proteins such as ataxin 1, 3 and 7, are known to be 
ubiquitylated and targeted for proteasomal degradation [196-198].  Several evidence suggest that 
the misfolding of the polyQ proteins might lead to difficulties in the recognition and degradation 
process by the proteasome, resulting in impaired clearance of mutant proteins (Reviewed in [199]). 
Moreover, the aggregates of these mutant proteins were also shown to directly impair UPS function 
[199]. 
Besides the proteasome, other components of the UPS have been implicated in the 
development of ataxia. For example, the loss of DUB activity of the Ups14 enzyme, that regulates 
important cellular processes such as inhibition of proteasome and protein turnover [200], causes 
ataxia in a mouse model, which is associated with synaptic transmission defects [201].  
 
1.3.6 Connection between UPS and neurodegeneration through autophagy 
Autophagy is a lysosomal-dependent degradation pathway that can be divided into 
macroautophagy (bulk degradation of the cytosol), chaperone-mediated autophagy (CMA) and 
mitophagy (selective degradation of mitochondria) (Reviewed in [202]). Protein aggregates that 
cannot be transported to and degraded by the proteasome are usually degraded by autophagy 
[203]. Therefore, it has been proposed that autophagy could serve as an alternative degradation 
pathway when the proteasome capacity is insufficient or its function is impaired (Reviewed in [204]). 
Clearance by autophagy has been shown for several disease proteins such as tau [205], α-synuclein 
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[206] and a range of polyQ expanded proteins [37, 205, 207, 208]. Interestingly, Wild type proteins 
show a much lower dependence on autophagy for their clearance, compared with their mutant 
counterparts, and can be rapidly degraded by the proteasome [206, 209].  
Nevertheless, recent findings showing that impairment of the proteasome also impairs 
autophagy and vice versa, suggested an interdependence of UPS and autophagy [39].  Indeed, it is 
known that ubiquitylation, mainly through K63 polyUb chains, can lead to autophagic degradation of 
the ubiquitylated targets [210]. In addition, several Ubl proteins, such as Atg5, 7, 8 and 12, are 
critical for autophagy; it was shown that mice lacking either Atg5 and Atg7 in the central nervous 
system (CNS) presented ubiquitylated aggregates, which were associated with neurodegeneration 
and motor deficits [211]. Also, mutations in proteasome subunits caused neurodegeneration in a 
Drosophila model, which was rescued by overexpression of the histone deacetylase 6 (HDAC6) in an 
autophagy-dependent manner [212]. Defects in autophagy have been linked to the pathology of 
several neurodegenerative diseases, such as AD, PD and HD (Reviewed in [213, 214]). It is believed 
that an abnormal autophagic activity leads to accumulation of intracellular protein aggregates in 
axons, dendrites and/or synapses, affecting the intercellular communication of selective neuronal 
populations [215].  
Opposing results, however, suggest that proteasome inactivation induces autophagy [204, 
216-218]. For example, Ding and co-workers showed that proteasome inhibition activates autophagy 
and, conversely, blockage of autophagy leads to the formation of polyubiquitylated aggregates [218].  
Also, proteasome inactivation induced autophagy via the hypoxia signaling in Drosophila [216]. 
These results suggest that a compensatory autophagy may be induced when the proteasome fails to 
efficiently remove aggregate-prone proteins. However, the fact that several substrates of autophagy 
and UPS overlap (Reviewed in [204, 217, 219]), may potentially explain why in some cases 
impairment of one of these pathways leads to impairment of the other. 
 
1.3.7 The UPS as a therapeutic target 
As described above, it is now widely accepted that the UPS contributes for the pathology of 
several neurodegenerative disorders. Therefore, targeting the proteasome or UPP components has 
emerged as an attractive therapeutic approach for these disorders (Reviewed in [17, 220-222]).  
One of the most appealing targets for therapeutic intervention is the proteasome itself. Since 
abnormal protein aggregates and inhibition of the proteasome are common features of 
neurodegenerative diseases, enhancement of proteasome activity might be an efficient way to 
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remove aggregates that accumulate in the brain (Reviewed in [223]). This may be achieved by 
employing the following strategies: i) increasing proteasome activity by promoting assembly of 19S 
and 20S complex of proteasome [224], ii) overexpressing the β5, the proteasome maturation 
protein (POMP) [225] or the arsenite-inducible RNA-associated protein (AIRAP) [226], all resulting in 
enhanced proteasome activity, iii) stimulating proteasome activity using natural and/or synthetic 
activators such as olive oil, fatty acids and SDS [227-229], iv) enhancing ubiquitylation of a 
substrate using proteolysis targeting chimera molecules (PROTACS), molecules comprising a ligand 
for the target protein, a linker moiety, and a ligand for an E3 Ub ligase [230], v) promoting 
SUMOylation of proteins implicated in neurodegenerative disorders such as tau, α-synuclein and 
huntingtin [231], vi) facilitating substrate proteasomal degradation through overexpression or 
modulation of heat shock proteins [232-234]. 
Besides the proteasome, other UPS components are now been envisaged as “druggable” 
targets to treat neurodegenerative diseases. As substrate specificity is mainly determined by E3s, 
they have been proposed as the best potential therapeutic targets [5, 32]. Therefore, modification of 
the active site of E3s either to increase or to decrease the affinity towards specific substrates, could 
be one strategy to selectively control the accumulation of ubiquitylated proteins [223]. However, 
interfering with E3s is not easy to devise due to the lack of knowledge about their mechanisms of 
catalysis (Reviewed in [235]). DUBs have also been attractive molecular targets for the development 
of therapeutic approaches. Perhaps the best example of the use of DUBs for therapy is USP14. Lee 
and colleagues showed that specific inhibition of the USP14 E3 ligase might improve clearance of 
misfolded proteins in neurodegenerative diseases [200]. However, one shall be mindful of the 
potential side effects from inhibiting/activating this DUB’s activity.  Indeed, it was shown that 
mutations or silencing of several DUBs in mice, including USP14, negatively impacted on the entire 
organism or on specific organ systems. Also, KD of most DUBs in a Drosophila model had negative 
physiological consequences during development and in adult animals [236].  
 
1.4 Machado-Joseph disease 
In the early 1990’s, converging lines of investigation identified a new type of mutation: the 
dynamic expansion of a trinucleotide repeat sequence within the coding region of a given gene, 
translated into a repetitive aminoacid sequence in the corresponding protein. Among them, the 
polyQ diseases, caused by CAG repeat expansions are the most common. To date, ten polyQ 
diseases have been characterized: Kennedy’s disease or spinobulbar muscular atrophy (SMBA) 
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[237], spinocerebellar ataxias (SCA) type 1 [238], 2, 3 [68], 6 [239], 7 [240], and 17 [241, 242], 
dentatorubral-pallidoluysan atrophy (DRPLA) [243, 244], HD and Huntington disease-like 2 (HDL2) 
[245]. These group of diseases share several features that suggest a common toxic mechanism, not 
yet fully understood: i) the CAG expansion is translated into an abnormally long tract of glutamines, 
ii) there is a negative correlation between the age of onset and the number of CAG repeats, i.e., the 
age of onset of symptoms decrease with increased polyQ length [241, 246-248], iii) the CAG repeats 
present an intergenerational instability, with a tendency for disease to worsen in successive 
generations (anticipation) [246, 249], iv) formation of protein aggregates or inclusion bodies in the 
nucleus and/or cytoplasm of neuronal cells [241]. 
 
Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is now 
known to exist worldwide [250], representing the most common dominantly inherited ataxia 
(Reviewed in [250-252]) and the second most common polyQ disease [253]. Despite the increasing 
number of therapeutic strategies assessed in mouse models of polyQ diseases (around 250 
preclinical therapeutic trials have already been described [254]), there are no effective treatments 
for these disorders, including MJD, and current therapeutic approaches are only able to provide 
limited symptomatic relief (Reviewed in [255]). 
 
1.4.1 Clinical and pathological features  
The core clinical feature in MJD is a slowly progressive ataxia, being the average age at 
onset 40 years and the mean survival time of 21 years (Reviewed in [256]). Numerous other clinical 
symptoms, including weight loss, dystonia, dysarthria, spasticity, rigidity, fasciculations, postural 
instability, proprioceptive loss, visual, speech and sleep disorders, dysphagia, amyotrophy, 
corticospinal and autonomic nervous system dysfunctions and neuopathy, are also frequently 
observed in MJD patients [257-261]. 
Neuropathologically, MJD is characterized by neuronal loss in the cerebellum, substantia 
nigra, striatum, thalamus, pontine nuclei, spinal cord and cranial nerves, precerebelar brainstem, 
cholinergic and dopaminergic midbrain, as well as visual, auditory, vestibular, somatosensory, and 
ingestion and urination-related systems. Retained integrity of the cortical and subcortical regions of 
the limbic system and mild degeneration of cerebral and cerebellar cortexes, white matter of 
cerebellum, inferior olive and Purkinje cells, are also characteristic of MJD [248, 258, 260, 262-
266]. Magnetic resonance imaging (MRI) and neuroimaging studies have revealed an enlargement 
Chapter 1. General Introduction 
 20 
of the fourth ventricule, atrophy of the pons, cerebellar vermis and hemispheres, basal ganglia, 
midbrain and medulla oblongata [267-271]. Regarding brain functionality, magnetic spectroscopy 
analysis has shown decreased metabolism in the cerebellum, brainstem, cerebral cortex, thalamus 
and putamen, suggestive of axonal dysfunction, at symptomatic ages [257, 259, 272-274]. 
 
1.4.2 MJD genetics 
The MJD causative gene – ATXN3 gene – was mapped to the long arm of chromosome 14 
(14q32.1) [68]. The gene spans 48 kb and contains 13 exons (two of them recently described), with 
the (CAG)n tract located at exon 10 [275, 276]. In the healthy population, the number of CAG repeats 
ranges from 12 to 44 CAG, while expanded alleles usually comprise from 61 to 87 repeat units 
(Reviewed in [277, 278]). Four different ATXN3 transcripts of approximately 1.4, 1.8, 4.5 and 7.5 
kb were described to be ubiquitously expressed in neuronal and non-neuronal human tissues [276, 
279]. These different mRNA species may result from differential splicing of exons 2, 10 and 11 of 
ATXN3 gene, and alternative polyadenylation of exon 10 [68, 276, 280]. A recent study proposed 
the existence of 50 potential new splice variants of ATXN3 gene, generated by different types of 
splicing events (exon skipping, new exons and usage of alternative 5’ or 3’ splice sites) [275]. This 
suggests that alternative splicing may be an important mechanism regulating ATXN3 expression. 
Additionally, the existence of ATXN3 transcripts carrying different 3’ untranslated regions (UTRs), 
suggest another potential level of regulation of ATXN3 expression [276], which remains unexplored. 
 
1.4.3 Therapeutic approaches 
To date, no effective treatment for MJD and other polyQ diseases have been developed. 
However, some symptoms of disease can be treated using pharmacological approaches. 
Importantly, efforts have been made to generate animal models of the disease that will facilitate the 
understanding of MJD pathogenic mechanisms and subsequent therapeutic testing (Reviewed in 
[281]). 
 
Silencing of ATXN3 gene 
Because the detailed pathogenic mechanism remains unclear in MJD, silencing strategies 
targeting the causative gene have shown to be the most promising. Indeed, Boy and collaborators 
showed that switching off the expression of the pathogenic protein reverted the disease phenotype 
(including motor deficits, inclusion formation and neuronal degeneration) in a conditional mouse 
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model of MJD [282]. Silencing of ATXN3 gene by RNA interference (RNAi) in a non-allele-specific 
manner has also been shown to mitigate degeneration in a rat model of MJD, indicating that 
silencing of Wild type ATXN3 together with the mutant protein appears not to be deleterious [283, 
284]. In fact, Atxn3 knockout mice do not show any signs of neurodegeneration [285]. Accordingly, 
Rodríguez-Lebrón and colleagues also showed that short term silencing of mutant ATXN3 in the 
cerebellum of an MJD mouse model, using RNAi sequences targeting 3’UTR of ATXN3, cleared 
abnormal nuclear accumulation of the disease protein [286]. However, and unexpectally, chronic 
RNAi treatment did not improve survival or motor function in treated transgenic mice. One possible 
explanation is that the RNAi-mediated suppression of Atxn3 expression was relatively low (roughly 
50%) and confined to the cerebellum, and the delivery of the virus occurred in lower extents to other 
CNS regions also affected in disease. The failure of the treatment to improve the motor dysfunction 
of the MJD mice suggests that the phenotype is not solely due to cerebellar dysfunction, as it likely 
happens in MJD patients. This illustrates the need of silencing strategies enabling broader delivery 
approaches, in order to target different brain regions/nuclei affected in the disease context. 
Other types of molecules targeting RNA, such as peptide nucleic acids (PNAs) and locked 
nucleic acids (LNAs) have also been shown to be effective in silencing ATXN3 in fibroblasts from 
MJD patients [287], supporting the idea that this strategy may constitute a potential route to MJD 
therapy. 
 
However, a major problem of ataxin-3 silencing may be the lack of knowledge about its 
function, specially in neurons. It is still unclear to what extent ataxin-3 is an essential protein for 
normal cellular function. Although studies using knockout (KO) animal models suggest that depletion 
of ataxin-3 is not detrimental [285, 288], we cannot exclude the existence of compensatory 
mechanisms masking the effects of the absence of the protein in these models. Of note, ataxin-3 
contains several highly evolutionarily conserved domains [289], which may indicate that the protein 
is not completely dispensable. Also, silencing of ataxin-3 in non-neuronal cultured cells [70, 290] 
resulted in cytoskeletal disruption, loss of cell adhesion, increased ubiquitylation and increased cell 
death, further suggesting that prolonged full knockdown of the normal protein could be harmful. 
Therefore, understanding the exact physiological(s) role(s) of ataxin-3 is of relevance for the 
development of efficient and safe therapeutic strategies. 
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An alternative oligonucleotide therapy proposes the removal of the polyQ tract from the 
ATXN3 protein by exon skipping, maintaining the expression levels and the main functional domains 
and Ub binding capacity of the protein [291]. However, it is still necessary to assess whether the 
resulting modified ataxin-3 protein is not toxic and to evaluate whether its localization and function 
are not affected. Furthermore, future studies are required to evaluate whether polyQ skipping 
ameliorates the phenotype of MJD animal models. 
 
Prevention of aggregation 
As previously described, ATXN3 protein aggregates are a hallmark of MJD, and probably 
play a central role in the disease mechanism. Therefore, preventing aggregation may have 
therapeutic potential. The finding that heat shock proteins (HSPs) co-localize with aggregates of 
mutant ataxin-3 [292-294], suggested that these chaperones act (or attempt to act) in promoting the 
correct refolding of the pathogenic proteins in order to reduce the formation of toxic aggregated 
forms. Therefore, it has been proposed that the use of compounds that induce expression of HSPs, 
might have a beneficial effect in the clearance of the mutant protein (Reviewed in [295, 296]). 
Indeed, increased activity of molecular chaperones such as heat shock protein 70 (HSP70) and heat 
shock protein 40 (HSP40) was shown to reduce both aggregation and toxicity of expanded polyQ 
tracts in cell and mouse models, resulting in improved phenotypes [297, 298]. It was proposed that 
these molecular chaperones increase the solubility of expanded polyQ tracts and subsequently, the 
degradation of the protein by the proteasome [299-302]. Pharmacologic inactivation of the heat 
shock protein 90 (HSP90) triggers overexpression of several molecular chaperones, activating the 
heat shock response (HSR), through the persistence of the heat shock factor 1 (HSF-1) action [303, 
304] and thus was thought to be a promising therapeutic strategy, warnessing the cell’s protective 
potential. Indeed, HSP90 inhibitors (such as 17-AAG and 17-DMAG) have been shown to reduce 
aggregate load and toxicity in cell, fly, nematode and mouse models of several neurodegenerative 
diseases, including Huntington and MJD [305-310]. For example, it was shown that exposure of 
ataxin-3 mutant C. elegans or mice expressing mutant ATXN3 to 17-DMAG improved the motility 
defects of these transgenic animals when compared to untreated controls [308, 311].  
 
Activation of autophagy 
Enhancing degradation of ATXN3 by stimulating cellular degradative systems that regulate 
its turnover may be an alternative therapeutic strategy for MJD. Indeed, pharmacological induction of 
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autophagy using tensirolimus (a rapamycin analogue already used in patients for treatment of renal 
cell carcinoma) resulted in increased degradation of mutant ATXN3, a reduction in the number of 
aggregates, and improved the motor phenotype (with some limitations) in a mouse model of MJD 
[312]. Additionally, overexpression of the autophagic protein beclin-1 was shown to increase 
clearance of the mutant protein and to prevented neurodegeneration in a rat model of localized 
ATXN3 over-expression [313].  
Other studies showed that treatment of Drosophila, C. elegans and mouse models of MJD 
with inhibitors of HSP90 decreased mutant ATXN3 aggregation and improved motor phenotype in 
MJD transgenic C. elegans and mouse models [308, 311, 314]. Although these compounds were 
expected to act by inducing chaperone expression and thus promoting refolding of the mutant 
protein, as described above, it has also been shown that these compounds are able to activate 
autophagy in different model systems [315-317]. 
Finally, lithium chloride was also shown to have therapeutic potential in a Drosophila MJD 
model through upregulation of autophagy [318]. While this was not confirmed in a mouse model of 
MJD [319], a recent phase II/III clinical trial with this compound, although not effective considering 
its major endpoint, showed a significant reduction in the progression of gait ataxia severity [320]. 
 
Proteolytic cleavage inhibition 
Proteolytic cleavage of ATXN3 may also be relevant for polyQ-expanded ATXN3 toxicity. 
There is indeed evidence supporting the proteolysis of ATXN3 in mammalian cells, transgenic 
animals and MJD brain tissue [321-324], and it has been proposed that this event is required for 
inclusion formation, because truncated ATXN3 is detected in neuronal inclusions in human brain 
[321, 325]. In line with this, inhibition of ATXN3 proteolysis, by mutating its putative cleavage sites, 
was shown to reduce toxicity in a Drosophila model of MJD [326, 327]. Also, inhibition of the 
calpains showed a good potential in reducing mutant ATXN3 toxicity in several cellular and animal 
models [324, 328-330].  
 
Antioxidants 
There is some evidence that impairment in the cellular defense mechanism against 
oxidative stress could play a role in MJD pathogenesis [331, 332]. Yu and colleagues showed that 
certain antioxidant enzymes such as glutathione reductase, catalase and superoxide dismutase 
(SOD) exhibit decreased activity in a mutant MJD cell line as compared to Wild type cells [331]. 
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Therefore, antioxidants might have a beneficial effect for neuronal dysfunction and 
neurodegeneration in MJD. Although antioxidants have been demonstrated to have beneficial effects 
for other polyQ diseases such as HD [333-338], nothing is known about their effects in MJD. 
Furthermore, creatine, a bioenergetic supplier for the cell, was also demonstrated to have 
antioxidant properties, which could have beneficial effects in these diseases [339-341]. Indeed, food 
supplementation with creatine was shown to improve muscle strength and motor coordination 
deficits in a MJD mouse model (Duarte-Silva, S. et al, in preparation). 
 
1.4.4 MJD protein: Ataxin-3 (ATXN3) 
Ataxin-3 (ATXN3) is an evolutionarily conserved protein, with orthologs in a wide range of 
eukaryotic organisms, from protozoans to vertebrates [279, 288, 342, 343]. Wild type human 
ATXN3 has a molecular weight of 42 kDa, the size slightly varying according to the length of the 
polymorphic glutamine tract. Despite the localized neuronal degeneration observed in MJD patients, 
ATXN3 is ubiquitously expressed among different body tissues and cell types, being widely 
expressed throughout the brain [20, 276, 325, 342, 344]. Also in terms of subcellular localization, 
ATXN3 is ubiquitously found and is able to translocate from the cytoplasm to the nucleus and vice-
versa [20, 153, 325, 344-346]. This ability was shown to be associated with the existence of a 
nuclear localization signal (NLS) and 6 potential nuclear export signals (NES) in the ATXN3 protein 
sequence [289, 346-348]. Furthermore, the first 27 amino acids of ATXN3 were shown to have a 
role in the regulation of ATXN3 nuclear localization [345]. Nuclear localization was also shown to be 
modulated by phosphorylation events. These phosphorylation sites were shown to be targets for the 
serine-threonine kinase 2 (CK2) and for the glycogen synthase kinase 3β (GSK 3β) [349, 350]. 
While likely important for pathogenesis [351], the biological relevance of this regulated subcellular 
distribution of ATXN3 remains to be clarified.  
 
Structure and domains 
ATXN3 belongs to the family of cysteine proteases. Structurally, it is essentially composed 
by a structured globular N-terminal – the catalytic Josephin domain (JD) – followed by a flexible C-
terminal tail that contains 2 or 3 ubiquitin interacting motifs (UIMs) and the polyQ tract [280, 289, 
352-355] (Figure 4). Comparative analysis of the JD showed that ATXN3 belongs to the papain-like 
cysteine protease family and contains two binding sites for Ub [355-357]. The Ub protease activity 
resides in the catalytic pocket, which comprises that catalytic triad, C14, H119 and N134, strictly 
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conserved among different classes of DUBs (Figure 4). The Q9 residue was also shown to be 
important for the catalytic activity of ATXN3 [355, 357]. Biochemical evidence confirmed that the 
DUB activity of this protein requires the active site cysteine 14 (Reviewed in [198, 354, 358]). The 
UIMs may help to recruit and position the polyubiquitylated substrates relative to the catalytic site, 
determining ATXN3 preference for specific topologies of polyUb chains and allowing for a sequential 
editing [357, 359]. However, despite this important role in the regulation of the type of chains that 
can be cleaved by ATXN3, UIMs seem to be dispensable for its activation [360]. Although several 
potential ATXN3 isoforms might be translated, only two have been studied in detail; both of these 
isoforms contain the polyQ tract and UIMs 1 and 2, but only one contains UIM3. The 3 UIMs protein 
was proposed to be the predominant isoform in the brain [325, 344, 361]. However, some 
important limitations may have affected this conclusion: the 2UIM ataxin-3 isoform is a less stable 
protein than the 3UIM ataxin-3 and is subjected to rapid proteasomal degradation, ii) the 2UIM 
ataxin-3 is more prone to aggregate than the 3 UIM protein, and iii) the YACs used for the generation 
of the mouse model possesses a slightly longer 2 UIM isoform with a predicted molecular weight 
very closed to the molecular weight of the 3 UIM ataxin-3. Therefore, further analyses are needed to 
conclude about the relative abundance of ATXN3 isoforms in the brain. 
Figure 4. Domain architecture, structure and post-translational modifications of ataxin-3. (A) ATXN3 
is mainly composed by a N-terminal catalytic domain, the Josephin domain with DUB activity, 
followed by a C-terminal tail containing 2 or 3 UIMs and a polyQ sequence of variable length. Five 
serine residues present in the UIMs (S236, S259, S260/S261, S340 and S352) have been 
identified as phosphorylation sites and an ubiquitylatable lysine residue was mapped to aminoacid 
117 in the JD. One functional NLS and two NES are also present in the JD. Adapted from [362]. (B) 
Solution structure of the JD (PBD code: 1YZB). The active site amino acid (Q9, C14, H119 and 
N134) localize in a cleft formed by the globular catalytic and the helical hairpin subdomains of the 
JD. Reproduced from [362]. 
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1.4.4.1 Function, biological function and molecular partners 
 
Deubiquitylating (DUB) activity and regulation of protein degradation: involvement in the UPS 
As for most DUBS, the precise physiological role of ATXN3 remains undetermined. However, 
multiple lines of evidence implicate ATXN3 in the UPS, playing a role in the cellular protein quality 
control. Supporting this idea, it is now widely accepted that ATXN3 has DUB activity in vitro 
mediated by the JD, being able to bind and cleave both K48 and K63-linked chains, in a UIM-
dependent manner [198, 354, 359, 363-365]. Curiously, Winborn and colleagues found that ATXN3 
preferentially cleaves K63-linked chains and chains of mixed K48 and K63 linkage, suggesting that it 
may function as a regulator of polyubiquitin chains with complex topology [359]. Additionally, ATXN3 
also interacts with polyubiquitylated proteins and subunits of the proteasome [198, 354, 363, 366], 
with the ubiquitin-like protein NEDD8 [367], with proteins known to be involved in the shuttling of 
substrates for proteasomal degradation, such as VCP/p97, Ubiquilin/PLIC1 and Rad23 homologues 
[363, 368-372], and with UBXN-5, an adaptor of substrate binding of VCP/p97 [373]. ATXN3 was 
also shown to bind polyUb chains in neuronal cells in a UIM-dependent manner [364]. 
Although when assessed using artificial substrates such as polyUb chains, Ub aldehyde and 
Ub-AMC, the DUB activity of ATXN3 in vitro appears to be very low, it was possible to determine that 
it has a preference for chains of no less than 4 Ub moieties, which notably corresponds to the 
smallest Ub stretch involved in the targeting of proteins for proteasomal degradation [285, 353, 
354, 357, 359]. In addition to facilitating protein degradation through the UPS, it has been proposed 
that ATXN3 partially deubiquitylates targeted proteins, preventing their degradation by binding 
through the UIMs. Indeed, it was shown that ATXN3 is able to block proteasome-dependent 
degradation of an artificial substrate in vitro, by editing K48-linked polyUb chains [374]. The low 
proteolytic activity of ATXN3 in vitro may be explained by the absence of an endogenous substrates 
and other external factor(s) that may be required for optimal proteolysis such as co-factors or 
activating molecular partners [375, 376]. In agreement with this idea, Reyes-Turcu and collaborators 
propose that as many DUBs, ATXN3 might require association with proper substrate(s) to acquire an 
optimal catalytsis-competent conformation. 
Studies using Atxn3 KO mice provided the first in vivo (albeit indirect) evidence that ATXN3 
may function as a DUB: these mice had increased levels of total ubiquitylated proteins, suggesting 
that ATXN3 may regulate the (de)ubiquitylation of target proteins [285, 288]. More recently, it was 
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also shown that the worm and mouse ATXN3 orthologues are involved in the turnover of a model 
substrate in vitro [288, 370]. 
The fact that mouse and nematode KOs for ATXN3 do not show an overt phenotype (other 
than a temperature sensitive movement impairment and an altered stress response in the worm 
[373, 377]) suggested the existence of redundancy among DUBS and/or compensatory mechanism 
in these organisms [70, 285, 288]. In contrast, the absence of ATXN3 in cell lines did lead to 
relevant cellular phenotypes, as described below, maybe because less compensation mechanisms 
take place. 
 
Transcriptional regulation 
Besides its role in protein degradation, ATXN3 has been involved in transcriptional 
regulation. The binding of ATXN3 to DNA together with in vitro and in situ molecular interaction 
studies, support a function of ATXN3 as a transcription regulator, through diverse mechanisms 
[378]. ATXN3 is known to interact with numerous transcriptional regulators (both activators and 
repressors): TATA box binding protein (TBP) associated factor 4 (TAF4) [379], cAMP response 
element-binding protein binding protein (CBP) [155, 378, 380], p300, p300/CBP associated factor 
(PCAF) [378], nuclear receptor co-repressor (NCoR1), HDAC 3 and 6 [374, 381], and forkhead box 
O (FOXO) transcription factor FOXO4 [382]. Moreover, through its interaction with HDAC3 and 
NCoR1, ATXN3 has been shown to decrease histone acetylation and consequent transcription, by 
inhibition of p300-mediated histone acetylation [378, 381].  
Interestingly, it has been proposed that the UPS may also be associated with transcriptional 
regulation. It has been hypothesized that ATXN3, through its DUB activity, may interfere with the 
turnover or the activation of transcription machinery components with which it interacts. Additionally, 
the structure of chromatin, which in turn regulates transcription, is also modulated by ubiquitylation 
[381]. 
 
Aggresome formation, cytoskeleton organization and myogenesis 
Another circumstance where ATXN3 has been associated with protein quality control 
systems is its proposed role in aggresome formation. Aggresomes are aggregates of misfolded/toxic 
proteins, found near the microtubule-organizing center (MTOC), when the UPS is compromised or 
overwhelmed. This protective process is dependent on microtubule-based transport [374]. Thus, the 
fact that ATXN3 interacts with dynein, HDAC6, PLIC1, microtubules, tubulin, and microtubule-
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associated protein 2 (MAP2), further supports the involvement of ATXN3 in aggresome formation. In 
agreement, ATXN3 was shown to co-localize with aggresomes and preaggresomes [290, 372, 374, 
383]. Indeed, a recent study showed that ATXN3 promotes the recruitment of a mutant version of 
superoxide dismutase 1 (SOD1, involved in ALS) to the aggresome, a process that was found to be 
dependent on the DUB activity of ATXN3 [384]. 
Besides its involvement in aggresome formation, ATXN3 has also been shown to be 
important for the organization of the cytoskeleton itself. Absence of ATXN3 was shown to cause 
disorganization of cytoskeleton components (microtubules, filaments and intermediate filaments), 
loss of cell adhesion and morphological alterations in different cell types (namely HeLa and C2C12 
cell lines) [70, 290].  ATXN3 was also shown to be critical for the initial myoblast differentiation 
steps in C2C12 cells, for organization of the cytoskeleton of myoblasts, and for regulation of the 
levels of integrin subunits [70], which are key participants in muscle differentiation (Reviewed in 
[385]). ATXN3 was shown to interact with the alpha-5 subunit of integrin (ITGA5) and to repress its 
degradation, with impact on myogenesis. 
 
Heat shock and oxidative stress response 
Several studies have proposed that ATXN3 may participate in the cellular stress response. It 
was shown that heat shock and oxidative stress increase the nuclear localization of ATXN3, most 
likely by regulating expression of genes that encode components of the cellular stress response 
[386]. Indeed, another study showed that upon oxidative stress, ATXN3 is translocated to the 
nucleus together with its molecular partner FOXO4, activating the transcription of manganese 
superoxide dismutase (SOD2), which in turn protects cells from oxidative damage [382]. 
Additionally, Reina and colleagues found that ATXN3 KO fibroblasts were more sensitive to heat 
stress than controls [386].  
Interestingly, C. elegans atx-3 KOs display a temperature-dependent phenotype: when 
subjected to a noxious heat shock stimulus, ATXN-3 mutants have an exarcebated stress response 
and survive significantly better than Wild type animals, as a result of activation of DAF-16 pathway 
and a consequent overexpression of molecular chaperones [377]. These results support the 
involvement of ATXN3 in stress response, in this case a negative regulatory role [373]. 
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Role in longevity 
Recent work provided the first indications for a role of ataxin-3 in the regulation of longevity. 
Through a synergistic interaction with the AAA ATPase valosin-containing protein (VCP/p97), ataxin-3 
was shown to be important in longevity, as double KOs in C. elegans have a longer lifespan than 
Wild type (WT) worms. Additionally, ataxin-3 also seems to regulate the ubiquitylation and 
degradation of components of the insulin/insulin-like growth factor 1 (IGF1) signaling pathway 
implicated in lifespan regulation, further suggesting a role for ataxin-3 in longevity [370]. 
Interestingly, the IGF1 pathway has been proposed as a link between aging, proteotoxicity and 
neurodegenerative diseases [387-389], as is a strong modifier of MJD pathogenesis [308].  
 
Regulation of E3s function 
Typically, DUBs oppose E3’s activity by mediating the removal of Ub from target proteins. 
However, and because they are often regulated by monoubiquitylation, DUBs can also modulate the 
activity of these enzymes. ATXN3 was demonstrated to deubiquitylate the Hsc70 interacting protein 
(CHIP), which in turn enhances the overall DUB activity of ATXN3 [390]. ATXN3 is recruited to the 
ubiquitylation complex by monoubiquitylated CHIP, where it limits the length of polyUb chains of 
substrates and terminates the ubiquitylation cycle by removing monoUb from CHIP [391]. The fact 
that changes in ATXN3 levels do not affect CHIP levels, makes it likely that ATXN3 regulates the E3 
ligase activity of CHIP rather than its degradation.  
ATXN3 also interacts with Parkin, the Parkinson Disease-associated E3. Through this interaction, 
ATXN3 regulates the ability of Parkin to ubiquitylate itself [392, 393] but does not affect its stability 
[69]. It is possible that ATXN3 controls the levels and edits the architecture of Ub chains linked to 
Parkin, thus targeting this protein for specific cellular pathways or affecting its activation state [69]. 
 
Neuroprotection 
ATXN3 has also been proposed to act as a neuroprotectant. Studies conducted in 
Drosophila showed that overexpression of ATXN3 alleviated neurodegeneration caused by several 
polyQ disease proteins, including ATXN3 itself, huntingtin and ataxin-1 [394]. Also, Tsou and 
collaborators recently demonstrated that catalytically active ATXN3 protects against polyQ-dependent 
degeneration in flies. This neuroprotective process seems to be dependent on ATXN3 ubiquitylation 
[395]. Of notice, Drosophila does not possess an orthologue of ATXN3. This may explain the 
contradictory evidence, showing that ATXN3 does not serve as a neuroprotectant in other species. 
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Hubener and colleagues showed that co-expression of normal ATXN3 with the pathogenic version 
did not have a beneficial effect in a mouse model of MJD [396]. Also, overexpression of Wild type 
ATXN3 did not protect against MJD pathology in a rat model of MJD [284] nor in a C. elegans model 
of the disease [397].  
 
DNA repair 
 A role for ATXN3 in DNA repair has also been suggested. Wang and collaborators found that 
ATXN3 interacts binds to important participants of the DNA repair pathway, the two human 
homologues of the yeast DNA repair protein RAD23, HHR23A and HHR23B [371].  
 
1.4.4.2 Regulation of Ataxin-3 DUB activity 
Due to its critical cellular function, DUBs are precisely regulated through diverse 
mechanisms. The cellular localization of ATXN3 is one of the mechanisms that might be influencing 
its function [376]. On the other hand, regulation of ATXN3 localization seems to be determined by 
post-translational modifications (PTMs) (Figure 4). Additionally, PTMs can enhance ATXN3 activity, 
as in vitro experiments reported low activity of ATXN3 in the absence of PTMS [355, 375].  
Another factor influencing ATXN3 DUB activity is its interaction with other proteins (scaffolds 
or adaptors), important for DUB activation and the correct placement of substrate molecules relative 
to the catalytic site, thus compensating for the possible low affinity with certain substrates [376]. 
PTMs may also be important in regulating these interactions and thus, interfering with ATXN3 DUB 
activity. 
Todi and co-workers demonstrated that ATXN3 monoubiquitylation increases its DUB activity 
[360]. Indeed, ubiquitylation of the residue K117 of the JD was sufficient to enhance ATXN3 DUB 
activity both in vitro and in cells [390] (Figure 4). 
Several E3 ligases and proteasome shuttle proteins were reported to be involved in ATXN3 
proteasome-mediated degradation, such as E4B/VCP, HIP/HSP70, E6-AP/HSP70 and Gp78 [398-
401]. Direct binding to the 19S proteasome also seems to control ATXN3 degradation [402]. More 
recently, it was shown that this ubiquitination-independent degradation of ATXN3 is also regulated by 
protein interactions with the proteasome-associated proteins Rad23A/B, through an ubiquitin-
binding site 2 (UbS2) located in the N terminal domain of ATXN3 [403]. However, it remains unclear 
whether other protein quality control pathways may also be involved in the regulation of ATXN3 
turnover. Interestingly, ATXN3 turnover may also be regulated by its own DUB activity [404].  
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Objectives 
 
In the last years several published works have contributed for our understanding of ATXN3 
biochemical activity in vitro and in cells. Although the enzymatic activities described for this protein 
as a DUB suggest a role for ATXN3 in the UPS, the physiologic and cellular relevance of this activity 
has not been extensively characterized, specially in neurons, and the substrates of its action remain 
mostly unidentified. 
 
The goal of this work was to define the functional relevance of ATXN3 and to identify new 
substrates of its DUB activity in neurons. We also explored the potential perturbation (gain or loss) of 
ATXN3 function by expansion of the polyQ tract at its C-terminus, and its contribution to human 
disease. 
 
The specific aims of this work were: 
 
To characterize the phenotypic effects caused by absence of ATXN3 or 
overexpression of a catalytically inactive version of the protein: morphology, proliferation, 
migration, cell death, differentiation, signaling pathways and gene expression (Chapter 2) 
 
To study the effects of ATXN3 absence on alternative splicing: splicing of 
microtubule associated protein tau, global splicing patterns (Chapters 3, 4) 
 
To identify potential substrates of ATXN3 DUB activity in neurons: characterization 
of the ubiquitome of neuronal cells lacking ATXN3 (Chapter 4) 
 
To define the relevance of candidate ATXN3 substrates for the disease process 
in cellular and mouse models of MJD: cellular consequences of overexpression of mutant 
ATXN3 and link to MJD pathogenesis (Chapters 2, 3, 4) 
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The physiological function of Ataxin-3 (ATXN3), a deubiquitylase (DUB) involved in Machado–Joseph Disease
(MJD), remains elusive. In this study,wedemonstrate that ATXN3 is required for neuronal differentiation and for
normal cell morphology, cytoskeletal organization, proliferation and survival of SH-SY5Y and PC12 cells. This
cellular phenotype is associated with increased proteasomal degradation of a5 integrin subunit (ITGA5) and
reduced activation of integrin signalling and is rescued by ITGA5 overexpression. Interestingly, silencing of
ATXN3, overexpression of mutant versions of ATXN3 lacking catalytic activity or bearing an expanded polyglu-
tamine (polyQ) tract led to partially overlapping phenotypes. In vivo analysis showed that both Atxn3 knockout
and MJD transgenic mice had decreased levels of ITGA5 in the brain. Furthermore, abnormal morphology and
reducedbranchingwereobservedboth in culturedneuronsexpressingshRNA forATXN3and in thoseobtained
fromMJDmice. Our results show that ATXN3 rescues ITGA5 fromproteasomal degradation in neurons and that
polyQexpansion causes apartial loss of this cellular function, resulting in reduced integrin signalling andneur-
onal cytoskeleton modifications, which may be contributing to neurodegeneration.
INTRODUCTION
The importance of ubiquitin signalling in the nervous system is
becoming increasingly recognized (1–3). Impairment of the
ubiquitin-proteasome pathway (UPP) and mutations in some
of its components have been linked to both neurodevelopmental
and neurodegenerative disorders, the later including Alzhei-
mer’s, Parkinson’s and Huntington’s diseases (4–6). In the
context of the nervous system, deubiquitylases (DUBs) are
central players in the regulation of protein ubiquitylation in pro-
cesses, such as (i) axon guidance and establishment of neuronal
connectivity (7), (ii) dendritic and axon pruning (8,9), (iii) regu-
lation of synaptic number and size (10,11), (iv) regulation of
synaptic plasticity (11) and (v) modulation of the postsynaptic
structure (7,12).
Ataxin-3 (ATXN3) is a protein with DUB activity known to be
mutated in Machado–Joseph Disease (MJD), an autosomal
dominant neurodegenerative disorder caused by a polygluta-
mine (polyQ) tract expansion within the C-terminus of this
protein (13). PolyQ expansions are thought to cause deleterious
effects in neurons by conferring toxic properties to the proteins
into which they are inserted (gain of function model) and by per-
turbing some of the biological activities of these proteins (partial
loss of function model) (14–16).
Although the physiological role and substrates of ATXN3 are
mostly unknown, functional analyses in different cell and animal
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models have shed some light on its biological functions. Evi-
dence supports ATXN3 involvement in protein quality control
pathways: (i) DUB activity conferred by cysteine 14 (C14)
within the N-terminal Josephin-domain, which is essential for
its protease activity (17–19); (ii) interaction with ubiquitin,
polyubiquitin chains, ubiquitylated proteins (20–22) and prote-
asome subunits (21,23); (iii) interaction with the ubiquitin-like
protein NEDD8 and deneddylase activity (24) and (iv) binding
to and regulating the activity of VCP/p97, which is involved in
shuttling substrates for proteasomal degradation (25,26) and
binding to UBXN-5, an adaptor of substrate binding to VCP
(27). In addition to its involvement in the regulation of protein
degradation, the numerous molecular partners of ATXN3
known to date suggest that it is involved in other cellular pro-
cesses (28–31). Although mouse and nematode knockouts
(KO) for this gene are viable and show no gross phenotype,
our previous results showed that the absence of ataxin-3 in Cae-
norhabditis elegans affects the expression of several transcripts
related to cell structure/motility (32) and that ataxin-3 regulates
the degradation of integrin subunits such as a5 integrin subunit
(ITGA5), a molecular partner of ATXN3 (33). These regulatory
functions were shown to be important for the cytoskeleton organ-
ization of different cell types (31,33).
Integrins are the major family of transmembrane cell surface
receptors that mediate cell-to-cell and cell-to-extracellular
matrix (ECM) interactions, regulating many cellular functions
(34,35). Integrins are implicated in many aspects of neuronal
development and function, such as proliferation, survival, adhe-
sion, cytoskeletal organization, process outgrowth and synaptic
function (36–40). Furthermore, cumulative evidence suggests
that a disruption of the neuronal cytoskeleton network may be
a common feature contributing to several neurodegenerative dis-
eases (41,42). Data suggest that cytoskeletal deregulation initi-
ates a cascade of intracellular events that may underlie the loss
of synaptic connectivity, the decreased ability to transmit incom-
ing axonal information and the cell death that is observed in these
disorders (43–47).
In this work, we demonstrate that ATXN3 depletion deregu-
lates ITGA5 levels through increased proteasomal degradation,
which leads to decreased cell adhesion and disorganization of the
neuronal cytoskeleton. Loss of function of ATXN3 also has a
negative impact on neuronal differentiation and on the asso-
ciated exit from the cell cycle, promoting continued prolifer-
ation. Our data also indicate that an expanded polyQ tract
leads to a partial loss of the cellular function of ATXN3 that
may be relevant to neurodegeneration.
RESULTS
ATXN3 knock down results in altered morphology,
proliferation, migration and cell death in differentiating
SH-SY5Y cells
We evaluated the effects of ataxin-3 silencing in SH-SY5Y
human neuroblastoma cells, widely used as a model for neuronal
function and differentiation (1). After lentiviral infection and
puromycin selection, we obtained monoclonal stable SH-SY5Y
cell lines containing a shRNA sequence targeting ATXN3
(ATXN3shRNA), the empty vector pLKO.1 (SH-SY5Y-pLKO.1) or
a scrambled shRNA (SCRshRNA) sequence. A western blot analysis
of protein extracts confirmed that ATXN3 expression was mark-
edly suppressed and almost undetectable in ATXN3shRNA clones
when compared with SH-SY5Y-pLKO.1 and SCRshRNA con-
trols (Supplementary Material, Fig. S1A and B). We confirmed
by real-time quantitative reverse transcription polymerase chain
reaction (qRT-PCR) that the shRNA sequence used for silencing
ATXN3 did not interfere with similar mRNAs, as the expression
levels of the transcripts encoding the ATXN3-like (ATXN3L)
and Josephin-domain proteins (JOSD1 and JOSD2) were not
significantly different between ATXN3shRNA and SCRshRNA
cells (Supplementary Material, Fig. S1C). ATXN3 depletion
in non-differentiated SH-SY5Y cells had a mild impact on cell
morphology (Supplementary Material, Fig. S2A) and statisti-
cally significant effect in migration (Supplementary Material,
Fig. S2B); however, it did not affect cell cycle progression
(Supplementary Material, Fig. S2C) or survival (Supplementary
Material, Fig. S2E). Subsequently, we sought to analyze the
effect of ATXN3 depletion on retinoic acid (RA)-differentiated
SH-SY5Y cells. RA has previously been shown to induce differ-
entiation and inhibit the cellular growth of cultured human
SH-SY5Y cells (48). As shown in Figure 1A, after 7 days of
RA-induced differentiation, SCRshRNA control cells exhibited
branching neuritic networks with small rounded bodies and an
inhibition of cell proliferation, whereas cells in which ATXN3
had been silenced displayed large, flat cell bodies with very
few extensions. These striking morphological changes were
observed in the different clonal cell lines and were evident in
cells with only a few passages after silencing (fATXN3shRNA)
as well as cells with long-term silencing of ATXN3, albeit in
a more attenuated way in the latter. Such partial recovery in
cell morphology might be explained by compensatory mechan-
isms, as has been observed in different ATXN3 KO animal
models (32,49).
After RA treatment, there were significantly more ATXN3shRNA
cells when compared with SCRshRNA control cultures (P ¼
0.0019) (Fig. 1B). Consistent with a higher proliferation rate,
ATXN3shRNA cultures showed an increased number of
Ki-67-positive cells (61.57% versus 24.24% in control cells;
P ¼ 9.46 × 1026) (Fig. 1C and D). Accordingly, in comparison
to the control SCRshRNA cells, the ATXN3shRNA cell population
had a greater number of cells in S phase (24.4% compared with
14.5%; P ¼ 0.0018) (Fig. 1E and F). This higher cell prolifer-
ation was accompanied by an increased cell death in RA-treated
ATXN3shRNA cultures as determined by flow cytometry analysis
(22.8% versus 8.02% of PI-positive cells; P ¼ 0.0001) that was
even higher in fATXN3shRNA cultures (40.1%; P ¼ 5.60 ×
1025) (Fig. 1G). Because it has previously been demonstrated
that ataxin-3 interacts with and regulates the levels of integrins
(33) and because adhesion to the substrate is key for cell migra-
tion, we analyzed collective cell movement using a wound
healing assay (50). Cells were monitored for 24 h starting imme-
diately after the initial wound. As shown in Figure 1H and I,
ATXN3shRNA cells had partially recolonized the scratched area
and exhibited a 50% increase in the cell migration rate when
compared with SCRshRNA cells (P ¼ 4.42 × 1027), which sug-
gests that ATXN3shRNA cells did not adhere as well to the sub-
strate. The same was observed in two other clonal cell lines
with similar degrees of ATXN3 silencing. Interestingly, these
effects of ATXN3 absence seem to be generalized to different
neuronal cell types, as similar phenotypes were observed in
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Figure1.Characterization of a SH-SY5Y neuronal cell line stably silenced for ATXN3. (A) ATXN3shRNA cells were less elongated and showed thin cell extensions as
compared with the SCRshRNA controls after RA treatment. This phenotype was more pronounced in fATXN3shRNA cells. Scale bar: 100 mm. (B) RA treatment did not
inhibit proliferation of ATXN3shRNA cells. (C and D) Ki-67 staining (red) showed that RA did not inhibit proliferation of ATXN3shRNA cells. Nuclei were counter-
stained with DAPI (blue). Scale bar: 200 mm. (E and F) Flow cytometry analysis of the cell cycle showed an increase in the percentage of cells in S phase in
ATXN3shRNA cultures. (G) Flow cytometry analysis using PI showed an increased cell death in ATXN3shRNA cultures, which was even higher in fATXN3shRNA
cultures. (H and I) ATXN3 knockdown increased SH-SY5Y cell migration in a wound scratch assay. Bars represent migration rate expressed as a percentage
of control and calculated as the proportion of the distance between the borderlines caused by scratching, to the distance that remained cell-free after 24 h. n ≥ 3 in-
dependent biological replicates in all experiments. ∗∗P, 0.01; ∗∗∗P , 0.001.
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PC12 cells upon ATXN3 silencing (PC12_ATXN3shRNA), in the
context of nerve growth factor (NGF)-induced differentiation
(Supplementary Material, Figs S1D–F and S6).
ATXN3shRNA cells fail to progress towards a mature
neuronal phenotype
RA treatment increases the synthesis of neuron-specific enzy-
mes, neurotransmitters, neuropeptide hormones, growth
factors and cell surface receptors and induces changes in cyto-
skeleton markers in SH-SY5Y cells (51). Because we observed
that neuronal differentiation was impaired in ATXN3shRNA
cells, we wanted to further characterize the differentiation
status of these cells. For this, we evaluated several neuronal
markers associated with RA-induced differentiation (52).
As expected, we observed increased mRNA levels for most of
the neuronal markers in the SCRshRNA cells after RA treatment
and decreased expression of nestin, a marker of undifferentiated
cells (Fig. 2A). In contrast, the mRNA expression pattern in
RA-treated ATXN3shRNA cells was consistent with immature
stages of neuronal differentiation, with increased expression of
nestin (P ¼ 0.02) and decreased expression of bIII-tubulin
(P ¼ 0.0002), laminin (P ¼ 0.02), synaptophysin (P ¼ 0.01),
neurogenin (P ¼ 0.03), neuroD1 (P ¼ 7.63 × 1025) and dopa-
mine transporter (DAT) (P ¼ 0.04) (Fig. 2A). Consistently,
decreased expression of some neuronal differentiation
markers, including bIII-tubulin (P ¼ 0.01), was also observed
in NGF-treated PC12_ATXN3shRNA cells (Supplementary
Material, Fig. S6F). Immunocytochemistry confirmed that the
percentage of bIII-tubulin positive cells, a marker for mature
neurons, was lower in ATXN3shRNA cultures (86.26% versus
97.26%) upon RA treatment and more significantly so in
fATXN3shRNA cells (41.96%; P¼ 4.12× 1028) (Fig. 2B and C).
Additionally, the average neurite length was significantly
reduced in RA-treated fATXN3shRNA cells (P ¼ 1.18× 10215)
when compared with control cells (Fig. 2D), which is com-
patible with the immature filopodia phenotype observed in the
absence of ATXN3.
These results indicate that ATXN3-deficient cells fail to pro-
gress towards a mature neural phenotype upon RA treatment.
Nevertheless, we verified that these cells are able to respond to
RA, as demonstrated by the induction of the RA-responsive
tissue transglutaminase (tTG) gene (53) (Supplementary Mater-
ial, Fig. S3A).
ATXN3 depletion disrupts the actin cytoskeleton
network in SH-SY5Y cells
Neuronal development is highly dependent on controlled cyto-
skeleton dynamics and reorganization, and it has been shown
that in several neurodegenerative diseases, this reorganization
is defective (41,42). Phalloidin staining of actin polymers
revealed the presence of disarrayed actin filaments and aggre-
gates in ATXN3shRNA and fATXN3shRNA cells (Fig. 3A) as
well as in PC12_ATXN3shRNA cells (Supplementary Material,
Fig. S6G). Additionally, the ATXN3shRNA cells exhibited a
higher number of small filopodia (microspikes) and the
PC12_ATXN3shRNA cells grew mostly in multilayers, which
were not observed in the control cultures. These cytoplasmic
projections are normally present in migrating cells and at
initial stages of neurogenesis (54). This finding further supports
the hypothesis that in the absence of ATXN3, cells fail to prop-
erly complete differentiation and to establish mature neuronal
processes. Very importantly, primary neurons with silenced
ATXN3 expression also show a highly disrupted cytoskeleton
network as compared with the scrambled controls, providing
further evidence for the role of ataxin-3 in the regulation of the
cytoskeleton (Fig. 3B).
Absence of ATXN3 leads to downregulation
of a5 integrin signalling
Integrins play an important role in mediating cell adhesion to the
ECM proteins and activating signalling cascades that control
cytoskeletal organization and cell motility (55,56). We have pre-
viously reported that ataxin-3 regulates the degradation of integ-
rin subunits such as the ITGA5 (33). Accordingly, we observed
that depletion of ATXN3 downregulates ITGA5 protein levels in
SH-SY5Y (P ¼ 0.001) and PC12 (P ¼ 0.0047) cells induced to
differentiate (with RA and NGF treatment, respectively)
(Fig. 4A and B, Supplementary Material, Fig. S6H–J, respect-
ively), but does not affect those of other integrin subunits, such
as the a1 integrin subunit (Supplementary Material, Fig. S4A).
Because a5b1 is the receptor for fibronectin (FN), which has
been implicated in neuronal cell migration, adhesion, prolifer-
ation and differentiation both in vitro and in vivo (36), we next
assessed the FN-binding capacity of ATXN3shRNA cells using
a CultreCoatwFibronectin 96 well adhesion assay (Ambsio).
As expected, the adhesion of ATXN3shRNA cells to FN was sig-
nificantly reduced (89.5%; P ¼ 0.004) in relation to SCRshRNA
controls (Fig. 4C). We subsequently assessed cell migration on
an FN substrate. For this, we coated the plates with FN and per-
formed the wound healing assay as described above. As shown in
Figure 4D, RA-treated ATXN3shRNA cells had almost fully reco-
lonized the scratched area with an 89% increase in the wound-
healing rate when compared with the RA-treated SCRshRNA
control cells (P ¼ 0.0009). Interestingly, this phenotype was
specific for FN, because on laminin or poly-D-lysine substrates,
no significant differences between cells with or without ATXN3
were observed (Supplementary Material, Fig. S4B). Additional-
ly, it has been suggested that integrins modulate CDK5 activity,
which in turn modulates the activity of the ERK and PI3K/AKT
pathways (57) affecting neuronal development and survival
(58). Immunoblotting analysis of RA-treated ATXN3shRNA
cells showed a decreased expression of p35 (P ¼ 5.94 ×
1025), which is known to be associated with a decrease in
CDK5 activity (Fig. 4E and F). The decrease in CDK5/p35
complex activity is associated with reduced phosphorylation-
mediated activation of ERK1/2 (P ¼ 0.001), AKT (P ¼ 0.005)
and PI3K (P ¼ 0.012) in ATXN3shRNA cells, with no alteration
in the total levels of these proteins, and, with a downregulation
of BCL2 (P ¼ 0.007) (Fig. 4E and F). BCL2 inhibits BAX and
BAK apoptotic functions (59); therefore, decreased levels of
BCL2 may contribute to the increased neuronal death observed
in ATXN3shRNA cultures (Fig. 1G). Interestingly, the levels of
nuclear CDK5 were also significantly reduced in ATXN3shRNA
cells (Fig. 4E and F), which correlates well with the increased
proliferation (Fig. 1C and D) observed upon RA treatment
(60). Knowing that integrin cell signalling can modulate the ac-
tivity of Rho and Rac1 GTPases (61), we next investigated if the
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decreased levels of ITGA5 affected the activity of these regula-
tory proteins in neuronal cells lacking ATXN3. We found that
the activities of both Rho and Rac1 proteins were significantly
reduced in RA-treated ATXN3shRNA cells (Fig. 4G). To verify
the relevance of our findings in vivo, we assessed the levels of
Itga5 in the cerebellum of Atxn3 KO mice (62), confirming
that they were reduced as observed in the ATXN3 knockdown
neuronal cell cultures (Fig. 4H and I).
Based on previous observations in non-neuronal cells (33) and
considering that ATXN3 is a DUB enzyme, we hypothesized
that ATXN3 could modify ubiquitylation and regulate the deg-
radation of ITGA5 through the UPP. To test this hypothesis,
we assessed the levels of ITGA5 upon proteasome inhibition
with 5 mM MG132 for 24 h in cultures treated with RA and
found them to be significantly increased in ATXN3shRNA cells
(Fig. 4J). Additionally, inhibition of protein synthesis by cyclo-
heximide (CHX) treatment showed a decrease in ITGA5 half-
life in these cells (Fig. 4K); this suggests that ATXN3 normally
acts to inhibit ITGA5 degradation also in neurons. We found that
inhibition of the proteasome with MG132 increased the levels of
Figure 2. Impairment of the differentiation process in ATXN3shRNA cultures. (A) qRT-PCR analysis of the variation of neuronal markers after RA treatment showed
that the mRNA level was not altered for TH and DRD2, was increased for nestin and decreased for the other markers analyzed in ATXN3shRNA cultures. Transcript
levelswerenormalized to levels in undifferentiated cells and to theHBMSgene. (B andC) ATXN3shRNA culturespresenteda decreased numberofbIII-tubulinpositive
cells. (D) The average length of the neurites was reduced in fATXN3shRNA cells. This morphological alteration was attenuated after long-term silencing of ATXN3.
∗P, 0.05; n ≥ 3 independent biological replicates in all experiments. ∗∗P , 0.01; ∗∗∗P , 0.001.
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Figure 3.ATXN3 depletion affects the actin cytoskeleton network in neuronal cells. (A) Phalloidin staining (green) showed unparallel actin filaments and abnormal
filopodia in ATXN3shRNA cells. The right panel shows a detailed view of isolated cells. (B) Primary neurons silenced for ATXN3 (GFP positive cells) showed a dis-
rupted network of actin filaments as assessed by phalloidin staining (green). The lower panel shows a detailed view of isolated cells. Nuclei were counterstained with
DAPI (purple). n ≥ 3 independent biological replicates in all experiments. Scale bar is 5 mm.
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Figure4.Decrease in adhesion proteins and decreased activation of regulatory molecules in ATXN3shRNA cells. (A andB) Western blot analysis showed a decrease of
ITGA5 levels in ATXN3shRNA cells. (C) Depletion of ATXN3 leads to decreased FN responsiveness in SH-SY5Y cells. (D) ATXN3shRNA cells showed increased cell
migration on a FN substrate. Bars represent migration rate relative to control cells and expressed as the proportion of the mean distance that remained cell free after
24 h. (E andF) Deregulation of the ERK and PI3K/AKT pathways, with decreased levels of p35, pERK1/2, pAKT and PI3K, and decreased levels of nuclear CDK5 in
ATXN3shRNA cells. The resultswere normalized for H3 levels. (G) ATXN3shRNA cells showedsignificantly decreased levelsof active Rac1and Rho proteins. (Hand I)
Western blot analysis showed decreased levels of Itga5 in the cerebellum of Atxn3 KO mice. The results were normalized for a-tubulin levels. (J) Levels of ITGA5
were increased upon treatment with 5 mM MG132 for 24 h after induction of differentiation with RA for 7 days in ATXN3shRNA cells. (K) Relative amounts of ITGA5
in SCRshRNA and ATXN3shRNA cells at various cycloheximide treatment times. (L) Pulldown of polyubiquitylated proteins showed an increase in ubiquitylated
forms of ITGA5 in ATXN3shRNA cells. The results were normalized for H3 or CD147 levels. n ≥ 3 independent biological replicates in all experiments. ∗P, 0.05,
∗∗P, 0.01, ∗∗∗P, 0.001.
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ubiquitylated ITGA5 in ATXN3shRNA cells (P ¼ 0.02) (Fig. 4L).
We confirmed that ATXN3 affects the steady-state levels of
ITGA5 by acting at the protein level, as qRT-PCR analysis
revealed no significant differences in ITGA5 transcript levels
between ATXN3shRNA and SCRshRNA cells (Supplementary
Material, Fig. S3B). Together, these results suggest that exces-
sive degradationof ITGA5inATXN3shRNA cells induced todiffer-
entiate caused defects in adhesion to FN substrates, deregulation
of the ERK and PI3K/AKT pathways and a decrease in the activity
of small GTPases Rho and Rac1, leading to abnormal cell morph-
ology, motility, proliferation and differentiation.
Restoring the levels of ITGA5 ameliorates the phenotype
of ATXN3shRNA cells
To test if the ATXN3 depletion phenotype could be reverted by
the normalization of ITGA5 levels, we overexpressed ITGA5 in
ATXN3shRNA cells (ATXN3shRNA_a5) and evaluated their
phenotype upon RA treatment. We found that not only were
the cellular morphology (Fig. 5A) and cytoskeletal organiza-
tion (Fig. 5B) significantly restored but also the ATXN3shRNA_a5
cells expressed normal levels of the majority of the neuronal
markers tested (Fig. 5C). In addition, the migration rate
(Fig. 5D) and cell cycle progression (Fig. 5E and F) were
comparable to the SCRshRNA_a5 control cells. Therefore,
we conclude that most aspects of the phenotype observed in
ATXN3-deficient cells were caused by the reduction in the
ITGA5 levels.
Interference with the DUB activity of ATXN3 leads
to an abnormal neuronal phenotype that parallels
the loss of expression of this protein
To clarify whether the regulation of ITGA5 levels by ATXN3
was dependent on its DUB activity, we generated a SH-SY5Y
cell line that stably overexpressed a catalytically inert version
of ATXN3 (Supplementary Material, Fig. S5A), obtained by
mutating the catalytic cysteine residue (C14) (ATXN3_
C14A). Interestingly, cells expressing ATXN3_C14A recapitu-
lated many characteristics of ATXN3-deficient neurons: (i) a
round, flat shape with very few and short extensions in compari-
son to the controls (Supplementary Material, Fig. S5B); (ii) a
lack of proliferative inhibition after RA treatment as assessed
by Ki-67 staining (62.97% Ki-67-positive cells in
ATXN3_C14A cultures versus 25.03% for the pEGFP controls;
P ¼ 1.10 × 10214) (Fig. 6A and B) and cell cycle analysis
(74.9% in S phase versus 17.5%; P ¼ 0.0018) (Fig. 6C and D);
(iii) an increased cell death (32.1% versus 10.9%; P ¼ 0.002)
(Fig. 6E); (iv) a significant decrease in mRNA levels for
several neuronal markers, indicating an immature differenti-
ation status (Fig. 6F) and (v) misaligned actin with randomly dis-
tributed filaments (Fig. 6G). ATXN3_C14A cells also showed
decreased levels of ITGA5 (P ¼ 0.0017) and downstream
targets of CDK5 (the expression of p35 protein was not detect-
able) (Fig. 6H and I). These results suggest that ATXN3 with
the C14A mutation interferes with the function of normal
(endogenous) ATXN3 through a dominant negative effect, pro-
voking a more severe phenotype as compared with the silencing,
probably due to the lack of the compensatory mechanisms.
Importantly, as found in ATXN3shRNA cells (Fig. 4J), 5 mM
MG132 treatment for 24 h increased the levels of polyubiquity-
lated ITGA5 in ATXN3_C14A cultures treated with RA (Fig. 6H
and I), supporting the hypothesis that ITGA5 is a substrate of the
DUB activity of ATXN3 in neurons.
PolyQ expansion in ATXN3 causes a similar but milder
neuronal phenotype than the absence of this protein
To determine whether the presence of an expanded polyQ tract
within ATXN3 would lead to a gain or loss of function, we gen-
erated a SH-SY5Y cell line expressing an ATXN3 protein
bearing 83 glutamines (ATXN3_83Q) (Supplementary Mater-
ial, Fig. S5A). We found that, although expression of the
polyQ did not cause visible aggregation of the expanded
ATXN3, it led to a similar but slightly milder neuronal pheno-
type than the one observed in cells lacking this protein. Upon
RA treatment, the cells displayed: (i) an abnormal morphology
without extensions (Supplementary Material, Fig. S5B); (ii)
maintenance of their proliferative activity (64.39% Ki-67-
positive cells; P ¼ 1.03 × 10213) (Fig. 7A and B); an increased
proportion of cells in the S phase (80.5% versus 17.5% for the
pEGFP controls; P ¼ 0.0008) (Fig. 7C and D); (iii) increased
cell death (25.4% versus 18.4% for ATXN3_28Q; P ¼ 0.009
and 10.9% for the pEGFP controls; P ¼ 1.43 × 1025)
(Fig. 7E); (iv) reduced expression of several neuronal differenti-
ation markers (Fig. 7F) and (v) disorganization of the actin
cytoskeleton (Fig. 7G). ATXN3_83Q cells also had reduced
levels of ITGA5 (P ¼ 0.01) and decreased activation of its
downstream targets (Fig. 7H and I). While overexpression to
similar levels, i.e. 2.5-fold, of wild-type (WT) ATXN3 (with
28 glutamines) also caused some degree of perturbation in differ-
entiation and cytoskeleton organization, the effects were much
milder than those of ATXN3 loss of function or polyQ expansion
(Fig. 7). Together, these results suggest that the dose of ATXN3
needs to be strictly balanced and that polyQ expansion perturbs
the normal function of ATXN3 in neuronal cells.
In vivo evidence for downregulation ofa5 integrin signalling
in the context of Machado–Joseph disease
To investigate whether the partial loss of function of expanded
ATXN3 could contribute to the pathogenesis of MJD, we ana-
lyzed the levels of Itga5 in the nervous system of an MJD
mouse model (CMVMJD135) generated in our lab, expressing
an expanded human ATXN3 with 135 glutamines and mimick-
ing the neurological and neuropathological phenotype of the
human disease, as described elsewhere (63). As shown in
Figure 8A and B, CMVMJD135 mice had significantly
reduced levels of Itga5 in the brainstem (an affected brain
region) (P ¼ 0.04) and dorsal root ganglia (DRG) (P ¼
0.0019). Considering the cytoskeletal disorganization and
reduced branching phenotype observed in the absence of
ATXN3, we analyzed neurons isolated from the DRGs of
CMVMJD135 mice. We found a marked difference in the
morphology of these neurons (Fig. 8C and D), with a drastic re-
duction in both the total (P ¼ 1.4 × 1027) and mean (P ¼ 1.6 ×
10212) neurite length when compared with WT littermate con-
trols (Fig. 8C and D). Additionally, the cell bodies of the
DRGs from transgenic animals had a reduced diameter in com-
parison to those from WT controls (P ¼ 3.63 × 10210) (Fig. 8C
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Figure 5. The phenotype observed in ATXN3shRNA is dependent on a5 integrin subunit levels. (A) Overexpression of ITGA5 in ATXN3shRNA cells
(ATXN3shRNA_a5) restored their cellular morphology upon RA treatment. Scale bar: 100 mm. (B) ATXN3shRNA_a5 cells no longer presented detectable actin fila-
ment disorganization, as shown by phalloidin staining (green). Nuclei were counterstained with DAPI (purple). Upper panel scale bar: 20 mm. Lower panel scale bar:
5 mm. (C) mRNA levels of the neuronal markers analyzed by qRT-PCR in ATXN3shRNA_a5 cells were normal and comparable to the SCRshRNA_a5 control cells.
mRNA levels were normalized to undifferentiated cells andHMBSgene. (D) Normalized ITGA5 levels abolished their increased migration of ATXN3shRNA cells in a
woundscratch assay, 24 h after scratching. Bars represent migration rate expressed as a percentage of control and calculatedcalculated as the proportionof the distance
between the borderlines caused by scratching, to the distance that remained cell-free after 24 h. (E and F) Normal cell cycle in ATXN3shRNA_a5 cells. n ≥ 3 inde-
pendent biological replicates in all experiments. ∗P , 0.05.
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Figure 6.Effects of ATXN3 silencing is likely related to its DUB activity. (A andB) RA treatment did not inhibit proliferation of ATXN3_C14A cells, as assessed by
Ki-67 labelling (red). Nuclei were counterstained with DAPI (blue). Scale bar: 200 mm. (C andD) Flow cytometry analysis of the cell cycle showed an increase in S
phase in ATXN3_C14A cultures. (E) ATXN3_C14A cultures presented high percentage of cell death as compared with the pEGFP controls, as assessed by PI staining
followed by flow cytometry analysis. (F) ATXN3_C14A cells presented increased expression of nestin and decreased mRNA levels of neuronal markers. mRNA
levels were normalized to undifferentiated cells and HMBS gene expression. (G) Phalloidin staining (green) showed that actin filaments were disorganized and
not parallel in ATXN3_C14A cells. Nuclei were counterstained with DAPI (purple). Scale bar: 20 mm. (H and I) Western blot analysis showed a decrease of
ITGA5 levels and downstream targets of CDK5 in ATXN3_C14A cells. The results were normalized for H3 levels. n ≥ 3 independent biological replicates in all
experiments. ∗P, 0.05, ∗∗P , 0.01, ∗∗∗P , 0.001.
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and D). This supports the hypothesis that a partial loss of function
of ATXN3 due to the expansion of the polyQ tract may contrib-
ute to neuronal dysfunction in MJD.
DISCUSSION
Given the significance of DUBs to nervous system function and
homeostasis, we focussed here on characterization of the normal
function of ATXN3 in neuronal cells. Stable depletion of
ATXN3 in SH-SY5Y cells by lentiviral transduction of
shRNA inhibited neuronal differentiation following exposure
to RA. ATXN3-depleted cells displayed a markedly abnormal
morphology, becoming flat and with very few extensions, and
showing an altered structure of the actin cytoskeleton. Further-
more, the proliferative activity of these cells was not inhibited
by RA treatment, their motility was increased and cell survival
was significantly reduced.
Although ATXN3 KO animals do not show an overt pheno-
type, including any neuronal differentiation abnormalities,
which is likely due to compensatory mechanisms (32,49,62),
the current findings concur with previous studies showing abnor-
mal differentiation, adhesion and morphology in other, non-
neuronal, cellular models of ATXN3 loss of function (31,33).
Figure 7. Partial loss of function of expanded ATXN3. (A andB) Ki-67 staining (red) showed that ATXN3_83Q cells kept their proliferative activity upon RA treat-
ment. Nuclei were counterstained with DAPI (blue). Scale bar: 200 mm. (C andD) ATXN3_83Q cultures showed an increase in S phase of the cell cycle as assessed by
flow cytometry analysis. (E) Increased cell death in ATXN3_83Q cultures as assessed by flow cytometry analysis. (F) mRNA level of nestin was increased and
expression of neuronal differentiation markers was significantly decreased in ATXN3_83Q cells. mRNA levels were normalized to undifferentiated cells and
HMBS gene expression. (G) Actin filaments network was severely affected in ATXN3_83Q cells with unparalleled actin polymers, as shown by phalloidin staining.
Nuclei were counterstained with DAPI (purple). Scale bar: 20 mm. (H and I) Western blot analysis showed a decrease of ITGA5 levels and its downstream targets in
ATXN3_83Q cells. The results were normalized for H3 levels. n ≥ 3 independent biological replicates in all experiments. ∗P , 0.05; ∗∗P , 0.01; ∗∗∗P, 0.001.
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This is interesting, as cumulative evidence suggests that disrup-
tion of the neuronal cytoskeleton network may be a common
feature contributing to neurodegeneration in several diseases, in-
cluding polyQ disorders (41,64–66). In addition, ATXN3shRNA
cultures showed reduced levels of many neuronal markers while
maintaining expression of immature cell markers and a signifi-
cantly decreased neurite length, which is compatible with an im-
mature filopodia phenotype. Filopodia play an important role in
cell migration, neurite outgrowth and wound healing, and their
elongation depends on tightly regulated actin polymerization
(54). Thus, disruption of the actin filament network impairs
neurite elongation and ultimately cell differentiation, as we ob-
served in ATXN3-deficient neuronal cells. Interestingly, when
ATXN3shRNA cells were kept in culture for long, we observed
a partial recovery of several effects seen with silencing of
ATXN3, which might be explained by compensatory mechan-
isms similar to those occurring in ATXN3 KO animal models.
This recovery was less evident in cells expressing the cataly-
tically silent version of the protein. In the disease model
(ATXN3_83Q), the compensatory mechanisms also seem to
be prevented by the presence of the expanded protein, which
has a dominant negative effect.
Neuronal process outgrowth and maturation, as well as neur-
onal survival, are at least partially regulated by the integrin sig-
nalling pathway. We found that the phenotype observed in
ATXN3shRNA cells was due to a decrease in the expression of
ITGA5, associated with a decrease in the CDK5/p35 complex
activity and, consequently, to a deregulation of the PI3K/AKT
and ERK pathways. This had a negative impact on neurite out-
growth, cytoskeleton regulation, cell adhesion and motility
and survival. CDK5 plays an important role in neuronal differen-
tiation (60), morphogenesis (67), proliferation (68,69), survival,
axon guidance, synaptic transmission, neurocytoskeletal dy-
namics and neuronal degeneration (70–75). It has been shown
that inhibition of CDK5 either pharmacologically (with roscov-
itine) or by expression of a dominant negative form, causes a dra-
matic decrease in RA-induced cell differentiation (73).
Moreover, Cdk5-deficient neurons are significantly arrested or
delayed in their developmental program, both in vitro and
in vivo (60), and homozygous Cdk5 KO mice mutants die
in utero with neuronal migration deficits throughout the brain
(70). Additionally, we observed decreased activation of small
GTPases, both Rac1 and the Rho family, which are key actin
cytoskeleton regulators, further compromising actin dynamics.
Interestingly, a recent large-scale huntingtin–protein inter-
action study revealed that Rho family GTPases and actin remod-
elling play an important role in huntingtin function and
Huntington’s disease pathogenesis (76).
The fact that cells expressing the catalytically inactive
ATXN3 also show a reduction of ITGA5 protein levels and
that inhibition of the proteasome leads to an accumulation of
polyubiquitylated ITGA5 species in both ATXN3shRNA and
ATXN3_C14A cells suggests that ITGA5 protein levels are
regulated through the DUB activity of ATXN3 that defines the
extent of ITGA5 degradation by the proteasome. This proposed
mechanism is compatible with the previous finding that the
ITGA5 is a molecular partner of ataxin-3 (33). Confirming
the relevance of ATXN3 for regulation of ITGA5 in vivo, the
levels of this protein were significantly reduced in the nervous
system of Atxn3 KO mice.
To date, the type(s) of ubiquitylation of ITGA5 and the amino
acid position of this modification are not known. However, com-
paring the cytoplasmic tails of all humana integrins, Lobert and
Stenmark observed that the first lysine residue was strictly con-
served among human integrins and suggested that this might be
the site at which ubiquitylation occurs (77). Although it has been
described that ITGA5 may be degraded in lysosomes (78), there
are also reports demonstrating that it is degraded by the prote-
asome through the action of the E3 ligase Cbl (33,79). Indeed,
Kaabeche and colleagues showed that Cbl recruitment induced
by FGFR2 activation triggers ITGA5 proteasomal degradation
(79). These observations, together with the fact that FGFR2 ex-
pression is known to be upregulated by RA (80), lead us to
propose a mechanism that may explain the phenotype of
ATXN3shRNA cells upon RA treatment (Fig. 9). In this model,
ATXN3 prevents the degradation of ITGA5 triggered by the
RA-induced activation of FGFR2 (Fig. 9A). When ATXN3 is
silenced, RA treatment causes ITGA5 degradation to an extent
that leads to a deregulation of the CDK5, PI3K/AKt and ERK
pathways and affects neuronal morphology and cell adhesion,
proliferation, differentiation and survival (Fig. 9B). In agree-
ment with this model, overexpression of a catalytically inactive
form of ATXN3 led to similar morphological and biochemical
changes and the same differentiation impairment as the silencing
of ATXN3, suggesting that the regulation of ITGA5 levels in
neurons is dependent on the DUB activity of ATXN3. Further-
more, the fact that proteasomal inhibition prevents the decrease
of ITGA5 in ATXN3shRNA cells indicates that ATXN3 rescues
ITGA5 from degradation by the proteasome. Importantly,
restoring the levels of ITGA5 rescued most of the abnormal fea-
tures of ATXN3shRNA cells.
Given that this DUB is involved in the human neurodegen-
erative disease MJD, we conducted experiments to determine
the relevance of this abnormal phenotype and impairment in
neuronal differentiation to MJD pathogenesis. Interestingly,
similar but milder alterations were found in cultures expressing
expanded ATXN3, which suggests a partial loss of normal
function of the protein in the presence of this type of mutation.
Overexpression of the WT ATXN3 also caused some degree of
toxicity, suggesting the importance of a tight regulation of
ATXN3 expression levels, as has been described elsewhere
(81–85).
Confirming the perturbation of ATXN3 normal function by
polyQ expansion, we observed a downregulation of Itga5 in
the brainstem and DRGs of CMVMJD135 transgenic mice. Cul-
tures of DRG neurons from these animals showed that transgenic
neurons were smaller and displayed a drastic decrease in the
neurite length, as observed in neuronal cultures depleted for
ATXN3. This finding suggests that the loss of this normal cellu-
lar function of ATXN3 might be relevant for the neurodegenera-
tion caused by the polyQ tract. Although the in vitro assays
performed so far suggest that the polyQ expansion does not sig-
nificantly affect ATXN3 DUB activity (86), these assays were
performed using artificial substrates that may not mirror the bio-
logical substrates of ATXN3, or the post-translational modifica-
tions, co-factors and key partners that may be lacking. Improved
assays addressing DUB activity within a cellular environment
based on specific substrates and/or addressing ATXN3 as part
of multi-protein complexes would be important to adequately
assess WT and mutant ATXN3 activity.
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Figure 8. The polyQ expansion in ATXN3 affects the integrin signalling pathway. (A and B) Western blot analysis showed decreased levels of Itga5 in the nervous
system of CMVMJD135 mice (n ¼ 5 animals/genotype). The results were normalized fora-tubulin levels. (C andD) DRG neurons from CMVMJD135 mouse (two
pools of three animals for each genotype) showed no differences in the number of neurites and decreased neurite length and soma diameter as compared with the WT
controls. Neurite length was measured using NeuronJ software and Feret’s diameter was used to measure the soma (n ¼ 50 neurons/genotype). Scale bar: 200 mm.n ≥
3 independent biological replicates in all experiments. ∗P , 0.05; ∗∗∗P , 0.001.
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Overall, our data support the importance of ATXN3 in neur-
onal cells and the link between its biological function and
MJD. Loss of function of ATXN3 in neuronal cells affects deg-
radation of ITGA5 through its DUB activity, which affects many
processes that are important for neuronal development and func-
tion, such as cell adhesion, differentiation, cytoskeleton organ-
ization and neurite length. PolyQ expansion imparts loss of
this cellular function of ATXN3 in neurons, with effects on neur-
onal morphology and process extension, which chronically may
contribute to neurodegeneration.
MATERIALS AND METHODS
Cell culture
SH-SY5Y cell cultures: human neuroblastoma SH-SY5Y cell line
(ATCC, CRL-2266) was cultured in Dulbecco’s modified eagle
medium: nutrient mixture (DMEM)/F-12 (Invitrogen) supple-
mented with 10% (v/v) fetal bovine serum (FBS) (Biochrom),
2 mM glutaMAX (Invitrogen), 100 U/ml penicillin, 100 mg/ml
streptomycin and 25 ng/ml puromycin (Sigma Aldrich).
Medium was changed every 2 days. Differentiation was
induced by 0.1 mM all-trans-retinoic acid (Sigma Aldrich) in
opti-MEM (Invitrogen) supplemented with 0.5% FBS.
Medium was replaced every 2 days. PC12 cell cultures: rat
PC12 cells were cultured in DMEM (Invitrogen) supplemented
with 10% (v/v) FBS (Biochrom), 5% (v/v) horse serum (HS)
(Biochrom), 2 mM GlutaMAX (Invitrogen), 100 U/ml penicil-
lin, 100 mg/ml streptomycin and 25 ng/ml puromycin (Sigma
Aldrich). Medium was changed every 2 days. Differentiation
was induced by 1 mg/ml NGF (Invitrogen) in DMEM supple-
mented with 0.75% FBS and 0.75% HS. Medium was replaced
every 2 days. Primary cultures of dorsal root ganglion
neurons: for dorsal root ganglion (DRG) neuron culture, cells
isolated from 8 weeks-old mice were plated in poly-D-lysine
(Sigma) and laminin (Sigma) pre-coated coverslips at a
density of 5 × 103 cells/ml in DMEM/F12 supplemented with
10% (v/v) FBS, 100 U/ml penicillin, 100 mg/ml streptomycin,
50 ng/ml NGF (Millipore), 1 × B27 (Invitrogen) and 1.176 g/
L L-glutamine (Invitrogen) for 72 h. Primary cultures of hipoc-
campal neurons: hippocampal neuron cultures were prepared
from P4 Wister rats. Briefly, upon dissection, hippocampi
were submitted to a trypsin-based enzymatic digestion followed
by mechanical dissociation. Isolated cells were then plated on
coverslips previously coated with poly-D-lysine (Sigma) at a
density of 40 000 cells/cm2 using Neurobasal A medium
(Gibco) supplemented with 1 mM GlutaMAX (Gibco), 10 ng/ml
bFGF (Gibco), 0.1 mg/ml kanamycin (Gibco) and 1 × B27
(Gibco) for 7 days. Cells were incubated in a humidified 378C/
95% air/5% CO2 incubator.
Vectors and lentivirus packaging
HEK293T packaging cells were plated at a density of 3 ×
105 cells/well in 6-well plates, cultured in opti-MEM supple-
mented with 10% FBS and transfected on the following day
with the scrambled sequence vector (CAACAAGATGAAGAG
CACCAA), the pLKO.1/shRNA-ATXN3 vector (CCGGGCAG
GGCTATTCAGCTAAGTACTCGAGTACTTAGCTGAATA
GCCCTGCTTTTT) or the empty vector pLKO-1 (TRC1; Open
Biosystems) for virus production, following the RNAi Consor-
tium High-Throughput Lentiviral production protocol (87).
For overexpression the following plasmids were used: PPCB7/
ITGA5 (Addgene plasmid 16 041), pEGFP/ATXN3_28Q,
pEGFP/ATXN3_83Q and pEGFP/ATNX3_C14A. Medium
was changed in the next day and cells were cultured for 48 h.
Conditioned medium was then collected and stored at 2808C.
Figure 9. Model of a5 integrin subunit modulation of the PI3K/AKT and ERK cascades to insure neuronal differentiation and survival. (A) In normal functioning
neurons, ATXN3 is preventing degradation of ITGA5 triggered by the RA induced activation of FGFR2. (B) When ATXN3 is silenced, RA treatment causes
ITGA5 degradation to an extent that leads to a deregulation of the PI3K/AKt and ERK pathways affecting neuronal morphology and cell adhesion and survival.
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Transduction of target cells
A total of 2.5 × 105 SH-SY5Y or PC12 cells were seeded on a
6-well plate in complete DMEM/F-12 medium and transduced
by the lentiviral vectors. Medium was changed 24 h after, and
cells were incubated for 72 h. For selection of clones with
stable shRNA expression, fresh complete DMEM/F-12 or
DMEM medium containing 25 mg/ml puromycin was added to
the cells. During the selection period, medium was replaced by
fresh medium containing puromycin every 2 days. After 5
days, cells that formed colonies were selected and sub-cultured
in 96-well plates under puromycin selective pressure (2.5 mg/ml
puromycin) for subsequent expansion, with passaging every
3–5 days. The percentage of silencing of each clone was moni-
tored by immunoblotting.
High-throughput high-content functional imaging
SH-SY5Y cells were seeded at a density of 4 × 103 cells/well in
flat bottom 96-well plates previously coated with Matrigel (BD,
Biosciences), and 10 mM all-trans-retinoic acid (Sigma Aldrich)
was added the day after plating in DMEM/F-12 with 1% FBS.
After 5 days, cells were washed with DMEM/F-12 and incubated
with 50 ng/ml BDNF (Peprotech) in DMEM/F-12 without
serum for 3 days. Cells were then labelled for bIII-tubulin
(1:1000, R&D Systems), scanned at different locations of each
well and the quantitative analysis of total number of cells,
number of bIII-tubulin positive cells and neurite length were
automatically done using the automatic imaging system
Thermo Scientific Cellomicsw ArrayScanw VTI.
Pulldown
RA-treated SH-SY5Y cells were washed in ice-cold PBS, incu-
bated 5 min on ice in FISH buffer (50 mM Tris–HCl, pH 7.4,
2 mM MgCl2, 10% glycerol, 1% NP-40, 100 mM NaCl and prote-
ase inhibitors cocktail) and centrifuged for 5 min, 21 000 g, at
48C. Aliquots were taken from the supernatant to compare
protein amounts. The supernatant was incubated with bacterially
produced GST-PAK-CD or GST-RHOTEKIN-RBD fusion pro-
teins bound to glutathione-coupled sepharose beads (GE Health-
care) at 48C for 30 min. The beadsand proteinsbound to the fusion
protein were washed three times in an excess of FISH buffer,
eluted in Laemmli buffer and analyzed for bound Rho and Rac1
by immunoblotting. For the pulldown of polyubiquitylated pro-
teins, RA-treated cells were lysed in lysis buffer (50 mM
HEPES, pH 7.5, 0.15 M NaCl, 1 mM EDTA, 1% NP-40, 10% gly-
cerol, 50 mM PR-619 and protease inhibitors cocktail) and cen-
trifuged for 10 min, 14 000 g, at 48C, or treated with 5 mM
MG132 (Calbiochem) for 24 h prior to lysis. One milligram
of the supernatant were incubated with 100 ml of Agarose-
TUBEs (Lifesensors) and incubated 1 h at 48C. Beads were
washed three times with TBS-T and bound proteins were
eluted in Laemmli buffer.
Protein synthesis inhibition and proteasome inhibition
RA-treated SH-SY5Y cells were incubated with 5 mM CHX
(Merck) during 30, 60 or 180 min. For proteasome inhibition,
RA-treated cells were incubated with 5 mM MG132 (Calbio-
chem) for 24 h prior to lysis.
Immunoblotting
RA-treated SH-SY5Y cells or NGF-treated PC12 cells were pel-
leted and frozen in liquid nitrogen. For cellular and brain tissue
extracts, 50 mg of total protein isolated in RIPA buffer [150 mM
NaCl, 50 mM Tris–HCl, pH 7.6, 0.5% NP-40, 1 mM Phenyl-
methylsulfonyl fluoride, protease inhibitors (Roche)] were
resolved in 10% SDS-PAGE gels and transferred to a nitrocellu-
lose membrane (Bio-Rad). After incubation with the primary
antibodies against ATXN3 (1H9, 1:2000, Millipore),a5 integrin
(1:5000, Millipore), CDK5 (1:1000, Millipore), p35 (1:1000,
cell signalling), pERK1/2 (1:2000, cell signalling), ERK1/2
(1:1000, cell signalling), PI3K (1:1000, cell signalling), pAKT
(1:1000, cell signalling), AKT (1:3000, cell signalling), BCL2
(1:100, Abcam), pan-Rho (1:1500, Millipore) and Rac1
(1:2000, Millipore), overnight at 48C, membranes were incu-
bated with secondary antibodies for 1 h at room temperature
(anti-rabbit or anti-mouse, 1:10 000, Bio-Rad). Antibody affin-
ity was detected by chemiluminescence (Clarity kit, Bio-Rad).
Histone H3 (1:7500, Millipore), MCT4 (1:500, Santa Cruz),
CD147 (1:500, Santa Cruz) and a-tubulin (1:500, DSHB) were
assessed as loading controls.
Flow cytometry
For propidium iodide (PI) staining, RA-treated SH-SY5Y cells
or NGF-treated PC12 cells were collected and fixed using
ice-cold 70% ethanol for 1 h on ice. Pelleted cells were
washed with PBS and incubated with staining solution (0.1%
Triton-X100, 20 mg/ml PI solution, 250 mg/ml RNase in
PBS) for 1 h at 508C. For cell cycle analysis, cells were
starved for 6 h before RA treatment. Samples were washed
with PBS and analyzed using a FACSCaliber2 flow cytometer
(BD-Biosciences) with a 568-nm excitation laser. Signals from
30 000 cells/sample were captured in FL3 (.670 nm) at a flow
rate of 1000 cells/s. Offline data were processed with the
FlowJo (Tree Star) software and quantified with WinList
software.
Wound healing assay
SH-SY5Y cells were grown to confluent monolayers on 6-well
plates. After RA treatment, monolayers were wounded by a
pipette tip. This initial wounding and the movement of the
cells in the scratch were photographically monitored using the
Olympus IX-51 inverted microscope equipped with a TH4-200
camera for 24 h. This time window has been chosen because it
is shorter than the doubling time reported for SH-SY5Y cell
line (88). Eight different fields were considered for quantitative
estimation of the distance between the borderlines and in each
image five different equidistant points were measured. The mi-
gration rate was calculated as the distance between the border-
lines caused by scratching (defined at 0 h) minus the width that
remained cell-free after 24 h and expressed as a percentage of
the control.
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Real-time quantitative reverse transcription polymerase
chain reaction
One microgram of total RNA purified from RA-treated
SH-SY5Y cells or NGF-treated PC12 cells was reverse tran-
scribed using the One-step SuperScript kit (Bio-Rad). qRT-
PCR reaction was performed using the Quantitec SYBR Green
kit (Qiagen) and the primers previously described (52), in a
CFX96 real-time PCR detection system (Bio-Rad). Gene ex-
pression was normalized to HMBS levels. The results are pre-
sented as fold change.
Immunocytochemistry
Cells cultured on poly-D-lysine (Sigma Aldrich) and gelatin,
Collagen (BD Biosciences) or Ply-D-lysine pre-coated glass cov-
erslips (SH-SY5Y, PC12 or primary neurons, respectively) were
fixed with 4% paraformaldehyde in PBS for 30 min at room tem-
perature. Cells were permeabilized with 0.5% Triton X-100 in
PBS for 5 min. Next, cells were incubated with 10% fetal calf
serum blocking buffer for 1 h, followed by overnight incubation
with primary antibody against Ki-67 (1:300, Millipore) or bIII-
tubulin (1:1000, R&D systems) at 48C, or by incubation with
phalloidin (1:500, Sigma Aldrich) for 45 min and counterstained
with DAPI (1:2000, Sigma Aldrich) for 10 min at room tempera-
ture. Alexa Fluor 568 (A11004) conjugated antibody was used at
1:2000 (Molecular probes).
Animals
The MJD mouse model (CMVMJD135) was generated as
described (63). Wister Rats used for the primary cultures were
purchased from Charles River, Spain. For the mouse primary
cultures, two pools of three male animals for each genotype at ap-
proximately 2 months of age were used. Animals were sacrificed
by decapitation and the DRGs were removed along the spinal
cord. For the rat primary cultures, six P4 rats per experiment
were used. Animals were sacrificed by decapitation and brains
were dissected. All animal procedures were conducted in ac-
cordance with European regulations (European Union Directive
86/609/EEC) and approved by the joint Animal Ethics Commit-
tee of the Life and Health Sciences Research Institute, University
of Minho. Health monitoring was performed according to
FELASA guidelines (89). All animals were housed and main-
tained in a controlled environment at 22–248C and 55% humid-
ity, on 12 h light/dark cycles and fed with regular rodent’s chow
and tap water ad libitum. Animal facilities and the people direct-
ly involved in animal experiments (A.N.-C., S.D.-S. and A.S.-F.)
were certified by the Portuguese regulatory entity—Direcc¸a˜o
Geral de Alimentac¸a˜o e Veterina´ria. Animals were sacrificed
by decapitation at 8 weeks of age. Their brains were immediately
dissected and stored at 2808C.
Microscopy
Image acquisition of fixed cells was carried out in a Zeiss Axio-
Imager Z1 equipped with a Axiocam MR. Images represent
maximum-intensity projections of all Z planes acquired with
PLANAPO ×40 or ×63 objectives and following blind
deconvolution with a AutoquantX (Media Cybernetics).
Adobe photoshop CS5 (adobe Systems) was used for image
processing.
Statistical analysis
Comparison between the different cell lines was performed
using the t-test in the GraphPad prism version 5.0 software, as-
suming the homogeneity of the variances. For immunoblottings,
the mean density and area of each band were measured using at
least three experiments in TINA 2.0 software according to man-
ufacturer’s instructions. For qRT-PCR data, results were pre-
sented using the DDCt method, as described before (90). A
critical value for significance of two-tailed P, 0.05 was used
throughout the study.
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Figure S1. Establishment of a neuronal cell line with stably silenced ATXN3. (A, B) ATXN3shRNA cells 
showed a high decrease in ATXN3 expression, as compared to SCRshRNA and empty vector (pLKO.1) 
control cells. The ATXN3 level in the pLKO.1 cells expressing the empty vector was considered as 
100% and α-tubulin was used as a loading control. (C) qRT-PCR analysis showed that transcript 
levels of genes encoding ATXN3L and JOSD1 and JOSD2 proteins were similar between ATXN3shRNA 
and SCRshRNA cells. (D, E) PC12_ATXN3shRNA cells showed a high decrease in ATXN3 levels, as 
compared to PC12_SCRshRNA cells. The results were normalized for MCT4 levels. (F) Increased 
expression of ITGA5 in both SCRshRNA and ATXN3shRNA cells overexpressing ITGA5. mRNA levels were 
normalized to HBMS gene. *p<0.05. 
 
 
 
Chapter 2. Neuronal function of ATXN3 
 
 70 
 
 
Figure S2. Survival and cell cycle progression are not altered in non-differentiated neuronal cells 
lacking ATXN3. (A) ATXN3shRNA cells were flattened as compared with the SCRshRNA cells. (B) ATXN3 
knockdown increased SH-SY5Y cell migration in a wound scratch assay. Bars represent migration 
rate expressed as a percentage of control and calculated as the proportion of the mean distance that 
remained cell-free after 24 hours. (C, D) Flow cytometry analysis using PI showed no alterations of 
the cell cycle progression in ATXN3shRNA cells. (E) No effect on cell survival measured by propidium 
iodide (PI) incorporation caused by silencing of ATXN3. (F) Phalloidin staining (green) showed no 
major defects on the actin cytoskeleton in ATXN3shRNA cells as compared with the controls. Nuclei were 
counterstained with DAPI (purple). Scale bar: 20 μm.  ***p<0.001. 
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Figure S3. ATXN3 silencing does not affect expression of RA-responsive genes and does not alter 
the mRNA levels of several integrin subunits (A) Transcript levels of tTG, a RA-responsive gene, were 
not altered in ATXN3shRNA cells suggesting that these cells respond to RA treatment.  (B) ATXN3 did not 
regulate the amounts of ITGA5 in SH-SY5Y cells as measured by qRT-PCR. mRNA levels are 
normalized to HBMS gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. The phenotype of ATXN3shRNA cells is ITGA5-related. (A) Western blot analysis showed no 
differences in alpha-1 integrin levels comparing ATXN3shRNA and the SCRshRNA control cells. (B) Wound 
scratch assay showed no differences on migration comparing ATXN3shRNA and the SCRshRNA control cells, 
when using Laminin or Poly-D-Lysine coatings, 24 h after scratching.  
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Figure S5. Overexpression of both catalytic and expanded mutant versions of ATXN3 results in an 
abnormal cell morphology. (A) Overexpression of Wild type (ATXN3_28Q), catalytic mutant 
(ATXN3_C14A) or expanded ATXN3 (ATXN3_83Q) in SH-SY5Y cells. mRNA levels were normalized 
to HMBS gene. (B) Cells overexpressing catalytic mutant (ATXN3_C14A) or expanded ATXN3 
(ATXN3_83Q) cells failed to acquire a neuron-like morphology as compared with their counterpart 
controls, after RA treatment. Scale bar: 100 μm. *p<0.05, ***p<0.001. 
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Figure S6. Characterization of a PC12 neuronal cell line with stably silenced ATXN3. (A) 
PC12_ATXN3shRNA cells were less elongated and showed shorter extensions as compared with the 
PC12_SCRshRNA control cells after NGF treatment. Scale bar: 100 μm. NGF treatment did not inhibit 
proliferation of PC12_ATXN3shRNA cells as seen by optical microscopy (B) and (C, D) Ki-67 staining 
(red). Nuclei were counterstained with DAPI (blue). Scale bar: 200 μm. (E) Flow cytometry analysis 
using propidium iodide (PI) showed increased cell death in PC12_ATXN3shRNA cultures. (F) qRT-PCR 
analysis of the variation of neuronal markers after NGF treatment showed that mRNA levels were 
decreased for βIII-tubulin and Tau in PC12_ATXN3shRNA cultures. Transcript levels were normalized to 
levels in undifferentiated cells and to HMBS gene expression. (G) Phalloidin staining (green) showed 
that the actin cytoskeleton was less spread than in control cells, with less extensions, and that actin 
filaments were disorganized and not parallel in PC12_ATXN3shRNA cells. Nuclei were counterstained 
with DAPI (purple). Arrows mark evidences for higher adhesion in control cells and asterisks mark 
microspikes in PC12_ATXN3shRNA cells. Scale bar: 20 μm. (H, I) Western blot analysis showed a 
decrease of ITGA5 levels in PC12_ATXN3shRNA cells. The results were normalized for MCT4 
expression. (J) ATXN3 did not regulate the amounts of ITGA5 mRNA expression in PC12 cells, 
measured by qRT-PCR. mRNA levels were normalized to HMBS gene expression. 
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ABSTRACT 
The microtubule-binding protein tau is important for normal neuronal function in the nervous 
system. Alternative splicing of tau exon 10 originates tau isoforms including 3 or 4 microtubule-
binding repeats – 3R or 4R tau. Disruption of the 4R/3R tau ratio has been suggested to contribute 
to several neurodegenerative disorders. Ataxin-3 (ATXN3) is a protein with deubiquitylating (DUB) 
activity, known to bind microtubules and to regulate cytoskeletal organization. Expansion of a 
polyglutamine tract in the C-terminus of ATXN3 causes Machado-Joseph Disease (MJD) (also known 
as Spinocerebellar ataxia type 3 – SCA3). Here we show that loss of function of ATXN3 leads to a 
deregulation of tau exon 10 splicing resulting in a decreased 4R/3R tau ratio, negatively impacting 
in neuronal morphology and differentiation. Additionally, we found that SFRS7 (9G8), a regulator of 
tau exon 10 splicing, physically interacts with ATXN3 and shows altered polyubiquitylation patterns 
in neuronal cells lacking this protein. The fact that similar alterations were found in the brain of a 
mouse model of MJD expressing mutant human ATXN3 with an expanded polyglutamine tract, 
suggests that this mechanism might be contributing for the pathogenesis of MJD, and establishes a 
link between two key proteins involved in different neurodegenerative disorders. 
 
INTRODUCTION 
Tau proteins are microtubule-associated proteins (MAPs) predominantly expressed in 
neurons (Reviewed in [1]). Their major known biological function is the assembly and stabilization of 
microtubules, contributing to morphogenesis, cell division, axonal extension and axonal transport 
(Reviewed in [2]). Alternative splicing of the tau (MAPT) gene generates tau isoforms containing 3 or 
4 microtubule binding repeats, 3R tau or 4R tau [3, 4], in a 1:1 ratio [5, 6]. Although approximately 
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equal levels of 3R tau and 4R tau are found in a normal human adult brain, their expression is 
developmentally controlled, suggesting that the regulation of tau isoforms is important during brain 
formation [5, 7]. Disruption of the 4R/3R tau isoform ratio has been associated with 
neurodegenerative diseases. For example, it was found that the splicing of tau exon 10 was 
disrupted in some individuals with Frototemporal dementia with Parkinsonism liked to chromosome 
17 (FTDP-17) carrying silent and intronic mutation in tau gene (Reviewed in [8]). More recently, it 
was also demonstrated that the HTT mutation leads to an increase of the 4R/3R tau isoform ratio, 
which seems to contribut for Huntington Disease (HD) pathogenesis [9]. In addition to FTDP-17 and 
HD, altered 4R/3R tau ratio was also reported in Alzheimer’s disease (AD) brains, but the 
observations from different reports are contradictory; while some show an increase in 4R tau 
isoform, others report lower 4R/3R tau ratio values [10-14]. One possible explanation is that this 
ratio is differentially regulated in the different pathological conditions. Furthermore, exon 10 splicing 
is controlled by a complex set of splicing factors whose activity might be differentially affected in 
different diseases and/or by the Thus, the maintenance of this delicate balance appears to be 
critical for neuronal function (Reviewed in [11, 15-18]), and dependent on multiple etiological 
factors. The mechanism by which the 4R/3R tau ratio is disrupted in neurological diseases is still 
not completely understood. Alternative splicing of the MAPT gene has been shown to be regulated by 
enhancers and silencers as well as by trans factors and their phosphorylation [19-24], mostly 
belonging to two superfamilies – the SR (serine/arginine-rich)/SR-like and hnRNP (heterogeneous 
nuclear ribonucleoproteins) proteins (Reviewed in [25, 26]). One such protein, the SFRS7 
(serine/arginine splicing factor 7), also known as 9G8 [27], is believed to participate in the 
regulation of tau exon 10 alternative splicing [28, 29], usually acting as a splicing activator, leading 
to tau exon 10 inclusion [30-32]. Thus, an alteration of SFRS7 expression or function may be critical 
for both the splicing regulation and the disease-causing potential of the tau proteins. 
Deubiquitinating (DUB) enzymes modify ubiquitin (Ub) chains removing Ub units, and play an 
important role in the modulation of the degradation of proteins by the proteasome (Reviewed in [33-
35]) and in ubiquitin signaling in general. Ataxin-3 (ATXN3) is a protein with DUB activity, known to 
cause neurodegeneration in Machado-Joseph disease (MJD) [36], Interestingly, in addition to being 
involved in the ubiquitin-proteasome pathway (UPP) [37, 38], ATXN3 appears to play a role in the 
organization of the cytoskeleton network [39-41] has the ability to bind to microtubules and dynein 
[39, 40, 42], and seems to be involved in transcriptional regulation and DNA repair [43]. 
Additionally, our previous data suggested that SH-SY5Y cells lacking ATXN3 show decreased levels 
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of the adhesion protein α5-integrin (ITGA5), resulting in abnormal differentiation and decreased 
expression of several neuronal markers, including tau. Interestingly, overexpression of ITGA5 
ameliorated the neuronal phenotype of these cells and normalized the expression of most of the 
differentiation markers, but it did not rescue the levels of TAU, suggesting that complementary 
mechanisms are in place. 
In this work, we studied the effect of loss of function of ATXN3 on tau expression in neurons. 
We show that depletion of ATXN3 in SH-SY5Y cells led to a deregulation of tau exon 10 splicing 
which perturbs the 3R/4R tau ratio, a mechanism that seems to contribute for MJD pathogenesis. 
 
 
MATERIALS AND METHODS 
 
Cell culture 
Human neuroblastoma SH-SY5Y cells (ATCC, CRL-2266) were transfected with a shRNA 
sequence targeting ATXN3 or with a scrambled shRNA sequence as described before [41]. Stably 
infected cells were cultured in DMEM/F-12 (Invitrogen) supplemented with 10% (v/v) Fetal Bovine 
Serum (Biochrom), 2mM glutaMAX (Invitrogen), 100 U/mL penicillin, 100 µg/mL streptomycin and 
25 ng/mL puromycin (Sigma Aldrich). Cells were maintained in a humidified 37ºC/95%-air/5%-CO2 
incubator. The medium was replaced every two days. Differentiation was induced by 0.1 µM all-
trans-retinoic acid (RA) (Sigma Aldrich) in opti-MEM (Invitrogen) supplemented with 0.5% FBS for 7 
days. The medium was changed every two days.  
 
Vectors and lentivirus packaging 
The packaging cell line (HEK293T) was plated at a density of 3x105 cells per well in 6-well 
plates, cultured in opti-MEM supplemented with 10% FBS, and transfected on the following day with 
the pEYFP-N1_3R1N vector, the pEYFP-N1_4RN1 vector or the empty vector pEGFP for virus 
production, following the RNAi Consortium High-Throughput Lentiviral production protocol [44]. The 
medium was changed the next day and cells were cultured for 48 h. The conditioned medium, 
containing the viruses, was then collected and stored at -80ºC.  
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Transduction of target cells 
SH-SY5Y cells with stably silenced ATXN3 expression (ATXN3shRNA) and the scrambled shRNA 
controls (SCRshRNA) [41] were cultured at a density of 2.5x105 on a 6-well plate with 2 mL of complete 
DMEM/F-12 medium and transduced with the lentiviral vectors.  The medium was changed 24h 
after, and cells were incubated for 72h. Expression of the constructs was evaluated by fluorescence 
microscopy (GFP expression) and qRT-PCR. The transduced cell lines were cultured in complete 
DMEM/F-12 medium containing 2.5 µg/mL puromycin, passaging every 3-5 days.  
 
RT2 PROFILERT™ PCR array analysis of human cytoskeleton regulators 
The mRNA expression level of 84 key genes related to the intracellular scaffolding’s 
biogenesis, organization, polymerization and depolymerization, of 5 housekeeping genes and of 
controls for DNA contamination, reverse transcription and PCR efficiency, were determined 
simultaneously using Superarray technology (SABiosciences™). For this experiment, 5x104            
RA-treated SH-SY5Y cells were collected by trypsinization, immediately frozen in liquid nitrogen and 
stored a -80ºC. The RNA extraction was done using the RNasy® micro kit (Qiagen) following the 
manufacturer’s instructions. RNA samples were suspended in RNase-free water and RNA quality was 
monitored using the Experion™ Automated electrophoresis System (BioRad). 1µg of total RNA was 
first converted into first-strand cDNA using the RT2 First strand kit (SABiosciences™) and the          
RT-qPCR reaction was performed using the RT2 SYBR Green Mastermix (SABiosciences™), following 
the manufacturer’s guidelines. A total of 3 arrays per condition was hybridized. 
Pulldown of polyubiquitylated proteins 
RA-treated ATXN3shRNA and SCRshRNA cells were lysed by sonication on ice in lysis buffer (50 mM 
Tris-HCl pH 7.5, 0.15 M NaCl, 1mM EDTA, 1% NP-40, 10% Glycerol, protease inhibitors (Roche) and 
50μM UB/UBl protease inhibitor PR-619 (LifeSensors)). After lysis, 2 mg of total protein extract 
were incubated with 50 µL of pre-equilibrated Agarose-TUBEs 2  (LifeSensors), overnight at 4ºC on a 
rocking platform. Sedimented beads were washed 3 times with washing buffer (20 mM Tris pH 8.0, 
0.15 M NaCl, 0.1% Tween-20) before being eluted with 1x Laemmli buffer (62,5mM Tris-HCl pH 6.8, 
10% glycerol, 2% SDS, Bromophenol Blue). Eluted proteins were immediately boiled at 98ºC for 
15min and separated/analyzed in a 10% SDS-PAGE gel. 
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Cell fractionation 
RA-treated pelleted cells were resuspended in iced cold RSB buffer (10 mM Tris-HCl pH 7.4, 
10 M NaCl) and incubated on ice for 3 min. After centrifugation for 5 min, 4000 rpm at 4ºC, the 
pellet was resuspended in RSBG40 buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2,  10% 
glycerol, 0,5% NP-40, 0,5 mM DTT) and centrifuged for 3 min, 7000 rpm at 4ºC. The supernatant 
was collected as cytoplasmic fraction and stored at -80ºC. The nuclear pellet was resuspended in    
50 μL B1 buffer (20 mM Tris-HCl pH 7.9, 75 mM NaCl, 5% glycerol, 0.5 mM EDTA, 0.85 mM DTT, 
0.125 mM PMSF) and 450 μL B2 buffer (20 mM HEPES pH 7.6, 300 mM NaCl, 0.2 mM EDTA, 1 
mM DTT, 7,5 mM MgCl2, 1 M Urea, 1% NP-40). Samples were vortexed for  5 sec, incubated on ice 
for 10 min and centrifuged for 5 min, 15000 rpm at 4ºC. The supernatant was collected as nuclear 
fraction and stored at -80ºC. 
 
Immunoprecipitation 
RA-treated cells were washed in ice-cold PBS and lysed by sonication on ice in NP-40 buffer. 
Aliquots were taken from protein extracts as 10% inputs. 1 mg of total protein were pre-cleared for 3 
h at 4ºC by incubation with glutathione-coupled sepharose beads (GE Healthcare) previously 
equilibrated in Wash buffer 1 (50 mM Tris-HCl pH 7.5, 150 nM NaCl, 1% NP-40, 1x protease 
inhibitors (Roche)) for 3 times, 10 min at 4ºC. Beads were then centrifuged and the supernatant 
was incubated O/N at 4ºC with 50 μL equilibrated beads. After centrifugation, the supernatant was 
discarded and the beads were washed 2 times with Wash buffer 1 for 10 min at 4ºC. Beads were 
then washed twice with Wash buffer 2 (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.1% NP-40) for 10 
min at 4ºC, and once with Wash buffer 3 (50 mM Tris-HCL pH 7.5, 0.1% NP-40) for 20 min at 4ºC. 
The supernatant was discarded and the bound proteins were eluted with 1x Laemmli buffer, boiled 
for 5 min at 98ºC and run in a 10% SDS-PAGE gel. 
 
Immunoblotting 
RA-treated cells were pelleted and frozen in liquid nitrogen. For cellular extracts, 50µg of 
total protein isolated in NP-40 buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.6, 0.5% NP-40, protease 
inhibitors (Roche)). For CMVMJD135 brain tissue extracts, brain tissue was homogenized in cold  
0.1 M Tris-HCl pH 7.5, 0.1 M EDTA and protease inhibitors (Roche), and sonicated for 10s. 
Samples were resolved in 10% SDS-PAGE gels and then transferred to a nitrocellulose membrane. 
After incubation with the primary antibodies: TAU-5 (1:2000, Abcam), TAU-4R (1:1000, Millipore), 
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TAU-3R (1:2000, Millipore), TAU (E178) (1:1000, Abcam), Histone H3 (1:10000, Abcam), SFRS7 
(9G8) (1:1000, kindly provided by Dr. James Stévine), actin (1:200, DSHB) overnight at 4ºC, 
membranes were incubated with secondary antibodies for 1 hour at room temperature (anti-rabbit 
or anti-mouse, 1:10000, Bio-Rad, anti-goat, 1:5000, Santa-Cruz Biotecnhologies). Antibody binding 
was detected by chemiluminescence (Clarity kit, Bio-Rad).  
 
High-throughput high-content functional imaging 
Cells were seeded at an initial density of 4x103 cells/well in flat bottom 96-well plates 
previously coated with Matrigel (BD, Biosciences), and 0.1 μM RA was added the day after plating in 
DMEM/F-12 with 1% FBS. After 5 days, cells were washed with DMEM/F-12 and incubated with    
50 ng/mL BDNF (Peprotech) in DMEM/F-12 without serum for 3 days. Cells were then labeled by 
immunocytochemistry for βIII-tubulin (1:1000, R&D Systems) and scanned at different locations of 
each well. The quantitative analysis of total number of cells, number of βIII-tubulin positive cells and 
neurite length was performed using the automatic imaging system Thermo Scientific Cellomics® 
ArrayScan® VTI. 
 
qRT-PCR 
1 μg of total RNA purified from differentiated cells was reversed transcribed using the One-
step SuperScript kit (Bio-Rad). The qRT-PCR reaction was performed in a CFX96 Real-time PCR 
detection system (Bio-Rad) using the Quantitec SYBR Green kit (Qiagen) and the primers listed on 
Table 1. Gene expression was normalized to HMBS levels within each sample. Results are presented 
as fold change, comparing ATXN3shRNA with SCRshRNA control cells. 
Animals 
The MJD mouse model (CMVMJD135) was generated as described [45]. All animal 
procedures were conducted in accordance with European regulations (European Union Directive 
86/609/EEC) and approved by the joint Animal Ethics Committee of the Life and Health Sciences 
Research Institute, University of Minho. Health monitoring was performed according to FELASA 
guidelines [46]. Animal facilities and the people directly involved in animal experiments were 
certified by the Portuguese regulatory entity – Direcção Geral de Veterinária [46]. CMVMJD135 mice 
and control littermates were sacrificed at 45 weeks of age by decapitation, the brainstem (an 
affected area) was immediately removed and stored at -80ºC. 
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Statistical analysis 
For PCR arrays, data was analyzed using the SPSS software version 22.0. In order to 
identify differentially expressed genes having biological relevance, significantly altered genes 
identified by SPSS analysis (p<0.05) were further filtered using a 1.5 fold change cut-off. For all the 
other comparisons between the different cell lines were performed using t-test in the GraphPad 
prism version 5.0 software. For immunoblotings, the mean density and area of each band was 
measured using at least three experiments in TINA 2.0 software according to the manufacturer’s 
instruction. For real-time quantitative PCR data, the same approach was used and results were 
presented using the ΔΔCt method, as described before [47]. A critical value for significance of two-
tailed p<0.05 was used throughout the study. 
 
 
RESULTS 
 
Silencing of ATXN3 leads to changes in gene expression of cytoskeleton regulators 
Loss of function of ATXN3 was previously shown to cause a disruption of the cytoskeleton 
network [39, 40], loss of cell adhesion and perturbed differentiation [40], namely in neuronal cells 
[41]. Although increased degradation of alpha-5-integrin (ITGA5) - leading to loss of cell adhesion 
and altered signaling to the cytoskeleton - partially explains this cellular phenotype, the detailed 
mechanisms underlying the extensive modifications of the cytoskeleton remain mostly unknown. In 
the attempt to further define the pathways that are deregulated in the absence of ATXN3, specifically 
those affecting cytoskeletal organization, we quantified by qRT-PCR the expression of 84 genes 
controlling cytoskeleton biogenesis, fiber arrangement, polymerization and depolymerization, in 
Retinoic Acid (RA)-treated SH-SY5Y cells with stable silencing of ATXN3 (ATXN3shRNA cells). This 
analysis revealed a number of significant changes in expression, mostly corresponding to 
downregulation of cytoskeleton regulatory genes in ATXN3shRNA cells (Table 1). The 28 differentially 
expressed genes were distributed across different functional groups, related to cell projections 
(38%), kinases and phosphatases (38%), G-protein signaling (33.3%), actin filaments (28.6%), cell 
motility/migration (23.8%), cell cycle and division (9.5%), cytoskeleton adaptor activity (9.5%), 
calmodulin/calcineurin (9,5%), microtubules (4.8%), cell shape, size, polarity and morphogenesis 
(4.8%). This provided further evidence that ATXN3 is involved in the modulation of the cytoskeleton 
network and that its absence triggers changes in several important regulators.  
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Interestingly, we confirmed that the neurodegeneration-related gene MAPT, encoding the 
Tau protein, was among those with significantly reduced expression in ATXN3shRNA cells and belonged 
to one of the most representative functional groups (cell projections). As mentioned above, our 
previous data suggested that the neuronal phenotype of ATXN3shRNA cells was partial explained by the 
reduced levels of ITGA5 in these cells [41]. Interestingly, overexpression of ITGA5 in ATXN3shRNA cells 
ameliorated their neuronal phenotype and normalized the expression levels of several neuronal 
markers, but did not rescue the levels of TAU. Hence, we focused our analysis on the role of this 
specific gene and protein in cells lacking ATXN3. 
 
Table 1. Changes in gene expression of cytoskeleton regulators. The fold change is the average of 
3 biological replicates. A fold change of 1.5 was used as a cut-off.  
 
RefSeq Gene name Description Group p value Fold change 
NM_005910 MAPT Microtubule-associated protein tau Cell projections/ microtubules 0.000 -1.93 
NM_002481 PPP1R12B 
Protein phosphatase 1, regulatory 
(inhibitor) subunit 12B 
Cell projections/ kinases and phosphatases 0.001 -2.29 
NM_003941 WASL Wiskott-Aldrich syndrome-like 
Actin filaments/ cell projections/ cell 
motility/migration/ G-protein signalling 
0.001 -3.70 
NM_007174 CIT 
Citron (rho-interacting, serine/threonine 
kinase 21) 
Kinases and phosphatases/ cell cycle/ 
division/ G-protein signalling 
0.002 -1.79 
NM_003914 CCNA1 Cyclin A1 Cell cycle and cell division 0.003 -2.95 
NM_005719 ARPC3 
Actin related protein 2/3 complex, 
subunit 3, 21kDa 
Actin filaments/cell motility/migration 0.004 1.66 
NM_000377 WAS 
Wiskott-Aldrich syndrome (eczema-
thrombocytopenia) 
Cell motility/migration/ G-protein signalling 0.004 -2.88 
NM_001175 ARHGDIB Rho GDP dissociation inhibitor (GDI) B Actin filaments/cell motility/G-protein signalling 0.004 -15.29 
NM_002754 MAPK13 Mitogen-activated protein kinase 13 
Kinases and phosphatases/  
G-protein signalling 
0.007 -2.75 
NM_033389 SSH2 Slingshot homolog 2 (Drosophila) Actin filaments/ kinases and phosphatases 0.008 -2.04 
NM_000381 MID1 Midline 1 (Opitz/BBB syndrome) Microtubules 0.009 -2.41 
NM_014376 CYFIP2 Cytoplasmic FMR1 interacting protein 2 
Actin filaments/ cell projection/ cell shape, 
size, polarity/ morphogenesis/ G-protein 
signlling 
0.009 -1.37 
NM_003885 CDK5R1 
Cyclin-dependent kinase 5, regulatory 
subunit 1 (p35) 
Cell projections/ cell motility/migration/ 
kinases and phosphatases 
0.010 -1.96 
NM_005219 DIAPH1 Diaphanous homolog 1 (Drosophila) Actin filaments/ G-protein signalling 0.011 -5.41 
NM_002480 PPP1R12A 
Protein phosphatase 1, regulatory 
(inhibitor) subunit 12A 
Cell projections/ kinases and phosphatases 0.012 -1.81 
NM_003253 TIAM1 
T-cell lymphoma invasion and metastasis 
1 
G-protein signalling 0.013 -1.65 
NM_053025 MYLK Myosin light chain kinase 
Calmodulin/calcineurin/ kinases and 
phosphatases 
0.015 -1.71 
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NM_017737 FNBP1L Formin binding protein 1-like Actin filaments 0.018 -2.12 
NM_003160 AURKC Aurora kinase C 
Cell cycle and cell division/ kinases and 
phospatases 
0.020 -2.40 
NM_012418 FSCN2 
Fascin homolog 2, actin-bundling protein, 
retinal 
Actin filaments 0.020 -6.94 
NM_003688 CASK 
Calcium/calmodulin-dependent serine 
protein kinase 
Actin filaments, calmodulin/ calcineurin/ 
kinases and phosphatases 
0.024 -1.55 
NM_006340 BAIAP2 BAI1-associated protein 2 
Cell projections/ cytoskeleton  
adpator activity 
0.025 -2.73 
NM_002576 PAK1 
P21 protein (Cdc42/Rac)-activated 
kinase 1 
Cytoskeleton adaptor activity/ kinases and 
phosphatases 
0.029 -1.46 
NM_145753 PHLDB2 
Pleckstrin homology-like domain, family 
B, member 2 
Microtubules 0.035 -1.99 
NM_004935 CDK5 Cyclin-dependent kinase 5 
Cell projections/ cell motility/migration/ 
kinases and phosphatases 
0.043 -1.52 
NM_004954 MARK2 
MAP/microtubule affinity-regulating 
kinase 2 
Kinases and phosphatases/ cell shape,  
size, polarity, morphogenesis 
0.044 -2.33 
NM_033118 MYLK2 Myosin light chain kinase 2 
Calmodulin/calcineurin/ cell shape,  
size, polarity, morphogenesis/ kinases and 
phosphatases 
0.047 -3.92 
NM_002444 MSN Moesin 
Cell projections/ cell motility/migartion/ 
cytoskeleton adaptor activity 
0.053 1.66 
 
 
ATXN3 loss of function perturbs the 4R/3R tau ratio in SH-SY5Y cells 
Tau is a neuronal microtubule-associated protein of known relevance for the morphology, 
differentiation and survival of neurons, and is involved in central pathways of several 
neurodegenerative disorders (Reviewed in [48-50]. Considering this and taking into account the 
importance of a balanced ratio of 4R/3R tau isoforms in neurons, we next analyzed mRNA levels of 
these isoforms in ATXN3shRNA and SCRshRNA cells. We found a significant decrease (4.7 fold decrease, 
p=7.4x10-11) of the 4R tau isoform in ATXN3shRNA cells (Figure 1A), but no alteration of the 3R tau 
isoform (p=0.270) as compared with SCRshRNA control cells (Figure 1B), leading to an altered 4R/3R 
tau ratio (Figure 1C). 
 Interestingly, overexpression of a catalytically inert version of ATXN3 in SH-SY5Y cells 
(ATXN3_C14A) recapitulated the alterations on tau isoform expression seen in cells with silenced 
ATXN3, leading to decreased expression of total tau (5.7 fold decrease, p=3.7x10-6) (Figure 1D), 
decreased 4R tau expression (4.4 fold decrease, p=1.1x10-5) (Figure 1E) with no alterations on the 
3R tau isoform (Figure 1F), and decreased 4R/3R tau ratio (p=0.0088) (Figure 1G).  
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Figure 1. Disruption of 4R/3R tau ratio in ATXN3shRNA cells. (A) Depletion of ATXN3 lead to decreased 
transcripts levels of 4R tau and (B) no alterations in the mRNA levels of the 3R tau isoform. (C) 
ATXN3shRNA cells showed a significant decrease of the 4R/3R tau ratio comparing with the SCRshRNA 
controls. ATXN3_C14A cells present (D, E) decreased mRNA levels of tau and 4R tau isoform, (F) no 
alterations in 3R tau expression and (G) decreased 4R/3R tau ratio. 4R/3R tau ratio was obtained 
by dividing 4R and 3R tau mRNA levels. **p<0.01; ***p<0.001. 
 
Normalizing the levels of 4R tau isoform partially rescues the neuronal phenotype of 
ATXN3shRNA cells 
Besides the cytoskeleton deregulation, depletion of ATXN3 seems to perturb the 
differentiation process in neuronal cells, as we have previously described [41]: after induction of 
differentiation by RA treatment, ATXN3shRNA cells keep their proliferative activity (in spite of a parallel 
increase in cell death) and show decreased expression of several differentiation markers. 
Considering that the balance between tau isoforms is important for neuronal development (Reviewed 
in [51]) and that the 4R isoform suppresses proliferation and promotes neuronal differentiation [52], 
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we hypothesized that the deregulation of the 4R/3R tau ratio might be contributing to the neuronal 
phenotype observed in ATXN3shRNA cells. In order to test this hypothesis, we overexpressed the 3R or 
4R tau isoforms in ATXN3shRNA cells (ATXN3shRNA_3R and ATXN3shRNA_4R, respectively) (Figure S1) and 
evaluated their ability to differentiate into neuronal cells upon RA treatment. Indeed, the expression 
levels of several neuronal differentiation markers (MAP2, βIII-tubulin, neurogenin and DAT), which 
we had previously identified as reduced in cells lacking ATXN3 [41], were comparable between 
ATXN3shRNA_4R and SCRshRNA_4R cells and the increased expression of Nestin, a marker for 
proliferative cells [53] was also rescued by 4R tau isoform overexpression (Figure 2A). Accordingly, 
and in contrast with the observations in cells lacking ATXN3, the number of cells was similar 
between ATXN3shRNA_4R and SCRshRNA_4R (p=0.422) 7 days after induction of differentiation with RA 
(Figure 2B). Additionally, the number of βIII-tubulin positive cells was not significantly different 
among the two cell lines (p=0.8727) and thus restored if we compare them with those of cells after 
ATXN3 silencing (fATXN3shRNA) (Figure 2C). The average neurite length was also restored in 
ATXN3shRNA_4R cells as compared with fATXN3shRNA cells (p=1.7x10-10) (Figure 2D). Interestingly, 
although we observed that increasing the levels of the 3R isoform of tau also ameliorated the 
neuronal phenotype of ATXN3shRNA cells in terms of expression of differentiation markers (Figure 2E), 
neuronal maturation (Figure 2F) and neurite length (Figure 2G), it did not abolish the proliferative 
activity of ATXN3shRNA_3R upon RA treatment, as shown by the increased number of cells (p=0.0083) 
(Figure 2H) and the increased expression of Nestin (p=0.0006) (Figure 2E). 
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Figure 2. Overexpression of 4R tau ameliorates the phenotype of ATXN3shRNA cells. (A) mRNA levels 
of several neuronal markers analyzed in ATXN3shRNA cells were normalized by overexpression of 4R 
tau. mRNA levels were normalized to HMBS gene (B) After RA treatment the number of 
ATXN3shRNA_4R cells was similar to the number of SCRshRNA _4R cells. (C) Overexpression of 4R tau 
rescued the expression of βIII-tubulin and (D) the average length of neurites in cells lacking ATXN3. 
(E) Overexpression of 3R tau had a milder effect on the expression of differentiation markers, (F) 
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neuronal maturation, and (G) neurite length, and (H) no effect on the proliferative activity of 
ATXN3shRNA cells upon RA treatment. *p<0.05; **p<0.01; ***p<0.001. + corresponds to rescued 
expression. 
 
Cells lacking ATXN3 show decreased levels of SFRS7 (9G8), a protein involved in the 
splicing of tau exon 10 
Taking into account the altered 4R/3R tau ratio in ATXN3shRNA cells, and considering the 
involvement of ATXN3 in proteolytic pathways we assessed the levels of SFRS7, a splicing regulator 
of tau, in these cultures. ATXN3shRNA cells presented decreased levels of SFRS7 protein compared with 
the SCRshRNA controls (p=0.025) (Figure 3A), suggesting that in the absence of ATXN3, SFRS7 is being 
more degraded. Because SFRS7 normally presents a nuclear localization, we performed cell 
fractionation and analyzed the levels of SFRS7 in the nuclear fraction. As shown in Figure 3B, this 
assay confirmed the reduced levels of SFRS7 in ATXN3shRNA cells in comparison with the control cells 
(p=0.001). The expression of SFRS7 was undetectable in the cytoplasmic fraction (data not shown). 
To define whether ATXN3 affects the expression of SFRS7 at the protein or mRNA level, we 
extracted total RNA from ATXN3shRNA and SCRshRNA cells and performed qRT-PCR to determine the levels 
of SFRS7 transcripts. No significant differences (p=0.712) were observed between the two cell lines 
(Figure 3C), suggesting that the effect of ATXN3 depletion on SRSF7 levels occurs at the protein 
level. 
Figure 3. ATXN3shRNA cells show decreased SFRS7 protein levels. (A) Western-blot analysis showed a 
downregulation of both total and (B) nuclear SFRS7 levels in ATXN3shRNA cells. The results were 
normalized for H3. Relative band density for each protein was analyzed. (C) No significant 
differences were observed in the mRNA levels of SFRS7 between the ATXN3shRNA cells and the SCRshRNA 
controls. mRNA levels were normalized to the HMBS gene. *p<0.05; **p<0.01. 
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SFRS7 (9G8), a protein involved in the splicing of Tau exon 10, is a candidate 
substrate of ATXN3’s DUB activity 
Considering the decreased levels of SFRS7 associated with the loss of function of ATXN3, 
we next analyzed the ubiquitylation levels of this splicing factor. For this, we performed a pulldown of 
polyubiquitylated proteins using Agarose-TUBEs 2, followed by immunoblotting against the SFRS7 
protein. As shown in Figure 4A, we detected decreased levels of ubiquitylated forms of SFRS7 in 
ATXN3shRNA cells as compared with the scrambled control cells (SCRshRNA) (p=0.02). Given these 
observations, we hypothesized that SFRS7 could be a substrate of the DUB activity of ATXN3. To 
test this hypothesis, we first verified whether these two proteins interact in the context of neuronal 
cells. Co-immunoprecipitation using protein extracts from differentiated Wild type SH-SY5Y cells 
confirmed the interaction between ATXN3 and SFRS7, which is compatible with the hypothesis of 
SFRS7 being a substrate of ATXN3 in neurons (Figure 4B). To further explore the relevance of this 
interaction in the regulation of SFRS7 stability, we measured the levels of SFRS7 upon proteasome 
inhibition. In this condition, however, we found a similar downregulation of SFRS7 in ATXN3shRNA and 
SCRshRNA cells (Figure 4C). Indeed, as proteasome inhibition leads to a heat shock response [54], a 
blockade of splicing and a global downregulation of splicing factors have been described in cells 
exposed to proteasome inhibition [55], and this may be hampering our analysis of the possible link 
between ATXN3 degradation of SFRS7 by the UPS.  
 
 
 
 
 
 
 
 
 
Figure 4. Decreased levels of polyubiquitylated SFRS7 (9G8) in ATXN3shRNA cells. (A) Western-blot 
analysis after capture of polyubiquitylated proteins confirmed the decrease in polyubiquitylated 
forms of SFRS7 in ATXN3shRNA cells. (B) Human ATXN3 co-immunoprecipitates with SFRS7. (C) 
Western-blot analysis showed that the levels of SFRS7 decreased at similar levels both in ATXN3shRNA 
and SCRshRNA cells upon MG132 treatment. Relative band density for each protein was analyzed.  The 
results were normalized for H3.   
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Pathogenic ATXN3 causes similar molecular alterations as silencing 
In order to determine if the presence of an expanded polyglutamine (polyQ) tract within 
ATXN3 would lead to a modification of the activity of this protein in MAPT splicing regulation, altering 
the 4R/3R tau ratio, we analyzed a SH-SY5Y cell line expressing a version of ATXN3 bearing 83 
glutamines (ATXN3_83Q). Interestingly, we found that expression of ATXN3_83Q leads to a similar 
alteration on the expression of tau isoforms as that observed in cells lacking ATXN3 or expressing a 
catalytic mutant version of this protein: i) decreased expression of tau (2.7 fold decrease,    
p=7.5x10-6) (Figure 5A), ii) decreased expression of 4R tau isoform (2.4 fold decrease, p=8.1x10-5) 
and no alterations on the 3R tau isoform (Figure 5B and 5C, respectively), and iii) a decrease of the 
4R/3R tau ratio (p=0.0313) (Figure 5D). 
However, it is important to mention that the overexpression of the Wild type ATXN3 
(ATXN3_28Q) also caused some degree of perturbation (Figure 5), pointing to the importance of a 
tight regulation of ATXN3 dosage in neurons. These results suggest that the polyQ expansion caused 
a perturbation of the normal function of ATXN3 in neuronal cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. PolyQ expansion in ATXN3 affects tau splicing in neuronal cells. (A, B) Expression of 
ATXN3_C14A led to decreased mRNA levels of tau and 4R tau isoform, (C) no alterations in 3R tau 
expression and (D) decreased 4R/3R tau ratio. mRNA levels were normalized to the HMBS gene. 
**p<0.05; ***p<0.001. 
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Deregulation of tau splicing in the context of Machado-Joseph disease 
Considering that a partial loss of function of the expanded ATXN3 might be contributing to 
the pathogenesis of MJD, as has been suggested for other polyQ disorders [56-58]we analyzed the 
4R/3R tau ratio in the brains of transgenic mice expressing human expanded ATXN3 with 135 
glutamines (CMVMJD135) [45], a mouse model of MJD. Similarly to what we have observed in 
neuronal cells lacking ATXN3 or overexpressing the expanded protein, we found a significantly 
decreased expression of the 4R tau isoform in the brainstem (an affected brain area) of 
CMVMJD135 mice both at protein level (p=2.8x10-5) and mRNA level (3.7 fold decrease, p=7x10-5) 
comparing with the Wild type (WT) littermate controls (Figure 6A and 6B, respectively), but no 
alterations of the 3R tau isoform expression (Figure 6C and 6D). The decreased expression of 4R tau 
led to a decreased protein level of total Tau in CMVMJD135 mice (p=0.0049) comparing with the 
WT animals (Figure 6E) and an altered 4R/3R tau ratio (Figure 6F). Moreover, as seen in ATXN3shRNA 
cells, we found a downregulation of Sfrs7 protein level in CMVMJD135 mice as compared with the 
WT controls (p=0.0093) (Figure 6G), but no alterations at the mRNA level (Figure 6H).  
All together, these results suggest that the interaction of ATXN3 with SFRS7 and its impact 
on molecular pathways regulating tau splicing may be relevant in the pathogenesis of MJD. 
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Figure 6. Deregulation of tau splicing in CMVMJD135 mice. (A, B) CMVMJD135 mice presented a 
decrease in the protein and mRNA levels of 4R tau but (C, D) no statistically significant differences in 
the protein and mRNA levels of 3R tau in CMVMJD135 mice comparing with WT controls. (E) 
Expression of mutant human ATXN3 led to statistically decreased levels of total tau and (F) a 
disruption of the 4R/3R tau ratio in the brainstem of transgenic mice. (G) CMVMJD135 mice 
showed decreased levels of Sfrs7 but (H) no alterations in the expression of Sfrs7 at the mRNA level. 
mRNA levels were normalized to the HPRT gene. Relative band density for each protein was 
analyzed. The results were normalized for actin levels. **p<0.01; ***p<0.001. 
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DISCUSSION 
Tau is an important microtubule-binding protein in neurons. Abnormalities in tau expression 
and a disruption of MAPT exon 10 splicing have been suggested to play an important role in several 
neurodegenerative disorders [15-18]. Considering our observation of tau expression deregulation in 
ATXN3shRNA cells, we hypothesized that the 4R/3R tau ratio could be disrupted. Indeed, while it has 
been described that the normal adult human brain expresses approximately equal levels of 4R and 
3R tau isoforms [3, 5], we found that loss of function of ATXN3 disrupts this balance in SH-SY5Y 
cells exposed to a differentiation stimulus (RA), leading to a decreased 4R/3R tau ratio, that seems 
to be caused by decreased levels of SFRS7, a splicing regulator known to modulate inclusion of tau 
exon 10 [28, 29]. While this work was being done, an article was published showing an increased 
4R/3R tau ratio in the brains of subjects with HD, which seemed to be related with alterations in 
SFRS6, another known modulator of tau exon 10 splicing [59], strengthening the idea that an 
imbalance of tau isoforms might be contributing for the pathology of several neurodegenerative 
diseases, including poliQ diseases. In addition to that, ATXN3shRNA cells presented increased relative 
levels of the 3R tau isoform, which correlates with the immature phenotype of these cells that we 
previously described [41], since the 3R is the predominant tau isoform in undifferentiated SH-SY5Y 
cells [60, 61]. Importantly, normalizing the levels of 4R tau isoform partially ameliorates the 
neuronal phenotype of ATXN3shRNA cells in terms of expression of differentiation markers, neuronal 
maturation and neurite length. Taking into account that loss of function of ATXN3 deregulated the 
levels of SFRS7 at the protein level, we hypothesized that this splicing factor could be a substrate of 
the DUB activity of ATXN3, which could modulate its degradation. In line with that, we observed that 
ATXN3 co-immunoprecipitated with SFRS7, suggesting that these two proteins are molecular 
partners in neuronal cells. Moreover, the fact that SFRS7 was captured using the Agarose-TUBEs 
that have high affinity for polyubiquitin chains [62] suggests that this splicing factor is 
polyubiquitylated and thus might be degraded through the UPS. Trying to explore if this interaction 
could be indicative that ATXN3 is modulating the degradation of SFRS7 through the proteasome, we 
measured the levels of this protein upon proteasome inhibition; unexpectedly, we found similarly 
reduced levels of this splicing factor in ATXN3shRNA and SCRshRNA cells. Additionally, in the absence of 
proteasome inhibition, ATXN3shRNA cells presented decreased amounts of polyubiquitylated forms of 
SFRS7. Although we found no data in the literature specifically relating SFRS7 expression and 
MG132 treatment, it is known that proteasome inhibition elicits a stress response, globally 
repressing transcription and mRNA processing, including splicing. This stress induction may explain 
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our unexpected result, since SFRS7 is a heat shock suppressed gene [63-65]. Further experiments 
using conditions leading to milder proteasome inhibition may help overcome this technical limitation, 
which is hindering the clarification of the mechanism of SFSR7 reduction in cells lacking ATXN3.  
As mentioned before, SFRS7 has been involved in the splicing of tau exon 10, playing an 
important role in the regulation of the 4R/3R tau ratio balance [28, 29]. The effect of SFRS7 on tau 
splicing initially appears to be controversial on the literature: while some authors refer that it acts as 
a tau exon 10 splicing enhancer [66], others state that it suppresses tau exon 10 inclusion [28, 29]. 
An unifying explanation is that the function of SFRS7 acting as a splicing silencer or enhancer is cell-
type dependent. In this perspective, Van Abel and co-workers reported that SFRS7 acts as a tau 
splicing enhancer in the same type of cells that we have used in this study [66]; they observed a 
decreased 4R/3R tau ratio upon downregulation of SFRS7 in these cells, both of which we also 
observed in cells lacking ATXN3. Interestingly, we also found a decreased 4R/3R tau ratio as well as 
decreased protein levels of Sfrs7 in affected brain regions of 45 weeks-old CMVMJD135 mice as 
compared with their littermate controls. At this age, the transgenic animals display an overt 
phenotype resembling behavioral and pathological characteristics present in human patients [45]. 
Thus, the observed deregulation of tau splicing suggests that this mechanism may be contributing to 
MJD pathogenesis, as it does to other neurodegenerative disorders albeit in the opposing sense 
concerning 4R relative abundance. However, it still remains to clarify whether this change occurs 
before symptoms or if it is a consequence of the disease progression. Considering that we observed 
a similar phenomenon using cells lacking ATXN3 and cells expressing a catalytic mutant of the 
protein, it is reasonable to think that the DUB activity of ATXN3 is important in this process and that 
the polyQ expansion might cause a partial loss of this normal function of the protein, contributing to 
MJD pathologenesis. Future work should allow us to verify the relevance of these findings and to 
unravel how the imbalance of 4R/3R tau isoforms ratio leads to neurodegeneration. One possible 
scenario is that it leads to altered microtubule dynamics, which causes multiple subsequent 
intracellular alterations such as pathogenic disruption of axonal transport, a hypothesis that we are 
currently assessing. 
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ABSTRACT 
Ubiquitylation is a tightly controlled process that has been shown not only to mediate protein 
degradation, but also to modulate protein function and subcellular localization, playing a crucial role 
in the function and development of the nervous system. Deubiquitylating (DUB) enzymes have been 
recognized as central players in the maintenance of the correct ubiquitylation/deubiquitylation 
balance in cells. Ataxin-3 (ATXN3) is a protein with DUB activity mutated in Machado-Joseph disease 
(MJD). To date, besides the involvement of ATXN3 in the Ubiquitin-proteasome pathway (UPP) and 
its potential involvement in transcription regulation and DNA repair, its normal cellular functions 
remain mostly unknown and few substrates of its DUB activity have been identified. In this work, in 
the attempt to identify potential targets of the DUB activity of this protein, we characterized the 
ubiquitome of neuronal cells lacking ATXN3 (ATXN3shRNA cells) by mass spectrometry. We found that a 
large proportion of the proteins with altered polyubiquitylation in ATXN3shRNA cells were known to be 
involved in RNA post-transcriptional modification, namely splicing factors. Using transcriptomic 
analysis and reporter minigenes we confirmed that splicing was globally altered in cells lacking 
ATXN3. Among the mRNA targets with altered splicing were those of genes encoding components of 
the spliceosome itself, involved in ubiquitin mediated proteolysis, in axon guidance and in the MAPK 
signaling pathway. These findings lead us to propose that ATXN3 plays a role in splicing regulation in 
neurons, a novel function for this protein. 
 
INTRODUCTION 
Ubiquitylation is a highly dynamic biochemical modification in which an Ubiquitin (Ub) 
moiety is attached to a protein. This process is catalyzed by the sequential actions of a Ub-activating 
enzyme (E1), Ub-conjugating enzymes (E2) and UB-protein ligases (E3) that bind Ub to different 
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lysine (K) residues in the substrate, resulting in mono or poly Ub chains (Reviewed in [1]). 
Ubiquitylated substrates are then recognized by proteins containing Ubiquitin binding domains and 
directed to different fates. Different types of polyubiquitin (polyUb) chains are thought to be 
functionally linked to different fates. For example, K48 usually targets proteins for proteasomal 
degradation, which is initiated when a minimum of four ubiquitins is reached [1], while K63-linked 
polyUb regulates protein activation, subcellular localization or degradation in lysosome (autophagy) 
and is known to be relevant for DNA repair (Reviewed in [2]). Ubiquitylation and proteolysis by the 
ubiquitin-proteasome pathway (UPP) are now recognized as important mechanisms in the nervous 
system as this proteolytic pathway is known to degrade misfolded or short-lived regulatory proteins 
(Reviewed in [3-5]). Impairment of the UPP has been connected to several neurodegenerative 
diseases such as Alzheimer’s (Reviewed in [6]), Parkinson’s (Reviewed in [7]) and Hungtington’s 
(Reviewed in [8]) diseases. However, recent findings showing an accumulation of K63-linked 
polyubiquitin chains in neurodegenerative diseases suggest that the involvement of ubiquitylation in 
signaling pathways not related to protein control, such as autophagy, may also contribute to disease 
[9-11].  
Ubiquitin signaling has also been recently implicated in the regulation of splicing, that plays 
key roles in many processes important for the development and function of the nervous system, 
such as synaptogenesis, neurite outgrowth, axon guidance, ion channel activity and long-term 
potentiation (Reviewed in [12-14]). Ubiquitin and Ub-like proteins have been shown to co-purify with 
splicing complexes [15, 16] and ubiquitylated splicing factors have been identified in a proteomic 
screen [17]. Like most post-transcriptional modifications, ubiquitylation is a reversible signal and is 
counterbalanced by deubiquitylating (DUB) enzymes that remove Ub from target proteins and 
recycle the free Ub pool. Thus, the action of DUBs has a major impact on the ubiquitylated 
proteome (also known as ubiquitome). Ataxin-3 (ATXN3) is a protein with DUB activity known to be 
involved in Machado-Joseph Disease (MJD), a neurodegenerative disorder of adult onset caused by 
the expansion of a polyglutamine (polyQ) tract in this protein. A crucial step towards the 
understanding of ATXN3 function was the discovery of its DUB activity in vitro [18]. ATXN3 is able to 
cleave Ub from polyubiquitylated substrates, both with K48, K63 or mixed linkages [18-20], to 
interact with the ubiquitin-like protein NEDD8 [21], with subunits of the proteasome [18, 22], with 
VCP/p97 [19, 20], with UBXN5 [23] and with the E3 ligases Parkin [24] and CHIP [25]. Although 
these enzymatic activities of ATXN3 strongly suggest a role for the protein in the UPP, the biological 
consequences of these functions have not been extensively characterized yet and the substrates of 
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its action are not known, namely in neurons. In this work, we used Tandem ubiquitin binding entities 
(TUBES) [26] to purify polyubiquitylated proteins from a neuronal cell line lacking ATXN3, with the 
goal of identifying candidate targets of its DUB activity. Among the proteins found to have altered 
polyubiquitylation patterns in cells lacking ATXN3, a large proportion were proteins involved in RNA 
transport and processing, indicating that ATXN3 might be regulating these processes in neurons, a 
hypothesis that we validated using reporter minigenes and transcriptomic analysis. 
 
MATERIALS AND METHODS 
 
Cell culture 
The human neuroblastoma SH-SY5Y cell line (ATCC number CRL-2266) was transfected 
with a shRNA sequence targeting ATXN3 or a scrambled shRNA sequence as described elsewhere 
[27]. Stably infected cell lines were cultured in a 1:1 mixture DMEM/F-12 nutrient (Invitrogen) 
supplemented with 10% (v/v) Fetal Bovine Serum (FBS) (Biochrom), 2mM glutaMAX (Invitrogen), 
100 U/mL penicillin, 100 µg/mL streptomycin and 25 ng/mL puromycin (Sigma Aldrich). The cells 
were maintained in a humidified 37ºC/95%-air/5%-CO2 incubator. The medium was changed every 
two days. Differentiation was induced by 0.1 µM all-trans-retinoic acid (RA) (Sigma Aldrich) in      
opti-MEM (Invitrogen) supplemented with 0.5% FBS for 7 days. The medium was replaced every two 
days.  
 
Pulldown of polyubiquitylated proteins 
Cells treated with RA were lysed by sonication on ice in lysis buffer (50 mM Tris-HCl pH 7.5, 
0.15 M NaCl, 1mM EDTA, 1% NP-40, 10% Glycerol, complete protease inhibitors (Roche) and 50μM 
UB/UBl protease inhibitor PR-619 (LifeSensors)). After lysis, 2 mg of total protein extract were 
incubated with 100 µL of pre-equilibrated Agarose-TUBEs (LifeSensors), overnight at 4ºC on a 
rocking platform. Sedimented beads were washed 3 times with washing buffer (20 mM Tris pH 8.0, 
0.15 M NaCl, 0.1% Tween-20) before being eluted with 1x SDS sample buffer (62.5mM Tris-HCl   
pH 6.8, 10% glycerol, 2% SDS, Bromophenol Blue). Eluted proteins were immediately boiled at 98ºC 
for 15min and run in a 10% SDS-PAGE gel. 
 
 
 
Chapter 4. Ataxin-3 and splicing 
 104 
Immunoblotting 
Cells treated with 0.1 μM RA for 7 days were pelleted and frozen in liquid nitrogen. Proteins 
eluted from TUBEs were resolved in 10% SDS-PAGE gels and then transferred to a nitrocellulose 
membrane. After incubation with the FK2 anti-ubiquitin primary antibody (1:2000, Millipore) 
overnight at 4ºC, membranes were incubated with secondary antibody for 1 hour at room 
temperature (anti-mouse, 1:10000, Bio-Rad). Antibody binding was detected by chemiluminescence 
(Clarity kit, Bio-Rad).  
 
Digestion of proteins from preparative 1D-PAGE gel 
The 1D PAGE LC-MS/MS approach was used for protein identification as previously 
described [28]. Eluted proteins were separated using 1.5mm and 10% SDS-PAGE gels. The quality 
of purification was controlled by Coomassie Brilliant Blue g-250 (Sigma) staining before MS analysis. 
Gel image was acquired the Gel Doc™ EZ system (Bio-rad). After Coomassie staining, all the visible 
blue-stained protein spots were manually excised from the gel. The gel pieces were destained 
overnight at room temperature using 50% acetonitrile in 25 mM ammonium bicarbonate buffer,    
pH 8.5, and then dehydrated with 100% acetonitrile. The shrunken pieces were then re-swollen in 
50 mM ammonium bicarbonate buffer, dehydrated in 100% acetronitrile and dried in a speedvac® 
concentrator (Savant) for 30 min. The gel pieces were rehydrated in 60 µL of 20 µg/mL Trypsin 
(Promega) in 50 mM ammonium bicarbonate solution and incubated for 2h at 55ºC. The gel pieces 
were then incubated with 0.1% trifluoroacetic acid in 50% acetonitrile for 20 min at room 
temperature in order to extract the remaining peptides from the gel. The tryptic peptides were dried 
in a speedvac for 2 h.  
 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
After re-dissolution in 17 µL 0.1% acetic acid, samples were separated on a capillary C18 
column using a nano LC-ultra 1D plus HPLC system (Eksigent) and analyzed on-line with a 
electrospray LTQ-Orbitrap Discovery mass spectrometer (Thermo Fisher Scientific). MS/MS spectra 
were searched against a human database (uniprot_sprot, 2010_01) with the ProteinPilot™ software 
(version 3.0; AB-sciex) using the Paragon™ algorithm (version 3.0.0.0 [29]) as the search engine. 
The detected protein threshold (unused protscore (confidence)) in the software was set to 0.10 to 
achieve 20% confidence and the proteins identified were grouped to minimize redundancy. 
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Peptides with “unused” values < 2 have low confidence and were excluded from analysis. The 
“unused” value is defined in the handbook of ProteinPilot as a sum of peptide scores from all the 
non-redundant peptides matched to a protein. Peptides with confidence of ≥ 99% would have a 
peptide score of 2. Tryptic peptides shared by multiple proteins were assigned to the winner protein.  
 
RNA extraction and Array hybridization 
Total RNA was isolated from ATXN3shRNA and SCRshRNA cells using an miRNeasy mini kit (Qiagen) 
and quality assessment was achieved using RNA 6000 Nano labchip (Bioanalyzer, Agilent) and by a 
Nanodrop spectrophotometer (Thermo). Total RNAs RIN values were between 8.7 and 9.3 (average: 
9.17). Affymetrix Human Transcriptome Array 2.0 ST arrays were hybridized according Affymetrix 
recommendations using the Ambion WT protocol (Life technologies, France) and Affymetrix labelling 
and hybridization kits. Raw data, transcript data and exon data were controlled with Expression 
console (Affymetrix).  
 
Microarray data analysis 
Affymetrix Human Transcriptome Array 2.0 ST dataset analysis was performed using the 
GenoSplice technology (www.genosplice.com). Data were normalized using quantile normalization. 
Background corrections were made with antigenomic probes and probes were selected according to 
their %GC, cross-hybridization status and potential overlap with repeat region as previously described 
[PMID:23861464, PMID:23321315, PMID:23284676]. Only probes targeting exons and exon-exon 
junctions annotated from FAST DB® transcripts (release fastdb_2013_2) were selected 
[PMID:16052034, PMID:17547750]. Only probes with a DABG P value ≤0.05 in at least half of the 
arrays were considered for statistical analysis [PMID:23861464, PMID:23321315, 
PMID:23284676]. Only genes expressed in at least one compared condition were analyzed. To be 
considered to be expressed, the DABG P-value had to be ≤0.05 for at least half of the gene probes. 
We performed an unpaired Student’s t-test to compare gene intensities between ATXN3shRNA and 
SCRshRNA cells. Genes were considered significantly regulated when fold-change was ≥1.5 and P-value 
≤0.05 (unadjusted P-value). Analysis at the splicing level was first performed taking into account 
only exon probes (‘EXON analysis) in order to potentially detect new alternative events that could be 
differentially regulated (i.e., without taking into account exon-exon junction probes). Analysis at the 
splicing level was also performed by taking into account exon-exon junction probes (‘SPLICING 
PATTERN analysis) using the FAST DB® splicing pattern annotation (i.e., for each gene, all possible 
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splicing patterns were defined and analyzed. All types of alternative events can be analyzed: 
Alternative first exons, alternative terminal exons, cassette exon, mutually exclusive exons, 
alternative 5’ donor splice site, alternative 3’ acceptor splice sites and intron retention). EXON and 
SPLICING PATTERN analyses were performed using unpaired Student's t-test on the splicing-index 
as previously described [PMID:23861464, PMID:23321315, PMID:23284676]. Results were 
considered statistically significant for unadjusted P-values ≤ 0.05 and fold-changes ≥ 1.5 for 
SPLICING PATTERN analysis and unadjusted P-values ≤ 0.05 and fold-changes ≥ 2.0 for EXON 
analysis. Gene Ontology (GO), KEGG and REACTOME analyses of differentially regulated genes were 
performed using DAVID [PMID:19131956]. 
 
Plasmid purification  
Hybrid minigene reporter plasmids pyPY, AdML and α-globulin [30, 31] were kindly provided 
by Prof. Juan Valcárcel (Centre de Regulació Genòmica (CRG), Barcelona). Top10 competent cells 
(Invitrogen) were transformed with 100 ng of plasmid DNA, according to the recommended protocol. 
Briefly, the cells were incubated with the constructs on ice for 30 min followed by heat shock at 
42ºC for 1 min. After incubation on ice for 2 min, 500 uL of LB medium was added to the cell vial 
and incubated at 150 rpm for 60 min at 37ºC. Cultures were grown overnight at 37ºC in 
LB/ampicillin plates. The next day, one colony was inoculated in LB/ampicilin (100 mg/mL) at 
37ºC overnight. Plasmid extraction was carried out using the ZR Plasmid Miniprep™ (Zymo 
Research) according with the manufacturer’s protocol. DNA concentration was determined using 
Nanodrop (Alfagene) and integrity verified by running 200 ng in an agarose gel.         
 
Cell transfection  
4x105 cells per well were plated in gelatin-coated 6 well plates and incubated 24 h. Before 
transfection, the culture medium was changed to DMEM/F-12-AA without antibiotics and 
supplemented with 5% FBS. Cell were transfected with 200ng of the reporter plasmids using 
Lipofectamine® 2000 Transfection Reagent (Invitrogen) according with the manufacturer’s 
instructions. Briefly, reporter plasmid minigenes and the transfection reagents were appropriately 
diluted in Opti-MEM medium separately and incubated for 5 min at room temperature. The mixed 
reagents were then incubated at room temperature for 20 min allowing the formation of transfection 
complexes. The cells were then incubated for 24 h with the transfection mix.  
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Semi-quantitative PCR  
PCR amplification of pyPY, AdML and α-globin reporter genes was carried out using Taq 
DNA Polymerase (Thermo Fisher Scientific) following the manufacturer’s protocol. The cycling 
conditions were: 95ºC for 5 min followed by 24 cycles of denaturing at 95ºC for 1 min, annealing at 
60ºC for 45 sec, extension at 72ºC for 1 min and final extension at 72ºC for 5 minutes. The primers 
used are listed in Table A1. The PCR product was run in a 2% agarose gel. Gel analyses and splicing 
efficiency calculations were performed using Image Lab software (Bio-Rad).  
 
Statistical analysis 
Comparison between the different cell lines was performed using t-test in the GraphPad 
prism version 5.0 software. For real-time quantitative PCR data, the same approach was used and 
results were presented using the ΔΔCt method, as described before [32]. A critical value for 
significance of two-tailed p<0.05 was used throughout the study. 
 
RESULTS 
Pulldown of the ubiquitome of ATXN3shRNA cells using Tandem Ubiquitin Binding Entities 
(TUBEs) and identification of polyubiquitylated proteins by LC-MS/MS 
 In order to identify variations in the ubiquitome in neuronal cells lacking ATXN3 (ATXN3shRNA 
cells) [27], we used a recently developed methodology that combines Tandem Binding Ubiquitin 
Entities (TUBEs) with mass spectrometry (TUBEs-LC-MS/MS) [26]. Figure 1 summarizes the steps 
followed for the purification and identification of the polyubiquitylated proteins in ATXN3shRNA and 
SCRshRNA control cells. The integration of the data and the comparison between the proteins identified 
in ATXN3shRNA versus SCRshRNA cells resulted in a list of proteins with altered polyubiquitylation in cells 
lacking ATXN3; among these are potential direct targets of the DUB activity of ATXN3, i.e., putative 
ATXN3 substrates. 
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Figure 1. Experimental design – purification of polyubiquitylated proteins using TUBEs. (A-I, B) RA-
treated SH-SY5Y cells (with silenced ATXN3 or not) were lysed and protein extracts were incubated 
with TUBEs. (A-II) TUBEs-captured proteins were recovered with Laemmli buffer and analyzed by (C) 
comassie blue staining of the polyubiquitylated proteins purified using TUBEs run in a 1-D SDS-PAGE 
gel or (D) western blot with anti-ubiquitin FK2 antibody. (A-III) Polyubiquitylated proteins were trypsin 
digested and identified by LC-MS/MS. (E) After acquisition, data were processed and integrated in 
functional networks. Adapted from [33]. 
 
 
In each pulldown experiment, around 1200-1300 proteins were identified. When the results 
of all the independent experiments were merged, we observed that many of these proteins were 
sporadically detected across the different experiments. For the remaining analysis, these proteins 
were excluded, reducing the list to about 615 proteins. From these polyubiquitylated proteins, 
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around 193 proteins showed altered levels in ATXN3shRNA cells comparing with the SCRshRNA controls 
(p<0.05) (Table 1).  
Curiously, the majority of these polyubiquitylated proteins were absent (44.04%) or showed 
decreased polyubiquitylation levels (24.35%) in ATXN3shRNA cells. The proteins found to have altered 
polyubiquitylation levels in ATXN3shRNA cells where analyzed (enrichment analysis) using Ingenuity 
Pathways Analysis software (IPA, Ingenuity systems®) and can be grouped in 10 functional 
networks, including: (i) Gene expression, DNA replication, recombination and repair (17.7%), (ii) RNA 
post-transcriptional modification (13.3%), (iii) Molecular transport, RNA trafficking (10.8%), (iv) Cell 
death and survival (8.9%), and (v) Organ morphology (8.9%) (Figure 1E). The fact that a significant 
proportion of the proteins with altered polyubiquitylation in ATXN3shRNA cells are involved in RNA post-
transcriptional modification, around 8% of them being splicing factors (Table 1), suggested to us that 
ATXN3 could be playing a role in this cellular process. 
 
Table 1. Differences in polyubiquitylated proteins identified by TUBEs-MS in SH-SY5Y cells lacking 
ATXN3. List of polyubiquitylated proteins with altered levels in RA-treated ATXN3shRNA cells as 
compared with the SCRshRNA controls (p<0.05). These proteins were detected in at least 3 independent 
experiments. The values are the average of “unused” values given by the Proteinpilot algorithm. The 
absent “unused” values indicate the (near) complete absence of the polyubiquitylated protein. In red 
and green are proteins with increased and decreased polyubiquitylated levels, respectively. $ 
indicates splicing factors. 
 
 
Average unused values 
Name SCRshRNA ATXN3shRNA p value 
Network 1 – Gene expression, DNA replication and repair 
    
PGRMC1 (Membrane-associated progesterone receptor) 2.01 Absent 1.12E-14 
RANBP2 (E3 SUMO-protein ligase) Absent 2.02 6.16E-06 
NASP (Nuclear autoantigenic sperm protein) 2.01 Absent 6.21E-06 
PURB (Transcriptional activator protein Pur-beta) 2.01 Absent 6.22E-06 
EHMT2 (Uncharacterized protein) 2.01 Absent 6.22E-06 
CAP1 (Adenylyl cyclase-associated protein 1) 2.02 Absent 5.54E-05 
TNPO1 (Transportin-1) 2.02 Absent 9.80E-05 
DR1 (Protein Dr1) Absent 2.04 3.00E-04 
TRIM28 (Transcription intermediary factor 1-beta) 6.94 3.16 2.00E-03 
EIF6 (Eukaryotic translation initiation factor 6) 3.80 5.80 2.00E-03 
PLEC (Plectin) Absent 13.96 4.00E-03 
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SNRPN (Small nuclear ribonucleoprotein-associated protein N) 5.3 8.01 5.00E-03 
SFRS9 (Serine/arginine-rich splicing factor 9) 7 11.51   $ 7.00E-03 
HDAC2 (Histone deacetylase 2) 8.35 3.97 9.00E-03 
POLR2E (DNA-directed RNA polymerases I, II, and III subunit) 4.01 2.29 1.00E-02 
HSP90B1 (Endoplasmin) 12.18 5.2 1.00E-02 
SMARCB1 (Integraseinteractor 1b protein) 3.02 Absent 2.00E-02 
UBC (Ubiquitin C splice variant) 12.91 9.03 2.00E-02 
SKIV2L2 (Superkillerviralicidic activity 2-like 2) 5.18 Absent    $ 3.00E-02 
FUS (RNA-binding protein) 11.88 6.9    $            3.00E-02 
HNRNPK (Heterogeneous nuclear ribonucleoprotein K) 7.21 12.73   $ 3.00E-02 
FLOT1 (Flotillin-1) 3.27 Absent 4.00E-02 
CBX5 (Uncharacterized protein) 3.51 Absent 4.00E-02 
GNB2L1 (Guanine nucleotide-binding protein subunit beta-2) 6.26 Absent 4.00E-02 
SMARCC2 (SWI/SNF complex subunit SMARCC2) 9.22 6.44 4.00E-02 
TPM3 (Isoform 2 of Tropomyosin alpha-3 chain) 18.68 7.76 4.00E-02 
C14orf166 (UPF0568 protein) 3.18 8.34 4.00E-02 
ATRX (Transcriptional regulator) 5.31 13.08 4.00E-02 
GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) 17.00 11.55 5.00E-02 
Newtwork 2 – RNA pot-transcriptional modification 
      
RPS10 (RPS10-NUDT3 protein) 2.37 Absent 6.22E-06 
C1QBP (Complement 1Q subcomponent-binding protein) Absent 4.42 8.00E-04 
BPTF (Nucleosome-remodeling factor subunit) 2.08 Absent 1.00E-03 
PRPF8 (Pre-mRNA-processing-splicing factor 8) 44.08 73.98  $ 1.00E-03 
SFRS5 (Serine/arginine-rich splicing factor 5) 4.18 9.73    $ 5.00E-03 
EMD (Emerin) Absent 3.47 9.00E-03 
HMGB3 (Uncharacterized protein) 3.84 2.18 1.00E-02 
NUP205 (Nuclear pore complex protein) 8.3 30.67 1.00E-02 
PRKCA (Protein kinase C alpha type) 2.37 Absent 2.00E-02 
HNRNPA1P10 (Heterogeneous nuclear ribonucleoprotein A1) 7.8 Absent 2.00E-02 
LRPPRC (Leucine-rich PPR motif-containing protein) 4.5 2.08 2.00E-02 
AQR (Intron-binding protein aquarius) 8.71 12.1 2.00E-02 
CAPZA1 (F-actin-capping protein subunit alpha-1) 2.37 Absent 3.00E-02 
EEF1B2 (Elongation factor 1-beta) 3 Absent 3.00E-02 
RPL9 (60S ribosomal protein L9) Absent 4.42 3.00E-02 
RPL18 (Uncharacterized protein) 2.37 Absent 4.00E-02 
SRRT (Serrate RNA effector molecule) 3.25 2.02 4.00E-02 
RBMX (Heterogeneous nuclear ribonucleoprotein G) 18.01 12.08   $                   4.00E-02 
CNTN1 (Contactin-1) Absent 4.42 4.00E-02 
Chapter 4. Ataxin-3 and splicing 
 111 
THOC2 (THO complex subunit) 2.78 5.21 6.00E-02 
IARS (Uncharacterized protein) Absent 4.42 8.00E-02 
Network 3 – Molecular transport, RNA trafficking 
      
DBN1 (Uncharacterized protein) 2.01 Absent 6.22E-06 
UQCRC2 (Cytochrome b-c1 complex subunit 2) 4.04 Absent 1.38E-05 
CANX (Calnexin) 4.05 Absent 2.00E-04 
SPTBN1 (Spectrin beta chain) 6.34 3.01 1.00E-03 
CALR (Calreticulin) 3.32 Absent 2.00E-03 
KIF5C (Kinesin heavy chain isoform 5C) 7.65 Absent 2.00E-03 
PSMA4 (Proteasome subunit alpha type-4) 2.13 4.7 2.00E-03 
RAE1 (Uncharacterized protein) <2 5.77 2.00E-03 
CAND1 (Cullin-associated NEDD8-dissociated protein 1) 3.52 Absent 3.00E-03 
YWHAG (14-3-3 protein gamma) 6.61 2.71 5.00E-03 
PDIA3 (Protein disulfide-isomerase A3) 14.60 6.66 1.00E-02 
NUP107 (Nuclear pore complex protein) 2.48 5.51 1.00E-02 
NUP160 (Nuclear pore complex protein) 2.63 7.87 1.00E-02 
PTPLAD1 (Butyrate-induced transcript 1) 3 Absent 3.00E-02 
PSMC5 (26S protease regulatory subunit 8) 2.82 Absent 4.00E-02 
CTPS (CTP synthase 1) 5 Absent 4.00E-02 
Network 4 – Cell death and survival 
      
PSME2 (Uncharacterized protein) 2.01 Absent 1.78E-16 
GPI (Glucose-6-phosphate isomerase) 4.84 Absent 1.54E-05 
ASNS (Asparagine synthetase) 2.81 Absent 2.00E-04 
ESYT1 (Uncharacterized protein) 2.04 Absent 2.00E-04 
ATAD3A (ATPase family AAA domain-containing protein 3A) 3.61 Absent 8.00E-04 
ANXA5 (Annexin A5) 2.08 Absent 1.00E-03 
HSPH1 (Heat-shock protein 105 kDa) 2.09 Absent 2.00E-03 
RCC1 (Regulator of chromosome condensation) 4.93 3.47 2.00E-03 
HSPD1 (60 kDa heat shock protein) 20.74 9.12 2.00E-03 
PRDX1 (Uncharacterized protein) Absent 6.71 2.00E-02 
VARS (Valyl-tRNAsynthetase) 2.73 Absent 4.00E-02 
EIF4A1  (Eukaryotic initiation factor 4A-I) 7.52 3.45 4.00E-02 
RARS (Isoform Monomeric of Arginyl-tRNAsynthetase) 3.21 Absent 5.00E-02 
RPL21 (60S ribosomal protein L21) Absent 7.91 5.00E-02 
Network 5 –Organ morphology 
      
TBL2 (Uncharacterized protein) Absent 2.01 7.59E-14 
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PROSC (Prolinesynthetase co-transcribed) 2.04 Absent 1.19E-13 
GSR (Glutathione reductase) 2.01 Absent 6.22E-06 
BCLAF1 (Bcl-2-associated transcription factor 1) 2.19 Absent  $         4.71E-05 
PFKM (6-phosphofructokinase) 3.84 Absent 3.00E-03 
PDIA6 (Protein disulfide-isomerase A6) 17.24 12.22 4.00E-03 
NAP1L1 (Nucleosome assembly protein 1-like 1) 15.76 10.35 7.00E-03 
CKB (Creatine kinase B-type) 8.32 3.98 1.00E-02 
AHCY (Adenosylhomocysteinase) 4.00 Absent 3.00E-02 
PAICS (Multifunctional protein ADE2) 5.32 Absent 3.00E-02 
UBA1 (Ubiquitin-like modifier-activating enzyme 1) 8.38 4.57 3.00E-02 
RFC4 (Uncharacterized protein) Absent 3.01 3.00E-02 
MDH2 (Malate dehydrogenase) 11.14 5.87 4.00E-02 
MYH10 (Uncharacterized protein) 48.70 62.36 4.00E-02 
Network 6 - DNA replication, recombination and repair, cell death and Survival 
ATXN10 (Ataxin-10) 2.01 Absent 1.78E-16 
SNRPB2 (U2 small nuclear ribonucleoprotein B) Absent 2.01 3.26E-11 
SFRS2 (Splicing factor arginine/serine-rich 2) Absent 2.16   $ 5.36E-11 
RBM8A (RNA-binding protein 8A) Absent 4.01 1.56E-06 
MDC1 (Uncharacterized protein) Absent 2.01 6.22E-06 
SFRS7 (Serine/arginine-rich splicing factor 7) 7.45 5.29   $ 8.00E-04 
NHP2 (Uncharacterized protein) Absent 2.12 3.00E-03 
TFAP2B (Isoform 2 of Transcription factor AP-2-beta) 7.60 3.37 2.00E-02 
MAP1B (Microtubule-associated protein 1B) 11.14 6.12 2.00E-02 
CRKL (Crk-like protein) Absent 4.705 2.00E-02 
CAD (Uncharacterized protein) 3.56 Absent 4.00E-02 
VIM (Vimentin) 12.20 27.61 4.00E-02 
Network 7 - Cell cycle, Cell death and survival       
CS (Citrate synthase) 2.01 Absent 1.78E-16 
UBXN1 (UBX domain-containing protein 1) 2.01 Absent 1.78E-16 
TUBA4A (Tubulin alpha-4 chain) 4.05 Absent 3.00E-03 
SAFB (Uncharacterized protein) 6.01 6.32 4.00E-03 
ACLY (Uncharacterized protein) 2.2 Absent 8.00E-03 
BRD1 (Bromodomain-containing protein 1) 2.65 Absent 1.00E-02 
SON (Isoform C of Protein SON) 4.15 9.79 1.00E-02 
PHB2 (Prohibitin-2) 22.15 6.71 2.00E-02 
PRPF40A (Pre-mRNA-processing factor 40 homolog A) 7.17 10.6  $          2.00E-02 
PHB (Prohibitin) 13.05 4.96 3.00E-02 
Chapter 4. Ataxin-3 and splicing 
 113 
HSP90AB1 (Heat shock protein HSP 90-beta) 28.70 18.89 3.00E-02 
WDR3 (WD repeat-containing protein 3) 15.65 9.64 4.00E-02 
Network 8 - Cellular compromise, Cell death and survival     
MYL6 (Myosin light polypeptide 6) Absent 2.01 7.60E-14 
ENO2 (Enolase) 2.02 Absent 6.16E-06 
ERLIN2 (Uncharacterized protein) Absent 2.01 2.48E-05 
RPL23A (60S ribosomal protein) 4.16 2.23 5.63E-05 
CLIC1 (Chloride intracellular channel protein 1) 3.39 Absent 1.00E-03 
ATAD2B (ATPase family AAA domain-containing protein 2B) 4.15 Absent 1.00E-03 
ATP5B (ATP synthase subunit beta) 15.65 13.16 7.00E-03 
CDK5 (Cyclin-dependent kinase 5) 4.25 2.67 9.00E-03 
SPTAN1 (Spectrin alpha chain) 19.02 12.18 2.00E-02 
SPIN1 (Spindlin-1) Absent 2.85 2.00E-02 
GNAO1 (Guanine nucleotide-binding protein G(o) subunit 
alpha) Absent 4 4.00E-02 
Network 9 - Cellular growth and proliferation, Gene expression, Cell cycle 
GNAL (Guanine nucleotide-binding protein G(olf) subunit alpha)  Absent 2.07 2.05E-10 
EIF3L (Eukaryotic translation initiation factor 3) 2.01 Absent 6.22E-06 
EIF3B (Uncharacterized protein) 2.01 Absent 6.22E-06 
TMEM33 (Transmembrane protein 33) Absent 2.01 6.22E-06 
RAB5C (Uncharacterized protein) 3.35 Absent 9.71E-05 
SIX6 (Homeobox protein) 2.02 Absent 9.80E-05 
RPA1 (Replication protein A 70 kDa) 4.73 Absent 2.00E-02 
COPA (Coatomer subunit alpha) 5.69 Absent 2.00E-02 
MAB21L1 (Protein mab-21-like 1) 6.16 Absent 2.00E-02 
RAB1B (Ras-related protein) Absent 3.17 2.00E-02 
RBM12B (RNA-binding protein 12B) 6.09 7.91 2.00E-02 
Network 10 . Cellular development, Cell death and survival, Cell cycle 
RBM10 (RNA-binding protein 10) Absent 2.02 4.78E-19 
CCT8 (T-complex protein 1 subunit theta) 6.42 Absent 5.72E-08 
TCP1 (T-complex protein 1 subunit alpha) 6.01 Absent 2.77E-06 
PSMA1 (Proteasome subunit alpha type-1) 2.01 Absent 6.22E-06 
MAP1S (BPY2 interacting protein 1) Absent 2.04 5.43E-05 
GLTSCR2 (Uncharacterized protein) 2.02 Absent 9.80E-05 
CCT5 (T-complex protein 1 subunit epsilon) 2.04 Absent 2.16E-04 
GDI1 (Rab GDP dissociation inhibitor alpha) 4.77 Absent 9.16E-04 
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TUBB2C (Tubulin beta-2C chain) 20.31 Absent 4.76E-02 
CCT4 (T-complex protein 1 subunit delta) 5.16 2.46 4.78E-02 
Other       
CUTA (Isoform A of Protein CutA) Absent 2.01 7.59E-14 
GNAI3 (Guanine nucleotide-binding protein G(k) subunit alpha) Absent 2.01 7.59E-14 
TRAP1 (Uncharacterized protein) 2.04 Absent 6.58E-13 
ABT1 (Activator of basal transcription 1) Absent 2.02 2.34E-12 
PSMA8 (Proteasome subunit alpha type-7-like) 2.03 Absent 7.71E-12 
POTEE (POTE ankyrin domain family member E) Absent 2.02 7.49E-11 
C9orf114 (Uncharacterized protein) 4.01 Absent 1.56E-06 
SEPT7 (Uncharacterized protein) 2.01 Absent 6.21E-06 
HMBOX1 (Uncharacterized protein) 2.01 Absent 6.21E-06 
GLOD4 (CGI-150 protein) 2.01 Absent 6.22E-06 
DDX41 (DEAD-box protein abstrakt variant) 2.01 Absent 6.22E-06 
DDX56 (ATP-dependent RNA helicase) 2.05 Absent 2.38E-05 
PSMA8 (Uncharacterized protein) Absent 2.01 2.48E-05 
TOMM22 (Mitochondrial import receptor subunit) Absent 4.59 2.54E-05 
HIST2H2BD (Histone H2B type 2-D) Absent 2.77 9.17E-05 
BLVRA (Biliverdinreductase A) 2.7 Absent 2.00E-04 
ACTL6B (Actin-like protein 6B) Absent 2.525 3.00E-04 
LUC7L (Putative RNA-binding protein Luc7-like 1) 2.68 Absent 5.00E-04 
CHMP5 (Charged multivesicular body protein 5) 3.02 Absent 6.00E-04 
ISOC1 (Isochorismatase domain-containing protein 1) 3 Absent 7.00E-04 
RPL24 (60S ribosomal protein L24) 5.97 2.32   $ 2.00E-03 
ABCF1 (ATP-binding cassette sub-family F member 1) 2.75 Absent 3.00E-03 
BMS1 (Ribosome biogenesis protein) 5.64 9.42 4.00E-03 
PDS5B (Sister chromatid cohesion protein) 4.13 15.82 4.00E-03 
PSMD1 (26S proteasome non-ATPase regulatory subunit 1) 3.80 Absent 5.00E-03 
DIMT1 (Probable dimethyladenosinetransferase) 3.29 Absent 6.00E-03 
WDR75 (WD repeat-containing protein 75) 10.98 8.46 7.00E-03 
DDX10 (Probable ATP-dependent RNA helicase) 7.60 3 1.00E-02 
DPM1 (Uncharacterized protein) 2.61 6.08 1.00E-02 
SLC25A11 (Mitochondrial 2-oxoglutarate/malate carrier) 2.04 6.56 1.00E-02 
FN3K (Fructosamine-3-kinase) 2.32 Absent 2.00E-02 
ZNF828 (ZNF828 Zinc finger protein 828) 3.05 Absent 2.00E-02 
DDX49 (Probable ATP-dependent RNA helicase) 4.32 2.06 2.00E-02 
EIF5B (Eukaryotic translation initiation factor 5B) 3.97 10.36 2.00E-02 
RTL1 (Retrotransposon-like protein 1) 3.51 Absent 3.00E-02 
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RANP1 (Uncharacterized protein) 8.63 4.17 3.00E-02 
DHX8 (Uncharacterized protein) Absent 3.01              3.00E-02 
MYEF2 (Myelin expression factor 2) 5.58 2.89 4.00E-02 
HMGA1 (High mobility group protein HMG-I/HMG-Y) 3.85 3.1 4.00E-02 
PELP1 (Proline-, glutamic acid-, leucine-rich protein 1) 6.83 11.12 4.00E-02 
 
 
Absence of DUB ATXN3 leads to a deregulation of the splicing machinery in neuronal 
cells 
Given the altered ubiquitylation of splicing factors in ATXN3shRNA cells, we hypothesized that 
absence of ATXN3 could lead to a global deregulation of the pre-mRNA splicing process. To address 
this, we used three hybrid minigene reporter plasmids: the α-globin minigene for which the 
alternative splicing (exon skipping) is indicative of the performance of regulatory splicing factors such 
as hnRNP and SF proteins, the AdML minigene representing constitutive/strong splicing events, and 
the pyPY minigene, representing splicing events with alternative competing 3’ acceptor sites/splice 
sites [30, 31] (Figure 2A). As shown in Figure 2B and C, knockdown of ATXN3 significantly altered 
the processing of the 3 splicing reporters, suggesting a general deregulation of the splicing 
machinery.  
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Figure 2. Efficacy of RNA processing assessed by splicing reporter minigenes in ATXN3shRNA cells. (A) 
Schematic representation of the splicing reporter minigenes used for cell transfection. Exons are 
represented as colored boxes and introns by black lines. The AdML minigene contains one intron, 
giving rise to two bands: the upper band corresponds to the unspliced transcript, the lower band to 
the spliced product. The pyPY minigene contains two alternative splice sites originating three bands: 
an upper band corresponding to the unspliced transcript, a middle band corresponding to the 
splicing of the weak py tract and a lower band corresponding to the splicing product of the strong PY 
tract. The pyPY minigene contains two alternative 3’ splice sites associated with polypirimidine (Py) 
tracts with different strengths. The weak Py tract (py) is represented by thin black lines and the 
strong Py tract (PY) by a thick black line. The α-globin minigene contains two introns and a set of G 
triplets in intron 2 that promote the recognition of the 5’ splice site leading to skipping of exon 2.  (B, 
C) Semi-quantitative analysis of minigene alternative splicing showed a decreased efficiency of 
splicing in ATXN3shRNA cells. Schemes for the splicing products are indicated on the right. *p<0,05; 
**p<0,01; ***p<0,001. 
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Microarray analysis of alternative splicing in ATXN3shRNA cells 
To further explore the putative involvement of ATXN3 in splicing and in alternative splicing 
regulation in neuronal cells, we performed microarray analysis (Figure 3A) using specific arrays that 
contain additional probes for exon/exon junctions. In agreement with our hypothesis, a large 
proportion of the 7450 differentially expressed genes (43%) presented differentially regulated 
alternative splicing events (Table A2) in RA-treated ATXN3shRNA cells. The most prevalent alternative 
event types were related with exon cassettes (34%) and usage of alternative first exons (20%) (Figure 
3B).  
 
Figure 3. Experimental design – microarray analysis of alternative splicing. (A) Affymetrix Human 
Transcriptome Array 2.0 ST analysis were used to assess perturbation of global splicing patterns in 
RA-treated ATXN3shRNA cells. (B) Distribution of the differentially regulated alternative splicing events in 
ATXN3shRNA cells. Three independent biological replicates were used for analysis. 
 
KEGG pathway analysis of the genes with differentially regulated alternative splicing events 
identified 22 significant pathways (Table 2).  
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Table 2. KEGG pathway analysis of genes with altered splicing in ATXN3shRNA cells. The genes 
identified on the KEGG pathway analysis presented at least one differentially regulated exon/splicing 
pattern in ATXN3shRNA cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intriguingly, one of the top KEGG pathways was the spliceosome itself (p=0.000193) with 
33% of the genes involved in the pathway presenting altered splicing events in ATXN3shRNA cells (Figure 
4A). Some of these genes were also differentially expressed and had altered ubiquitylation in 
ATXN3shRNA cells (Table 1 and Figure 4A). Other relevant pathways were the ubiquitin mediated 
proteolysis, neurotrophin signaling, axon guidance, focal adhesion and MAPK signaling pathway, as 
well as the link to AD (Table 2). We next analyzed the candidate splicing factors related to the 
deregulated splicing events in ATXN3shRNA cells. Remarkably, around 6% of the proteins presenting 
altered polyubiquitylation levels in ATXN3shRNA cells while showing no alterations at the transcription 
level, were identified in the bioinformatic analysis of the microarray data as predicted regulators of 
genes with a differentially regulated exon/splicing pattern in these cells. Among these, four splicing 
factors did not present alterations in expression nor differentially regulated exons, but showed 
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decreased abundance in the polyubiquitylated protein fraction: SFRS2, SFRS5, SFRS7 and SFRS9 
(Figure 4B). These proteins are good candidate substrates of ATXN3. While SFRS 2,7,and 9 were 
predicted to regulate splicing events of a large amount of genes (Table S2), SFRS5 was predicted to 
regulate only the TRIM36 gene, which presents alternative first exon and exon cassette events 
differentially regulated in ATXN3shRNA cells. Together, these results support our hypothesis that ATXN3 
may play a role in pre-mRNA splicing regulation through modulation of the ubiquitylation of splicing 
factors in neuronal cells. 
 
 
Figure 4. Absence of ATXN3 alters expression, ubiquitylation and exon regulation of splicing 
components. (A) Scheme of the spliceosome assembly pathway, involving genes differentially 
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regulated in ATXN3shRNA at the alternative splicing (blue/black), total mRNA expression (white/red), 
both alternative splicing and total mRNA expression (blue/red) and ubiquitylation (green dot) level. 
(B) Venn diagram showing overlapping of splicing factors presenting globally altered expression, 
differentially regulated exons and altered polyubiquitylation levels in ATXN3shRNA cells. p≤0.05. 
 
 
DISCUSSION 
Ubiquitin signaling is now widely recognized as a fundamental molecular mechanism 
controlling a broad range of intracellular events in the nervous system (Reviewed in [5, 34, 35]). 
Taking into account the importance of DUB enzymes in maintaining the ubiquitylation balance, we 
focused on the characterization of the ubiquitome of neuronal cells lacking ATXN3 [27]. Using 
TUBEs, that enable the pulldown of polyubiquitylated proteins without further genetic manipulation 
or inhibition of the proteasome [26], in combination with LC-MS/MS, we were able to consistently 
identify around 615 proteins per condition, which seems to be a yield comparable to those 
described in other studies [33, 36]. Among the proteins identified, approximately one third 
presented altered levels of polyubiquitylation in ATXN3shRNA cells. Curiously, the majority of these 
proteins presented decreased levels of polyubiquitylation, suggesting that normally ATXN3 might be 
preventing their degradation for instance by editing the substrate’s ubiquitylation and preventing its 
degradation. Therefore, when ATXN3 is silenced, the ubiquitin signaling is not removed, which may 
result in an increased degradation of the targeted protein. We have previously shown that absence of 
ATXN3 causes a decrease of the polyubiquitylated forms of α5-integrin, a potential substrate of 
ATXN3 DUB activity, in parallel with a decrease of the total levels of this protein [27, 37].  
The fact that a significant proportion of the proteins with altered polyubiquitylation levels in 
ATXN3shRNA cells were splicing factors and proteins involved in RNA processing, led us to raise the 
hypothesis that ATXN3 could be playing a role in the pre-mRNA splicing process in neuronal cells. 
Indeed, the relative concentration of splicing factors and heterogeneous nuclear ribonucleoproteins 
(hnRNPs) have been shown to regulate alternative splicing (Reviewed in [38]). When we assessed 
general splicing effectiveness in cells depleted of ATXN3 using artificial reporter minigenes, we found 
a reduction in reporter splicing, further suggesting the involvement of ATXN3 in the regulation of the 
splicing machinery. Additionally, genome wide microarray analysis of splicing events revealed that 
absence of ATXN3 leads to an alteration in the pattern of alternative splicing events in a large 
number of genes in neuronal cells, including genes encoding spliceosome components, but also 
genes related with protein degradation, adhesion, axon guidance and signaling pathways. These 
findings are interesting, since we have previously described that absence of ATXN3 leads to 
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impairment in neuronal differentiation and adhesion, and deregulates the degradation of target 
proteins [27]. Significantly, a portion of predicted regulators of those genes were found to have 
altered levels of polyubiquitylation in our proteomic analysis, the majority of them being 
Serine/arginine (SR)-rich phosphoproteins. Proteins of the SR family are key players in the control of 
alternative splicing, regulating the selection of alternative sites (Reviewed in [39, 40]). Protein 
kinases such as AKT that are involved in the phosphorylation of SR and hnRNP, usually acting as 
antagonists of SR proteins in alternative splicing process, were also found to have altered 
ubiquitylation patterns in our study [41]. Interestingly, we have previously observed that the 
phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway was deregulated in ATXN3shRNA cells [27]. 
While the majority of the identified SR factors were predicted to regulate a large number of genes 
(Supplementary Table A2), the serine/arginine-rich splicing factor 2 (SFSR2) was predicted to 
regulate the Tripartite motif 36 (TRIM36) gene. TRIM36 is an E3 ubiquitin ligase [42, 43] that 
mediates ubiquitylation and subsequent proteasomal degradation of target proteins and was also 
reported to be associated with the microtubule cytoskeleton [44, 45] and to regulate cell cycle [45]. 
As we have previously observed that ATXN3shRNA cells showed a disruption of the cytoskeletal network 
and that they keep proliferating even after being induced to differentiate, it would be interesting to 
dissect the contribution of SFSR2 and TRIM36 to this phenotype.  
Overall, our data suggest that ATXN3 is involved in splicing regulation probably through the 
modulation of the ubiquitylation of splicing factors. This regulatory role may be mediated through the 
DUB activity of ATXN3 by modulating activation, degradation and/or subcellular localization of 
splicing factor, or may be an indirect result of the modulation of E3 ligases specific for these targets. 
It remains to be seen whether this finding is also relevant for the neurodegeneration observed in 
MJD.  Recently, several pieces of evidence have suggested an association between perturbation of 
alternative splicing and several neurodegenerative disorders, including AD, HD, PD, SMA and ALS 
(Reviewed in [46-48]). For example, it was described that several ataxia-causing proteins interact 
with splicing factors [49]. Also, the RNA-binding protein TDP-43 has been found to be the major 
component of the characteristic inclusions seen in a number of neurodegenerative diseases [50-52]. 
Sun and colleagues have shown that expression of mutant ATXN3 bearing an expanded polyQ tract 
in HeLa cells alters the ability of the subnuclear domains known as Cajal bodies to participate 
efficiently in small nuclear ribonucleoprotein (snRNP) biogenesis pathway and reduces the efficacy of 
splicing of reporter genes, and suggested that this was a consequence of the disruption of the 
normal function of ATXN3 in the UPS [53]. This possibility should be further explored in neuronal 
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cells and animal models expressing expanded ATXN3. This should contribute to our understanding 
whether the role of ATXN3 in splicing is important for MJD pathogenesis.  
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5.1 The neuronal function(s) of ATXN3 
The precise physiological role(s) of ATXN3 are still poorly identified. This is particularly true 
when focusing on its biological function in neurons. However, the selective neuronal degeneration 
observed in MJD highlights the importance of determining what is ATXN3 doing in neurons, for our 
understanding of the pathogenic mechanism(s). We chose the SH-SY5Y human neuroblastoma cell 
line as a model to generate mutant cell lines of ATXN3 knockdown, to gain insight into the 
physiological function of ATXN3 in neuronal cells. Interestingly, ablation of ATXN3 function in these 
cells led to a clear phenotype, which will be discussed in the following sections.  
 
5.1.1 Defining the ubiquitome of SH-SY5Y ATXN3 KD cells 
As mentioned above, although it has been demonstrated that ataxin-3 is a DUB enzyme, its 
substrates remain mostly unidentified. To date, it was only demonstrated that ataxin-3 
deubiquitylates CHIP [1] and parkin both in vitro and in cells [2], and it most likely regulates the 
ubiquitylation and degradation of α5-integrin [3, 4]. However, the fact that Atxn3 KO mice present 
increased total levels of ubiquitylated proteins [5] suggests that ataxin-3 may regulate the 
ubiquitylation status of many proteins. 
 
Typically, researchers study the fate of a single Ub substrate, characterize its mode of 
recognition and ubiquitylation, and study its regulation under variable pathophysiological conditions. 
In this study, taking into account the suggested diversity of substrates for ATXN3, we took an 
integrated approach based on mass spectrometry. There are at least three confounding factors that 
could limit this approach: (i) only a small percentage of a given protein is ubiquitylated in the steady 
state, (ii) the enzymatic action of DUBs decrease the levels of ubiquitylated proteins upon cell lysis, 
and (iii) the existence of ub-like proteins. To overcome these limitations, we used a recently 
described methodology based in Tandem Ubiquitin Binding Entities (TUBEs) to isolate 
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polyubiquitylated proteins from our cell lines depleted for ATXN3 and compare them to control cells. 
This strategy presents the following advantages over the classical approaches: TUBEs (i) protect 
polyubiquitylated proteins against DUBs and the proteasome, (ii) do not require the presence of 
chemical inhibitors, addition of tags, protein overexpression or genetic manipulations, (iii) reduce the 
effects on Ub chain architecture, and (iv) specifically recognize polyUB chains and no other Ub-like 
proteins [6, 7].   
 
From this experiment, we have successfully identified 615 ubiquitylated proteins, from 
which 193 were present at altered levels in ATXN3 KD cells, some of which may constitute 
candidate substrates of ATXN3’s DUB activity. 
 
5.1.2 The balance of ubiquitylation and ATXN3 
 Because ubiquitylation has been shown to play a crucial role in the regulation of neuronal 
development, differentiation and function, it needs to be tightly controlled (Reviewed in [8]). Thus, 
loss of DUB enzymes and consequent disruption of the ubiquitylation homeostasis might disturb 
neuronal function, by altering the stability of individual proteins, leading to neuronal dysfunction. In 
agreement with this hypothesis, we found that silencing of ATXN3 in neuronal cells led to an 
alteration of the polyubiquitylation in 32% of the identified proteins in our TUBES-LC-MS/MS 
approach (Chapter 4). Curiously, the majority of these proteins showed decreased abundance in the 
polyubiquitylated protein fraction in ATXN3 KD cells, and we showed that proteasome inhibition 
leads to an accumulation of such proteins (Chapter 2). This suggests that ATXN3 might be 
preventing the degradation of these proteins. One good example is ITGA5. We have shown that 
ATXN3 interacts with ITGA5 [3] and normally acts to inhibit ITGA5 degradation, affecting its steady-
state levels; when ATXN3 is silenced, more ubiquitylated ITGA5 accumulates in the cell (detectable 
only upon proteasome inhibition), and ITGA5 is extensively degraded causing defects in cell 
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adhesion and deregulation of downstream cascades (Chapter 2). Interestingly, this regulatory 
mechanism seems to be important for different cellular types, since our team has shown before that 
rescue of Itga5 from proteasomal degradation by mouse Atxn3 is essential for muscle cell 
differentiation in vitro [3]. Another finding illustrating this concept is the decreased levels of SFRS7 
that are observed in ATXN3 depleted cells (Chapter 3). In this case, technical limitations excluded 
the confirmation of SFRS7 as a target of direct regulation by ATXN3, as the inhibition of the 
proteasome leads to a general inhibition of splicing factors expression. Optimization of this assay is 
ongoing. However, the possibility remains that SFRS7 and other proteins can also be indirect targets 
of the DUB activity of ATXN3. It is possible that ATXN3 is modulating the activity of E3 ligases for 
these substrates and this way controlling their degradation. In line with that, ATXN3 was already 
shown to regulate the activity of some E3s, such as Parkin [2] and CHIP [9]. In the case of ITGA5, at 
least one E3 ligase was already identified that coordinates its degradation by the proteasome – Cbl 
[10]. To better understand the regulation of ITGA5 by ATXN3, it would be valuable to determine 
whether ATXN3 interacts directly with the intracellular domain of this protein and deubiquitylates it in 
vitro, or whether it interacts with and regulates Cbl activity.  
Alternatively, many of these molecular alterations may also occur due to cellular 
compensatory mechanisms and/or be a consequence of other cellular changes due to the absence 
of ATXN3. In this case, overexpression of an ATXN3 version lacking the cysteine 14 residue 
(ATXN3_C14A), critical for its DUB activity [11] allows us to dissociate the ubiquitome changes 
induced by the absence of ATXN3 (and cellular compensations induced by this absence) from the 
ones associated with the abolishment/perturbation of its DUB activity. 
 
Looking at the overall changes in the ubiquitome of neuronal cells lacking ATXN3, it seems 
evident that ATXN3 is contributing (either direct or indirectly) to the regulation of proteasomal 
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degradation of many diverse substrates and can be participating in different biological pathways. 
Grouping the proteins with altered levels of polyubiquitylation in ATXN3 mutant cells, we found that a 
significant number were involved in: i) gene expression, ii) RNA post-transcriptional modifications, iii) 
molecular transport and RNA trafficking, and iv) cell death and survival, classes that were in 
concordance with other findings, which supports the importance of the ubiquitylation balance for 
cellular homeostasis. This will be discussed in the next sections. 
 
5.1.3 Splicing and ATXN3 
 The fact that a significant proportion of the proteins with altered polyubiquitylation levels in 
ATXN3 cells were splicing factors and proteins involved in RNA processing caught our attention.  
Recently, the use of new technologies such as exon arrays and RNA-seq to study the human 
transcriptome have revealed an association between alternative splicing and a number of 
neurodegenerative disorders, including AD, HD, PD, Spinal Muscular Atrophy (SMA), Amyotrophic 
lateral sclerosis (ALS) and Frontotemporal lobar degeneration (FTDP-17) (Reviewed in [12-15]). For 
example, mutations in presenilin 1 (PSEN1) and presenilin 2 (PSEN2), proteins involved in AD 
pathology, lead to the formation of aberrant transcripts bearing in frame insertions or lacking exon 4, 
resulting in increased β-amyloid levels, causally linked to AD [16-18]. Also, mutant Huntingtin (htt), 
the disease-protein involved in HD, was shown to affect alternative splicing of the BDNF gene, in a 
transgenic mouse model of HD [19]. Recently, it was shown that mutant HTT alters alternative 
splicing of tau exon 10 causing a deregulation of the 4R/3R tau isoform ratio and ttal tau content, a 
phenomenon that seems to be playing a role in HD pathogenesis [20]. The alteration of FUS-
regulated RNA processing has also been proposed as a key event in ALS (Reviewed in [21-23]). The 
skipping of exon 7 of survival motor neuron (SMN) gene leads to a truncated and highly unstable 
protein resulting in SMA [13]. The RNA-binding protein TDP-43 is a major component of inclusions 
characteristic of a number of neurodegenerative conditions [24-26]. Although not yet explored in 
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detail, interaction of several ataxia-causing proteins with splicing factors have also been described, 
namely for proteins linked to SCA2, 8, 10 and 12 (Reviewed in [27]).  
Indirect pieces of evidence suggest that ubiquitylation may regulate splicing: i) Ub and Ub-
like proteins co-purify with splicing complexes [28, 29], ii) ubiquitylated splicing factors have been 
identified in proteomic studies [30], iii) several protein domains related to the UPS were found in key 
spliceosome proteins [31-34], iv) essential splicing factors as Prp19 and Prp8 have Ub ligase activity 
in vitro [31, 35, 36], and v) Ub mutants (I44A) with diminished capacity for protein-protein 
interactions strongly inhibit splicing in vitro [37]. Additionally, the relative concentration of splicing 
factors and heretogeneous nuclear ribonucleoproteins (hnRNPs) have been shown to regulate 
alternative splicing (Reviewed in [38]). Considering that ATXN3 is an Ub hydrolase, we hypothesized 
that it could also be playing a role in the regulation of pre-mRNA processing.  
 
Indeed, we have shown that ATXN3 interacts with the splicing factor SRSF7, a protein acting 
on the alternative splicing of tau mRNA. Additionally, we demonstrated that absence of ATXN3 leads 
to a deregulation of tau exon 10 alternative splicing, perturbing the 3R/4R tau isoform ratio (Chapter 
3). We further demonstrated that this effect might be relevant for MJD pathogenesis, since we have 
observed similar events in cells overexpressing mutant ATXN3 and in the brain of a transgenic 
mouse model of MJD. Interestingly, overexpression of the 4R isoform in cells lacking ATXN3, 
rescued some of the phenotypic abnormalities of these cells, described in Chapter 2. This result 
prompted us to ask whether the potential role for ATXN3 in the pre-mRNA splicing process was 
specific for the MAPT gene or if absence of ATXN3 could have a global impact on splicing 
machinery. Interestingly, we found that knockdown of ATXN3 significantly reduced the efficacy of the 
processing of three hybrid minigene reporters, suggesting a global deregulation of the splicing 
process in the cell (Chapter 4). In addition to this, by performing microarray analysis of alternative 
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splicing, we uncovered dramatic changes in alternative splicing (mostly exon cassettes and usage of 
alternative first exons) in neuronal cells lacking ATXN3. Remarkably, several proteins presenting 
altered polyubiquitylation levels in ATXN3 mutant cells were identified in the bioinformatic analysis of 
the microarray data as predicted regulators of splicing genes with an altered splicing pattern in these 
cells, namely SFRS2, 5, 7 and 9. Among them, SFRS2 caught our attention because it was 
predicted to regulate the tripartite motif 36 (TRIM36) gene. TRIM36 is an E3 Ub ligase reported to 
regulate cell cycle [39] and to be associated with the microtubule cytoskeleton [40]. As we have 
observed that absence of ATXN3 causes a disruption of the cytoskeleton network and that mutant 
cells have an abnormal proliferative activity (Chapter 2), it would be interesting to evaluate the 
contribution of TRIM36 to this phenotype. Furthermore, KEGG pathway analysis of the microarray 
data identified several genes with altered alternative splicing patterns belonging to Ub mediated 
proteolysis, neurotrophin signaling, axon guidance, focal adhesion and MAPK signaling pathways, as 
well as linked to AD, which would also be interesting to further explore.  
In line with our observations, Sun and colleagues have shown that expression of mutant 
ATXN3 (bearing an expanded polyQ tract) disturbs the biogenesis of small nuclear 
ribonucleoproteins (snRNPs) and reduces the efficacy of splicing reporter genes in HeLa Cells [41]. 
It would be interesting to further explore if this novel role of ATXN3 is also relevant for the 
neurodegeneration observed in MJD, by analyzing this process in primary cultures of neuronal cells 
and in affected brain regions of animal models expressing expanded ATXN3. If this were the case, it 
would also be interesting to determine whether the splicing alterations were age-related (since MJD 
is a late onset disease) and if they could correlate with the symptoms and neurodegeneration 
present in MJD patients. Indeed, it was reported that age-related splicing changes occur in healthy 
individuals and that this event may constitute a link between aging and neurodegeneration in AD 
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[42]. The tissue-specific splicing patterns coud also provid a key to neurospecificity in MJD and other 
neurodegenerative diseases.  
 Other pathways enriched in our analysis were pathways related with cancer and nucleotide 
excision repair (NER). Indeed, several recent reports have been demonstrating a link between 
alteration of splicing profiles and cancer [43-45]. It is thought that altered activity, expression levels 
or even mutations of splicing regulators may be associated with tumor progression and to contribute 
to metastases formation [46]. Interestingly, in the last few years a tight connection between SRSFs 
and cancer has been demonstrated. Also, although some aspects of the relantionship between DNA 
repair mechanisms and alternative splicing have not been fully explained, a link between mRNA 
metabolism and genomic stability has been provided by the following observations: i) the mRNA 
splicing pattern of crucial genes is altered in DNA damage response [47], ii) the intracellular 
distribution of splicing factors changes following genotoxic damage (Reviewed in [48, 49]), iii) DNA 
damage inhibits transcription [48, 49], and iv) mRNa stability is affected by DNA damage (Reviewed 
in [50]). 
 Therefore, understanding how alternative splicing factors can contribute to disease and, in 
turn, the splicing pattern alterations in pathological conditions can be valuable for the discovery of 
novel targets for therapies of diverse diseases, including several types of cancer and 
neurodegenerative disorders.  
 
5.1.4 Cell structure, cytoskeleton and ATXN3 
 Neurons are highly dependent on a well-structured dynamic cytoskeleton network. The 
neuronal cytoskeleton is essential for the maintenance of the structural integrity of the neuron, 
neurite outgrowth and axonal transport, as well as cell-cell interactions and cell connections with 
extracellular matrix (ECM) components. Therefore, although the initiators of neuronal dysfunction 
may differ, disruption of the neuronal cytoskeleton has been suggested to be a common feature 
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contributing to neurodegeneration in several diseases, including polyQ diseases (Reviewed in [51-
54]). For example, mutations in the cytoskeletal protein β-III spectrin were shown to cause SCA5. 
Also, abnormal aggregates of cytoskeletal components such as intermediate filament proteins and 
microtubule-associated proteins (MAPs) (e.g. tau) have been identified as neuropathological 
signatures of many neurodegenerative diseases. Although there was no data so far regarding 
cytoskeletal involvement in MJD, the demonstration that ATXN3 interacts with alpha-tubulin [55] 
suggested to us that this protein could play a role in cytoskeleton regulation. Indeed, subsequent 
studies from our lab and others further supported this hypothesis: i) large proportions of ataxin-3 
molecular partners identified in Yeast-two hybrid and pull down screenings are cytoskeleton 
components [56, 57], ii) ataxin-3 interacts with HDAC6, which mediates post-transcriptional 
modifications of cytoskeleton proteins (Reviewed in [58]), iii) ATXN3 is a MAP [55], iv) ATX-3 KO C. 
elegans have a significant transcriptional deregulation of cytoskeleton proteins [59], and v) ATXN3 
KD leads to obvious cytoskeleton defects and abnormal cell morphology in C2C12 and HeLa cells 
[3, 55]. But could this function be important also for the nervous system? Could ATXN3 be involved 
in cytoskeleton organization and cell structure maintenance also in neuronal cells? In this work, we 
showed that absence of ATXN3 lead to a deregulation of the cytoskeleton network of SH-SY5Y cells, 
which was associated with an abnormal morphology and reduced branching (Chapter 2). Although 
the increased degradation of ITGA5 and consequent alteration of the signaling to the cytoskeleton 
can partially explain this cellular phenotype, we believe that silencing of ATXN3 perturbs several 
different pathways that may contribute to this cellular phenotype. Indeed, we found that in the 
absence of ATXN3 many genes controlling cytoskeleton biogenesis and reorganization were 
differentially transcribed impacting, for example, on cell projections, G-protein signaling, cell 
motility/migration, cell cycle and division and cell shape. One of the genes that caught our attention 
was the MAPT gene, which was significantly downregulated in the mutant cells (Chapter 3). This 
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finding, together with the observations that i) ATXN3 interacts with SFSR7 in SH-SY5Y neuronal cells, 
ii) absence of ATXN3 disturbed tau splicing – ATXN3 mutant cells presenting reduced levels of the 
4R tau isoform, iii) normalizing the levels of the 4R isoform partially rescued the phenotype of the 
KD cells, and iv) overexpression of ITGA5 did not rescue the levels of tau, suggest that deregulation 
of tau expression may also contribute for the abnormal morphology and cytoskeleton disorganization 
observed in ATXN3 KD cells. Furthermore, because ATXN3 is known to interact with dynein, a 
stabilizer of the microtubules [58], it would be valuable to determine whether the 
localization/function of this protein may be perturbed in the absence of ATXN3, originating a 
disorganization of the cytoskeleton. Recently, it has been proposed that some MAPs also function to 
decrease oxidative stress in neurons, for example by protecting the microtubules from degradation 
[60, 61]. Considering that ATXN3 is a MAP, it would be interesting to clarify if it has this particular 
function, and if it could have a neuroprotective role. But how is ATXN3 regulating the cytoskeleton 
network? We have previously shown that the levels of the major cytoskeletal components were not 
altered in absence of ATXN3, making it unlikely that they are direct substrates of ATXN3 DUB activity 
[55]. However, in this work we showed that ATXN3 is modulating the degradation or the expression 
of other proteins important for a correct cytoskeletal organization, such as ITGA5 and tau isoforms. 
Supporting the relevance of the DUB activity of ATXN3 for these cellular functions, we have shown 
that overexpression of a catalytic deficient version of ATXN3 (C14A) recapitulated the alterations 
both on ITGA5 degradation (Chapter 2) and tau expression (Chapter 3).  
Finally, we asked whether the presence of the polyglutamine expansion within ATXN3 could also 
lead to similar alterations. Indeed, we found decreased levels of both ITGA5 and tau as well as 
decreased expression of 4R tau isoform both in neuronal cells overexpressing an expanded ATXN3 
and in the nervous system of MJD mice (Chapters 2 and 3). In addition, neurons isolated from the 
DRG of the CMVMJD135 transgenic mice displayed a drastic reduction in neurite length, as we have 
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observed in the cells lacking ATXN3. Together, these findings not only suggest that a disruption of 
the cytoskeleton network may be contributing for the neurodegeneration observed in MJD, but also 
that a partial loss of the normal cellular function(s) of ATXN3 may contribute for MJD pathogenesis. 
 
5.1.5 Cell signaling and ATXN3 
 As discussed above, ATXN3 is regulating the degradation of ITGA5, impacting on 
cytoskeleton organization. But it seems that not only the cytoskeleton is affected in the absence of 
ATXN3, since our work revealed that ATXN3 KD cells appear to have reduced adhesion to 
fibronectin, which may be explained by the lower levels of ITGA5 (Chapter 2). Interestingly, and in 
agreement with this finding, HeLa and C2C12 cells and neurons of Atxn3 KO mice also display low 
levels of integrin subunits in the absence of ataxin-3, in association with low cell-cell interconnectivity 
[3, 55] (Chapter 2). Besides participating in cell attachment to other cells and to the ECM, integrins 
also play a role in the transduction of signals from ECM components, the so-called “outside-in” 
signaling. This integrin-mediated signal transduction is achieved through a variety of intracellular 
protein kinases and adaptor molecules. We found that low expression of ITGA5 in ATXN3 KD cells 
was associated with a decrease in the CDK5/p35 complex activity and a change on its subcellular 
localization, and consequently, to a deregulation of the PI3K/AKT and ERK pathways. The inhibition 
of CDK5 activity has been shown to impair neuronal differentiation, function and survival (Reviewed 
in [62-69]). Interestingly, CDK5 has been proposed as a candidate for a therapeutic target for AD 
due to its role as a mediator of tau hyperphosphorylation [70]. As we observed a deregulation of tau 
expression in the absence of ATXN3, it would be interesting to assess tau phosphorylation in this 
situation. Additionally, we also found that silencing of ATXN3 leads to a decreased activation of the 
small GTPases Rac1 and Rho family, which compromised cell cycle and actin cytoskeleton 
regulation as well as increased motility.  
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In agreement with an involvement of ATXN3 in cell signaling pathways, is the deregulation of 
the ubiquitylation levels of a variety of substrates observed in the absence of ATXN3 (Chapter 4). It 
would be important now to determine which of these proteins are direct substrates of ATXN3. 
ATXN3 was shown to have DUB activity against K48, K63 and mixed polyUb linkages [1]. While 
usually K48-linked polyUb chains target protein for proteasomal degradation, K63 chains regulate, 
among other processes, protein activation and/or subcellular localization (Reviewed in [71, 72]). 
This may indicate that besides modulating protein degradation, ATXN3 may also regulate activation 
of specific substrates. Importantly, the UPS has emerged as a crucial mechanism for the normal 
nervous system development and function (Reviewed in [73, 74]). Therefore, it would be of 
interesting to i) determine whether ATXN3 is modulating the degradation of the proteins presenting 
altered levels of polyubiquitylation, by assessing their levels, or ii) to clarify whether this deregulation 
reflects an alteration of the subcellular localization and/or activity of these proteins. These 
experiments could also provide some additional clues about the specificity of the neuronal 
dysfunction observed in MJD. Nonetheless, we have already determined that cells expressing the 
expanded ATXN3 also presented decreased levels of ITGA5 and similar alterations on the integrin-
mediated signaling. Additionally, the levels of Itga5 in the brainstem and DRG of the transgenic mice 
were also downregulated, not only confirming the perturbation of ATXN3 normal function by polyQ 
expansion, but also suggesting that it may be relevant for the disease mechanism. 
 
5.1.6 Transcription and ATXN3 
 In addition to its role in protein degradation, ataxin-3 has also been proposed to function in 
transcriptional regulation (see section 1.4.4.1). In order to understand which molecular changes 
were occurring in the ATXN3 KD cells, we performed a detailed transcriptomic analysis of these 
cells. Even though our bioinformatic analyses were more focused on the splicing events, we found 
that a large proportion of genes (7450 genes) were differentially expressed in the absence of ATXN3 
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(data not shown). Also, previous transcriptomic studies from our lab identified 290 genes altered in 
ATX-3 KO C. elegans [59]. Although a transcriptional repressor role has been attributed to ataxin-3, 
we found approximately the same proportion of genes up and downregulated in cells depleted of 
ATXN3. Although it is possible that many of these genes are ATXN3 direct transcriptional targets, 
these alterations may alternatively be a consequence of cellular compensatory mechanisms or 
changes in repressor complexes in which ATXN3 does not take part. As an example, it was recently 
described that the USP15 DUB enzyme regulates the proteasomal degradation of the transcriptional 
repressor RE1 silencing transcription factor (REST), which is critical both for neuronal differentiation 
and for activation of the mitotic exit [75]. Therefore, if absence of ATXN3 indirectly perturbs this 
mechanism of REST stability control by USP15, it will result in a change in transcription that 
ultimately may be related with an impairment in neuronal differentiation, that we actually observed 
in ATXN3 KD cells. A way of identifying ATXN3 direct transcriptional targets would be by performing: 
i) CHIP-seq analysis, ii) CLIP-seq (a method to purify protein-RNA complexes coupled with high 
throughput sequencing) [76], and/or iii) similar transcriptomic analysis in cells expressing C14A 
ATXN3. Another possibility is that the observed alterations are a consequence of changes in the 
levels of transcription factors downstream of ATXN3. Indeed, we found a proportion of transcription 
factors differentially expressed in ATXN3 KD cells. This observation suggests that these changes 
may occur at a transcriptomic stage. However, we cannot exclude the possibility that ATXN3 is 
modulating the degradation of transcription factors, thus impacting on transcription. Indeed, several 
of the proteins presenting altered polyubiquitylation levels and no alterations at the transcriptional 
level in ATXN3 KD cells in this study were previously identified as regulators of gene transcription 
(Chapter 4), which may indicate that ATXN3 is regulating their degradation and/or activity. 
Another question that remains to elucidate is: are these transcriptomic changes relevant in 
the context of MJD? Trying to investigate this, we are already performing transcriptomic analysis in 
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pre and post symptomatic MJD mice (Silva-Fernandes A. et al., in preparation). Besides finding 
transcriptomic changes associated with disease progression, we also aim to look for overlapping 
changes between silencing of ATXN3 and overexpression of the expanded protein. This, in turn, may 
help to further elucidate how a partial loss of the normal function of ATXN3 on transcriptional 
regulation may contribute to disease. 
 
5.1.7 Neuronal differentiation and ATXN3 
One of the most striking effects of ATXN3 silencing in SH-SY5Y human cells was the 
impairment of the differentiation process. We found that mutant cells fail to progress toward a 
mature phenotype, as after RA treatment (normally a neuronal differentiation stimulus) they present: 
i) deficient inhibition of the proliferative activity, ii) increased expression of Nestin and decreased 
expression of several markers for mature neurons, iii) significantly reduced average neurite length, 
iv) increased number of small filopodia, v) large and flat cell bodies with reduced extensions, vi) 
severe disruption of the cytoskeleton network, and vii) increased cell migration (Chapter 2).  
Interestingly, overexpression of mutant ATXN3 bearing an expanded polyQ tract led to a 
similar phenotype as the overexpression of a catalytic mutant or the absence of ATXN3. Additionally, 
neurons from our CMVMJD135 mouse model showed abnormal morphology and neuritic branching, 
which provides evidence supporting that the polyQ expansion causes a partial loss of the normal 
function of the protein in vivo. 
But how does ATXN3 modulate neuronal differentiation? Regarding our results, we 
hypothesized that ATXN3 prevents the degradation of ITGA5 normally triggered by the activation of 
FGFR2 by RA [10]. This, in turn, activates the PI3K/AKT and ERK pathways, regulating neuronal 
morphology and cell adhesion and survival. However, we believe that this is not the only role of 
ATXN3 on neuronal differentiation. We also found that ATXN3 is involved in the regulation of tau 
isoform expression, which plays an important role in neuronal differentiation and axonal trafficking. 
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While we have already found that overexpression of 4R tau isoform partially rescues the neuronal 
differentiation phenotype of ATXN3 KD cells, it will now be interesting to evaluate whether silencing 
of ATXN3 or expression of the expanded protein causes an impairment of the axonal transport, 
which we are currently doing. 
 
5.1.8 Other functions of ATXN3 – DNA repair 
Recent data also support a role for ATXN3 in DNA repair. It was found that ATXN3 interacts 
and activates the Polynucleotide Kinase 3’-Phosphatase (PNKP) – a DNA strand break repair 
enzyme – suggesting a role for ATXN3 in PNKP-mediated DNA strand breaks repair (Chatterjee et al, 
2014, PLoS Genetics, submitted for publication). Also, it has been found that the interaction of the 
DUB ataxin-3 bearing a disease-causing mutation with the polynucleotide kinase 3’-phosphatase 
(PNKP) – a DNA strand break repair enzyme – inactivates its activity, resulting in persistent 
accumulation of DNA strand breaks as well as chronic activation of DNA damage-response ataxia 
telangiectasia mutated (ATM) signaling, which may lead to cell death and neurodegeneration (Gao R, 
et al, 2014, submitted for publication). 
 
5.2 Effects of absence of ATXN3 in cells and organisms: discrepancies and 
communalities 
 The fact that the C. elegans [59] and mouse ataxin-3 KO models [5, 77] are viable and 
exhibit no obvious phenotype at basal conditions was initially surprising. One possible explanation is 
the redundancy of function between ataxin-3 and other Josephin domain containing proteins. While 
in C. elegans another member of the Josephin family exists, Y71H2AR.3 (which, however, does not 
present a NLS or UIM and was not overexpressed in KO animals), in mouse at least two more, 
Josd1 and Josd2, and in humans three proteins were described, JOSD1, JOSD2 and ATXN3L. 
Because all these Josephin proteins are thought to be DUB enzymes [78, 79], it has been proposed 
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that they compensate for ataxin-3 absence. Additionally, a recent study showed that the DUB activity 
of JOSD1 is regulated by ubiquitylation through a conformational change at the catalytic site, 
similarly to ATXN3 [78, 80, 81]. The significance of this redundancy would be strengthened by 
experiments using double and triple mutants, i.e., mutants lacking ataxin-3 and the Josephin-like 
proteins, to evaluate their phenotype. To study this hypothesis, we have crossed a KO strain for the 
Josephin protein with atx-3 mutants. However, we found no significant differences between atx-3 KO 
animals and the double mutants, suggesting that the absence of the Josephin protein does not 
aggravate the phenotype of atx-3 mutants (unpublished data). 
On the other hand, however, when ATX-3 KO C. elegans were challenged with a protein 
homeostasis stress (heat shock), they showed an enhanced stress response, which was correlated 
with increased expression of several molecular chaperones, probably an adaptative mechanism to 
deal with the absence of the DUB activity of ataxin-3 [82].  
 
Contrary to the multicellular organisms, both mouse and human cells depleted of ataxin-3 
show clear phenotypes, with severe cytoskeletal defects, increased ubiquitylated foci, increased 
sensitivity to heat shock [83] and oxidative stress [84]. Moreover, as we have shown in the present 
work that human neuronal cells depleted for ATXN3 display an abnormal cell morphology, 
cytoskeletal defects, and an impairment in the differentiation process.  
This seems somehow incongruent, but a cellular model is indeed different from a 
multicellular system. Also, in most studies using cellular models, silencing of ataxin-3 was transiently 
performed and so, cells might not have time to adjust to this situation, while mouse and worm KO 
animals may undergo an adaptative process during development. In agreement, in our study, where 
we used cells stably silenced for ATXN3, we observed a partial recovery in cell morphology and 
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proliferation rate with multiple passages (Chapter 2). A conditional ataxin-3 KO model would be 
therefore valuable for a better understanding of these adaptative and compensatory mechanisms. 
 
Nevertheless, we cannot exclude that both mouse and worms have yet undiscovered subtle 
defects. Indeed, although not yet studied in detail, we found a decreased expression of Itga5 in 
neurons of Atxn3 KO mice, which may be associated with a disruption of the cytoskeletal network 
and decreased process length as we observed in cells. In line with this, we previously found that 
ATX-3 KO C. elegans have a significant change in the transcriptomic profile [59], which may be 
indicative of subtle anomalies not found so far. 
 
Finally, it was interesting that both ataxin-3 mutant cells and worms displayed signs of 
cellular stress, supporting that there probably exist some common features between cells and 
organisms. 
 
5.3 Relevance of the novel findings and main conclusions of the work 
As described in Chapter 1, Ub signaling is now widely known as a fundamental mechanism 
controlling a broad range of intracellular events in the nervous system. The reverse process, the 
removal of the Ub moieties, is carried out by DUBs. Although these enzymes have been recognized 
as central players in maintaining the correct ubiquitylation balance in cells, their mechanisms of 
regulation and substrate specificity are poorly understood. 
 
This work added new knowledge about the relevance for neurons of one specific DUB, 
ataxin-3, and provided evidence for perturbation of this normal function in the context of disease, 
through a dominant negative effect.  
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We showed that ATXN3 function is important for neuronal differentiation, as silencing or 
DUB activity abrogation of this protein has a strong negative impact on cell morphology, leading to 
altered neurite extension, cytoskeletal disorganization, and altered proliferation and survival of SH-
SY5Y cells. At the molecular level, this phenotype was shown to result from an excessive 
proteasome-dependent degradation of ITGA5 subunit levels in the absence of ATXN3 activity, which 
was observed both in vitro and in vivo. ITGA5 is the first ATXN3 substrate identified in neurons. This 
knowledge may be of relevance for the development of therapeutic strategies. In addition, we also 
showed that loss of function of ATXN3 leads to a deregulation of tau exon 10 splicing, resulting in a 
decreased 4R/3R tau ratio, which we demonstrated to be also contributing for the impairment in the 
differentiation process and the abnormal morphology of the mutant cells. Besides impacting on 
neuronal maintenance, these cytoskeletal changes can also have a negative impact on axonal 
transport. 
 
The loss of ATXN3 transcriptional regulation role may also have caused significant changes 
in the transcriptomic profile in our cellular model, an aspected we did not dissect in detail in this 
work. Because neurons are a highly sensitive and specific cell type, and their function needs to be 
precisely regulated, these transcriptional changes can be extremely deleterious if they also occur in 
the context of human expanded polyQ-related disease. 
 
Through its DUB activity, ATXN3 seems to function in regulating the ubiquitome in cells. We 
found that silencing of ATXN3 in SH-SY5Y cells causes a deregulation of the polyubiquitylation levels 
of a significant number of target proteins. These proteins are good candidates for being targets of 
the DUB activity of ATXN3 and, depending on their function and relevance for the cell, can also be 
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potential therapeutic targets. Among the proteins found to have altered polyubiquitylation patterns in 
the absence of ATXN3, a large proportion were proteins involved in RNA post-transcriptional 
modification. This data, together with the observation that absence of ATXN3 perturbs alternative 
splicing and specifically the splicing of tau, suggested to us that ATXN3 could be regulating this 
process in neurons, a hypothesis that we validated using reporter minigenes and transcriptomic 
analysis. These findings lead us to propose that ATXN3 plays a role in splicing regulation more 
globally in neurons, a novel function for this protein. 
 
5.3.1 Ataxin-3 in the disease context: gain or loss of function? 
This work was based on the idea that the study of the normal molecular and physiological 
function of ATXN3 is also important for the understanding of the pathogenic mechanism. Currently, 
studies in several polyQ diseases support the combinatory pathogenic model of gain and loss of 
function. In this way, for example, the identification of the ubiquitome in cells expressing expanded 
ataxin-3 may be an important contribution for the understanding of the pathogenic mechanism. This 
can also help to explore the proposed gain and loss of function model, given that ataxin-3’s 
interactions with its substrates can either be gained or lost in the context of disease. The functional 
study of these interactions and the involvement of ataxin-3 in the suggested pathways can thus give 
important insights into the pathogenic mechanism and can also help to explain the selective 
neurodegeneration observed in MJD, which might be correlated with the stability and expression of 
the specific substrates, or with tissue-specific splicing patterns. 
 
Indeed, our data supports this line of thought: the role of ATXN3 in regulating ITGA5 
stability, here described, was shown not only to be relevant in physiological conditions for neuronal 
differentiation but also to be potentially involved in MJD pathogenesis. Interestingly, α5-integrin 
subunit is known to be a key regulator of the actin cytoskeleton, and also to be implicated in the 
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regulation of spine morphogenesis, synapse formation and synaptic plasticity. According to this 
evidence, we may speculate that the reduced levels of α5-integrin subunit and the reduced 
branching found in the presence of expanded ATXN3, both in vitro and in vivo, may be impairing 
synaptic plasticity thus contributing for MJD pathology. 
Also consistent with this hypothesis, we found that both silencing of ATXN3 or expression of 
an expanded version led to a deregulation of tau exon 10 splicing, also with effect on neuronal 
morphology and differentiation. This is another evidence that partial loss of the normal function(s) of 
ataxin-3 might be contributing for MJD. In addition, these results also establish a link between two 
key proteins involved in different neurodegenerative diseases. Curiously, a relation between ataxin-3 
and proteins associated with other neurodegenerative diseases, including Parkin [2], CHIP [81] and 
SOD1 [85], has already been observed, suggesting that there may exist common pathogenic 
mechanisms. 
 
Altogether, these data support the idea that we should not look at MJD exclusively as a gain 
of function disease. Even tough it is well established that the polyQ expansion triggers the disease, a 
partial loss of the cellular DUB activity(ies) of ATXN3 through dominant-negative effects, may also 
modulate and contribute for disease progression and the specificity of neurodegeneration. 
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Table A1. List of primers used in this study.  
Name Forward (5’-3’) Reverse (5’-3’) 
pyPY TGAGGGGAGGTGAATGAGGAG TCCACTGGAAAACCGCGAAG 
py AGGCTTTGAGAACCTGTGGA AACCGCGAGCTTGAACAG 
PY AGGCTTTGAGAACCTGTGGA TGAGAGTCATTTCACCTTGAACA 
AdML GTCGACGACACTTGCTCAAC AAGCTTGCATGCAATCAGTAG 
α-globulin GTCGACGACACTTGCTCAAC AAGCTTGCATGCAATCAGTAG  
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Table A2. Genes with altered splicing in ATXN3shRNA cells. List of genes with altered splicing in RA-treated ATXN3shRNA cells as compared with the SCRshRNA controls. 
Genes were considered significantly regulated when fold-change was ≥1.5 and p≤0.05. The predicted upstream regulators of the splicing events are listed 
(based on SpliceAid-F database).  
 
 
 
   Prediction of upstream regulator 
Gene 
Symbol 
Alter. Event Type 
Fold 
change 
p-value Splicing Factor Symbol(s) 
FAM213B Intron Retention 2.26 3.80E-05 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, SC35, YB-1, ZRANB2 
DFFB 
Alter. Acceptor Site 1.89 7.42E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e3-4) 1.62 6.48E-03 
Exon Cassette 1.62 6.48E-03 
UBE4B Exon Cassette 1.76 5.84E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KIF1B 
Alter. First Exon (e1-11,e14-
16,e18-25,e27-30) 
3.09 5.15E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e26) 3.35 1.24E-04 
CLCN6 // NPPA-
AS1 
Alter. Terminal Exon (e4) 1.64 4.79E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.58 1.44E-03 
DDI2 // RSC1A1 Alter. Terminal Exon (e5) 1.96 1.46E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MST1P2 Alter. Acceptor Site 1.82 9.58E-03 hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, Nova-2, SC35, YB-1 
CDC42 Exon Cassette 1.92 9.06E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZBTB40 Intron Retention 2.60 1.22E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
SRRM1 
Exon Cassette 2.05 9.02E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.53 3.54E-06 
WDTC1 Intron Retention 1.66 1.84E-03 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PHACTR4 Exon Cassette 2.14 1.16E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
YTHDF2 Intron Retention 1.70 3.06E-03 ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, TIA-1, TIAL1, YB-1 
EPB41 
Alter. Terminal Exon (e14) 1.90 4.36E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.84 3.93E-05 
ZCCHC17 Exon Cassette 1.58 5.62E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HDAC1 
Alter. Terminal Exon (e6) 1.58 5.06E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.61 1.10E-03 
S100PBP Exon Cassette 2.10 2.04E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AGO3 
Alter. Terminal Exon (e7-8) 1.67 3.67E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 5.99 5.80E-05   
PPIE 
Alter. Donor Site 2.28 1.79E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.93 4.10E-03 
Intron Retention 2.01 1.04E-04 
CCDC30 
Mutualy Exclusive Exons (e9-
11,e13-15) 
2.06 6.60E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF691 Intron Retention 1.66 1.36E-02 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, KSRP, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
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AKR1A1 
Exon Cassette 1.54 6.03E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.66 2.56E-04 
RAD54L Complex 1.58 9.76E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
ZYG11B Exon Cassette 2.08 3.90E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SGIP1 Exon Cassette 8.34 2.00E-05 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FPGT//FPGTTNN
I3K//TNNI3K 
Alter. Terminal Exon (e22) 1.77 8.94E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ACADM Exon Cassette 1.52 1.76E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FNBP1L Intron Retention 2.18 2.42E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
AMY2B // 
RNPC3 
Alter. First Exon (e17-18) 1.81 4.77E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PRPF38B 
Alter. Terminal Exon (e5-6) 1.67 2.24E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.59 2.98E-04 
AHCYL1 Alter. Acceptor Site 1.54 1.46E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
STRIP1 Intron Retention 1.56 5.30E-03 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuD, Nova-1, SRp20, TIA-1, TIAL1, YB-1 
RAP1A Exon Cassette 1.61 1.46E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DDX20 Intron Retention 1.69 1.08E-02 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, SRp20, TIA-1, TIAL1, YB-1 
RBM8A Intron Retention 2.55 2.30E-03 ETR-3, HTra2beta1, SC35 
PIAS3 Intron Retention 1.67 2.12E-03 ETR-3, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), MBNL1, Nova-1, SC35, SRp20, TIA-1, TIAL1, YB-1 
VPS45 Intron Retention 2.05 8.84E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, TIA-1, TIAL1, YB-1 
SETDB1 Intron Retention 1.66 4.14E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PIP5K1A Exon Cassette 1.96 1.28E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PSMB4 Intron Retention 1.89 9.24E-04 ETR-3, hnRNP I (PTB), hnRNP P (TLS), Nova-1, SC35, YB-1 
RIIAD1 Alter. First Exon (e1-5) 6.53 5.60E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CHTOP Alter. Terminal Exon (e3) 1.72 7.62E-04   
INTS3 Intron Retention 1.52 1.61E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SF2/ASF, 
SRp30c, TIA-1, TIAL1, YB-1 
HAX1 Intron Retention 2.05 1.63E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, RBM5, SC35, TIA-1, TIAL1, YB-1 
SLC50A1 Exon Cassette 1.59 1.28E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
USP21 Intron Retention 1.89 7.40E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, RBM5, Sam68, SC35, YB-1 
NDUFS2 Intron Retention 1.82 3.36E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, KSRP, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
UHMK1 Intron Retention 1.60 6.06E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, YB-1, ZRANB2 
MPZL1 Exon Cassette 3.71 1.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DCAF6 Exon Cassette 1.59 2.23E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SOAT1 Exon Cassette 1.81 4.84E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TSEN15 Exon Cassette 2.10 1.04E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CD46 Exon Cassette 1.73 4.30E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYT14 Complex (e2-4) 1.84 1.06E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VASH2 
Alter. Terminal Exon (e9-11) 1.59 2.08E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.59 9.62E-03 
RPS6KC1 Intron Retention 2.54 9.59E-05 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, YB-1, ZRANB2 
PROX1 Complex 3.00 2.29E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MARK1 Exon Cassette 1.73 1.69E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
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MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
COG2 Intron Retention 1.51 5.80E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, 
SF2/ASF, SRp20, TIA-1, TIAL1, YB-1 
GNPAT Exon Cassette 1.65 4.70E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LGALS8 Exon Cassette 2.00 3.64E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
SLC35E2B 
Alter. Terminal Exon (e6) 1.60 7.64E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.63 1.83E-04 
WRAP73 Intron Retention 1.79 5.83E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
CTNNBIP1 
Alter. First Exon (e1-2,e4) 2.90 1.08E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e2,e4-7) 1.83 4.60E-04 
EXOSC10 Intron Retention 1.79 1.17E-04 CUG-BP1, ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HTra2beta1, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
CASP9 Alter. Acceptor Site 1.62 1.13E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, YB-1 
MFAP2 Intron Retention 3.86 1.45E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
AKR7A2 Alter. Terminal Exon (e3) 1.60 2.84E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HP1BP3 
Alter. Acceptor Site 1.75 1.66E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e3) 1.72 1.50E-03 
RAP1GAP Complex (e2,e4) 2.29 5.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C1orf63 Alter. Acceptor Site 1.61 5.84E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
STMN1 Intron Retention 2.03 1.21E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
SRSF4 
Exon Cassette 2.35 1.37E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.36 3.03E-04 
BAI2 Alter. First Exon (e2-4) 1.61 1.02E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BSDC1 Intron Retention 1.97 4.79E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FHL3 Intron Retention 1.58 2.95E-02 ETR-3, hnRNP K, hnRNP P (TLS), MBNL1, SC35, SF1, YB-1 
EBNA1BP2 Intron Retention 2.44 4.97E-04 ETR-3, Fox-1, Fox-2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, YB-1 
HYI Intron Retention 2.00 1.43E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, SC35, SRp30c, TIA-1, TIAL1, YB-1 
POMGNT1 Intron Retention 2.31 5.16E-03 hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, MBNL1, Nova-1, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
FAF1 Exon Cassette 1.75 1.33E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EPS15 
Alter. First Exon (e1-8,e10-13) 1.74 1.81E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e9) 1.64 8.46E-03 
LRP8 Exon Cassette 1.55 9.70E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HSPB11 Intron Retention 1.57 6.56E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
CDCP2 // 
CYB5RL 
Alter. Terminal Exon (e6,e7-10) 1.91 1.16E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.64 1.32E-02 
Exon Cassette 1.91 1.98E-02 
MYSM1 Intron Retention 1.86 3.06E-03 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
ITGB3BP 
Alter. Terminal Exon (e8) 1.87 1.06E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.91 1.85E-04 
ZRANB2 Intron Retention 1.56 6.04E-03 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, PSF, Sam68, SF1, SRp20, TIA-1, TIAL1, YB1 
ZZZ3 Intron Retention 1.54 6.94E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FUBP1 
Exon Cassette 1.57 1.65E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, HuD, Nova-1, RBM5, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 2.63 7.92E-05 
TTLL7 Exon Cassette 1.65 2.38E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DDAH1 Alter. First Exon (e4) 2.16 3.84E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DBT Alter. Acceptor Site 1.64 4.54E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
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EXTL2 Exon Cassette 2.20 1.69E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DPH5 Exon Cassette 2.14 1.23E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OLFM3 
Alter. First Exon 2.28 2.00E-05 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 13.23 2.78E-06 
DRAM2 
Complex 12.17 2.95E-07 ETR-3, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 Exon Cassette 12.01 2.95E-07 
RSBN1 Exon Cassette 2.16 1.12E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TRIM33 
Alter. Terminal Exon (e16) 1.66 6.12E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.82 3.48E-03 
NOTCH2 Exon Cassette 5.23 8.60E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
APH1A Intron Retention 1.67 2.50E-03 hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ARNT Exon Cassette 1.67 2.38E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CDC42SE1 Intron Retention 1.62 2.56E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, KSRP, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
VPS72 Complex 1.78 2.84E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
JTB Intron Retention 1.67 1.30E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, SC35, TIA-1, TIAL1 
SHC1 Alter. First Exon (e2) 3.28 7.76E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GBA // GBAP1 Alter. First Exon (e1) 3.17 4.61E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
YY1AP1 Exon Cassette 1.50 2.62E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCT3 
Exon Cassette 2.20 1.98E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp30c, TIA-
1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.54 1.14E-02 
ARHGEF11 Intron Retention 1.67 4.06E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
IGSF9 Exon Cassette 2.28 5.23E-04 ETR-3, FMRP, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, SC35, YB-1, ZRANB2 
USF1 Alter. First Exon (e1) 2.41 6.04E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
B4GALT3 Intron Retention 1.58 6.36E-04 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ASTN1 Alter. Acceptor Site 2.90 6.36E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SF1, SRp20, TIA-1, TIAL1, YB-1 
FAM129A 
Alter. Term Exon (e3,e4,e8-13) 3.74 3.50E-06 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.90 1.76E-02 
TRMT1L Exon Cassette 2.02 1.33E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PLEKHA6 
Exon Cassette 7.80 9.62E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons (e10) 3.42 7.59E-05 
ANGEL2 
Alter. First Exon (e1) 1.89 1.66E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e4) 2.75 1.86E-03 
ESRRG 
Complex (e10) 5.07 4.53E-06 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 5.07 4.53E-06 
NVL Exon Cassette 1.60 4.01E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WDR26 Exon Cassette 1.51 7.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MRPL55 
Complex 2.04 5.58E-04 
 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
Exon Cassette 1.73 3.65E-04 
TAF5L Alter. Terminal Exon (e4) 1.62 5.64E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TTC13 Exon Cassette 1.83 8.29E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NID1 Exon Cassette 1.73 7.00E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RGS7 Complex (e7-8) 1.66 2.98E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
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HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
OPN3 Alter. Donor Site 1.79 2.02E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OPN3 Alter. First Exon (e1-2) 2.33 3.69E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF692 
Complex 1.55 2.94E-03 
ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, MBNL1, Nova-1, RBM5, SC35, TIA-1, TIAL1 
Intron Retention 1.86 1.36E-04 
FBXO18 Alter. First Exon (e4-5) 2.04 1.16E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CACNB2 Mutualy Exclusive Exons (e11) 2.25 9.75E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MLLT10 Exon Cassette 1.59 1.12E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BMI1//COMMD3 Intron Retention 1.61 6.08E-05 ETR-3, hnRNP A1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
SPAG6 Exon Cassette 2.96 5.65E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MYO3A Alter. First Exon (e1-33) 1.86 1.55E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZEB1 Alter. First Exon 2.18 1.78E-02 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MAPK8 
Complex 2.71 1.04E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Mutualy Exclusive Exons (e7) 5.44 1.34E-06 
Exon Cassette 2.90 5.01E-04 
PHYHIPL Exon Cassette 2.60 1.36E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VPS26A Exon Cassette 1.84 1.67E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SEC24C 
Exon Cassette 1.67 1.22E-04 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.75 3.25E-04 
ZSWIM8 Alter. Terminal Exon (e1-2) 1.59 1.02E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VDAC2 Exon Cassette 2.09 1.19E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
ZMIZ1 Exon Cassette 3.18 3.45E-04 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
BTAF1 Alter. Donor Site 2.70 7.80E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, YB-1, ZRANB2 
AS3MT/C10orf32 Alter. First Exon (e7) 1.70 3.92E-05 hnRNP E1, hnRNP E2, SC35, SRp30c, TIA-1, TIAL1 
SFR1 Intron Retention 2.52 4.63E-04 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1, ZRANB2 
MXI1 Exon Cassette 2.32 1.96E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VTI1A Exon Cassette 1.62 1.10E-02 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-
1, Nova-2, RBM5, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRUB1 Complex 1.83 1.83E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WDR11 Intron Retention 1.67 6.85E-04 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, SC35, SF1, SRp20, SRp30c, YB-1, ZRANB2 
TACC2 Exon Cassette 2.68 5.60E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PLEKHA1 
Exon Cassette 1.71 6.37E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, 
SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.76 6.37E-04 
BCCIP Alter. Terminal Exon (e6) 2.16 3.69E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LRRC27 Exon Cassette 2.26 1.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DIP2C Alter. Terminal Exon 1.68 1.76E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SEPHS1 
Alter. Donor Site 2.07 6.99E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e6) 2.17 6.48E-03 
Exon Cassette 1.90 3.24E-04 
ABI1 Exon Cassette 1.54 4.19E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
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Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
ANKRD26 Exon Cassette 1.51 6.49E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF438 Exon Cassette 3.02 1.20E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ITGB1 Exon Cassette 1.83 1.77E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF37BP Intron Retention 1.68 6.82E-04 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ERCC6 // 
ERCC6-PGBD3 // 
Intron Retention 1.53 2.12E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZWINT Intron Retention 2.15 5.41E-04 ETR-3, hnRNP P (TLS), HTra2beta1, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM13C Alter. Terminal Exon (e13-14) 2.42 1.10E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RTKN2 Exon Cassette 1.81 7.60E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RUFY2 Alter. First Exon (e1) 1.84 4.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LRRC20 Alter. First Exon (e2) 1.52 1.03E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CAMK2G 
Exon Cassette 1.67 5.00E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.60 9.82E-04 
Exon Cassette 2.08 1.54E-03 
ATAD1 Exon Cassette 1.59 9.14E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ACTA2 Exon Cassette 2.47 6.23E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SORBS1 
Alter. Acceptor Site 3.57 2.42E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 3.60 1.61E-04 
Exon Cassette 1.59 4.83E-04 
ARHGAP19 // 
SLIT1 
Alter. Terminal Exon (e21,e22-
27,e29-54) 
1.92 1.06E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
POLL Alter. Terminal Exon (e7) 1.60 4.78E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LDB1 Alter. Terminal Exon (e11) 2.31 7.56E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NT5C2 
Exon Cassette 2.01 1.22E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SRp20, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.00 1.78E-04 
SORCS1 
Alter. Terminal Exon (e25) 1.53 1.70E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e2) 1.62 2.83E-04 
SMNDC1 Intron Retention 1.58 4.00E-03 ETR-3, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SF2/ASF, SRp20, YB-1, ZRANB2 
BBIP1 
Alter. Terminal Exon (e4) 1.96 9.74E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.41 1.42E-04 
Exon Cassette 1.71 1.95E-05 
C10orf118 Alter. Acceptor Site 1.81 1.80E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1 
TIAL1 
Alter. Terminal Exon (e12) 1.83 4.38E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.22 2.17E-04 
NSMCE4A Intron Retention 1.71 4.01E-04 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
OAT Alter. Acceptor Site 1.71 1.92E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STK32C Alter. First Exon 3.01 1.35E-07 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM80 Intron Retention 2.18 1.60E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BRSK2 Complex 1.78 1.93E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, SC35, 
SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RRM1 Alter. Donor Site 1.77 1.19E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB1 
ILK Intron Retention 1.61 1.57E-02 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP P (TLS), HTra2beta1, KSRP, SRp30c 
Appendices 
 160 
TEAD1 
Complex 2.06 1.02E-03 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 Exon Cassette 2.06 1.02E-03 
NAV2 Exon Cassette 2.40 3.40E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DNAJC24 
Alter. Terminal Exon (e4-5) 1.70 1.62E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 2.14 8.40E-04 
Exon Cassette 2.05 8.40E-04 
HIPK3 Exon Cassette 1.53 8.38E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP I (PTB), HuB, Nova-1, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
KIAA1549L Exon Cassette 1.87 3.96E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ACCS // EXT2 
Alter. Terminal Exon (e19,e20-
21,e23-25,e27-33) 
1.86 6.72E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PRDM11 Alter. Terminal Exon 1.96 8.33E-05 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DGKZ Alter. First Exon (e1-29) 1.74 3.32E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TTC9C Exon Cassette 1.74 8.79E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VEGFB Alter. Acceptor Site 1.54 2.42E-04 hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, MBNL1, Nova-1, Nova-2, Sam68, SRp30c, TIA-1, TIAL1, YB-1 
MUS81 Intron Retention 1.70 2.62E-03 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ANKRD13D Intron Retention 1.64 8.40E-04 ETR-3, hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, SC35, SRp20, SRp30c, YB-1 
NDUFV1 Intron Retention 2.62 8.41E-04 hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, PSF, SC35, SF2/ASF, SRp30c, YB-1 
TPCN2 Exon Cassette 2.16 1.58E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
MRPL48 Exon Cassette 1.60 2.40E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
UVRAG Exon Cassette 1.96 6.36E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C11orf30 Exon Cassette 1.56 3.95E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM126B Exon Cassette 1.84 1.80E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C11orf73 Alter. Terminal Exon (e6-7) 2.19 1.23E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
C11orf54 Exon Cassette 1.78 1.48E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DIXDC1 Alter. First Exon (e3-7,e10-12) 1.75 1.02E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SDHD 
Exon Cassette 1.77 8.06E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons 2.26 1.62E-03 
NCAM1 
Complex (e17-20) 3.21 1.67E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.05 2.36E-05 
VPS11 Complex 2.01 2.77E-04 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
HMBS Intron Retention 1.73 3.76E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, MBNL1, SRp30c, YB-1, ZRANB2 
HINFP Intron Retention 1.50 8.25E-05 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, Y 
ARHGEF12 Exon Cassette 1.51 1.92E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TBCEL 
Complex 1.59 4.24E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.70 9.42E-04 
TBRG1 Exon Cassette 1.70 2.32E-05 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1 
STT3A Exon Cassette 1.95 6.35E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SF1, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FOXRED1 Alter. Donor Site 1.74 1.74E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ACAD8 
Complex 1.51 1.58E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.71 1.33E-02 
RNH1 
Alter. Acceptor Site 1.56 3.00E-03 
ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. First Exon (e1) 1.60 3.52E-03 
Complex 1.71 4.99E-04 
Exon Cassette 1.54 3.82E-03 
Appendices 
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MOB2 Alter. First Exon (e1) 1.99 1.86E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NAP1L4 Exon Cassette 1.54 1.88E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF195 Exon Cassette 2.48 2.16E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
APBB1 Intron Retention 1.64 1.64E-02 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, RBM5, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
ARFIP2 
Alter. Acceptor Site 2.00 2.83E-04 
ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 Alter. Terminal Exon (e3) 1.65 1.80E-04 
Intron Retention 2.07 7.98E-05 
DKK3 
Alter. First Exon (e1-3) 5.91 4.20E-06  9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.53 3.21E-04 
FBXO3 Alter. Terminal Exon (e11) 1.99 1.06E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PHF21A Mutualy Exclusive Exons (e16) 5.71 1.07E-07 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AMBRA1 Exon Cassette 1.52 1.45E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LPXN Exon Cassette 1.53 3.72E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GANAB Exon Cassette 1.50 7.84E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, RBM5, SC35, SF2/ASF, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
UBXN1 
Intron Retention 2.01 7.64E-05 
ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, Nova-1, Sam68, SC35, SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1 Intron Retention 2.92 2.81E-04 
Intron Retention 2.25 8.44E-04 
SNHG1// 
SNORD22 
Intron Retention 1.70 3.84E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP P (TLS), HuB, KSRP, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
RELA 
Alter. Acceptor Site 2.73 4.56E-04 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), PSF, SC35, SRp30c, YB-1 
Intron Retention 2.34 7.51E-05 
SUV420H1 Exon Cassette 1.77 1.14E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NUMA1 
Alter. First Exon (1-6) 1.79 8.78E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.64 4.43E-05 
Exon Cassette 2.34 2.25E-05 
CTSC Alter. Donor Site 2.03 2.16E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, TIA-1, 
TIAL1, YB-1, ZRANB2 
MRE11A Alter. Terminal Exon 1.52 5.95E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CWC15 Intron Retention 1.94 9.80E-04 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HTra2beta1, HuB, Nova-1, Sam68, SC35, TIA-1, TIAL1 
CADM1 
Alter. First Exon (e1-10) 1.86 1.06E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.60 3.89E-06 
Mutualy Exclusive Exons 1.92 1.44E-04 
TMEM218 
Alter. Acceptor Site 1.56 3.01E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e1-3) 2.23 2.11E-05 
Exon Cassette 2.17 3.03E-04 
ETS1 
Complex 1.68 2.66E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.53 2.31E-05 
ARHGAP32 Intron Retention 2.15 3.98E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DYRK4 
Alter. Term Exon (e10,e11-16) 1.57 2.66E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.95 3.96E-04 
CD9 
Alter. First Exon 2.29 2.24E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon 2.81 1.76E-03 
Complex (e3-7) 3.21 1.68E-05 
PTMS 
Alter. Acceptor Site 2.64 4.99E-04 
ETR-3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, KSRP, MBNL1, Nova-1, Nova-2, PSF, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. First Exon (e1) 1.90 8.19E-04 
ATN1//C12orf57 Intron Retention 1.85 1.21E-04 ETR-3, hnRNP P (TLS), HuB, KSRP, Nova-1, SC35, SRp30c, TIA-1, TIAL1 
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FAM66C Exon Cassette 1.73 7.45E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GABARAPL1 
Complex 2.05 3.28E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.52 1.70E-03 
ATF7IP Alter. First Exon (e1) 2.29 5.59E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FGFR1OP2 
Alter. Terminal Exon (e5) 2.38 1.78E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.60 5.98E-05 
CCDC91 Exon Cassette 2.24 2.36E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BICD1 
Complex 1.92 1.88E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.92 1.02E-02 
IRAK4 Exon Cassette 1.50 3.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARID2 Exon Cassette 1.96 5.90E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PFKM Intron Retention 3.04 1.86E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), MBNL1, Nova-1, Nova-2, SRp30c, YB-1, ZRANB2 
SPATS2 Exon Cassette 2.84 6.64E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LETMD1 Exon Cassette 1.62 2.49E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EIF4B Exon Cassette 2.24 1.02E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RAB5B Complex 1.85 4.78E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ERBB3 Complex 2.46 2.42E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MYL6 
Alter. Terminal Exon (e7-8) 1.90 8.75E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, KSRP, MBNL1, SC35, SRp30c, TIA-1, TIAL1, YB-1, 
ZRANB2 Complex 1.65 9.60E-04 
NABP2 Alter. First Exon (e1) 1.63 2.72E-02 ETR-3, hnRNP A1, hnRNP C1, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, Nova-1, Sam68, SC35, SRp20, YB-1, ZRANB2 
DTX3 
Alter. Acceptor Site 2.56 6.92E-03 
ETR-3, hnRNP A1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HTra2beta1, HuB, KSRP, Nova-1, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
Intron Retention 2.20 5.97E-04 
ARHGEF25 // 
SLC26A10 
Complex 1.74 1.60E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, 
SC35, SRp30c, YB-1, ZRANB2 Exon Cassette 1.89 5.20E-03 
SRGAP1 Alter. Terminal Exon (e10) 1.50 1.10E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TBC1D30 Alter. Terminal Exon (e14-16) 1.90 1.10E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HELB Exon Cassette 1.58 1.01E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FRS2 Exon Cassette 1.80 1.04E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CNOT2 Intron Retention 1.84 1.08E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LGR5 Complex 2.43 1.20E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, RBM5, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYT1 Complex 1.58 9.99E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MRPL42 Exon Cassette 3.45 8.84E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PLXNC1 Alter. First Exon 1.89 5.98E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VEZT Exon Cassette 2.33 8.80E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
VEZT Exon Cassette 1.72 5.62E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMPO 
Alter. Terminal Exon (e4-5) 2.24 1.56E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.45 3.79E-04 
SLC25A3 Intron Retention 1.55 2.10E-03 CUG-BP1, ETR-3, FMRP, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
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PARPBP Exon Cassette 1.75 2.08E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RIC8B Exon Cassette 1.95 1.64E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
UBE3B 
Complex 1.51 1.17E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.80 3.88E-03 
IFT81 Exon Cassette 1.83 2.78E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ERP29 Exon Cassette 2.04 1.40E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SETD8 Alter. First Exon (e1) 1.52 4.48E-03 
ETR-3, FMRP, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ZNF10 // 
ZNF268 
Complex 1.65 2.50E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DCP1B Exon Cassette 1.71 1.94E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FOXM1 Exon Cassette 2.06 3.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PARP11 Exon Cassette 2.08 1.50E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TNFRSF1A Alter. First Exon (e1,e3,5-6,8-11) 1.74 3.16E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LMO3 Alter. First Exon (e3) 7.88 7.84E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CAPRIN2 Exon Cassette 2.22 3.35E-06 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DENND5B Exon Cassette 1.89 1.98E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KIF21A Exon Cassette 2.62 4.43E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HDAC7 
Exon Cassette 2.06 1.20E-02 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 2.09 7.62E-03 
Complex 1.68 6.00E-04 
MCRS1 Intron Retention 1.60 2.22E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP K, hnRNP P (TLS), HuB, Nova-1, Nova-2, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
LIMA1 Alter. First Exon (e1-3) 2.05 2.84E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CSAD Exon Cassette 1.60 6.86E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CALCOCO1 Intron Retention 1.73 1.97E-02 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CBX5 Alter. First Exon (e1) 1.60 5.52E-03 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ITGA5 
Exon Cassette 3.03 7.38E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB, CUG-BP1, ETR-3, Fox-1, Fox-2 Alter. First Exon (e1) 3.71 2.17E-05 
GTSF1 Alter. First Exon (e1) 3.71 2.17E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
RNF41 Exon Cassette 1.54 9.98E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
CS Exon Cassette 2.07 2.20E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DCTN2 Complex (e4) 2.22 3.34E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
IKBIP 
Complex (e1-2) 2.10 1.39E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.19 3.45E-04 
SART3 Intron Retention 1.82 1.24E-03 ETR-3, hnRNP C1, hnRNP I (PTB), HTra2beta1, HuB, KSRP, Nova-1, SC35, SRp20, TIA-1, TIAL1, YB-1 
GIT2 Exon Cassette 4.53 9.24E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C12orf76 
Complex 2.14 1.14E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.86 4.41E-04 
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ATXN2 
Complex 1.68 9.50E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.52 6.04E-03 
TBX3 Exon Cassette 2.63 3.67E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
RPLP0 Intron Retention 1.65 9.19E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Sam68, SC35, YB-1 
RSRC2 
Alter. Donor Site 2.07 3.12E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.55 6.52E-03 
CDK2AP1 Alter. First Exon (e1) 1.55 2.21E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, YB-1, ZRANB2 
EIF2B1 Alter. Terminal Exon (e5) 1.52 2.16E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
SCARB1 Exon Cassette 3.91 4.69E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC15A4 Exon Cassette 1.97 5.82E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RIMBP2 Exon Cassette 2.07 1.81E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZMYM2 Exon Cassette 1.89 2.12E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IFT88 
Complex 1.53 2.58E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.52 1.30E-03 
POLR1D Complex 1.66 5.02E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GPR180 Exon Cassette 2.71 4.94E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARHGEF7 
Alter. First Exon (e1) 2.86 3.63E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.11 3.89E-05 
CDC16 Intron Retention 1.61 5.02E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
DCLK1 Alter. Terminal Exon (e8) 2.49 1.24E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MTRF1 Intron Retention 1.83 5.84E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), HTra2beta1, HuB, HuD, KSRP, Nova-1, SC35, SRp20, TIA-1, TIAL1, YB-1 
SUCLA2 Alter. First Exon (e1-2,e5) 1.56 8.90E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DHRS12 Exon Cassette 1.59 6.80E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MRPS31P5 // 
THSD1P1 
Complex 2.60 1.17E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SF1, 
SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DOCK9 Alter. Acceptor Site 2.40 4.45E-04 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
TMTC4 Alter. Terminal Exon (e15) 2.27 3.61E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GAS6 Alter. First Exon (e1-2,e4) 1.67 2.72E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RASA3 Exon Cassette 1.99 3.46E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PARP2 Alter. Donor Site 5.19 1.14E-06 hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
OXA1L Intron Retention 2.16 4.31E-06 ETR-3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), Nova-1, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
DHRS2 
Alter. Acceptor Site 3.21 1.88E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e1-5) 3.29 3.29E-06 
IRF9 // RNF31 Alter. Terminal Exon (e29-31) 1.68 1.56E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AKAP6 Alter. First Exon (e1-2) 1.81 4.92E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PRPF39 Exon Cassette 1.69 2.50E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, Nova-1, Sam68, YB-1 
SAMD4A Exon Cassette 2.06 2.41E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KTN1 
Exon Cassette 1.71 1.84E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 Intron Retention 1.81 1.84E-03 
PRKCH Alter. First Exon (e1-11) 5.88 1.83E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZBTB1 Exon Cassette 1.93 1.62E-02 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
Appendices 
 165 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CHURC1 // 
FNTB 
Exon Cassette 1.91 4.78E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FUT8 
Complex (e3-4) 1.61 4.40E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP L, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.61 4.40E-04 
GPHN Exon Cassette 2.19 6.13E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GALNT16 Complex 1.60 1.55E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SRSF5 
Alter. Acceptor Site 1.94 8.24E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e6,e7-9) 1.80 5.59E-05 
Intron Retention 2.24 7.90E-05 
RBM25 Intron Retention 1.63 2.13E-02 hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
PTGR2 // 
ZNF410 
Alter. Donor Site 2.05 5.10E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.05 5.10E-03 
PAPOLA Intron Retention 1.63 2.46E-02 CUG-BP1, ETR-3, hnRNP C1, hnRNP I (PTB), HuB, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
EVL Alter. Terminal Exon (e14) 1.86 8.22E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MARK3 Exon Cassette 2.42 4.11E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
APOPT1 // KLC1 
Alter. Donor Site 1.69 4.75E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e19-23) 1.82 1.37E-04 
Complex 3.63 1.61E-05 
Exon Cassette 1.90 2.83E-04 
SIVA1 Intron Retention 1.60 4.94E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ADSSL1 Alter. First Exon (e2-3) 1.70 1.80E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCNB1IP1 Exon Cassette 2.07 3.36E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HNRNPC 
Complex 2.29 1.40E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.99 7.16E-04 
AJUBA // HAUS4 Alter. Terminal Exon (e1-9) 3.76 1.56E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C14orf93 Complex (e2-3) 2.03 5.03E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TINF2 Intron Retention 1.54 9.14E-03 ETR-3, hnRNP C1, HuB, HuD, MBNL1, SC35, TIA-1, TIAL1, YB-1 
SDR39U1 Intron Retention 1.53 5.72E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, HuB, KSRP, Nova-1, Nova-2, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BAZ1A Exon Cassette 1.97 6.99E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SAV1 Exon Cassette 1.76 3.39E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, 
SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NIN Exon Cassette 3.68 5.00E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PYGL Exon Cassette 9.18 2.67E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DDHD1 
Alter. Terminal Exon (e12) 3.16 6.15E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.76 2.57E-04 
GCH1 Alter. Terminal Exon (e5) 1.80 2.07E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
 
Complex 1.82 1.38E-03 
RTN1 Exon Cassette 2.95 1.24E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AREL1 Exon Cassette 1.93 2.72E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NEK9 Intron Retention 1.54 9.52E-03 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuD, KSRP, Nova-1, Sam68, SC35, SRp30c, YB-1, ZRANB2 
GALC Alter. First Exon (e1-2) 4.70 2.83E-06   
EML5 Exon Cassette 2.40 1.18E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, PSF, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
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SMEK1 
Alter. Terminal Exon (e8) 1.53 4.21E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.51 4.61E-04 
MOK 
Exon Cassette 1.51 1.27E-02 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.61 2.18E-03 
XRCC3 Exon Cassette 2.99 1.28E-03 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C14orf2 
Complex 2.43 2.48E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, YB-1, ZRANB2 
Exon Cassette 2.43 2.48E-03 
EMC4 Complex (e5) 2.16 3.76E-04 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SRP14-AS1 Alter. Terminal Exon (e3-4) 1.59 6.36E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RAD51 Exon Cassette 1.81 8.79E-04 
ETR-3, hnRNP A1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
TUBGCP4 Exon Cassette 1.57 5.08E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, TIA-1, 
TIAL1, YB-1, ZRANB2 
HYPK // SERF2 
Alter. Acceptor Site 1.79 2.74E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 Complex 1.91 2.48E-03 
CTDSPL2 Complex 1.69 5.05E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SORD Alter. Acceptor Site 1.87 7.84E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SEMA6D Exon Cassette 2.55 4.18E-06 
9G8, CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GALK2 Exon Cassette 1.88 6.20E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TCF12 
Alter. First Exon (e2-4) 1.70 1.16E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 5.09 8.28E-05 
TPM1 
Alter. First Exon (e1-3) 2.83 1.64E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 4.27 2.41E-05 
Exon Cassette 3.59 2.41E-05 
USP3 Alter. First Exon (e1-2) 1.69 7.45E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LRRC49 Exon Cassette 3.26 1.01E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
PML 
Alter. Terminal Exon (e5-10) 1.52 2.00E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.51 1.04E-02 
Exon Cassette 1.52 1.57E-02 
SCAMP5 Mutualy Exclusive Exons (e2) 5.63 3.86E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
COMMD4 Intron Retention 1.69 1.42E-03 hnRNP P (TLS), KSRP, SC35, SRp30c, YB-1 
C15orf27 Alter. First Exon (e1-11) 2.59 3.40E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IREB2 Intron Retention 2.00 3.50E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PSMA4 Intron Retention 1.94 3.78E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZFAND6 
Alter. First Exon (e1-2,e5-7) 1.69 3.90E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.17 4.02E-03 
AKAP13 Exon Cassette 3.89 9.02E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FANCI 
Complex 1.65 1.03E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.65 1.98E-03 
SLCO3A1 Alter. First Exon (e1-4) 3.21 4.01E-05 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2  
Alter. Terminal Exon (e16-17) 7.53 5.98E-05 
 
Complex 8.28 5.98E-05 
CHD2//MIR3175 Intron Retention 1.85 1.53E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, YB-1, ZRANB2 
GABRB3 Exon Cassette 3.97 8.40E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
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RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TJP1 Exon Cassette 2.33 1.18E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C15orf57 // 
MRPL42P5 
Alter. Donor Site 2.03 7.96E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
EHD4 Complex 1.50 5.44E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VPS39 Complex 2.21 2.14E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TTBK2 Exon Cassette 2.06 1.50E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PPIP5K1 Complex 1.65 1.09E-02 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, YB-1, ZRANB2 
MYEF2 Intron Retention 2.10 3.02E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP P (TLS), HuB, Nova-1, Nova-2, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
DMXL2 
 
Exon Cassette 1.76 2.62E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon 4.94 8.32E-05 
SLTM Intron Retention 1.56 1.17E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, SRp30c, YB-1, ZRANB2 
CA12 Exon Cassette 1.59 1.43E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CSNK1G1 // 
KIAA0101 
Alter. Terminal Exon (e5) 2.49 1.55E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IGDCC4 Alter. First Exon (e1-18) 3.50 1.78E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DPP8 Exon Cassette 2.20 3.56E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MYO9A Exon Cassette 2.23 8.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PKM Complex 1.67 9.02E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ADPGK Exon Cassette 1.52 5.16E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WDR61 Intron Retention 1.66 3.70E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, PSF, SC35, SRp20, TIA-1, TIAL1, YB-1,  
CHRNB4 Alter. Donor Site 2.40 1.76E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1 
MFGE8 Exon Cassette 2.18 4.71E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PEX11A Exon Cassette 2.35 1.81E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 AP3S2/C15orf38 Exon Cassette 1.59 5.70E-03 
PRC1 
Complex 1.62 2.88E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.73 1.18E-03 
RHOT2 Intron Retention 1.78 7.36E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), MBNL1, Nova-1, SRp30c, YB-1, ZRANB2 
UBE2I Exon Cassette 1.95 1.56E-04 
ETR-3, hnRNP A1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
TELO2 Complex (e13-15) 1.52 7.57E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-
2, RBM5, Sam68, SC35, SF2/ASF, SRp30c, YB-1, ZRANB2 
MAPK8IP3 Intron Retention 9.59 1.68E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C16orf59 Intron Retention 2.00 1.56E-02 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, PSF, SC35, SF2/ASF, SRp30c 
MGRN1 Exon Cassette 2.51 6.22E-04 
 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MKL2 Intron Retention 2.79 2.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp30c, TIA-
1, TIAL1, YB-1 
TNRC6A 
Alter. First Exon (e14) 1.55 2.29E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.07 2.80E-04 
TAOK2 Alter. Terminal Exon (e16-17) 1.67 3.30E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CORO1A Intron Retention 1.88 3.16E-03 ETR-3, hnRNP LL, hnRNP P (TLS), HuB, SC35, YB-1 
STX4 Intron Retention 1.87 9.61E-04 ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), Nova-1, SC35, YB-1, ZRANB2 
FUS Intron Retention 2.82 8.22E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ORC6 Alter. Terminal Exon (e4) 2.32 3.00E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
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MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CYLD Exon Cassette 1.85 5.34E-03 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC6A2 Exon Cassette 4.03 4.23E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
COQ9 Intron Retention 1.55 5.60E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, SC35, TIA-1, TIAL1, YB-1 
GPR56 
Complex (e7) 3.50 2.42E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.19 1.50E-03 
NDRG4 
Alter. Acceptor Site 2.54 3.48E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e8) 1.82 3.67E-05 
Exon Cassette 1.86 2.19E-04 
SETD6 Intron Retention 1.60 5.72E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1 
FAM65A Complex 1.62 3.48E-03 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1,  
EDC4 Intron Retention 1.71 4.38E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP I (PTB), hnRNP K, HuB, KSRP, Nova-1, SC35, TIA-1, TIAL1, YB-1 
NFATC3 Alter. First Exon (e3) 2.06 1.07E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NFAT5 Exon Cassette 1.96 4.34E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNRF1 Exon Cassette 2.11 6.04E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NUDT7 Exon Cassette 2.56 1.96E-05 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MAP1LC3B Exon Cassette 2.13 2.82E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
JPH3 Alter. Terminal Exon (e3) 1.72 2.60E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZC3H18 Exon Cassette 2.65 1.41E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRAPPC2L Complex 1.61 5.56E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, SC35, SF2/ASF, SRp30c, TIA-
1, TIAL1, YB-1, ZRANB2 
TUBB3 
Alter. First Exon (e3-8) 14.05 2.20E-07 
 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 11.53 4.37E-05 
Exon Cassette 4.69 1.71E-05 
C16orf13 Intron Retention 1.79 2.43E-05 Fox-1, Fox-2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, SRp30c, YB-1 
RNPS1 Exon Cassette 1.78 1.39E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ROGDI Intron Retention 2.01 1.32E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), Nova-1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1 
NAGPA Exon Cassette 1.56 1.54E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), MBNL1, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
TVP23A Alter. Acceptor Site 3.14 1.50E-06 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TXNDC11 Complex (e1-2) 2.31 2.80E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KIAA0430 Intron Retention 3.21 4.75E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CDIPT Intron Retention 2.10 2.82E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KCTD13 Complex 1.81 2.92E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
DOC2A 
Alter. Term Exon (e14,e15-18) 1.95 3.04E-04  ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Donor Site 2.24 8.45E-04 
C16orf93 
Alter. Acceptor Site 2.61 1.42E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, 
SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e4-9) 1.93 2.12E-03 
Intron Retention 1.83 9.82E-03 
ZNF423 Alter. First Exon (e1-4) 2.46 2.61E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BBS2 Intron Retention 1.57 1.92E-02 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DYNC1LI2 Intron Retention 1.78 3.72E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM96B Intron Retention 1.58 5.60E-05 hnRNP I (PTB), hnRNP P (TLS), Nova-1, RBM5, SC35, SRp30c, YB-1, ZRANB2 
ACD Intron Retention 1.94 2.42E-04  ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), Nova-1, TIA-1, TIAL1 
MTSS1L Complex 1.55 3.02E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
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HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
COG4 Intron Retention 2.04 1.94E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, Nova-1, Sam68, SC35, SRp20, YB-1, ZRANB2 
AP1G1 Exon Cassette 1.60 4.19E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF821 Exon Cassette 2.01 4.20E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RFWD3 Exon Cassette 1.76 1.50E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM170A Alter. First Exon (e1) 1.56 4.24E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZDHHC7 Exon Cassette 2.34 6.33E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DPH1 // OVCA2 Intron Retention 1.67 2.10E-03 ETR-3, hnRNP A1, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SGSM2 
Exon Cassette 1.68 4.17E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, PSF, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 Intron Retention 1.70 3.46E-03 
RABEP1 Exon Cassette 1.76 2.11E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RPAIN Intron Retention 2.15 3.77E-05 ETR-3, hnRNP A1, hnRNP P (TLS), HuB, MBNL1, Nova-1, SC35, YB-1, ZRANB2 
ELP5 Alter. Terminal Exon (e6) 2.58 5.23E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, RBM5, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CD68//EIF4A Intron Retention 2.24 1.37E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), SC35, SRp20, TIA-1, TIAL1, YB-1 
CNTROB Intron Retention 1.65 4.01E-04 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1 
MAP2K4 Exon Cassette 2.49 2.76E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C17orf76-AS1 
Complex (e2-3) 1.66 7.91E-05 
 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.71 2.29E-05 
Intron Retention 2.01 3.84E-05 
MPRIP Exon Cassette 1.52 7.57E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LLGL1 Intron Retention 2.16 2.15E-02 ETR-3, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, SC35, SF2/ASF, SRp30c, YB-1, ZRANB2 
EPN2 Exon Cassette 1.76 8.42E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KSR1 Exon Cassette 1.63 9.65E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ERAL1 Complex 1.87 4.90E-03 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ADAP2 Exon Cassette 1.86 1.04E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NF1 Exon Cassette 4.86 9.84E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMUB2 Exon Cassette 2.26 6.79E-04 9G8, ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
C17orf104 Alter. Terminal Exon 2.90 2.21E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NSF // NSFP1 Complex 1.85 1.32E-02 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NFE2L1 Exon Cassette 1.54 2.14E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PDK2 Alter. First Exon (e1,e4) 2.44 4.63E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SPATA20 Intron Retention 1.52 2.15E-04 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), Nova-1, Nova-2, RBM5, Sam68, SC35, TIA-1, TIAL1, YB-1 
LUC7L3 Intron Retention 2.20 4.41E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-
1, TIAL1, YB-1, ZRANB2 
PSMC5 Intron Retention 1.82 1.16E-04 ETR-3, hnRNP A1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
PITPNC1 Exon Cassette 1.77 1.74E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BPTF 
Alter. Terminal Exon (e32) 1.83 1.99E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.77 1.36E-04 
PRKAR1A 
Alter. Donor Site 1.50 8.43E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e3) 1.66 3.66E-03 
COG1 Exon Cassette 1.53 4.48E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
RPL38 Alter. Terminal Exon (e3) 1.88 1.52E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, 
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SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SNHG16 Complex 2.38 1.94E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MGAT5B Exon Cassette 2.05 2.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC40 
Alter. First Exon (e1-7) 2.10 7.42E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e11,e13) 1.94 1.20E-03 
NARF 
Exon Cassette 1.73 1.14E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1 Intron Retention 2.45 1.77E-04 
GLOD4 Complex 1.84 2.50E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, SC35, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1 
C17orf85 Complex 1.97 1.53E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, 
SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC25A11 Intron Retention 1.51 5.02E-03 hnRNP P (TLS), HTra2beta1, HuB, KSRP, TIA-1, TIAL1, YB-1 
CAMTA2 Exon Cassette 1.52 1.16E-03 ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, Nova-1, RBM5, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DLG4 Alter. First Exon (e1-3,e5) 3.62 2.98E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PLSCR3 // 
TMEM256 
Alter. First Exon 1.57 4.37E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF18 Alter. First Exon (e2-4) 1.57 2.13E-05 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CDRT4 // 
TVP23C 
Alter. Terminal Exon (e6) 2.00 5.36E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.88 2.88E-03 
NCOR1 Exon Cassette 2.36 1.70E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC46A1 Exon Cassette 1.86 1.43E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ALDOC Alter. Donor Site 1.59 7.19E-04 ETR-3, hnRNP A1, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, Nova-1, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
SDF2 Complex 1.77 1.04E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM222B 
Complex (e2) 1.76 1.16E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.76 1.16E-03 
PHF12 Complex 2.16 1.72E-03 
ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MYO18A // 
TIAF1 
Exon Cassette 3.55 6.77E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYNRG 
Alter. Donor Site 2.57 4.28E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.81 3.63E-06 
DDX52 Intron Retention 1.92 1.14E-02 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
MIEN1 Intron Retention 1.70 5.96E-05 hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MED24 
Alter. First Exon (e1) 1.60 3.05E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1 
Complex 2.39 1.18E-03 
Exon Cassette 2.39 1.18E-03 
KRT222//SMARC
E1 
Exon Cassette 5.92 8.48E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 
LEPREL4 Alter. First Exon (e1) 2.14 2.98E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, PSF, RBM5, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PSMC3IP 
Alter. Donor Site 2.17 7.84E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.17 7.79E-04 
ETV4 
Alter. First Exon (e1-4) 3.67 8.54E-03 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HuB, Nova-1, RBM5, SC35, SRp30c, YB-1, ZRANB2 
Exon Cassette 7.00 2.00E-05 
MPP3 Intron Retention 2.92 1.08E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GPATCH8 Exon Cassette 2.37 6.74E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PLEKHM1 Exon Cassette 1.86 4.04E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KANSL1 Exon Cassette 2.35 3.62E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
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SPAG9 
Alter. First Exon (e1-4) 6.50 8.88E-08 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.68 2.50E-03 
MBTD1 
Exon Cassette 2.13 6.03E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.62 4.80E-03 
SRSF1 Intron Retention 1.73 6.22E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ICAM2 
Alter. Donor Site 4.98 2.63E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e1) 5.13 4.04E-04 
PLEKHM1P 
Alter. Donor Site 1.56 1.12E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.43 1.15E-04 
AMZ2P1 Intron Retention 2.20 9.01E-04 ETR-3, hnRNP C1, hnRNP I (PTB), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SRp20, YB-1 
HN1 Exon Cassette 1.83 1.22E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
UNC13D Intron Retention 3.98 2.61E-04 ETR-3, KSRP, PSF, SC35, SRp30c, YB-1 
FBF1 // MRPL38 Complex 1.64 7.62E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1,  
ACOX1 Complex 1.64 4.82E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
EXOC7 
Alter. Acceptor Site 2.70 1.68E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e4) 1.62 7.01E-04 
Complex 2.36 8.85E-04 
Exon Cassette 2.99 1.90E-05 
Intron Retention 1.73 1.10E-02 
CYTH1 Exon Cassette 1.96 6.63E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CSNK1D 
Alter. First Exon (e1,e3) 1.56 1.02E-03 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.50 6.19E-04 
ANKRD12 
Alter. Terminal Exon (e12-16) 1.72 5.78E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.52 2.06E-03 
GREB1L Exon Cassette 2.41 5.05E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF271 
Complex 2.03 4.18E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.90 4.18E-04 
C18orf25 Exon Cassette 1.84 5.48E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RNF165 Exon Cassette 1.88 1.76E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ELAC1 // SMAD4 Exon Cassette 2.80 5.01E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
POLI Intron Retention 1.87 3.60E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF532 Alter. First Exon (e1,e6-10,e12) 1.77 3.63E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TNFRSF11A Exon Cassette 1.88 2.62E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ATP9B Exon Cassette 1.51 4.88E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NFATC1 Exon Cassette 2.62 3.13E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LAMA1 Complex 2.99 9.39E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF519 Exon Cassette 1.52 4.94E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ESCO1 Exon Cassette 1.84 1.72E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM241 Exon Cassette 1.53 8.63E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 
SS18 Exon Cassette 2.77 6.96E-04 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZSCAN30 Alter. Donor Site 1.59 1.76E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
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KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATP5A1 Alter. Donor Site 2.50 5.66E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MBD1 
Complex 1.52 2.98E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP P (TLS), KSRP, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.53 2.98E-04 
TCF4 
Alter. First Exon (e1-2,e4-
20,e23) 
3.27 5.47E-07 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CBLN2 Alter. First Exon (e1-3) 2.80 5.76E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CIRBP Intron Retention 1.89 2.15E-04 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, KSRP, MBNL1, RBM5, SC35, SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NFIC Exon Cassette 1.55 2.11E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HMG20B Intron Retention 2.61 1.92E-03 hnRNP F, hnRNP H1, hnRNP H2, hnRNPI (PTB), hnRNP P (TLS), HTra2beta1, HuB, Nova-1, Nova-2, SC35, TIA-1, TIAL1, YB1 
ATCAY 
Alter. First Exon (e3-4,e6-
15,e17) 
2.69 9.52E-05 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 3.45 8.08E-05 
MAP2K7 Exon Cassette 1.88 2.39E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
SNAPC2 Alter. First Exon (e2) 1.64 6.28E-03 hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
ZNF317 Intron Retention 1.52 7.72E-03 ETR-3, Fox-1, Fox-2, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, PSF, RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
PIN1 Exon Cassette 1.67 1.40E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1 
DNM2 // QTRT1 
Intron Retention 2.07 4.40E-04 
ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Mutualy Exclusive Exons (e22) 1.52 7.18E-04 
SMARCA4 
Complex 1.86 9.08E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.86 9.08E-03 
ANKLE1/BABAM Intron Retention 1.63 5.06E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, SC35, SF2/ASF, YB-1, ZRANB2 
MAU2 Intron Retention 1.77 2.50E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP I (PTB), hnRNP P (TLS), KSRP, SC35, SRp30c, YB-1, ZRANB2 
ZNF257 Exon Cassette 2.78 1.60E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF254 Alter. First Exon (e1-2,4,e11-12) 1.89 2.56E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF507 Alter. Terminal Exon (e4) 1.69 3.06E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FXYD5 Alter. First Exon (e1-5) 2.97 3.51E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LSR Exon Cassette 2.69 3.82E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HKR1 Exon Cassette 1.79 9.24E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SPINT2 Exon Cassette 4.10 1.68E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HNRNPUL1 Alter. Donor Site 1.86 1.76E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF574 Alter. First Exon (e3) 1.81 2.58E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF283 Alter. Terminal Exon (e7) 1.59 1.40E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PVR Alter. Donor Site 1.97 1.42E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, 
TIAL 
CLASRP Alter. First Exon (e1-11) 1.50 6.20E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PPP5C Intron Retention 1.84 4.16E-03 ETR-3, Fox-1, Fox-2, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), MBNL1, Nova-1, TIA-1, TIAL1 
SNRNP70 
Complex 2.24 6.21E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 Exon Cassette 2.45 3.45E-04 
PRMT1 Alter. Donor Site 3.66 4.45E-04 
CUG-BP1, ETR-3, hnRNPA1, hnRNPC1, hnRNPD, hnRNPE1, hnRNP E2, hnRN F, hnRNPH1, hnRNPH2, hnRNPI (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuD, KSRP, MBNL1, Nova-1, RBM5, SC35, SF2/ASF, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2  
Alter. First Exon (e1-4) 1.96 1.73E-05 
 
Exon Cassette 1.55 1.28E-03 
ZNF480 Exon Cassette 1.63 3.72E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
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KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MYADM Alter. First Exon (e2) 1.80 8.99E-04 
ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, 
SRp30c, TIA-1, TIAL1, YB-1 
CNOT3 Intron Retention 1.58 6.98E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, 
TIAL1, YB-1 
RPS9 
Alter. Donor Site 1.81 1.32E-03 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 1.79 2.48E-03 
RPL28 Alter. Terminal Exon (e3) 1.99 5.64E-04 
ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF542 
Alter. First Exon (e2) 3.35 5.80E-04 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, TIAL1 
Complex 3.51 4.15E-04 
ZNF551 Exon Cassette 1.71 1.44E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF135 Exon Cassette 2.50 3.64E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, Nova-1, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MFSD12 Complex 1.72 1.36E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PTPRS Exon Cassette 2.59 4.00E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF266 Intron Retention 2.50 5.00E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, Nova-1, Nova-2, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TYK2 Complex (e6-7) 1.88 3.63E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EPOR // RGL3 Complex 1.98 4.99E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STX10 Intron Retention 2.07 3.59E-04 ETR-3, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, YB-1, ZRANB2 
GIPC1 Exon Cassette 1.94 1.41E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NOTCH3 Exon Cassette 2.29 3.05E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SRp30c, YB-1, ZRANB2 
RAB3A 
Alter. First Exon (e1) 2.29 1.57E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, SC35, SRp20, SRp30c, YB-1, ZRANB2 
Intron Retention 1.56 1.02E-03 
C19orf12 Exon Cassette 1.79 5.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF565 
Alter. First Exon (e1,e4) 1.75 1.58E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.75 2.36E-03 
ZNF260 
Complex 2.59 4.78E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.41 3.45E-04 
ZNF571 Exon Cassette 2.02 2.22E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF573 Exon Cassette 1.74 7.53E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HNRNPL Exon Cassette 2.32 1.02E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1,  
FBXO17//SARS2 Intron Retention 1.82 1.55E-04 Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, Nova-1, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF780B Exon Cassette 2.26 9.12E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
AKT2 Exon Cassette 1.76 1.14E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RTN2 Exon Cassette 1.81 6.45E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PIH1D1 Alter. Acceptor Site 3.02 1.72E-05 ETR-3, hnRNP A1, hnRNP I (PTB), hnRNP P (TLS), HuB, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
NOSIP Complex 2.54 4.40E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYT3 Alter. First Exon (e1-2) 1.50 6.02E-03 9G8, ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ZNF615 Exon Cassette 2.03 7.80E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF83 
Alter. First Exon (e1.3,e8) 2.09 1.90E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.03 8.12E-05 
ZNF611 Exon Cassette 3.38 1.99E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF415 Exon Cassette 9.39 2.33E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, 
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Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF667 Alter. First Exon (e1-2) 5.77 2.13E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF772 Exon Cassette 1.55 5.29E-07 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
ZNF550 Exon Cassette 2.35 2.08E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF606 
Alter. Terminal Exon 2.01 1.58E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.54 3.12E-03 
ZNF329 Exon Cassette 2.44 1.64E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RNF144A Alter. First Exon (e1) 4.83 1.77E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HPCAL1 Alter. First Exon (e1,e3-5) 2.16 7.69E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAM228A // 
FAM228B 
Complex (e4) 2.14 2.40E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.64 8.26E-03 
CENPO Complex 1.54 5.64E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KHK Exon Cassette 2.17 4.39E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SNX17 Exon Cassette 1.57 2.14E-03 ETR-3, hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, PSF, SC35, SRp30c, TIA-1, TIAL1, YB-1 
BRE Exon Cassette 1.99 5.28E-03 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPP1CB // 
SPDYA 
Complex 1.66 5.32E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NDUFAF7 Intron Retention 2.37 1.03E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HuB, KSRP, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
EML4 Exon Cassette 9.66 2.44E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MTA3 Alter. Terminal Exon 2.20 1.63E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PAPOLG 
Exon Cassette 1.58 8.70E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.66 1.98E-02 
KIAA1841 Complex (e18-19) 1.81 4.33E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CEP68 
Alter. First Exon (e1) 3.00 1.10E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 2.51 1.43E-04 
Exon Cassette 1.71 3.28E-03 
MEIS1 Intron Retention 1.94 4.38E-03 hnRNP C1, hnRNP I (PTB), Nova-1, SRp20, SRp30c, YB-1, ZRANB2 
NAGK Intron Retention 1.66 2.65E-04  ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MPHOSPH10 Alter. Terminal Exon (e5) 1.56 8.40E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF638 
Alter. Acceptor Site 2.41 8.03E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.43 8.90E-03 
TTC31 Intron Retention 1.70 2.38E-03 hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, MBNL1, RBM5, SC35, SRp30c, YB-1 
ELMOD3 
Exon Cassette 2.02 9.44E-04 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 Intron Retention 1.60 1.11E-02 
CIAO1 Intron Retention 1.75 1.19E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp30c, YB-1, ZRANB2 
ITPRIPL1 Exon Cassette 2.12 7.66E-05 
ETR-3, hnRNPA1, hnRNPD, hnRNPDL, hnRNPE1, hnRNPE2, hnRNP F, hnRNPH1, hnRNH2, hnRNP I (PTB), hnRNPK, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, 
SRp30c, TIA-1, TIAL1, YB1 
INPP4A Alter. Donor Site 2.39 2.02E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MAP4K4 Alter. Terminal Exon (e18-33) 2.31 5.39E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BCL2L11 
Complex (e3,e9-13) 1.73 1.50E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.91 3.06E-03 
POLR1B Exon Cassette 2.35 5.62E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Appendices 
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DBI 
Complex (e2-3) 2.30 4.58E-04 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.28 6.60E-04 
PKP4 Alter. Terminal Exon (e17) 1.93 4.36E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DNAJC10 Complex 1.85 1.54E-03 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
CARF Exon Cassette 1.56 6.26E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FASTKD2 Intron Retention 1.66 1.79E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PIKFYVE Alter. Terminal Exon (e13) 1.83 3.64E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MAP2 Exon Cassette 3.56 1.94E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SPAG16 Complex (e1) 1.82 1.74E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PLCD4 
Alter. Terminal Exon (e11) 2.54 6.05E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.67 9.88E-03 
BCS1L Complex 1.57 4.00E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZFAND2B Alter. Terminal Exon (e8) 1.92 2.16E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, Nova-1, PSF, Sam68, SC35, SF1, SRp20, SRp30c, YB-1, ZRANB2 
DNAJB2 Intron Retention 1.87 4.60E-04  ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ASIC4 Intron Retention 3.53 1.91E-05 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, SC35, SRp30c, YB-1 
STK11IP Intron Retention 1.73 2.03E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, Nova-1, SC35, TDP43, TIA-1, TIAL1, YB-1 
NYAP2 Exon Cassette 1.74 3.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RHBDD1 Exon Cassette 1.79 5.56E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MFF Exon Cassette 1.59 3.99E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GIGYF2 Alter. Terminal Exon (e8) 1.57 1.88E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LRRFIP1 
Alter. First Exon (e1,e3-20,e23) 2.78 2.16E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e21) 4.06 5.00E-06 
ATG4B 
Complex (e6) 1.81 1.18E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.68 8.48E-03 
SH3YL1 Alter. First Exon (e2) 2.77 3.00E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1,  
KIDINS220 Exon Cassette 2.30 1.38E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMC6 Exon Cassette 1.66 2.05E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SDC1 Alter. First Exon (e1-2,e4-6) 1.53 1.28E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PUM2 Exon Cassette 1.75 1.26E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DNAJC27 Exon Cassette 1.97 2.02E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DNMT3A Alter. First Exon (e1) 2.85 4.72E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DTNB Exon Cassette 1.58 1.14E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HADHA Alter. Terminal Exon 2.93 5.96E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PREB Intron Retention 1.65 2.84E-03 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
GTF3C2 Exon Cassette 1.75 2.44E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
EIF2B4 Intron Retention 1.74 1.60E-03 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, YB-1 
SUPT7L Intron Retention 3.24 3.89E-05 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, SC35, YB-1 
SOS1 Exon Cassette 2.98 4.96E-07 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
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MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MAP4K3 Exon Cassette 1.57 4.21E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
THUMPD2 Exon Cassette 1.52 6.80E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PREPL 
Complex 1.71 1.71E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.03 2.60E-04 
PIGF Exon Cassette 1.87 1.00E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ASB3 // GPR75 Alter. Donor Site 1.58 4.98E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMEK2 Exon Cassette 1.76 4.62E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, KSRP, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PUS10 Exon Cassette 1.54 8.63E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SF1, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
FAM161A Exon Cassette 1.58 2.40E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCT4 
Complex 1.63 1.63E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, 
TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.71 4.21E-04 
FAM136A 
Complex 2.03 2.58E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.85 3.99E-04 
RTKN Alter. First Exon (e1) 2.59 2.07E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC142 // 
MRPL53 
Alter. First Exon (e1-8) 1.58 3.20E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AUP1 Intron Retention 1.69 8.63E-04 ETR-3, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
SNRNP200 Exon Cassette 1.73 6.79E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANKRD36B Exon Cassette 1.52 2.28E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CLASP1 
Exon Cassette 3.97 1.69E-05 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons 4.88 1.69E-05 
BIN1 Exon Cassette 1.84 1.04E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, SC35, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ERCC3 Intron Retention 1.70 1.76E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HuB, MBNL1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CACNB4 
Alter. Termin Exon (e12-15,e17) 1.62 1.02E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.70 5.64E-03 
PRPF40A Exon Cassette 3.71 9.84E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, MBNL1, Nova-1, Sam68, SC35, 
SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
BAZ2B Complex 1.58 2.39E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KCNH7 Alter. Terminal Exon (e10-19) 3.18 1.63E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LRP2 Alter. First Exon (e1-50) 2.19 7.98E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GPR155 Exon Cassette 2.49 2.63E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ATF2 
Alter. Terminal Exon (e9) 1.75 4.59E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.97 2.42E-05 
PRKRA Exon Cassette 2.27 2.16E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, TIA-1, 
TIAL1, YB-1, ZRANB2 
ORMDL1 Intron Retention 1.77 2.86E-03 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, MBNL1, Nova-1, SRp20, TIA-1, TIAL1, YB-1 
PGAP1 Exon Cassette 1.77 8.20E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CLK1 // PPIL3 
Alter. Acceptor Site 1.93 6.56E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. First Exon (e1-3,5-8,10-11) 1.82 7.01E-04 
Intron Retention 1.98 4.42E-03 
ALS2 Alter. Terminal Exon (e23) 1.55 3.68E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
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ABCA12 Exon Cassette 1.68 6.20E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
OBSL1 Alter. Terminal Exon (e9) 1.57 7.76E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PAX3 Alter. Term Exon (e6-8,e10-11) 1.75 8.84E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FARSB Exon Cassette 1.68 4.39E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DOCK10 Exon Cassette 2.08 2.81E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
NDUFA10 Intron Retention 1.87 2.45E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SEC23B Complex 1.57 1.16E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EPB41L1 Alter. First Exon (e3-6) 1.53 2.50E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
 
Complex (e3-7,e9) 2.21 1.44E-04 
SRSF6 Exon Cassette 2.23 4.93E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
STK4 Alter. Terminal Exon (e2,e10) 1.52 8.16E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PCIF1 Intron Retention 1.54 6.13E-05 hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, YB-1 
ARFGEF2 Exon Cassette 1.53 7.28E-03 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
DDX27 Intron Retention 1.56 2.48E-02 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, YB-1 
ZFAS1 Exon Cassette 2.79 4.80E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NELFCD 
Alter. Donor Site 1.74 8.60E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, SC35, YB-1, ZRANB2 
Intron Retention 2.15 3.57E-04 
LSM14B 
Alter. Acceptor Site 1.83 5.02E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e6) 1.97 5.44E-03 
Exon Cassette 2.01 1.62E-03 
ARFGAP1 Intron Retention 1.62 6.96E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, SC35, YB-1 
TCEA2 
Complex 1.72 5.22E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, Nova-1, Nova-2, RBM5, Sam68, SC35, 
SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.22 1.82E-05 
LINC00266-
1/MYT1/PCMTD 
Alter. Terminal Exon (e21-25) 2.70 3.51E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.44 4.01E-06 
TBC1D20 Intron Retention 1.99 6.86E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
SNRPB Exon Cassette 2.20 4.22E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB 
IDH3B Intron Retention 1.80 1.20E-02 ETR-3, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, SC35, TIA-1, TIAL1, YB-1 
CPXM1 Complex 2.73 9.39E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), MBNL1, Nova-1, SC35, SRp20, SRp30c, YB-1 
PCED1A Intron Retention 2.11 3.24E-03 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, RBM5, SRp20, SRp30c, YB-1 
SLC4A11 Alter. Acceptor Site 1.76 1.83E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
NAPB 
Alter. First Exon (e1-3) 1.64 1.08E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon 2.12 3.83E-04 
Exon Cassette 1.56 1.16E-02 
BCL2L1 
Complex 1.95 4.84E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.20 4.21E-04 
UQCC 
Alter. Terminal Exon (e8) 1.87 3.76E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.62 3.30E-03 
CPNE1 // NFS1 
// RBM12 
Alter. Terminal Exon (e21-38) 1.53 5.80E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.62 2.02E-03 
Exon Cassette 1.75 3.44E-03 
Intron Retention 2.95 9.27E-07 
RBM39 Exon Cassette 1.90 1.34E-03 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DSN1 Intron Retention 1.64 4.06E-03 ETR-3, hnRNP C1, HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
SNHG17 
Alter. First Exon (e1-3) 1.57 1.14E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e2) 1.62 4.36E-03 
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Complex 2.16 5.45E-07 
Exon Cassette 1.78 1.34E-03 
Intron Retention 1.95 2.56E-03 
ELMO2 Intron Retention 1.51 1.48E-03 CUG-BP1, ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PREX1 Intron Retention 2.12 1.80E-04 hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, SC35, SRp20, SRp30c, YB-1 
TMEM189//UBE
2V1 
Alter. First Exon (e1,3,e5-7,e15) 1.94 1.26E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 2.18 2.60E-03 
Exon Cassette 2.18 2.49E-03 
Mutualy Exclusive Exons 
(e11,e14) 
2.18 2.49E-03 
DIDO1 Alter. Term Exon (e7-8,e17-18) 1.56 4.28E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARFRP1 Alter. First Exon (e1) 1.56 4.68E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
USP25 Exon Cassette 1.61 1.88E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
USP16 Intron Retention 1.55 3.75E-02 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP DL, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, Nova-1, RBM5, Sam68, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
ITSN1 Exon Cassette 2.39 4.24E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PCBP3 
Alter. Terminal Exon (e12-16) 2.25 1.52E-05 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.82 5.02E-04 
MCM3AP-AS1 Alter. Terminal Exon (e5) 1.82 2.14E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PRMT2 Exon Cassette 1.71 2.99E-04 ETR-3, hnRNP A1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
APP Exon Cassette 5.04 1.05E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SCAF4 Alter. Terminal Exon (e19) 1.55 2.76E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ATP5O/CRYZL1/
/DONSON 
Alter. Acceptor Site 1.64 8.16E-04 
9G8, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
ZBTB21 Exon Cassette 1.52 2.26E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
U2AF1 
Alter. First Exon (e1) 1.59 1.69E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SF1, SF2/ASF, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.58 6.34E-03 
HSF2BP Exon Cassette 1.61 2.33E-02 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DGCR8 Intron Retention 2.11 1.40E-03 
ETR-3, Fox-1, Fox-2, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, 
ZRANB2 
MED15 Complex 1.58 5.18E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC2A11 Alter. Terminal Exon 1.56 6.18E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp20, TIA-1, TIAL1, 
YB-1, ZRANB2 
SGSM1 Exon Cassette 3.67 2.19E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MTFP1 // 
SEC14L2 
Complex 1.52 1.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TUG1 Exon Cassette 1.56 6.78E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LIMK2 Alter. First Exon (e1-2) 1.54 6.19E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TIMP3 Complex 1.63 2.19E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MCM5 Intron Retention 1.52 1.38E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
MPST Intron Retention 1.76 8.45E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SGSM3 Alter. First Exon (1-17) 1.56 5.02E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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RBX1 // 
XPNPEP3 
Exon Cassette 1.94 4.79E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PANX2 Exon Cassette 1.92 5.66E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BID 
Alter. First Exon (e2,e4-7) 1.61 1.66E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e4-6) 1.66 1.20E-03 
Exon Cassette 2.03 5.64E-05 
DGCR2 // 
DGCR11 
Complex (e2) 1.52 3.24E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRMT2A Intron Retention 1.52 4.18E-04 ETR-3, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, Nova-2, SC35, YB-1, ZRANB2 
YPEL1 Complex 2.57 8.96E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PRAME 
Alter. First Exon (e1) 3.60 1.52E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.64 2.25E-05 
FAM211B Alter. Donor Site 1.76 4.75E-06 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, YB-1, ZRANB2 
HPS4 Intron Retention 1.77 2.70E-03 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, SC35, TIA-1, TIAL1, YB-1 
THOC5 Exon Cassette 1.62 7.38E-03 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, Nova-1, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
PATZ1 
Alter. Terminal Exon (e4) 1.67 2.43E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.58 1.08E-03 
CSNK1E Alter. Terminal Exon (e8) 2.24 8.44E-04 
 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DDX17 Intron Retention 5.12 1.11E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, Nova-1, Nova-2, PSF, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RPL3 Alter. Acceptor Site 4.77 5.71E-05 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, KSRP, Nova-1, Sam68, SC35, SRp30c, YB-1, ZRANB2 
MKL1 Exon Cassette 1.83 1.80E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC25A17 Exon Cassette 2.90 6.62E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RANGAP1 Alter. First Exon (e1,e6) 1.80 6.30E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CENPM Complex (e4) 1.85 9.56E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1,  
KIAA0930 Alter. First Exon (e4) 2.42 6.57E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SF2/ASF, SRp30c, YB-1 
HDAC10 // 
MAPK12 
Alter. Terminal Exon (e13) 1.95 3.99E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DENND6B Intron Retention 2.51 1.41E-04 ETR-3, hnRNP P (TLS), SC35, YB-1 
RABL2B 
Alter. Donor Site 1.66 1.12E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1 
Intron Retention 1.68 2.34E-03 
CNTN4 Alter. First Exon (e1-3,e6-8) 2.97 1.43E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LRRN1 Alter. First Exon (e1) 6.09 7.65E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SETD5 Complex 1.87 4.35E-04 ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
IL17RC 
Complex 1.62 5.77E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.97 3.04E-04 
NR2C2 
Exon Cassette 1.62 1.18E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.72 4.20E-04 
RAB5A Exon Cassette 1.91 6.98E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CMTM8 Exon Cassette 1.71 2.91E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
OXSR1 Exon Cassette 1.87 4.14E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
XYLB Alter. Terminal Exon (e18) 1.60 2.93E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARIH2 Exon Cassette 1.80 5.41E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
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HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RBM5 // RBM6 
Complex 1.68 9.08E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.98 1.66E-03 
TEX264 Exon Cassette 1.63 4.00E-04 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-
1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PDE12 Intron Retention 1.74 4.57E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1 
RPP14 Alter. First Exon (e1,e3) 1.55 1.12E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PXK Exon Cassette 1.53 7.96E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KCTD6 Alter. First Exon (e2) 1.58 6.44E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
EPHA3 Alter. Terminal Exon (e9-19) 2.01 2.05E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NIT2 Complex 1.62 1.18E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SRp20, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C3orf52 Exon Cassette 1.53 3.66E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
UMPS Exon Cassette 2.61 1.09E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IFT122 Intron Retention 1.57 3.39E-04 ETR-3, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
CEP63 Exon Cassette 1.58 1.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAIM Mutualy Exclusive Exons (e3) 2.18 1.99E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZBTB38 Alter. First Exon (e1-5,e7,e9) 2.24 1.75E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RNF7 
Complex 1.67 2.02E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.67 2.02E-02 
TSC22D2 Exon Cassette 1.83 8.21E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GFM1 Exon Cassette 1.78 8.52E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1 
IQCJ // SCHIP1 Exon Cassette 6.05 3.73E-07 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMC4 Intron Retention 1.54 1.33E-02 ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, PSF, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MYNN Exon Cassette 1.65 2.20E-03 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1, ZRANB2 
EIF2B5 Intron Retention 1.67 1.79E-04 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), MBNL1, Nova-1, Nova-2, SC35, TIA-1, TIAL1, YB-1 
EIF4A2 Alter. Terminal Exon (e10) 2.61 4.12E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LPP Alter. First Exon 1.91 4.37E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC50 Exon Cassette 1.81 5.68E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OPA1 Exon Cassette 2.12 1.32E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CRBN Intron Retention 1.76 1.60E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, YB-1 
VGLL4 Alter. First Exon (e1-6) 2.93 4.50E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DPH3 
Complex 1.84 9.00E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.91 5.21E-04 
SLC4A7 Exon Cassette 1.76 1.34E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EOMES 
Alter. Acceptor Site 1.54 4.50E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, RBM5, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.90 3.04E-04 
CLASP2 
Alter. First Exon (e1-7,e20-21) 3.52 6.48E-05 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 3.90 3.42E-03 
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LRRFIP2 Exon Cassette 2.60 2.40E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IP6K2 
Alter. Terminal Exon (e9-11) 1.55 7.96E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.61 1.84E-04 
QRICH1 Exon Cassette 1.62 5.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
QARS Alter. Acceptor Site 2.54 1.36E-03 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
CAMKV Complex 1.68 2.14E-03 ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, Nova-1, Nova-2, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
PCBP4 
Exon Cassette 2.15 2.05E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, SC35, 
SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.68 3.43E-04 
NT5DC2 Alter. Donor Site 1.58 9.56E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PBRM1 Exon Cassette 1.59 7.18E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CADPS 
Alter. First Exon  (e1-6,e8-
14,e16-21,e60-27,e29-31) 
2.65 9.98E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FOXP1 
Complex (e14,e17) 1.53 1.72E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.53 1.02E-03 
Intron Retention 1.62 2.94E-02 
PDZRN3 Alter. First Exon (e1-3,e7) 6.25 7.62E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC14 Intron Retention 2.00 5.06E-03 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, HuB, Nova-1, Sam68, TDP43, YB-1, ZRANB2 
GATA2 Intron Retention 3.27 3.84E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ASTE1 Exon Cassette 1.64 1.21E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, 
SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
ACAD11/NPHP3 Intron Retention 2.29 1.81E-05 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, Sam68, SC35, YB-1, ZRANB2 
STAG1 
Alter. Terminal Exon (e10) 1.86 1.30E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.15 1.01E-02 
CCNL1 Intron Retention 1.52 4.18E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
B3GALNT1 Exon Cassette 3.63 4.20E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PHC3 Alter. Terminal Exon (e4) 1.60 4.46E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NCEH1 Exon Cassette 1.52 1.02E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TBL1XR1 
Alter. First Exon (e1-2) 1.53 5.00E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.79 2.30E-03 
CLDN1 Complex (e2-4) 5.08 1.24E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NCBP2 Intron Retention 2.46 1.85E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
KIAA0226 Exon Cassette 2.46 3.08E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KIAA0226 Intron Retention 2.22 1.14E-03 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
FAM114A1 Complex 1.93 1.04E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KLHL5 
Alter. First Exon (e2) 2.50 2.21E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.19 7.95E-05 
LIMCH1 Exon Cassette 3.52 1.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GUF1 Exon Cassette 2.09 8.35E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, TIA-1, TIAL1, YB-1 
DCUN1D4 Exon Cassette 4.06 1.90E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
REST 
Alter. First Exon (e1) 2.46 2.44E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e5-12) 2.09 3.61E-04 
Complex 2.38 8.03E-04 
Mutualy Exclusive Exons 2.41 7.43E-04 
NPFFR2 Alter. First Exon (e1) 14.72 1.03E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
Appendices 
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(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MTHFD2L 
Alter. Terminal Exon (e16) 1.80 2.70E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.86 2.50E-03 
THAP6 Alter. Terminal Exon (e4) 1.54 2.43E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PRDM8 Alter. First Exon (e2-7) 2.60 6.24E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
THAP9 Exon Cassette 1.63 2.76E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AFF1 Alter. First Exon (e1-3) 2.08 1.86E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TET2 Exon Cassette 1.61 1.30E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AP1AR Exon Cassette 1.77 1.24E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EXOSC9 Intron Retention 1.84 1.39E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, Nova-1, Sam68, SC35, SF1, SRp20, 
TIA-1, TIAL1, YB-1, ZRANB2 
INTU Exon Cassette 1.55 1.23E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARHGAP10 Alter. First Exon (e1-18) 1.54 4.62E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARFIP1 Exon Cassette 2.45 7.76E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TRIM2 
Alter. First Exon 2.04 3.99E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e6-7) 2.15 7.17E-04 
GUCY1B3 Exon Cassette 4.09 3.07E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, PSF, RBM5, SC35, YB-1 
ETFDH Exon Cassette 1.94 2.72E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FNIP2 Intron Retention 1.74 3.56E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CEP44 Alter. Donor Site 2.72 2.54E-06 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CYP4V2 Intron Retention 1.86 2.24E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I(PTB), hnRNP P TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
RNF212 Exon Cassette 2.94 2.03E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM128 Intron Retention 1.55 1.05E-02 ETR-3, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RAB28 Exon Cassette 2.26 1.59E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
APBB2 
Alter. First Exon (e1-13) 1.60 4.54E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.89 1.09E-02 
ATP8A1 Mutualy Exclusive Exons (e7) 1.56 2.90E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FRYL Alter. Terminal Exon (e5) 1.62 8.80E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NUP54 Exon Cassette 1.98 2.44E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RASGEF1B Exon Cassette 2.59 8.35E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HNRNPD Exon Cassette 3.92 1.18E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HNRNPDL Exon Cassette 2.01 3.38E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HPSE 
Complex 2.29 6.24E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.18 3.87E-05 
WDFY3 Exon Cassette 1.60 3.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPM1K Exon Cassette 1.72 9.70E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM13A Alter. First Exon (e1-9,e11-23) 2.71 7.62E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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UNC5C Exon Cassette 4.29 3.77E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ADH5 Alter. Terminal Exon (e6) 2.34 1.56E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF1, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DNAJB14 Alter. Terminal Exon (e2-5) 1.90 5.95E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MANBA Exon Cassette 1.90 1.08E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC9B2 Alter. Terminal Exon (e13) 1.95 6.12E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TBCK Exon Cassette 1.79 1.52E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TBCK Exon Cassette 2.47 2.97E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
LEF1 Exon Cassette 2.74 6.41E-04 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PITX2 Exon Cassette 2.02 5.91E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C4orf21 Alter. Terminal Exon (e22-31) 1.54 7.70E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SORBS2 
Complex (e6-8) 9.13 1.62E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 7.86 8.41E-05 
BRIX1 Intron Retention 1.86 5.80E-03 ETR-3, HuB, Nova-1, Sam68, TIA-1, TIAL1 
SLC1A3 Complex 2.97 1.93E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C7 
Alter. First Exon 5.42 1.60E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon 1.78 7.46E-03 
MAP3K1 Intron Retention 1.98 1.11E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HuB, MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, TIA-1, TIAL1, YB-1 
GPBP1 Exon Cassette 1.91 5.40E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SREK1 
Exon Cassette 2.68 7.65E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.67 2.16E-02 
OCLN 
Complex (e4) 1.67 1.94E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.62 2.21E-04 
FCHO2 Alter. First Exon (e1-17,e12-17) 1.53 1.62E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARHGEF28 Alter. Terminal Exon (e16-38) 1.59 3.84E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RASA1 
Complex 1.65 2.90E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.08 2.96E-03 
PPIP5K2 Exon Cassette 2.24 5.81E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
PHF15 
Alter. First Exon (e1) 1.58 9.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e12-13) 1.98 1.98E-03 
Complex 1.75 2.08E-03 
DDX46 
Exon Cassette 2.42 6.52E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, 
YB-1 Intron Retention 1.67 1.87E-02 
MATR3 // 
SNHG4 
Alter. First Exon (e1-4,e6-7) 2.27 3.45E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e4) 2.48 6.34E-05 
WDR55 Intron Retention 2.02 1.59E-04 ETR-3, Fox-1, Fox-2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, Nova-2, SRp20, YB-1, hnRNP H2, SC35, SRp30 
HARS2 Intron Retention 2.74 3.77E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PCDHGA1-
12/3/PCDHGB1-
7/PCDHGC3-5 
Alter. Donor Site 2.75 1.78E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARHGAP26 
Alter. Donor Site 1.58 8.86E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e23-24) 1.59 5.85E-04 
Exon Cassette 1.59 5.85E-04 
CPLX2 Alter. First Exon (e1-2,e4-6) 2.07 1.18E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
Appendices 
 184 
Complex 2.69 1.18E-03 (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TSPAN17 Intron Retention 1.55 1.50E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF2/ASF, SRp20, 
SRp30c, YB-1 
UNC5A Exon Cassette 5.59 3.97E-05 
ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
TRIM41 Intron Retention 1.92 4.98E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP P (TLS), MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BRD9 Complex 1.54 5.76E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MYO10 Complex (e1-3) 2.97 6.04E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZFR Intron Retention 1.81 3.24E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SF1, TIA-1, TIAL1, YB-1, ZRANB2 
NADK2 Exon Cassette 1.98 9.17E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PDE4D Exon Cassette 3.91 1.95E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GUSBP9 Exon Cassette 1.78 4.90E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM161B Exon Cassette 1.62 4.14E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NR2F1-AS1 Exon Cassette 1.78 1.50E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ELL2 Complex 3.34 8.14E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NUDT12 Intron Retention 1.62 3.59E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MCC 
Alter. First Exon (e1-3) 4.52 7.60E-05 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e19) 1.96 6.96E-04 
CEP120 Complex 1.67 5.02E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FBN2 
Alter. Term Exon (e15,e17-43) 1.58 2.50E-02 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.43 4.56E-04 
HINT1 
Alter. Donor Site 1.88 7.22E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, Sam68, 
SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.15 6.24E-05 
FNIP1 // 
RAPGEF6 
Alter. First Exon (e1-2,e20-24) 3.70 7.42E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CDKL3 // 
PPP2CA 
Alter. Terminal Exon (e11-
14,e17) 
1.68 1.19E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM13B Exon Cassette 1.70 1.30E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HARS Intron Retention 1.88 1.02E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, SRp30c, YB-1, ZRANB2 
GNPDA1 
Complex 1.74 2.24E-04 
ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 1.61 1.92E-03 
FAXDC2 Exon Cassette 1.67 7.99E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCNJL Exon Cassette 4.13 6.21E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C5orf54 Exon Cassette 2.82 3.04E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RNF44 Intron Retention 1.97 2.76E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
DBN1 Intron Retention 1.69 4.02E-04 hnRNP I (PTB), hnRNP P (TLS), PSF, SC35, YB-1 
DDX41 Intron Retention 2.96 3.52E-05  ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, YB-1 
CLK4 Intron Retention 2.03 3.25E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, TIA-1, TIAL1, YB-1 
FLT4 Alter. Acceptor Site 2.64 1.60E-03 hnRNP E1, hnRNP E2, hnRNP P (TLS), KSRP, Nova-1, SC35, SRp20, SRp30c, YB-1, ZRANB2 
DUSP22 Intron Retention 2.27 1.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
JARID2 Alter. First Exon (e1-4) 3.00 1.83E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MYLIP Exon Cassette 1.70 2.08E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
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BTN2A3P Alter. Acceptor Site 1.96 4.22E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
BTN2A1 Alter. First Exon (e1-7,e10) 2.89 5.92E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZSCAN16 
Alter. Terminal Exon (e3) 1.50 1.40E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 Intron Retention 2.01 3.54E-03 
HLA-F Alter. Terminal Exon (e5-6,e8-9) 1.81 3.61E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNRD1 Intron Retention 1.56 3.80E-04 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPP1R11 Exon Cassette 1.70 4.70E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, MBNL1, Nova-1, PSF, RBM5, SC35, TIA-1, TIAL1, YB-1 
DDR1 Alter. Acceptor Site 1.65 2.52E-03 ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, Nova-1, Nova-2, PSF, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1 
PHF1 Intron Retention 2.14 1.30E-03 hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP P (TLS), HTra2beta1, KSRP, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
ANKS1A Exon Cassette 1.58 1.90E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF76 Alter. Terminal Exon (e10) 1.74 2.38E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PPARD Alter. Terminal Exon (e9-10) 1.69 7.66E-05 
ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF1, SF2/ASF, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MAPK14 Mutualy Exclusive Exons (e9) 1.90 3.74E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SRSF3 Exon Cassette 1.87 3.77E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, 
SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
POLR1C Intron Retention 1.66 1.36E-03 ETR-3, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
TMEM63B Exon Cassette 3.97 2.38E-06 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, TIA-1, 
TIAL1, YB-1, ZRANB2 
EFHC1 Intron Retention 2.66 2.50E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
FAM135A 
Alter. First Exon (e1-10,e12-15) 1.67 4.37E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.30 2.01E-04 
KCNQ5 Exon Cassette 1.67 9.79E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BCKDHB Exon Cassette 1.79 2.40E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P(TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
RWDD2A Intron Retention 2.50 1.09E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ORC3 Exon Cassette 2.30 4.26E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GRIK2 Exon Cassette 6.77 6.27E-05 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FOXO3 Alter. First Exon (e2) 14.11 1.57E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRAF3IP2-AS1 
Alter. Terminal Exon (e2-5) 2.18 7.41E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.70 2.42E-04 
RNF146 
Complex 1.50 1.16E-02 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.08 1.84E-05 
MYB 
Complex (e10-12) 1.72 1.62E-03 ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, 
SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.36 7.45E-04 
STXBP5 Exon Cassette 2.61 2.22E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OPRM1 
Complex 2.35 4.04E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.74 6.79E-04 
ARID1B Exon Cassette 1.79 1.50E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-
2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
QKI Intron Retention 1.59 6.56E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TFAP2A 
Alter. First Exon (e3) 3.37 2.77E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.16 2.17E-05 
KIF13A Exon Cassette 2.22 1.78E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TDP2 Alter. Donor Site 1.53 5.78E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
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TRIM27 Intron Retention 1.70 4.40E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, Nova-1, Nova-2, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPP1R18 Alter. First Exon (e1) 2.48 3.41E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCHCR1 
Alter. Terminal Exon (e16) 1.72 2.63E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, 
SRp30c, YB-1, ZRANB2 Complex 2.06 4.54E-03 
HLA-C Complex 2.25 4.50E-06 hnRNP P (TLS), KSRP, Nova-1, Nova-2, SC35, SF2/ASF, SRp20, SRp30c, YB-1 
BAG6 Alter. First Exon (e1) 1.82 1.57E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, MBNL1, RBM5, SC35, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HLA-DOB // 
TAP2 
Alter. First Exon (e1-11) 2.00 1.12E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e18-20) 1.59 1.10E-02 
Complex 2.10 3.54E-05 
HLA-DMA 
Alter. Terminal Exon (e2,e4-6) 2.67 2.94E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e2) 3.07 4.48E-05 
Intron Retention 2.10 1.43E-04 
RXRB 
Alter. Terminal Exon (e7) 1.64 1.48E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.78 4.16E-04 
VPS52 
Alter. Terminal Exon (e13) 1.77 8.21E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.32 7.89E-05 
WDR46 
Complex (e2-3) 1.96 2.04E-05 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2alpha, HTra2beta1, KSRP, Nova-1, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
Intron Retention 2.32 8.56E-04 
RGL2 
Exon Cassette 1.58 6.36E-04 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp30c, YB-1, 
ZRANB2 Intron Retention 2.12 8.42E-04 
CUTA 
Alter. First Exon (e1) 1.61 2.76E-04 
ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), Nova-1, RBM5, Sam68, SC35, YB-1, ZRANB2 Complex 1.51 2.60E-03 
Intron Retention 1.88 3.71E-05 
YIPF3 Intron Retention 1.62 2.36E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, YB-1 
DST 
Alter. First Exon (e1-3) 3.40 1.48E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.65 7.99E-05 
SNAP91 Exon Cassette 6.09 2.15E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MAP3K7 Exon Cassette 1.52 3.00E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PNISR 
Intron Retention 1.72 1.96E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, Nova-1, Sam68, SC35, YB-1 
Intron Retention 1.53 1.49E-02 
HACE1 Exon Cassette 1.86 8.36E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MICAL1 // 
ZBTB24 
Alter. Terminal Exon (e2) 1.69 1.74E-03 ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.31 4.80E-04 
WASF1 Exon Cassette 1.56 5.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HDDC2 Exon Cassette 1.68 4.83E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ECHDC1 Exon Cassette 1.91 9.16E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PTPRK 
Complex 2.52 1.83E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.58 3.92E-05 
AHI1 Exon Cassette 1.53 1.08E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNPE1, hnRNP E2, hnRNPF, hnRNH1, hnRNH2, hnRNPH3, hnRNPI(PTB), hnRNPP(TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, 
SRp30c, TDP43, TIA1, TIAL1, YB1 
BCLAF1 Exon Cassette 3.81 3.62E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, Nova-1, Nova-2, RBM5, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HYMAI // 
PLAGL1 
Alter. Donor Site 1.77 4.58E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e8-19) 3.09 3.16E-04 
Exon Cassette 1.97 3.58E-05 
EPM2A Alter. First Exon (e2) 1.68 7.76E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SYNE1 
Alter. First Exon (e1-6,e8-
15,e19-88,e90-133,e135) 
1.58 3.62E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Appendices 
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PDE10A Complex (e5) 2.17 1.66E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DLL1 Alter. Terminal Exon (e5-11) 3.05 1.22E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PSMG3-AS1 Exon Cassette 1.53 5.64E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NUDT1 Alter. First Exon (e2-3) 1.75 7.02E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
WIPI2 Exon Cassette 1.62 1.12E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RAC1 Exon Cassette 3.26 3.80E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KLHL7 Alter. Terminal Exon (e6-7) 2.15 6.04E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAM221A Exon Cassette 3.31 9.40E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KLHL7 
Alter. Terminal Exon (e6) 2.15 6.04E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon 2.12 4.82E-04 
FAM221A Exon Cassette 3.31 9.40E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPIA Exon Cassette 2.21 1.34E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, 
SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
UPP1 
Alter. Acceptor Site 2.04 5.14E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.66 6.83E-04 
ZNF138 Exon Cassette 1.78 7.56E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STAG3L4 Exon Cassette 1.77 1.56E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, 
TIAL1, YB-1 
AUTS2 Exon Cassette 1.68 7.60E-03 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WBSCR22 Intron Retention 1.62 5.06E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
ELN 
Complex 1.57 4.63E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.75 2.56E-04 
GTF2IRD1 Intron Retention 1.51 4.04E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp30c, YB-1 
MAGI2-AS3 Exon Cassette 2.39 5.44E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DMTF1 Alter. Acceptor Site 1.58 2.87E-02 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, TDP43, TIA-1, TIAL1, YB-1 
ADAM22 Alter. Terminal Exon (e29) 1.53 6.17E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GTPBP10 Exon Cassette 2.41 4.78E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF655 Alter. Terminal Exon (e4-7) 2.67 4.84E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNHIT1 Exon Cassette 1.66 2.42E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PMPCB Intron Retention 2.16 2.21E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
DLD Alter. Acceptor Site 1.65 2.68E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
ST7 // ST7-OT3 
Alter. First Exon (e1) 4.12 1.54E-05 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e25) 2.26 7.15E-04 
Exon Cassette 2.56 8.78E-04 
NAA38 Intron Retention 1.69 2.70E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CALU Exon Cassette 1.59 7.94E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
NDUFB2 Exon Cassette 1.79 2.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GSTK1 Intron Retention 1.56 6.56E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), Nova-1, Nova-2, SRp30c, TIA-1, TIAL1, YB-1 
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CASP2 Intron Retention 2.33 7.81E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, PSF, Sam68, SC35, SF1, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ATP6V0E2 Exon Cassette 1.59 9.00E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, 
SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
INSIG1 Exon Cassette 1.71 3.38E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RNF32 Exon Cassette 1.56 2.63E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ICA1 Exon Cassette 2.80 1.50E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
ETV1 
Alter. First Exon (e4-8) 1.70 9.97E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.97 5.67E-05 
TRA2A Intron Retention 1.85 2.30E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, YB-1 
HNRNPA2B1 Intron Retention 1.93 3.20E-04 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, PSF, Sam68, SC35, TIA-1, TIAL1, ZRANB2 
ELMO1 Complex (e19) 6.02 3.51E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
COA1 
Alter. First Exon (e1-2,4-6,e8-10) 1.60 2.65E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e9) 1.70 2.16E-04 
Exon Cassette 1.61 1.23E-04 
POLM Intron Retention 1.65 1.62E-02 hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), Nova-1, Nova-2, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CAMK2B Exon Cassette 1.81 2.23E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FIGNL1 Intron Retention 1.85 5.18E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DDC Exon Cassette 2.23 2.01E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PMS2P4 
Alter. Acceptor Site 1.82 2.55E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e5-6) 2.13 1.64E-03 
TMEM120A Intron Retention 1.84 1.81E-04 hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-2, SC35, SRp20, SRp30c, YB-1 
MAGI2 Alter. First Exon (e1,e3,e6-7) 1.69 1.62E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KIAA1324L Alter. First Exon 3.19 4.78E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ABCB1 
Alter. First Exon 1.72 1.10E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.61 1.50E-03 
SGCE Exon Cassette 2.70 8.94E-07 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
PON2 Complex (e2) 1.65 1.80E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C7orf43 Alter. Acceptor Site 2.35 1.06E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EPHB4 Alter. Donor Site 1.64 1.10E-02 ETR-3, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RABL5 Intron Retention 1.91 7.28E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
PNPLA8 
Complex (e3-5) 1.81 1.54E-03 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.90 1.05E-04 
DPAGT1 Intron Retention 1.52 6.56E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, Nova-2, SC35, SRp20, TIA-1, TIAL1, YB-1 
AASS Exon Cassette 1.93 8.37E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CHCHD3 Exon Cassette 1.87 3.16E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HIPK2 Alter. Acceptor Site 2.63 4.66E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EZH2 Intron Retention 1.53 6.28E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB1 
ZNF746 Complex 1.58 9.18E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF767 Exon Cassette 1.93 4.85E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CDK5 Intron Retention 2.72 3.70E-06 hnRNP F, hnRNP H1, hnRNP H2, RBM5, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SMARCD3 Intron Retention 1.90 7.85E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PRKAG2 Complex (e7) 1.50 1.56E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Appendices 
 189 
KMT2C Intron Retention 1.57 2.20E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FDFT1 Alter. First Exon (e1) 2.86 1.55E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATP6V1B2 Intron Retention 1.82 9.99E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BNIP3L Alter. First Exon (e2) 2.30 3.80E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FZD3 Exon Cassette 2.43 2.37E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HMBOX1 
Complex 2.08 6.00E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 3.86 2.30E-05 
NRG1 
Complex (e6-10) 2.53 1.08E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.10 2.45E-04 
TACC1 
Alter. Terminal Exon 
(e8,e10,e12-21) 
2.45 8.36E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AP3M2 Exon Cassette 1.60 2.98E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, SRp20, TIA-1, TIAL1, YB-1 
CHCHD7 Exon Cassette 2.06 5.05E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, TIA-1, 
TIAL1, YB-1 
CSPP1 Exon Cassette 1.68 5.94E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
STMN2 
Alter. First Exon (e1) 2.43 5.97E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 10.17 1.83E-05 
LRRCC1 Alter. Donor Site 2.21 2.25E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OTUD6B Exon Cassette 1.66 5.36E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OXR1 
Alter. First Exon (e1-11,e13) 2.32 2.22E-05 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.49 4.56E-06 
ENY2 Intron Retention 2.27 4.04E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp30c, TIA-1, TIAL1, YB-1 
RPL23AP53 Exon Cassette 2.08 8.08E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM167A Alter. First Exon (e2,e4) 2.11 5.76E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STMN4 Exon Cassette 5.15 2.80E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, SRp30c, YB-1 
KIF13B Exon Cassette 2.15 2.54E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FUT10 Alter. Terminal Exon (e5) 1.56 1.10E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PLAT Complex 5.33 1.20E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
RPS20 Alter. First Exon (e1-4) 1.68 1.17E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
COPS5 Intron Retention 1.65 9.76E-04 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
EYA1 
Alter. Acceptor Site 3.42 1.81E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP K, HuB, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 Complex 3.39 1.81E-05 
Intron Retention 4.49 1.81E-05 
STAU2 Alter. Terminal Exon (e18) 1.55 9.21E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IL7 
Complex (e6) 1.79 1.62E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.03 1.62E-03 
C8orf59 Exon Cassette 1.51 2.02E-04 
9G8, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
RUNX1T1 Exon Cassette 2.21 1.08E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRIQK 
Complex (e6) 1.92 3.64E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.97 3.64E-03 
ZNF706 Alter. First Exon (e2) 1.51 8.59E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, 
Appendices 
 190 
Exon Cassette 1.92 8.24E-05 SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KLF10 Alter. First Exon (e1) 2.60 3.92E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, TIA-1, 
TIAL1, YB-1, ZRANB2 
VPS28 Intron Retention 1.96 2.67E-07 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), KSRP, Nova-1, RBM5, SC35, SRp30c, YB-1, ZRANB2 
PRSS3 Alter. First Exon (e1,e3) 25.11 1.24E-06 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NUDT2 Exon Cassette 1.58 2.66E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GALT Intron Retention 1.87 8.61E-04 hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), SC35, SRp30c, YB-1, ZRANB2 
RUSC2 Alter. Donor Site 1.89 1.00E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CREB3 
Intron Retention 1.74 2.02E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SF1, SF2/ASF, TIA-1, TIAL1, YB-1 Exon Cassette 1.65 2.61E-04 
RMI1 Complex (e1-2) 2.09 1.66E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NTRK2 
Alter. Terminal Exon (e20-22) 1.65 6.77E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e1-3) 1.57 8.98E-04 
ANKRD19P Alter. Terminal Exon (e11-12) 2.65 2.59E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PTPDC1 Alter. Terminal Exon (e8) 1.66 1.00E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ERCC6L2 Exon Cassette 1.75 6.85E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC180 Alter. First Exon (e1-12,e14-15) 2.00 6.39E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MSANTD3 // 
TMEFF1 
Alter. Terminal Exon (e5-6) 2.11 5.66E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMC2 Exon Cassette 1.74 3.34E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, PSF, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MRRF 
Complex 2.34 6.37E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.22 1.19E-04 
MVB12B Alter. Terminal Exon (e8) 2.37 5.96E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GARNL3 Exon Cassette 2.42 5.78E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CERCAM Complex 1.64 1.66E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP LL, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, PSF, RBM5, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ODF2 Exon Cassette 2.34 3.40E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FUBP3 Exon Cassette 1.55 1.09E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GRIN1 
Alter. Terminal Exon (e20-21) 2.53 9.64E-04 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1 Exon Cassette 2.20 9.79E-04 
CBWD1 
Alter. Terminal Exon (e4) 1.56 1.87E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.55 4.99E-04 
MPDZ Exon Cassette 1.55 1.10E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LINGO2 
Complex (e3-5) 5.74 1.96E-06 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.34 1.96E-06 
DCTN3 Intron Retention 2.64 2.59E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, 
SF1, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C9orf41 Exon Cassette 1.61 5.04E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GKAP1 Exon Cassette 1.96 4.64E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZCCHC6 Intron Retention 1.54 2.94E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
SEMA4D Alter. First Exon (e1-17,e19) 1.95 2.30E-02 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
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(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NOL8 Exon Cassette 3.07 3.78E-04 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
SLC35D2 Exon Cassette 1.63 8.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TRIM14 Alter. Terminal Exon (e9-10) 2.61 2.26E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LPAR1 Alter. First Exon (e2-3) 2.85 1.44E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CDC26 // 
FKBP15 
Alter. First Exon (e20-34) 1.59 4.64E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
POLE3 Intron Retention 1.67 7.96E-05 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
AKNA Alter. First Exon (e1-5) 1.82 5.22E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FBXW2 Alter. Donor Site 1.95 1.11E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ANGPTL2 Complex 2.59 3.90E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SH2D3C 
Complex 4.79 6.45E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.84 2.98E-04 
RAPGEF1 Exon Cassette 1.59 1.88E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DDX31 Alter. First Exon (e1-2) 1.54 2.68E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GBGT1 // 
RALGDS 
Alter. Donor Site 2.19 2.09E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. First Exon (e2-7,e9) 1.88 1.10E-02 
Intron Retention 2.21 1.97E-05 
SEC16A Exon Cassette 1.57 6.64E-04 
ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TDP43, TIA-1, TIAL1, 
YB-1, ZRANB2 
ABCA2 Intron Retention 1.87 1.16E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP P (TLS), KSRP, RBM5, SC35 
NSMF 
Alter. First Exon (e1-5) 1.52 2.80E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, SC35, SF2/ASF, SRp30c, TIA-
1, TIAL1, YB-1, ZRANB2 
Complex 2.94 4.11E-06 
Exon Cassette 1.73 3.58E-04 
Intron Retention 1.63 1.90E-03 
PPEF1 Alter. First Exon (e1-3) 4.83 3.37E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DDX3X Alter. Terminal Exon (e4) 1.58 4.40E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KRBOX4 
Complex (e5-6) 2.49 1.34E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.42 1.34E-03 
CDK16 Intron Retention 1.91 1.67E-02 hnRNP D, hnRNP E1, hnRNP E2, hnRNP P (TLS), KSRP, Sam68, SC35, YB-1 
USP11 
Alter. Donor Site 1.98 9.78E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.18 1.91E-02 
HDAC6 Intron Retention 1.58 1.68E-03 hnRNP P (TLS), KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
PQBP1 Intron Retention 1.54 7.72E-03 hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, Nova-1, SC35, YB-1 
NUDT10 Alter. First Exon (e1) 2.55 1.72E-07 ETR-3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, MBNL1, Nova-1, PSF, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
MAGED1 
Alter. First Exon (e1) 5.02 2.32E-06 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.54 9.86E-03 
XAGE1D Complex 2.71 1.98E-07 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNPI (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
MAGED2 Intron Retention 1.84 4.22E-04 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, PSF, SC35, SRp30c, YB-1, ZRANB2 
TRO Alter. Donor Site 2.02 1.88E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, RBM5, SC35, SF2/ASF, SRp30c, YB-1, ZRANB2 
NLGN3 
Alter. First Exon (e1-3) 2.30 3.75E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.89 1.28E-03 
NONO Exon Cassette 2.51 2.21E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OGT 
Alter. Acceptor Site 1.63 1.68E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, 
SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e4-6) 1.82 8.47E-05 
DOCK11 Exon Cassette 1.85 2.24E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
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Nova-1, Nova-2, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZBTB33 Exon Cassette 1.90 8.76E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STAG2 Complex (4e4-15) 1.66 5.58E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STAG2 Exon Cassette 2.37 2.04E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FMR1 Exon Cassette 1.82 6.17E-04 
ETR-3, hnRNPA1, hnRNP A2/B1, hnRNPC1, hnRNPD, hnRNPE1, hnRNPE2, hnRNP F, hnRN H1, hnRNPH2, hnRNPI (PTB), hnRNPK, hnRNPP (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB1 
RPL10 Intron Retention 1.88 1.58E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, PSF, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
GDI1 Intron Retention 2.02 1.02E-04 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, PSF, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MID1 
Alter. First Exon (e1,e3,e14-15) 3.01 1.15E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.88 2.38E-04 
Exon Cassette 2.07 2.01E-04 
MAP7D2 
Complex 1.52 1.04E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.56 2.92E-03 
TAB3 Intron Retention 1.82 1.17E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF182 // 
ZNF630 
Exon Cassette 1.70 5.26E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYP Intron Retention 1.51 4.78E-03 ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, PSF, SC35, SRp30c, YB-1, ZRANB2 
FAM120C Alter. Terminal Exon (e2) 2.33 1.20E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FGD1 Intron Retention 1.54 5.41E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, Nova-2, RBM5, SC35, SF2/ASF, YB-1, ZRANB2 
FAM104B Alter. Donor Site 1.70 4.48E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ZC4H2 
Alter. First Exon (e1) 2.26 6.01E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.46 7.62E-04 
Intron Retention 1.82 3.98E-03 
BRWD3 Exon Cassette 1.87 2.80E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RPS6KA6 Exon Cassette 3.29 7.45E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARMCX2 Alter. Donor Site 1.74 1.11E-02 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, SC35, TIA-1, TIAL1, YB-1 
ZMAT1 Exon Cassette 1.57 2.73E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MORF4L2 Exon Cassette 1.56 2.94E-03 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NUP62CL Exon Cassette 1.88 1.76E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KLHL13 Alter. First Exon (e1-4) 2.86 1.02E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CUL4B Alter. First Exon (e1-2) 1.91 1.44E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CUL4B Intron Retention 1.84 4.86E-03 ETR-3, hnRNP C1, HuB, MBNL1, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1 
AIFM1 
Alter. First Exon (e1-2,e4-10) 1.52 1.22E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 2.89 6.31E-05 
Exon Cassette 4.52 7.35E-04 
HS6ST2 Alter. First Exon (e1-2) 1.73 3.15E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CSAG4 // 
MAGEA2B 
Complex 2.16 1.52E-03 
ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, SC35, SRp20, SRp30c, YB-1, ZRANB2 
Exon Cassette 1.61 2.64E-03 
HAUS7 // TREX2 Alter. Terminal Exon (e8) 2.18 1.85E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NAA10 Intron Retention 1.65 3.84E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), RBM5, SC35, TIA-1, TIAL1 
MECP2 Complex (e1,e3) 1.62 7.02E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CMC4 // MTCP1 Complex 1.61 2.56E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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CTGLF9P // 
PARG 
Alter. Terminal Exon (e18-25) 1.74 4.32E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CTGLF9P // 
PARG 
Alter. Terminal Exon (e18-25) 1.85 3.99E-06 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.20 1.40E-04 
LINC01001 Exon Cassette 1.69 1.82E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, 
Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
GTF2IRD2 
Alter. Terminal Exon (e3,e6-8) 1.72 2.60E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.65 1.65E-02 
Intron Retention 1.50 1.46E-03 
ZNF26 Exon Cassette 1.81 3.32E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF302 Complex 1.61 1.84E-03 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
RABGGTB Complex 1.52 3.80E-02 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TDP43, TIA-1, TIAL1, YB-1 
C1orf85 
Complex 2.33 8.27E-05 
ETR-3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
Exon Cassette 2.31 8.27E-05 
FAS Exon Cassette 1.91 8.36E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C11orf80 // 
RCE1 
Alter. First Exon (e1,e4-15) 1.64 4.60E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.04 5.95E-05 
ALG9 // CRYAB 
// FDXACB1 
Alter. First Exon (e6) 1.77 2.66E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, 
SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPHLN1 
Alter. First Exon (e1,e3-8) 1.56 1.16E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.10 1.19E-04 
LRRC23 Complex 1.51 8.62E-03 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
TRIM13 Intron Retention 1.77 4.21E-05 ETR-3, Fox-1, Fox-2, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CLK3 Intron Retention 1.77 3.58E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, PSF, RBM5, SC35, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
IPW//SNORD116 Intron Retention 4.18 3.01E-06 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
CCNDBP1 
Alter. Terminal Exon (e10-11) 1.56 2.20E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNPE1, hnRNPE2, hnRNPF, hnRNPH1, hnRNPH2, hnRN I (PTB), hnRNPK, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF2/ASF, SRp20, TIA-1, TIAL1, YB1 Intron Retention 1.71 3.34E-03 
MAPT Alter. First Exon (e1-3) 2.29 1.39E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ABCA5 Exon Cassette 2.16 3.22E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF583 Alter. First Exon (e1-3) 2.02 7.64E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CARD8 
Intron Retention 1.60 5.18E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.27 8.10E-05 
WDR6 
Alter. Acceptor Site 1.95 8.25E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e4) 2.32 1.06E-03 
Intron Retention 2.41 8.06E-05 
CNR1 
Complex (e2,e4) 5.98 4.16E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 5.98 4.16E-04 
ERAP1 
Alter. First Exon (e2) 1.80 7.01E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e20) 2.16 2.14E-03 
RAB24 Intron Retention 1.87 1.12E-02 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, RBM5, SC35, SRp30c, YB-1 
APBB3 Intron Retention 1.98 8.55E-04 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, RBM5, SC35, SRp30c, YB-1, ZRANB2 
POLR2J2 // 
RASA4 // 
UPK3BL 
Exon Cassette 2.47 1.12E-03 
CUG-BP1, ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
NSUN5P1//TRIM
73/74 
Intron Retention 2.12 3.36E-03 ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
NSUN5 Intron Retention 2.42 6.76E-04 ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ARF5 
Intron Retention 1.66 9.61E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e22-23,e36) 1.69 7.61E-04 
HCG18 Exon Cassette 1.53 1.50E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
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KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FBXL6 Intron Retention 2.00 1.96E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, KSRP, MBNL1, Nova-1, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
WASH3P 
Alter. First Exon (e1-2) 2.10 4.76E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 1.57 2.71E-02 
Exon Cassette 1.92 2.68E-03 
GPR161 Alter. First Exon (e1-2,e6) 1.63 1.05E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AHNAK Alter. Terminal Exon (e5-7) 1.84 4.36E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FXYD2 // FXYD6 Exon Cassette 1.95 1.63E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAM101A // 
ZNF664 
Exon Cassette 1.54 1.04E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GPR19 Alter. First Exon (e1-2) 6.22 1.61E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RRN3P1 Alter. First Exon (e3-8) 1.59 1.32E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC7A5P1 Alter. First Exon (e1) 1.74 1.15E-02 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NPIPB3 // 
SLC7A5P2 
Alter. First Exon (e11) 1.52 2.10E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TPM3P9 // 
ZNF761 
Alter. First Exon (e1,e4-6) 1.52 1.10E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARL17B Alter. Terminal Exon (e5) 2.70 1.14E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C18orf32/RPL17 Complex 1.53 2.80E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-2, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
OAZ1 Intron Retention 2.37 3.16E-04 hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), Nova-1, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CALR3/CHERP/
MED26/SLC35E 
Exon Cassette 1.73 4.98E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANKRD36 Exon Cassette 1.54 1.12E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SCLY // UBE2F Exon Cassette 1.62 5.20E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FIP1L1 
Alter. Acceptor Site 1.71 1.83E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.83 4.02E-04 
Intron Retention 1.83 4.02E-04 
MFSD8 Exon Cassette 2.32 3.64E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GTF2H4//VARS2 Intron Retention 1.70 9.26E-03 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
MCM9 Alter. Terminal Exon 1.68 1.18E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MRPS24 // 
URGCP 
Alter. First Exon (e1,e4-5) 1.64 5.30E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.52 2.30E-02 
ADCY10P1 // 
NFYA 
Complex 2.73 2.26E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARMCX5 // 
GPRASP2 
Alter. Acceptor Site 1.68 5.74E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, SC35, SF1, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2, Fox-1, Fox-2 
Complex (e3) 2.70 9.97E-05 
Exon Cassette 2.70 9.97E-05 
WAC 
Complex (e5) 1.55 3.16E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, Nova-1, RBM5, Sam68, SC35, 
SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.55 2.66E-02 
Intron Retention 1.73 1.39E-02 
RBM26 Intron Retention 1.69 2.82E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AKT1S1 // IL4I1 
// NUP62 
Alter. First Exon (e2-4,e19,e22) 1.74 4.02E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.56 6.40E-04 
Intron Retention 2.55 2.43E-04 
COX17 // 
POPDC2 
Exon Cassette 2.04 2.97E-04  CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons (e4-5) 2.36 1.22E-04 
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CSNK2B // 
LY6G5B 
Complex (e3-4,9-10) 1.58 4.00E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e3-4) 1.52 2.01E-04 
Exon Cassette 1.65 6.26E-05 
Intron Retention 2.06 1.57E-04 
GMDS-AS1 
Complex 1.58 9.04E-04 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e1-2) 1.72 6.63E-04 
DOWNREGULATION OF SPLICING INDEX 
AGTRAP Exon Cassette 1.78 3.70E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
VPS13D 
Complex (e40) 1.75 5.88E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.74 5.88E-03 
PDPN Exon Cassette 5.20 2.14E-05 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RCC1 // SNHG3 Exon Cassette 2.03 9.70E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SERINC2 Exon Cassette 1.78 1.38E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1 
ADC Alter. First Exon 1.73 1.25E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1,  
DNALI1 Alter. Terminal Exon 2.33 1.28E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PTPRF Exon Cassette 7.31 3.01E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DMAP1 
Alter. Acceptor Site 1.70 2.58E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, PSF, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.21 2.36E-04 
NSUN4 Alter. First Exon (e1) 2.95 2.30E-03 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, TIA-1, TIAL1, YB-1 
OSBPL9 
Complex (e16) 2.07 9.38E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.17 9.38E-04 
TCEANC2 Exon Cassette 1.92 1.72E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PDE4B 
Alter. First Exon (e1-9) 6.11 9.61E-07 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e3-4) 7.15 1.67E-05 
SRSF11 
Alter. First Exon (e1-3) 2.69 8.43E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.50 3.70E-05 
LPHN2 
Alter. First Exon (e1-6) 2.41 1.57E-05 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.80 6.99E-04 
PRKACB Alter. First Exon (e1,e7) 1.67 6.59E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SH3GLB1 Exon Cassette 4.73 4.43E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HS2ST1 Alter. First Exon (e2-7) 1.94 1.71E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KIAA1324 Complex 1.53 3.26E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AMPD2 Exon Cassette 1.57 1.90E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MOV10 
Alter. First Exon (e1) 2.64 1.34E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.54 4.64E-03 
Intron Retention 1.59 8.60E-03 
Exon Cassette 1.58 6.74E-03 
TRIM46 
Complex 1.58 1.72E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SF2/ASF, SRp30c, TDP43, TIA-1, 
TIAL1, YB-1 Exon Cassette 1.93 8.02E-04 
RGS4 Complex 2.46 2.41E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, Nova-1, Nova-2, Sam68, SC35, TIA-1, TIAL1, YB-1 
PBX1 Exon Cassette 1.59 1.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RABGAP1L Alter. Terminal Exon (e32-37) 2.65 9.60E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM163A Alter. Terminal Exon (e8-9) 14.59 1.87E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DHX9 // NPL Alter. First Exon (e1,4-6,9-12-15) 1.86 1.34E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
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Exon Cassette 2.10 3.88E-03 HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMG7 Exon Cassette 2.17 4.33E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
RGL1 Exon Cassette 1.54 5.19E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PLA2G4A Exon Cassette 1.84 1.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CAMSAP2 Exon Cassette 2.07 1.58E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SHISA4 Complex 2.59 8.55E-04 hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, Nova-2, SC35, SRp30c, YB-1 
NFASC 
Alter. Terminal Exon (e21,e22-25,e27-
29,e34-36) 
1.77 1.19E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.03 1.28E-03 
CDK18 Intron Retention 1.53 1.86E-02 SC35, SRp20, YB-1 
CD55 
Alter. Donor Site 3.86 6.05E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 4.69 3.34E-03 
Intron Retention 3.86 6.05E-05 
PSEN2 Exon Cassette 1.85 1.16E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF678 Exon Cassette 1.81 5.38E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GUK1 
Exon Cassette 1.61 4.48E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.51 6.35E-04 
ACTN2 Exon Cassette 2.85 1.12E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNPI (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp30c, TIA-1, TIAL1, YB-1 
KIF26B Complex 3.79 2.59E-06 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SDF4 Complex 3.77 3.22E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CDK11A/B // 
GNB1 
Exon Cassette 1.95 3.83E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, 
TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.51 2.09E-02 
ACOT7 
Complex 1.59 4.21E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.15 5.95E-05 
RERE 
Alter. First Exon (e1-9) 1.56 1.44E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.64 1.18E-03 
RCC2 Alter. First Exon (e1) 1.53 2.15E-02 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
TMEM234 Exon Cassette 1.71 8.41E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MEAF6 Exon Cassette 7.44 1.82E-05  ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
 
Mutualy Exclusive Exons (e7) 5.41 2.42E-05 
LEPRE1 Intron Retention 1.67 2.70E-03 Fox-1, Fox-2, hnRNP P (TLS), HTra2beta1, Nova-1, SC35, SRp30c, YB-1 
ATPAF1 // 
EFCAB14 
Exon Cassette 1.94 6.70E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, 
SC35, SRp20, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TTC39A Alter. Terminal Exon (e17-18) 1.56 2.21E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
YIPF1 Exon Cassette 2.14 1.82E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DOCK7 Exon Cassette 2.57 1.16E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WLS Exon Cassette 5.99 8.34E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DEPDC1 Exon Cassette 2.04 1.10E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF1, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MCOLN3 Exon Cassette 4.14 2.85E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMED5 Exon Cassette 2.16 8.32E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 
SLC16A1 Complex 1.89 1.06E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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MTMR11 Exon Cassette 1.60 9.80E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ENSA Alter. Terminal Exon (e5) 1.79 1.83E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SELENBP1 
Alter. Acceptor Site 2.23 4.41E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 4.98 8.39E-05 
S100A13 
Alter. First Exon (e1-3) 1.81 1.42E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.57 2.02E-04 
TPM3 
Alter. First Exon (e5-9) 1.63 3.41E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.51 1.58E-03 
Intron Retention 2.38 1.74E-03 
NES Complex 1.95 2.18E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMCO1 Complex 3.81 2.03E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TNR Alter. First Exon (e1-2) 2.36 7.78E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KCNT2 Complex 3.12 4.36E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KCNT2 Exon Cassette 2.42 4.36E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IRF6 Exon Cassette 2.08 3.99E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ENAH Exon Cassette 1.59 4.44E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM63A Alter. Terminal Exon (e22-26) 2.87 3.84E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AKT3 Complex 2.17 6.37E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HSPA14 Exon Cassette 1.56 2.68E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PTER Exon Cassette 2.19 2.12E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CDH23 
Alter. Acceptor Site 2.39 2.84E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. First Exon (e1--27,49-66) 3.63 2.40E-04 
Alter. Terminal Exon (e34-38) 1.54 3.25E-02 
AGAP11/FAM25A Intron Retention 2.01 4.00E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, TIA-1, TIAL1, YB-1 
SUFU Alter. Terminal Exon (e13-14) 1.65 6.22E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ADD3 Exon Cassette 4.47 8.44E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SHOC2 Exon Cassette 1.52 1.16E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TCF7L2 
Alter. First Exon (e1-3,e5-6,e10) 2.34 2.44E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.67 2.32E-03 
Mutualy Exclusive Exons (e20) 1.86 1.13E-02 
INPP5F Alter. Terminal Exon (e11-16,e18-22) 2.04 5.23E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PITRM1 Intron Retention 2.91 8.60E-03 ETR-3, Fox-1, Fox-2, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARHGAP21 
Alter. First Exon (e9) 3.61 9.76E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.54 1.53E-05 
EPC1 Complex 1.75 3.64E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NRP1 
Alter. Terminal Exon (e11,e13-14) 2.58 1.21E-06 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.73 4.04E-03 
Appendices 
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ZNF248 
Alter. Terminal Exon (e7) 1.56 1.53E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 1.70 5.28E-03 
MARCH8 Complex 1.80 9.80E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANK3 
Complex (e2) 2.68 1.02E-02 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.39 2.40E-04 
TYSND1 Alter. First Exon (e1-2) 1.54 8.21E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, 
ZRANB2 
ASCC1 Alter. Donor Site 3.97 1.19E-04 
ETR-3, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-
1, ZRANB2 
P4HA1 Exon Cassette 1.61 3.30E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPP3CB Exon Cassette 1.70 4.94E-03 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KCNMA1 
Alter. First Exon (e1,e8,e10-15) 1.69 7.92E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon  (e1,5,10-
23,25,29-30e32-34,36-39,41) 
3.46 5.25E-09 
TCTN3 Intron Retention 1.93 1.80E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, MBNL1, Nova-1, Sam68, SC35, 
SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
NDUFB8 // 
SEC31B 
Complex 1.98 1.24E-02 ETR-3, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, SC35, SF2/ASF, SRp30c, TIA-
1, TIAL1, YB-1 Exon Cassette 2.96 3.36E-06 
SH3PXD2A Alter. First Exon  (e1-3,e5-6,e9,e12) 3.55 4.48E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SFXN4 Intron Retention 1.59 1.42E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, 
SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RGS10 Alter. First Exon 2.80 6.64E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FGFR2 
Complex (e15) 6.62 2.42E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.63 5.67E-05 
ATE1 Exon Cassette 1.56 1.02E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MKI67 Exon Cassette 2.46 1.64E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
PTDSS2 Alter. First Exon (e1) 1.67 4.79E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CD151 
Alter. First Exon (e1,e4) 1.53 1.40E-04 
ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.51 2.59E-04 
TSPAN4 
Alter. First Exon (e1) 1.69 7.05E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.61 7.79E-04 
STIM1 Alter. Donor Site 1.57 6.04E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYT9 Exon Cassette 2.26 2.28E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LDLRAD3 Exon Cassette 1.54 1.18E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DDB2 
Complex 1.64 9.77E-04 
ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, MBNL1, Nova-1, PSF, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.71 9.77E-04 
MADD Exon Cassette 2.93 3.99E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC39A13 Alter. First Exon (e6-7) 1.58 9.58E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
CTNND1 // 
TMX2 
Alter. Acceptor Site 1.71 2.60E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.84 8.50E-03 
SLC3A2 Exon Cassette 2.15 2.54E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
RTN3 Exon Cassette 2.95 3.61E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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FAM89B Complex 3.00 4.26E-05 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, 
TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SIPA1 Alter. Terminal Exon (e9-11,e13-19) 2.00 1.43E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCND1 Complex 3.26 8.20E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPFIA1 
Complex 2.37 7.84E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 5.07 2.19E-04 
ATG16L2 
Complex 2.18 3.01E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, 
SC35, SF1, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.01 1.38E-04 
TMEM135 Complex 1.57 5.36E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C11orf63 Alter. Terminal Exon (e5-10) 1.55 1.72E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PIDD Intron Retention 1.59 1.82E-04 ETR-3, Fox-1, Fox-2, hnRNP E1, hnRNP E2, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
IFITM10 Alter. Donor Site 1.79 1.34E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
H19 
Complex (e5) 1.73 2.62E-02 
ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, PSF, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1 
Exon Cassette 1.88 3.42E-03 
IGF2 // INS 
Alter. First Exon (e1-2,e4-5) 3.98 1.17E-04 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e11-13) 4.90 7.76E-05 
RIC3 
Complex 3.15 1.64E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.40 1.64E-04 
CYP2R1 Alter. First Exon (e2) 2.03 2.19E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ABCC8 Exon Cassette 1.73 3.43E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PAX6 
Alter. Donor Site 6.28 5.84E-05 
ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 6.30 3.78E-05 
CD59 Alter. First Exon (e1-3,e6) 2.94 8.48E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAM168A Exon Cassette 4.08 4.92E-07 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RAB6A 
Exon Cassette 1.86 2.23E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons 2.14 1.70E-03 
XRRA1 Exon Cassette 1.93 3.66E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC90B 
Complex 2.41 2.36E-04  ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.79 5.97E-04 
PICALM Exon Cassette 1.59 2.30E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EXPH5 Exon Cassette 1.52 4.00E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC37A4 
Alter. First Exon (e1-2) 2.03 1.02E-03 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.73 1.96E-03 
Exon Cassette 1.71 2.40E-03 
MSANTD2 Exon Cassette 1.72 7.63E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PUS3 Exon Cassette 1.78 5.22E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WNK1 Exon Cassette 2.10 3.95E-05 
 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, Sam68, 
SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ERC1 Exon Cassette 4.10 6.08E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MGST1 Alter. First Exon (e2) 3.66 1.10E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARNTL2 Alter. Donor Site 1.85 5.54E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FGD4 Alter. First Exon (e2) 2.63 5.89E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
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Alter. Terminal Exon (e21) 2.28 1.92E-03 HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CACNB3 Exon Cassette 2.41 4.95E-04 ETR-3, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
SLC4A8 Alter. Terminal Exon (e10-23,e25-30) 1.58 1.40E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MDM2 
Alter. First Exon (e2-3) 3.62 6.60E-07 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.61 1.16E-02 
BTBD11 Alter. First Exon (e1-3) 2.58 2.40E-05 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RPH3A Alter. First Exon (e2-19) 2.03 3.73E-05 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
P2RX7 
Exon Cassette 2.23 4.28E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons (e5) 1.74 4.07E-05 
RAD52 Alter. Terminal Exon (e2) 2.08 1.85E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC2A14 Alter. First Exon (e3,e8-14) 3.18 1.96E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ITPR2 Alter. Terminal Exon  (e27-43,e45-61) 1.80 2.84E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CPNE8 Alter. First Exon (e2) 1.62 1.19E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC38A1 Alter. First Exon (e1) 1.68 3.18E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STAT2 Complex 1.75 1.52E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
R3HDM2 // 
STAC3 
Exon Cassette 1.69 1.00E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, PSF, 
Sam68, SC35, SRp30c, YB-1, ZRANB2 
GNS Exon Cassette 1.75 3.77E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
OSBPL8 
Alter. First Exon (e1-8) 2.14 4.71E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 2.55 1.61E-05 
Exon Cassette 2.54 1.61E-05 
SLC6A15 Alter. Terminal Exon (e5) 1.70 3.44E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LTA4H Complex 3.21 2.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CDK17 Intron Retention 1.61 4.17E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ALDH1L2 Alter. Acceptor Site 2.88 7.22E-07 ETR-3, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
TAOK3 Alter. First Exon (e1-8,e10-15) 2.04 1.55E-02 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CAMKK2 Exon Cassette 1.61 1.32E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WASF3 Mutualy Exclusive Exons (e7) 1.64 8.22E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EXOSC8 
Alter. Acceptor Site 1.94 3.69E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 1.75 6.38E-03 
COG3 Alter. Terminal Exon (e13-23) 1.58 9.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SETDB2 Exon Cassette 1.54 1.60E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DLEU1 
Complex 2.26 9.74E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.04 7.39E-04 
SLAIN1 
Alter. First Exon (e2-3) 2.67 1.76E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.76 1.62E-06 
ZIC2 Complex 4.68 3.08E-07 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MCF2L Complex 2.14 4.60E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Appendices 
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MTIF3 Alter. First Exon (e1-3) 1.83 8.04E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FLT1 
Alter. First Exon (e1-11,e13,e15-
16,e18,e21-27,e29-35) 
2.16 9.94E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon  (e4-11,e13,e15-
16,e18,e21-24,e26-27,e29-35,e37-38) 
3.08 2.44E-04 
SUPT20H Exon Cassette 1.78 6.75E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
FOXO1 // 
LINC00598 
Alter. First Exon (e2) 2.73 1.60E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TSC22D1 Alter. First Exon (e1) 1.56 1.09E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
COMMD6 Exon Cassette 1.62 1.82E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
COL4A1 Complex 1.66 2.20E-03 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANKRD10 
Alter. First Exon (e1-3) 2.07 7.18E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.73 1.37E-04 
SCFD1 Exon Cassette 1.56 1.76E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DAAM1 Exon Cassette 1.84 5.84E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
JKAMP 
Complex (e1-2) 1.54 1.73E-02 
ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.83 1.40E-02 
SYNE2 Exon Cassette 2.15 8.79E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPP2R5C Mutualy Exclusive Exons (e3) 1.96 1.08E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MTA1 Exon Cassette 1.60 9.15E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CRIP2 Exon Cassette 2.10 1.85E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, SC35, SF2/ASF, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HECTD1 Alter. First Exon (e1-3,e6-20,e22-29) 1.60 1.44E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RALGAPA1 // 
RALGAPA1P 
Alter. Terminal Exon (e46) 2.22 1.76E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e20) 2.56 8.83E-04 
NID2 Exon Cassette 3.84 2.03E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TIMM9 Exon Cassette 2.68 1.10E-03 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ACTN1 Alter. First Exon (e1-13) 1.69 1.95E-02 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATXN3 
Complex  (e2-3,e5-6,e8-11) 1.81 4.14E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.17 7.24E-03 
WARS 
Alter. First Exon (e1) 1.50 1.20E-03 9G8, CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.53 1.21E-04 
HSP90AA1 Alter. First Exon (e1-2) 2.95 2.99E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BRF1 Complex 1.64 1.62E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ELK2AP // IGHD 
// IGHG1 
Alter. First Exon (e15-16,e101) 2.78 4.07E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
APBA2 Exon Cassette 2.36 6.84E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C15orf41 Intron Retention 1.61 1.70E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MAPKBP1 Complex (e29-30) 1.75 1.04E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1 
CAPN3 // GANC 
Alter. First Exon (e30-31,e33-35,e37-
42) 
1.82 8.81E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NEO1 
Alter. Acceptor Site 7.98 1.78E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.31 1.72E-05 
Appendices 
 202 
PPCDC Alter. First Exon (e1-2) 1.76 4.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NGRN // TTLL13 Complex 1.77 1.39E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WHAMMP3 Exon Cassette 1.51 5.15E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1 
OCA2 Exon Cassette 1.50 2.62E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HERC2 Alter. First Exon (e1-2,e4,e6-49) 1.72 7.54E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC12A6 
Alter. First Exon (e1-3) 3.45 2.19E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.07 8.45E-05 
ZSCAN29 Alter. First Exon (e1) 2.16 1.58E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
MYO5C Exon Cassette 2.04 7.58E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NEDD4 Exon Cassette 1.82 6.34E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANXA2 
Alter. First Exon (e1-2) 3.44 1.63E-04 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.93 1.63E-04 
RORA Complex (e2) 1.99 1.24E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VPS13C 
Alter. Terminal Exon (e83) 2.31 2.44E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 12.31 2.84E-06 
CELF6 // HEXA 
// PARP6 
Exon Cassette 13.77 5.68E-07  ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 3.17 6.36E-04 
CTSH Exon Cassette 2.42 8.56E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Sam68, SC35, SF2/ASF, 
TIA-1, TIAL1, YB-1 
SEC11A Exon Cassette 2.51 1.58E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CIB1 Complex 1.58 2.54E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), RBM5, SC35, SRp30c, ZRANB2 
RGMA Alter. First Exon 3.35 5.04E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TTC23 
Exon Cassette 1.63 3.94E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e4) 1.52 4.05E-05 
ABAT 
Alter. First Exon (e1) 3.37 2.18E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e5-18) 2.62 3.90E-05 
Exon Cassette 3.52 3.61E-05 
C16orf45 Complex 2.23 1.37E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF720 Complex 1.81 1.54E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PLA2G15 Alter. First Exon (e1) 1.88 5.96E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZFP90 Alter. First Exon (e3-6) 1.90 5.78E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CDH1 Alter. First Exon (e1-2) 5.20 1.40E-06 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HAGH Exon Cassette 1.65 4.95E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, 
SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZSCAN32 Exon Cassette 1.70 1.34E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RPS15A Complex 2.06 3.19E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1, ZRANB2 
DCUN1D3 // 
ERI2 
Alter. Acceptor Site 1.52 2.82E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, 
ZRANB2 
DNAH3 Alter. Terminal Exon (e46-66) 1.70 2.80E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SULT1A1 Alter. First Exon (e1-4) 2.39 1.99E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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DOK4 Exon Cassette 1.52 1.72E-03 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, Nova-1, PSF, RBM5, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
PDXDC2P Exon Cassette 1.71 2.46E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
VAC14 Alter. Terminal Exon (e11-15,e17-21) 1.52 1.47E-02 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CYBA Complex (e1) 1.72 1.97E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 
PIEZO1 Complex 3.53 2.57E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANKRD11 Exon Cassette 1.60 7.96E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ACADVL 
Alter. Terminal Exon (e12-22) 3.26 1.06E-03 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.37 1.82E-05 
CHRNB1 Intron Retention 1.79 4.58E-04 CUG-BP1, ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, MBNL1, Nova-1, RBM5, SC35,YB1 
ARHGAP44 
Exon Cassette 2.73 5.72E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.74 5.72E-03 
TBC1D26 // 
ZNF286A 
Alter. First Exon (e1-6) 1.99 8.24E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC47A1 
Alter. First Exon (e2-8) 3.50 4.96E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 3.31 2.18E-05 
Exon Cassette 3.06 2.41E-05 
Intron Retention 2.12 3.17E-04 
DHRS7B Alter. Terminal Exon (e3) 1.82 7.16E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
WSB1 
Alter. First Exon (e1-5) 1.69 2.08E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.74 2.00E-04 
ANKRD13B Complex 2.16 1.56E-04 ETR-3, hnRNP A1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, MBNL1, Nova-1, PSF, SC35, SRp30c, YB-1, ZRANB2 
LRRC37B Alter. Terminal Exon (e13,e15-18) 1.90 1.06E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ERBB2 
Alter. First Exon (e1-8) 1.92 4.12E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon 1.88 8.16E-04 
NBR2 
Alter. Terminal Exon (e7) 2.26 3.44E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.78 4.24E-03 
CDK5RAP3 Alter. First Exon (e2-6) 1.66 3.64E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ATP5G1 Alter. First Exon (e1) 2.53 5.60E-05 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1 
ACSF2 Alter. First Exon (e1-11) 1.74 4.20E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NME1 // NME2 Complex 13.82 3.09E-06 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), Nova-1, SC35, SRp30c, YB-1, ZRANB2 
AKAP1 Alter. First Exon (e2) 1.76 5.84E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BCAS3 Exon Cassette 2.72 9.79E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TBX2 Complex 2.08 3.76E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ARSG Alter. First Exon (e1) 6.15 4.32E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SPHK1 Alter. First Exon (e1-8) 1.69 1.28E-02 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CBX2 Alter. Terminal Exon (e4-5) 1.83 1.20E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ABR Complex 1.79 1.70E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CDRT1 // 
TRIM16 
Alter. Terminal Exon (e10) 1.76 3.62E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAM83G Alter. Terminal Exon (e7) 2.40 1.18E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RDM1 Exon Cassette 1.90 2.20E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
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KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C17orf58 Alter. Donor Site 1.98 2.58E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
SLC25A19 Alter. First Exon (e1-3) 1.66 2.00E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, 
SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CANT1 Intron Retention 1.53 2.66E-03 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, RBM5, SF2/ASF, SRp30c, YB-1 
TBC1D16 Alter. First Exon (e1-5,7) 1.52 8.64E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MYL12B Alter. First Exon (e1) 1.51 2.48E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TGIF1 Alter. First Exon (e7) 1.50 2.10E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RBBP8 Alter. First Exon (e2) 2.36 7.66E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF397 Alter. Terminal Exon (e3) 1.61 1.28E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C18orf54 
Alter. Donor Site 1.77 1.84E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), HTra2beta1, HuB, KSRP, Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
Complex 1.97 2.96E-03 
NEDD4L 
Alter. First Exon (e1-10) 4.27 1.01E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e7) 1.72 9.72E-05 
Exon Cassette 1.67 5.64E-04 
COLEC12 Alter. First Exon (e1) 2.79 9.79E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
EPB41L3 
Complex (e23-25) 4.96 1.18E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.24 2.20E-04 
DSC3 Exon Cassette 2.25 9.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DSC2 Exon Cassette 2.77 2.79E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, RBM5, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
INO80C Exon Cassette 1.55 1.60E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SYT4 Complex 1.99 4.56E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BSG Alter. First Exon (e2,e4) 1.64 1.64E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FSD1 Complex 1.68 3.95E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PNPLA6 Alter. First Exon (e2,e4) 1.53 6.17E-04 hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, SC35, SRp20, SRp30c, YB-1, ZRANB2 
ZNF177 // 
ZNF559 
Alter. Acceptor Site 2.10 3.24E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.79 1.82E-03 
Intron Retention 2.23 5.62E-03 
SLC44A2 
Complex 2.42 1.79E-04 
ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
Exon Cassette 1.93 1.28E-03 
CARM1 Exon Cassette 3.81 3.62E-05 
ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-
1, TIAL1, YB-1, ZRANB2 
ZNF69 Alter. First Exon (e1-4,e6) 1.88 3.70E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF136 Exon Cassette 1.53 1.20E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GTPBP3 
Alter. Acceptor Site 1.52 1.06E-03 
ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 
Alter. First Exon (e3-4) 1.97 1.20E-02 
Complex  2.38 3.96E-04 
IFI30 // PIK3R2 Alter. First Exon (e1-19) 13.13 1.89E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF90 Exon Cassette 2.08 8.02E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF85 Alter. First Exon (e1-3) 2.17 5.95E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LTBP4 
Alter. First Exon (e1-4) 1.94 5.61E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.53 1.38E-03 
EGLN2 // MIA // Alter. Terminal Exon (e8-14) 1.62 4.18E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
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RAB4B HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BCAM Complex 1.87 5.60E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
FCGRT Alter. Terminal Exon (e6) 1.77 2.23E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MED25 Complex (e9) 1.55 1.29E-02 hnRNP I (PTB), KSRP, MBNL1, Nova-1, Nova-2, SRp30c, YB-1 
ZNF610 Exon Cassette 3.48 6.36E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF525 // 
ZNF765 
Mutualy Exclusive Exons (e2) 1.64 2.71E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BRSK1 
Alter. First Exon (e1-11) 1.67 9.84E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e14-22) 1.59 2.80E-03 
ZNF586//ZNF58
7/B // ZNF776 
Complex 1.51 3.22E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM205 Complex 1.67 2.23E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
ZNF20 //ZNF625 Alter. First Exon (e1-5) 8.44 2.62E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF564 // 
ZNF709 
Alter. Terminal Exon (e6-8) 1.78 8.41E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DMKN 
Complex 1.69 1.86E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.06 8.58E-04 
ATP5SL Exon Cassette 1.56 4.26E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC8A2 Exon Cassette 2.20 3.59E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF28 Alter. First Exon (e1-3) 3.94 1.04E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF320 Alter. Terminal Exon (e10) 1.92 2.82E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF321P // 
ZNF816 
Alter. Terminal Exon (e4-5) 1.86 5.96E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF160 
Alter. Acceptor Site 4.64 6.11E-05 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e5-8) 2.87 4.36E-03 
ZNF677 Alter. Terminal Exon (e5) 1.79 9.61E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SYT5 Exon Cassette 5.63 2.13E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, YB-1, ZRANB2 
CHMP2A Complex 1.92 9.97E-04 9G8, ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, MBNL1, Nova-1, SC35, SF2/ASF, SRp20, SRp30c, YB-1 
COLEC11 
Exon Cassette 2.60 4.04E-04 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.67 4.04E-04 
GREB1 Complex 2.48 9.74E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LPIN1 
Alter. Terminal Exon (e14-19,e21-29) 1.84 2.03E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.77 1.00E-02 
ABHD1 Exon Cassette 1.65 2.74E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNPD, hnRNPE1, hnRNP E2, hnRN F, hnRN H1, hnRNPH2, hnRNPK, hnRNP P (TLS), HTra2alpha, HTra2beta1, KSRP, MBNL1, SC35, TIA-1,TIAL1, YB1 
ATRAID Complex (e1) 1.57 3.76E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GPN1 // ZNF512 Alter. First Exon (e1-6,e8-15,e19) 1.66 5.18E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC30A6 Exon Cassette 1.64 8.40E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
PLEKHH2 Alter. First Exon (e1-9) 1.82 5.36E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
EPAS1 Alter. First Exon (e1-11) 1.86 1.22E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SPTBN1 Alter. First Exon (e2-3) 1.54 2.41E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VRK2 Complex 2.86 7.57E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
Appendices 
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Exon Cassette 2.71 7.57E-05 KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BOLA3-AS1 
Complex 1.95 5.84E-03 
hnRNP A1, hnRNP K, HuB, Nova-1, SC35, YB-1 
Intron Retention 1.75 1.24E-02 
SULT1C4 
Alter. Terminal Exon (e4-7) 2.95 2.19E-04 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.73 3.83E-05 
MERTK Alter. Terminal Exon (e19-20) 1.67 2.17E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DPP10 Alter. First Exon (e1-6) 1.96 1.82E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GLI2 Complex 2.91 1.56E-03 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNPI (PTB), hnRNP K, hnRNP P(TLS), HuB, KSRP, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
CNTNAP5 
Alter. Terminal Exon (e18-24) 2.35 1.01E-02 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.44 8.46E-03 
UGGT1 
Alter. Donor Site 1.84 8.24E-07 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.80 2.05E-04 
R3HDM1 Exon Cassette 1.68 1.24E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FMNL2 
Complex 1.58 4.24E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.66 4.12E-03 
DYNC1I2 Exon Cassette 8.47 6.10E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RAPGEF4 
Alter. First Exon (e1) 3.13 9.24E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.97 1.82E-02 
CDCA7 Exon Cassette 2.02 3.33E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
OSBPL6 Exon Cassette 1.98 1.24E-03 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
COL3A1 Alter. First Exon (e1-47) 2.25 2.16E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NABP1 Exon Cassette 1.98 2.39E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CCDC150 
Alter. First Exon (e1-2,e5,e8-12,e14-
17,e20-21,e23-25) 
1.88 7.37E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 1.79 1.10E-02 
CASP8 
Alter. Termi Exon  (e13,16-18) 4.29 5.80E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex  (e4-5) 1.91 2.85E-04 
Exon Cassette 2.12 8.56E-04 
INPP5D Alter. First Exon (e1-5) 5.01 2.27E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FAM132B Alter. First Exon (e1-2) 3.65 1.70E-05 ETR-3, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
MYT1L 
Alter. First Exon (e1-2,e4-5) 4.53 5.98E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e25,28) 4.82 8.16E-07 
YWHAQ Complex 4.22 1.18E-03 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, MBNL1, SC35, SRp30c, YB-1 
WDR35 Exon Cassette 5.90 4.14E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-
2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
C2orf43 Exon Cassette 1.62 1.38E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATL2 Complex 4.22 5.61E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
NRXN1 
Alter. First Exon (e1-3,e5,e8-
19,e21,e24-26) 
3.59 4.91E-06 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RTN4 Exon Cassette 2.50 6.18E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AAK1 
Alter. Terminal Exon (e14-18) 1.64 2.21E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.61 5.77E-05 
ASPRV1 // 
PCBP1-AS1 
Alter. First Exon (e1) 2.09 8.19E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e11) 1.74 9.95E-04 
PCGF1 Alter. First Exon (e1) 1.73 1.02E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HuB, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
KANSL3 Alter. First Exon (e1) 1.51 3.66E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
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MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FHL2 Complex 1.80 2.48E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CD302 // LY75 Alter. Terminal Exon  (e14-35,e37-41) 1.67 3.41E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SLC25A12 Exon Cassette 4.01 2.12E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FKBP7 
Complex 2.03 1.90E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.99 1.90E-03 
TTN Exon Cassette 1.92 1.98E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ICA1L Intron Retention 1.70 3.12E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FN1 
Complex 1.79 2.20E-05 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.63 1.18E-06 
ABCB6 // ATG9A 
Alter. Terminal Exon (e16,e17-30,e32-
35) 
1.76 3.18E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SERPINE2 Alter. First Exon (e3-4) 2.34 9.21E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
KIF1A Complex  (e2,e3-38,e40-47) 2.22 1.18E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PRNP Complex 2.18 6.38E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PLCB1 Alter. First Exon (e2,e4-5,e7) 1.98 6.38E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BTBD3 Alter. First Exon (e2) 1.85 1.57E-02 ETR-3, hnRNP I (PTB), HTra2alpha, HTra2beta1, HuB, Nova-1, Sam68, SC35, YB-1 
CBFA2T2 Exon Cassette 1.51 1.24E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AAR2 Complex 1.99 2.02E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RPN2 Exon Cassette 1.87 1.60E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PPP1R16B Alter. Terminal Exon (e3-12) 3.35 1.64E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GDAP1L1 
Alter. First Exon (e2) 5.59 3.22E-07 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.62 8.19E-05 
TTPAL Alter. First Exon (e1-2) 1.72 8.74E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DBNDD2// SYS1 Complex 1.72 6.96E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
UBE2C Alter. First Exon (e1) 1.77 5.59E-04 9G8, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, SC35, SF2/ASF, SRp30c, YB-1, ZRANB2 
SLC9A8 Alter. Acceptor Site 2.04 1.24E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
NPEPL1 // 
STX16 
Alter. First Exon (e9,e12) 1.82 1.66E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GNAS 
Alter. First Exon (e2,e8) 1.57 4.40E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e10,e13) 1.52 1.76E-03 
TPD52L2 Exon Cassette 11.59 6.51E-07 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CSNK2A1 Exon Cassette 1.83 6.14E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM230 Complex 1.97 2.32E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp30c, TIA-1, TIAL1, YB-1,  
SNX5 Alter. First Exon (e1-2) 1.62 2.76E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GGT7 
Alter. First Exon (e1-3) 1.94 1.00E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.12 8.38E-04 
STAU1 Exon Cassette 1.66 2.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZFP64 Alter. First Exon (e1-5) 3.35 1.36E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
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HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BTG3 Exon Cassette 1.70 9.18E-04 
9G8, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PSMG1 Exon Cassette 1.66 1.35E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
UBE2G2 Alter. First Exon (e1,e3-5) 1.86 3.59E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TPTEP1 Exon Cassette 1.59 5.82E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EWSR1 
Alter. First Exon (e1-8) 11.13 2.16E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.88 3.80E-03 
NF2 Exon Cassette 1.51 8.62E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SMTN 
Complex 1.56 2.70E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, Nova-1, Nova-2, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.86 3.28E-03 
KCTD17 
Complex 1.78 5.04E-04 
hnRNP I (PTB), Nova-1, RBM5, SC35, SRp20, TIA-1, TIAL1, YB-1 
Complex 1.53 1.40E-03 
NOL12 // 
TRIOBP 
Alter. First Exon (e1-9,14,16-17) 2.05 9.75E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 3.64 5.38E-04 
Intron Retention 1.86 1.73E-05 
SYNGR1 // TAB1 Intron Retention 2.35 1.00E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ARHGAP8 // 
PRR5 
Alter. First Exon (e4-19,e12) 2.99 1.23E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.87 3.36E-04 
CRELD2 Intron Retention 1.64 1.56E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, TDP43, TIA-1, TIAL1, YB-1 
CLTCL1 Alter. Donor Site 1.57 8.38E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, TIA-1, 
TIAL1, YB-1 
TXNRD2 Alter. First Exon (e3) 1.56 4.21E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PI4KA Alter. First Exon (e1-32) 1.81 1.70E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GSTT1 Exon Cassette 1.56 1.42E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CHEK2 Exon Cassette 1.51 4.52E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C1QTNF6 Intron Retention 1.98 2.54E-03 
ETR-3, FMRP, Fox-1, Fox-2, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, 
SRp30c, TIA-1, TIAL1, YB-1 
DNAL4 // SUN2 Complex 2.24 1.04E-03 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
ITPR1 Exon Cassette 1.59 1.70E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ARPC4 // TTLL3 Alter. Terminal Exon (e5-6) 3.93 1.84E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BTD Alter. First Exon (e1) 2.20 3.82E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RPL15 
Alter. Donor Site 1.73 2.22E-04 
hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e1) 1.75 4.97E-04 
Intron Retention 1.82 4.58E-03 
MLH1 
Complex 1.96 1.26E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.00 3.91E-05 
GOLGA4 Exon Cassette 2.08 5.63E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MYD88 Exon Cassette 1.99 6.14E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EXOG Complex 2.73 7.36E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNPE2, hnRNP F, hnRNPH1, hnRNP H2, hnRNPI(PTB), hnRNP P(TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB1 
CTNNB1 
Complex 1.90 1.18E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 1.78 8.56E-04 
NKTR 
Alter. First Exon (e1-7) 1.92 5.80E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.67 4.70E-03 
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SACM1L 
Alter. First Exon (e1-4,e6-14) 1.58 1.76E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.85 1.34E-03 
Exon Cassette 1.88 2.40E-03 
DAG1 
Alter. First Exon (e1-6) 1.79 1.22E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.50 9.75E-05 
MAPKAPK3 Alter. First Exon (e1-3) 1.97 2.36E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FLNB 
Alter. First Exon (e1-26) 1.69 7.46E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.78 2.19E-05 
PTPRG 
Alter. First Exon 1.67 4.42E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.84 8.70E-03 
CADM2 
Complex 5.40 9.86E-05 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.99 3.78E-05 
PVRL3 Alter. Donor Site 1.82 1.77E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PHLDB2 // 
PLCXD2 
Alter. First Exon (e1-3) 3.88 7.76E-05 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CD200 Exon Cassette 2.03 4.18E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuR, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MAATS1 Exon Cassette 3.75 2.08E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PDIA5 Intron Retention 2.31 3.20E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, Sam68, SC35, TIA-1, TIAL1, YB-1 
PPP2R3A Exon Cassette 2.54 7.53E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CLSTN2 Complex 6.58 4.24E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PLS1 Alter. First Exon (e2,e5) 1.70 5.44E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRPC1 Exon Cassette 1.83 1.58E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AGTR1 Exon Cassette 1.51 4.84E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
GPR160 Exon Cassette 5.14 4.01E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATP11B Exon Cassette 2.12 1.17E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MAP3K13 Alter. Terminal Exon (e13-19) 1.53 2.63E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LRCH3 Exon Cassette 3.88 1.22E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TADA3 Complex (e2-4) 1.52 6.82E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNPI (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SRp30c, TIA-1, TIAL1, Y 
ATP2B2 Complex 1.92 4.70E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FGD5-AS1 Alter. Terminal Exon (e4) 1.65 9.56E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RFTN1 Alter. First Exon (e1-6,e8-9) 1.89 1.15E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TOP2B Alter. First Exon (e1) 2.34 6.63E-04 CUG-BP1, ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1 
GLB1 // TMPPE Exon Cassette 1.55 2.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC26A6 Intron Retention 1.54 1.72E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, Nova-2, SC35, SRp30c, YB-, Fox-1, Fox-2 
DALRD3 
Alter. Acceptor Site 2.68 7.83E-04 
ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
Complex 3.16 3.17E-04 
AMT 
Complex (e5) 1.82 1.25E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.85 1.44E-04 
MAGI1 Exon Cassette 2.56 2.21E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Appendices 
 210 
EOGT 
Alter. First Exon (e1-2) 1.81 1.04E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.74 6.72E-03 
ABI3BP 
Alter. Terminal Exon (e14,e15-31,e36-
43) 
1.62 2.37E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 3.05 8.61E-04 
CD47 
Alter. Ter Exon  (e9,e10-12) 4.44 9.80E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF1, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 4.93 2.45E-04 
LSAMP Alter. Terminal Exon 2.04 9.72E-05 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HEG1 Exon Cassette 1.61 1.34E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
PFN2 Complex 3.38 2.50E-07 ETR-3, Fox-1, Fox-2, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
TNIK Exon Cassette 3.39 3.53E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNPA1, hnRNPA2/B1, hnRNPC1, hnRNPF, hnRNPH1, hnRNPI(PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova1, Nova2, PSF, Sam68, SC35, SF1, TIA-1, TIAL1, YB-1 
DLG1 
Exon Cassette 3.81 4.29E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons (e23) 4.03 2.29E-05 
PIGG Complex 1.87 1.20E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PCGF3 Exon Cassette 1.82 2.77E-04 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
TMEM175 Alter. Acceptor Site 1.88 2.78E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, Nova-2, PSF, SC35, TIA-1, TIAL1, YB-1 
FGFR3 Complex 2.08 1.12E-03 ETR-3, hnRNP E1, hnRNP E2, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, YB-1, ZRANB2 
WHSC1 Exon Cassette 1.70 1.02E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM193A 
Alter. First Exon (e3-7) 1.90 3.64E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.76 1.66E-03 
ADD1 
Alter. Donor Site 2.88 3.94E-03 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 6.87 2.23E-07 
Alter. First Exon (e2-8) 8.73 2.80E-06 
EXOC1 Exon Cassette 2.38 9.64E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC4A4 
Alter. First Exon (e1-5) 3.86 3.55E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.81 2.32E-03 
SHROOM3 Alter. Terminal Exon  (e8-11,e13-15) 1.91 1.20E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NPNT 
Complex 2.83 1.20E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 11.30 2.24E-05 
CYP2U1 Alter. Terminal Exon (e3-7) 1.69 1.27E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ANK2 
Alter. First Exon 3.04 2.44E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 4.37 4.22E-05 
Exon Cassette 2.49 1.84E-05 
UGT8 Alter. First Exon (e1) 1.52 5.75E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
USP53 Exon Cassette 1.63 2.14E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM144 Intron Retention 2.80 7.38E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, TIA-1, TIAL1, YB-1 
CLCN3 Alter. Terminal Exon (e5,e6-15,e17) 1.51 2.38E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HAND2-AS1 
Alter. Acceptor Site 1.68 8.78E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-
2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 7.13 3.83E-05 
Exon Cassette 2.89 6.31E-05 
HAUS3 // POLN 
Alter. Term Exon (e7-8,23-32) 3.21 8.80E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e19,e20-21) 2.32 6.02E-04 
Exon Cassette 2.32 6.02E-04 
SEPSECS Exon Cassette 1.67 3.14E-02 
ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF2/ASF, SRp20, 
TIA-1, TIAL1, YB-1 
UGDH Exon Cassette 1.70 2.43E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
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Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LIN54 Alter. Donor Site 1.53 6.32E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
 
Alter. Terminal Exon 1.53 7.38E-04 
  
Exon Cassette 1.65 7.00E-03 
MAPK10 Alter. First Exon (e3) 2.79 7.01E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CAMK2D Exon Cassette 2.54 4.36E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SCLT1 
Alter. First Exon  (e1-4,e6,e8-10) 1.83 1.72E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.66 1.45E-04 
SLC10A7 Complex (e7) 1.56 1.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PDLIM3 Alter. Donor Site 1.83 1.31E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAT1 Exon Cassette 6.37 4.15E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LINC01021 
Complex (e5-7) 13.04 4.11E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 12.45 3.95E-05 
KIF2A Exon Cassette 5.88 4.26E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SLC30A5 Alter. Acceptor Site 2.03 3.20E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, TIA-1, TIAL1, YB-1, ZRANB2 
TNPO1 Alter. First Exon (e1) 2.75 3.22E-06 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BTF3 Complex 1.61 9.18E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HuB, Nova-1, PSF, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
IQGAP2 Exon Cassette 2.23 2.05E-05 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SCAMP1 Alter. First Exon (e1-7) 5.18 7.66E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PAPD4 Complex (e3) 9.26 3.45E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
VCAN Exon Cassette 2.62 5.23E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GPR98 
Alter. First Exon  (e1-22,e24-26,e28-
85) 
1.54 5.76E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CAST Alter. First Exon (e2) 4.27 1.41E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PAM Exon Cassette 2.12 2.24E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMAD5 Exon Cassette 1.52 1.02E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TCERG1 Exon Cassette 1.80 5.20E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SAP30L 
Complex 1.54 3.30E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.73 3.78E-03 
CNOT8 Complex 1.77 5.81E-05 
 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NSD1 Intron Retention 1.63 2.97E-04 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF454 
Alter. Donor Site 2.75 1.17E-04 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, 
SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. First Exon (e1) 8.16 5.70E-05 
Complex 2.60 9.89E-05 
PPAP2A 
Complex (e1-2) 2.08 4.99E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.87 4.22E-04 
P4HA2 Alter. First Exon (e1) 2.91 1.82E-03 ETR-3, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, Nova-1, SC35, YB-1, ZRANB2 
SPOCK1 Complex (e3) 1.52 3.90E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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ARAP3 Exon Cassette 1.67 4.44E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, 
YB-1, ZRANB2 
FGF1 
Complex 2.22 6.39E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.31 5.88E-05 
DPYSL3 Complex 5.80 3.00E-06 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PHYKPL Complex 1.57 6.56E-03 ETR-3, Fox-1, Fox-2, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, YB-1, ZRANB2 
TFAP2A-AS1 Intron Retention 1.70 8.70E-03 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), KSRP, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
CDKAL1 Alter. Terminal Exon (e8-17) 1.83 1.08E-02 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PRSS16 Exon Cassette 4.45 7.56E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, 
RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HLA-E Complex 1.69 7.99E-04 Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), MBNL1, Nova-1, SC35, SRp20, SRp30c, YB-1, ZRANB2 
ATAT1 
Alter. Terminal Exon (e10-11) 1.53 1.80E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, RBM5, Sam68, SC35, 
SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.52 7.61E-05 
Intron Retention 1.81 3.94E-03 
MSH5-SAPCD1 
// SAPCD1 
Alter. Acceptor Site 1.71 2.88E-03 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
PSF, RBM5, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.67 5.61E-04 
SKIV2L 
Intron Retention 1.77 1.69E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Donor Site 3.66 1.65E-04 
HLA-DPB1 Alter. Terminal Exon (e2-4) 3.13 1.44E-06 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
HMGA1 Complex 1.96 1.02E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TJAP1 
Complex 3.20 3.84E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, PSF, RBM5, Sam68, SC35, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
Exon Cassette 4.51 4.14E-05 
Intron Retention 1.76 7.42E-03 
VEGFA Alter. First Exon (e1-3) 1.68 2.76E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-
2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RIMS1 
Alter. First Exon  (e7,e10-22,e25,e30) 2.20 5.36E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.66 1.81E-07 
CD109 
Alter. Terminal Exon 2.74 3.87E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon 2.70 4.39E-05 
Complex 2.78 3.87E-05 
Complex 2.74 4.39E-05 
DOPEY1 Alter. First Exon (e1) 1.85 4.78E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C6orf165 // 
SLC35A1 
Alter. First Exon (e1-11) 1.55 2.83E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SOBP Alter. Terminal Exon (e7-11) 1.65 2.90E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DCBLD1 Alter. First Exon (e1) 8.42 4.95E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMPDL3A 
Alter. First Exon (e1) 4.78 7.65E-05 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.28 1.35E-06 
TPD52L1 
Alter. First Exon (e1) 6.09 3.71E-06 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e8-9) 3.59 8.38E-07 
NCOA7 
Alter. Acceptor Site 5.14 9.75E-05 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon  (e3,e5,e7-14) 1.96 6.62E-04 
TRMT11 Alter. Terminal Exon (e12-16) 1.58 1.74E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
L3MBTL3 Exon Cassette 5.99 2.64E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
ULBP2 Alter. Terminal Exon (e4-5) 2.23 3.76E-04 
ETR-3, hnRNP A1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZDHHC14 Alter. Acceptor Site 2.65 1.01E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM181 Alter. First Exon 6.34 1.06E-06 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
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C6orf70 Exon Cassette 2.10 1.60E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATXN1 
Complex 2.11 9.78E-04 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.22 2.19E-04 
ZNF204P Alter. First Exon (e1-3) 1.61 1.74E-02 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GNL1 Complex (e1-7) 1.61 3.78E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, SC35, SF1, 
SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HLA-DQB1 Alter. First Exon (e1) 1.78 1.41E-04 ETR-3, Fox-1, Fox-2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
HLA-DMB 
Alter. Terminal Exon (e3) 2.20 2.22E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, 
RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.44 4.19E-04 
Mutualy Exclusive Exons (e4) 1.92 1.52E-03 
PEX6 
Alter. Terminal Exon  (e9,e10-18) 1.58 2.38E-02 ETR-3, Fox-1, Fox-2, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, 
SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e11-12) 1.55 3.06E-03 
CUL7 
Alter. First Exon (e9-10) 1.51 7.85E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-
1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.97 5.53E-05 
ENPP5 Exon Cassette 4.01 5.82E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
ME1 Exon Cassette 1.71 2.22E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RARS2 
Alter. Donor Site 1.55 1.53E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e1) 2.38 4.16E-03 
USP45 Exon Cassette 2.57 3.39E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CDK19 
Complex 1.75 1.72E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.71 2.78E-03 
TRAF3IP2 Exon Cassette 1.93 2.12E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FYN 
Exon Cassette 3.35 1.22E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Mutualy Exclusive Exons (e11) 2.30 1.22E-04 
CEP85L Alter. First Exon (e4) 1.69 4.96E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
EPB41L2 
 
Complex 7.69 1.85E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 9.63 1.71E-05 
Alter. First Exon (e2-3) 2.92 1.64E-04 
Exon Cassette 2.30 2.96E-04 
ADAT2 Alter. First Exon (e1) 1.94 7.22E-04 
CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ULBP3 Complex 6.21 4.08E-06 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1,  
SFT2D1 Intron Retention 1.62 1.35E-02 ETR-3, hnRNP A1, hnRNPA2/B1, hnRNP C1, hnRNP F, hnRNPH1, hnRNPH2, hnRNP (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova1, Nova2, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1 
PHF10 Alter. Terminal Exon (e12) 1.88 4.36E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
IQCE Exon Cassette 1.66 1.14E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 SDK1 Alter. First Exon (e27-40) 1.53 2.36E-02 
RBAK// RBAKDN 
// RNF216P1 
Alter. Terminal Exon (e15) 1.67 1.54E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PMS2CL Alter. Terminal Exon (e5-15) 3.23 6.40E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, 
HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MPP6 Exon Cassette 1.50 1.22E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AQP1//FAM188
B // INMT 
Complex (e27,e31) 2.31 7.57E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BBS9 Exon Cassette 2.32 1.02E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZMIZ2 Complex 1.69 1.42E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CCM2 Exon Cassette 1.61 5.84E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
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HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
LANCL2 Complex 1.57 9.64E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CRCP Exon Cassette 1.55 3.30E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RHBDD2 Exon Cassette 1.51 5.78E-04 
ETR-3, hnRNPA1, hnRNP A2/B1, hnRN C1, hnRNPE1, hnRNP E2, hnRNPF, hnRNPH1, hnRNPH2, hnRNI(PTB), hnRNPK, hnRNPP(TLS), HuB, HuD, KSRP, MBNL1, Nova1, Nova2, PSF, RBM5, Sam68,SC35, 
SRp20,SRp30c, TDP43, TIA1, TIAL1, YB1 
CCDC146 
Alter. First Exon (e1-6) 1.77 1.39E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 1.69 1.34E-03 
STEAP1 Alter. Terminal Exon (e5) 2.64 1.40E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
STEAP2 Alter. First Exon (e2-3) 2.09 4.41E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
AKAP9 Exon Cassette 2.13 2.40E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, MBNL1, Nova-1, Nova-2, Sam68, 
SC35, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
TRIP6 Exon Cassette 2.98 1.78E-04 hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, RBM5, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FOXP2 
Alter. Terminal Exon (e18-25) 3.43 7.50E-05 
 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, K 
Complex (e8-9) 1.75 2.10E-03 
Exon Cassette 3.68 1.96E-04 
CAV1 Alter. Donor Site 2.99 5.99E-04 ETR-3, hnRNP A1, hnRNP C1, hnRNP D, hnRNPE1, hnRNP E2, hnRNP F, hnRNPH1, hnRNP H2, hnRNPI (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova1, RBM5, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
C7orf55 // 
LUC7L2 
Alter. First Exon (e2,e4) 2.02 4.18E-03 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.73 2.96E-03 
CNTNAP2 Alter. First Exon (e1-17) 9.38 1.78E-08 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP 
LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NUB1 Alter. Terminal Exon (e9) 1.52 1.99E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PAXIP1-AS2 Alter. Terminal Exon 3.49 4.14E-05 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, 
SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PDGFA Alter. First Exon (e1-2) 1.95 5.55E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-
2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
PRKAR1B Alter. First Exon (e1-6,e8-11) 1.70 3.39E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
FTSJ2 Complex 1.72 7.18E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
RADIL Exon Cassette 1.79 3.04E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FAM126A Exon Cassette 1.58 1.02E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
POLR2J4 Alter. Terminal Exon (e9-10,e12-15) 2.15 1.79E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
HUS1 Intron Retention 1.68 7.77E-04 ETR-3, hnRNP C1, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
GUSB Intron Retention 1.56 7.79E-05 ETR-3, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Sam68, SC35, SF2/ASF, SRp20, TIA-1, TIAL1, YB-1, ZRANB2 
TBL2 Alter. Acceptor Site 1.66 2.88E-03 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-
2, PSF, RBM5, Sam68, SC35, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
STX1A Complex 1.85 2.11E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SEMA3C Alter. First Exon (e2) 1.64 1.51E-02 
ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, 
SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ASNS Exon Cassette 1.77 1.16E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GAL3ST4/GPC2 Complex 2.03 2.18E-04 CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, SC35, SRp30c, TIA-1, TIAL1, YB-1 
PMS2P1 Exon Cassette 1.61 3.10E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
C7orf49 Alter. First Exon (e1-4) 1.64 8.56E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, PSF, RBM5, 
Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
KCNH2 
Alter. First Exon (e1-5,e7-16) 3.37 1.22E-06 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 6.20 1.22E-08 
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FASTK 
Alter. First Exon (e1) 1.59 2.12E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, 
TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.52 1.14E-02 
PTPRN2 Complex (e1,e4) 1.77 2.52E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ESYT2 Exon Cassette 1.69 9.22E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
DPYSL2 Complex 2.43 1.25E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
IKBKB Exon Cassette 1.74 3.24E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, Nova-1, RBM5, Sam68, SC35, SRp20, TIA-1, TIAL1, YB-1 
CLVS1 Alter. First Exon (e1-5) 4.00 1.90E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
VPS13B Exon Cassette 1.50 1.84E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, 
TIAL1, YB-1, ZRANB2 
RIMS2 Exon Cassette 1.95 5.19E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MTUS1 Alter. Terminal Exon (e8-9,e11,e13-20) 1.98 6.94E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ASAH1 Alter. First Exon (e1) 1.72 3.88E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
LZTS1 Complex (e1-2) 2.76 6.18E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
FGFR1 
Complex 2.62 4.41E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.58 9.51E-05 
MRPS28 // 
TPD52 
Exon Cassette 3.65 6.44E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
EIF3E 
 
Alter. First Exon (e1) 1.95 9.24E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
  
Alter. Terminal Exon (e6) 1.94 1.26E-02 
Complex (e2,e5-6) 1.58 9.36E-04 
EEF1D 
Complex 8.74 1.30E-06 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 5.26 7.74E-07 
PLEC Alter. First Exon (e4) 3.38 7.91E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
CYHR1 Alter. First Exon (e2) 1.68 1.50E-03 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), SC35, SF2/ASF, SRp30c, YB-1 
COMMD5 // 
ZNF250 
 
Alter. First Exon  (e1-5,e7-10) 2.29 2.35E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.69 1.64E-03 
Exon Cassette 4.72 4.41E-04 
Mutualy Exclusive Exons 2.59 2.52E-03 
CHMP5 Exon Cassette 1.87 5.79E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, 
Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TJP2 Complex 1.81 6.35E-04 ETR-3, hnRNP A1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp30c, TIA-1, TIAL1, YB-1 
C9orf89 Alter. First Exon (e1-2) 1.65 1.12E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DAB2IP 
Alter. Acceptor Site 1.56 2.10E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. First Exon (e5-7) 2.06 1.40E-03 
NEK6 Alter. First Exon (e2) 1.54 4.36E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DNM1 Mutualy Exclusive Exons (e10) 2.02 3.45E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
COQ4 
Alter. First Exon (e2-4) 1.50 2.66E-03 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.86 1.23E-04 
POMT1 
Alter. First Exon (e1,e4) 1.61 1.02E-02 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, 
Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 1.55 2.24E-03 
KIAA1984 // 
RABL6 
Alter. First Exon (e1-4) 1.97 4.58E-04 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon (e25-33) 1.77 2.72E-03 
KIAA0020 Alter. Terminal Exon (e3-19) 2.00 2.90E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
RFX3 Exon Cassette 1.57 9.30E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Appendices 
 216 
NFIB Alter. First Exon (e1,e3) 3.43 1.81E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ELAVL2 Alter. First Exon (e1,e4) 2.63 4.02E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
BAG1 Complex 2.23 5.72E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-
1, Nova-2, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AQP3 Intron Retention 3.84 2.38E-04 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), Nova-1, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ANKRD18A // 
FAM95C 
Alter. Terminal Exon (e16-18,e20-22) 2.85 5.67E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
TMEM2 Alter. First Exon (e20-22) 2.28 1.06E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BICD2 Intron Retention 2.08 2.66E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1 
IKBKAP Alter. First Exon (e1-8) 1.61 1.11E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TOR2A Intron Retention 2.25 3.51E-05 ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), KSRP, MBNL1, Nova-1, RBM5, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
SH3GLB2 
Alter. First Exon (e1-7) 1.62 4.78E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 2.17 2.23E-04 
FNBP1 
Alter. First Exon  (e1-10,e12,e14-
18,e20) 
1.68 5.36E-04 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TTF1 Exon Cassette 2.57 1.85E-04 
9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
STS Alter. First Exon (e2) 1.56 8.81E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MSL3 Alter. First Exon (e1) 1.78 2.18E-04  
 
Alter. First Exon (e1) 1.64 2.11E-02 
ETR-3, hnRNP A1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Intron Retention 2.10 1.18E-03 
PRRG1 Complex 5.72 6.12E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
RRAGB Exon Cassette 2.04 7.18E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNF711 
Exon Cassette 2.10 2.18E-03 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP P (TLS), HTra2beta1, HuB, HuD, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-
1, ZRANB2,  TDP43 Intron Retention 1.73 4.45E-02 
CSTF2 Exon Cassette 3.06 5.56E-04 
CUG-BP1, ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, 
PSF, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ALG13 
Alter. First Exon (e1) 1.58 1.76E-02 ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, 
RBM5, Sam68, SC35, SF2/ASF, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.09 2.16E-03 
FHL1 Exon Cassette 5.02 3.75E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HuB, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, 
SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MTMR1 Alter. First Exon  (e2-3,e5-11) 1.82 1.20E-02 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATP2B3 
Alter. Terminal Exon (e21,e23) 2.23 3.60E-04 9G8, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.22 1.56E-04 
TAZ Intron Retention 1.83 1.51E-05 hnRNP P (TLS), RBM5, YB-1 
GEMIN8 Alter. First Exon (e1) 1.69 2.50E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
AP1S2 
Alter. Terminal Exon (e4,e8) 2.05 1.41E-04 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex (e5) 2.62 5.41E-04 
MAOB Exon Cassette 1.61 4.86E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SMC1A Alter. First Exon (e1) 1.77 7.90E-03 ETR-3, hnRNP I (PTB), hnRNP P (TLS), Nova-1, SC35, SF2/ASF, TIA-1, TIAL1, YB-1 
ARHGEF9 Complex 1.59 1.71E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
XIST 
Alter. Acceptor Site 1.55 1.04E-03 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Complex 4.29 1.10E-03 
GPC3 
Alter. First Exon (e1) 12.44 3.56E-05 CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 5.68 3.53E-05 
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ATP11C Exon Cassette 3.08 4.98E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, 
MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BCAP31 
Alter. First Exon (e3) 1.57 2.12E-05 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, Sam68, SC35, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 1.50 1.81E-04 
FAM3A Exon Cassette 1.73 4.96E-03 ETR-3, hnRNP A1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), KSRP, Nova-1, SC35, SRp20, TIA-1, TIAL1, YB-1 
MPP1 Exon Cassette 2.10 7.84E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
TRA/TRAC/TRAV
12-1/TRAV20 
Alter. Term Exon  (e35,144,e152-155) 1.74 1.48E-03 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Intron Retention 1.69 2.16E-02 
LINC00338 // 
SEC14L1 
Alter. Terminal Exon (e8-9,e11-25) 2.34 9.64E-04 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
SDHAP1 Exon Cassette 2.83 3.80E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
GTF2I Alter. Terminal Exon (e12-35) 1.79 2.06E-05 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CD99 
Alter. Terminal Exon (e3-11) 6.59 4.83E-07 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex 4.23 2.88E-07 
Complex 1.83 9.17E-04 
SH3D21 
Alter. First Exon (e1-3) 1.84 2.14E-03 
ETR-3, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, KSRP, Nova-1, Nova-2, PSF, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1 
Complex 1.59 4.46E-03 
MDM4 Exon Cassette 1.82 1.98E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), HTra2alpha, HTra2beta1, 
HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
PLEKHA5 
Alter. First Exon (e1) 1.61 8.84E-03 CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Complex 2.50 3.76E-03 
SLC12A4 
Alter. First Exon (e2) 1.59 3.42E-03 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
Complex (e22-29) 1.78 3.63E-04 
Complex 1.76 3.63E-04 
Exon Cassette 1.81 1.88E-03 
SLC13A3 
Alter. First Exon (e1-2) 2.58 5.15E-04 9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P 
(TLS), HTra2alpha, HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 2.84 4.03E-05 
AHRR // PDCD6 
Alter. First Exon (e8-12) 3.64 3.40E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Exon Cassette 2.02 1.04E-03 
Intron Retention 2.40 1.36E-03 
ANXA1 Complex (e2-3) 2.19 1.95E-02 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
MKNK1 // 
MOB3C 
Alter. Terminal Exon (e3-5) 1.67 4.22E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
DIP2B Alter. First Exon (e1-16) 1.77 4.78E-03 
9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
CHMP4A/PO4/M
DP1/NEDD8/TM
9SF1 
Alter. Donor Site 2.14 2.07E-05 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, MBNL1, Nova-1, 
Nova-2, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 Alter. Terminal Exon  (e24,e25-54) 2.05 2.42E-04 
SDHAP3 Alter. Terminal Exon  (e4,e6-8) 1.77 3.21E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, KSRP, 
MBNL1, Nova-1, Nova-2, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
MAST4 Exon Cassette 3.19 2.66E-03 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2beta1, HuB, HuD, KSRP, Nova-1, Nova-2, 
PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
ZNRD1-AS1 Alter. First Exon (e1) 1.51 1.14E-02 ETR-3, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HuB, KSRP, Nova-1, PSF, Sam68, SC35, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
ATF6B Complex 1.54 2.62E-04 
ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, 
Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF2/ASF, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
BLOC1S5/EEF1E
1/TXNDC5 
Alter. First Exon  (e6-7,e9,e11) 2.94 5.96E-05 
9G8, CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), 
HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
Alter. Terminal Exon (e7,e9,e11-12) 1.82 1.03E-02 
Exon Cassette 1.60 1.84E-03 
PCSK5 
Alter. Terminal Exon (e7-22) 3.29 1.17E-04 9G8, CUG-BP1, ETR-3, FMRP, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP LL, 
hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, HuD, HuR, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 Exon Cassette 3.37 1.06E-03 
SLC16A10 Alter. Terminal Exon (e3) 1.59 7.04E-03 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP DL, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP H3, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, 
HTra2beta1, HuB, HuD, KSRP, MBNL1, Nova-1, Nova-2, PSF, RBM5, Sam68, SC35, SF1, SF2/ASF, SRp20, SRp30c, TDP43, TIA-1, TIAL1, YB-1, ZRANB2 
NBPF10 // 
NOTCH2NL 
Complex 2.18 6.17E-04 
CUG-BP1, ETR-3, Fox-1, Fox-2, hnRNP A1, hnRNP A2/B1, hnRNP C1, hnRNP D, hnRNP E1, hnRNP E2, hnRNP F, hnRNP H1, hnRNP H2, hnRNP I (PTB), hnRNP K, hnRNP P (TLS), HTra2alpha, HTra2beta1, HuB, 
KSRP, Nova-1, Sam68, SC35, SF1, SRp20, SRp30c, TIA-1, TIAL1, YB-1, ZRANB2 
